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ABSTRACT 
Context: Adiponectin is a hormone involved in energy metabolism. However, its 
response to weight loss achieved through Exercise + Diet as compared to Diet Alone, is 
not fully understood. In addition, the impact of Exercise and Diet on adiponectin related 
hormones has not been thoroughly investigated in the specific cohort of men ages 35-55 
years of age who are overweight and obese.
Objectives: To determine; (1) the influence of 12 weeks of supervised resistance 
training combined with a hypocaloric macronutrient scheduled diet (Exercise + Diet) 
on fasting adiponectin in overweight and obese men, (2) the influence of the above 
modalities on TNF-α, leptin, ghrelin, and testosterone, and (3) the relationship of 
regional adiposity and body fat topography with these hormones.
Design, Setting, Participants: The study was a randomized control trial of fifty-one 
healthy inactive males (35-55 years old), with a BMI of 25-35 kg/m2, in St. John’s NL 
between August 2011 and August 2014. 
Intervention: Subjects received either a 12 weeks of Exercise + Diet or a Diet Alone 
weight loss intervention.  
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Main Outcome Measure: Biochemical analysis to determine energy regulating 
hormones including adiponectin, TNF-α, leptin, ghrelin and total testosterone, as well as 
metabolic risk factors, anthropometrics, and physical fitness measurements were 
collected at baseline and following the interventions.
Results: There was no difference in adiponectin or weight loss (~4.5%) between 
interventions however, when controlling for regional adiposity, adiponectin decreased in 
the Exercise + Diet and increased in the Diet Alone group. Leptin changed with body 
weight loss (p<0.001), with no difference between groups. TNF-α, testosterone, and 
ghrelin showed no significant changes with either intervention. When controlling for 
lean body mass, ghrelin showed a decrease in the Diet Alone group (p=0.05). Lastly, 
visceral fat was positively associated with adiponectin (p<0.04), leptin (p<0.003) and 
ghrelin (p<0.01), while exercise increased lean body mass (p<0.001) and decreased 
triglycerides (p<0.007), and diastolic blood pressure.
Conclusions: Exercise + Diet improved body composition, cardiometabolic risk factors 
and fitness. Irrespective of these health improvements, this investigation could not 
determine whether Exercise + Diet induced weight loss provided additional benefit from 
adiponectin over diet induced weight loss alone.
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When controlling for body composition, adiponectin did increase through Diet Alone, 
but it decreased in the Exercise + Diet induced weight loss. It is possible that this altered 
response with exercise may be due to the insulin sensitizing effects of physical activity, 
however further research is needed to clearly identify this phenomenon. The decrease in 
appetite suppressing hormone leptin, coupled with the increase in appetite regulating 
hormone ghrelin in the Exercise + Diet group indicates that exercise may increase the 
stimulus for food consumption. Lastly, subcutaneous adipose tissue is not correlated to 
energy regulating hormone concentration in this population. The current Exercise + Diet 
program provides a clinical prescription for effective weight loss and health 
improvements. 
However, more substantial weight loss, or adjustments to insulin sensitivity, may be 
required to elicit a significant adjustment in adiponectin concentration. Consequently, 
further investigations of the influences of resistance training in combination with diet on 
adiponectin are necessary.  
 
Trial Registration: This study was approved by the Health Research Ethics Authority 
(HREA), Memorial University of Newfoundland and Labrador (#11.327).   
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Introduction 
Obesity is a complex multifaceted condition consisting of environmental and 
physiological factors (P. Patel & Abate, 2013). It is defined as the abnormal or excessive 
accumulation of fat tissue which is the result of energy imbalance between calories 
consumed and calories expended (World Health Organization, 2015) Obesity status has 
been grouped as overweight (BMI 25.00–29.99), and obese (BMI ≥ 30-34.99), as 
recommended by the World Health Organization (WHO) (World Health Organization, 
2015). Centralized obesity has been associated with metabolic disorders such as 
hypertension, diabetes mellitus, hypertriglyceridemia, hypertension and early mortality 
(Kaur, 2014). These disease states and processes of energy regulation are controlled by 
various hormones, including adipokines (hormones produced by adipose tissue) such as 
adiponectin, and TNF-α, as well as those responsible for energy intake such as leptin, 
ghrelin, and insulin, in addition to other hormones that promote muscle anabolism 
including the androgen testosterone.  
Managing obesity has traditionally revolved around the achievement of weight loss. 
However, a growing understanding of the role of energy regulating hormones is 
providing important insights into the cause of and associated health risks related to 
obesity.  
A growing understanding of the relationship between these hormones, weight loss and 
regional adiposity has emerged as a new aspect of obesity research due to the advent of 
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advanced adipose tissue imaging techniques (De Lorenzo et al., 2013). Of particular 
relevance to the current study is that obesity impacts populations differently, as middle 
aged men are more susceptible to obesity-related diseases then women (Yim, Heshka, 
Albu, Heymsfield & Gallagher, 2008). In addition, regional adiposity has sex specific 
differences, where the central fat patterning which is characteristic of men has a greater 
impact on the incidence of disease then the peripheral fat patterning of women (Despres, 
2007; Gautier et al., 1998; Geer & Shen, 2009; Katsuki et al., 2003a; Machann et al., 
2005; P. Patel & Abate, 2013; Smith et al., 2001; Taksali et al., 2008; Wajchenberg, 
Giannella-Neto, da Silva, & Santos, 2002; Yim, Heshka, Albu, Heymsfield, & 
Gallagher, 2008).  Obesity is strongly associated with cardiometabolic diseases, however 
these disease states are more closely attributed to the dysregulation of energy regulating 
hormones than obesity itself (Blüher, 2014). Although obesity-related diseases account 
for 1 in 5 deaths per year in North America, obesity is one of the most preventable 
diseases (Raine et al., 2014).  Therefore, studies focusing on the management of obesity 
must investigate metabolic disease associated clinical markers, including energy 
regulating hormones, along with weight loss to develop better understanding of obesity 
management interventions.  
Current obesity interventions include pharmacology, bariatric surgery, exercise and diet 
weight management interventions.  
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The most popular and accessible of these interventions are diet and exercise (Miller, 
Koceja, & Hamilton, 1997). If adequate exercise is performed on a regular basis, 
physical activity can increase metabolism and reduce the risk of developing obesity and 
its co-morbidities, including protection from loss of lean body mass, improved 
cardiorespiratory fitness, and an increase in overall quality of life (Okay, Jackson, 
Marcinkiewicz, & Papino, 2009). There are various forms of exercise, ranging from 
cardiovascular to resistance training, and within each category there are varying levels of 
intensity, volume and duration (ACSM, 2014). Exercise in isolation has shown limited 
results with respect to weight loss, however has been shown to be more effective with 
respect to reducing body fat when when aerobic training is employed and when exercise 
training is supervised versus unsupervised (Conn, Hafdahl, Phillips, Ruppar, & Chase, 
2014). A goal of this research was determine if high intensity resistance training 
designed to increase energy expenditure to a greater extent than traditional resistance 
training was sufficient to achieve the same impact as combined aerobic and resistance 
training at improving weight loss outcomes.  
Similar to exercise, diet is also a broadly defined term some of which is more successful 
than others. A variety of approaches have been employed to successfully reduce body fat 
in a range of populations (Miller et al., 1997). Countless dietary protocols exist with 
some approaches restricting total calories, others restricting specific macronutrients and 
others which restrict both calories and macronutrients (Miller et al., 1997).  
The literature suggests that the macronutrient content of meals as well as meal frequency 
are important aspects of diet (Astrup, 1999; Dansinger, Gleason, Griffith, Selker, & 
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Schaefer, 2005; Ebbeling et al., 2012; Foster et al., 2003; Lambert, Frank, & Evans, 
2004; Mansoor, Vinknes, Veierod, & Retterstol, 2016; Rees et al., 2013; Sofi, Cesari, 
Abbate, Gensini, & Casini, 2008). Whether calories are consumed in the form of protein, 
carbohydrates or fats impacts an individual’s satiety, energy metabolism, and body 
composition (Bowen, Noakes, Trenerry, & Clifton, 2006; Erdmann, Topsch, Lippl, 
Gussmann, & Schusdziarra, 2004; Niwano et al., 2009). Although diet alone may be 
effective for weight loss, it is not as effective as when it is combined with exercise, nor 
is it as effective at maintaining weight loss (Miller et al., 1997).  Although these 
approaches have benefits, what is not clear is the most effective way to combine specific 
modes of diet and exercise for both weight loss and weight management. Investigations 
into supervised resistance training programs combined with a hypocaloric macronutrient 
scheduled diet may help to address this gap in current obesity management and add to 
the literature. Thus, the assessment of intervention effectiveness should not be limited to 
weight loss and changes in adiposity. Such assessments should also measure metabolic 
biomarkers, including hormones associated with energy regulation.  
Adiponectin is one of several hormones that is related to obesity, and has been inversely 
associated with insulin resistance (Weyer et al., 2001). The response of adiponectin to 
weight loss achieved through diet and exercise has been quite variable, as circulating 
concentrations have been observed to increase, decrease, and remain the same (S. Bluher 
et al., 2014; Boudou, Sobngwi, Mauvais-Jarvis, Vexiau, & Gautier, 2003; Bruun, Helge, 
Richelsen, & Stallknecht, 2006; Christiansen, Paulsen, Bruun, Pedersen, & Richelsen, 
2010; Esposito et al., 2003; Fatouros et al., 2005; Giannopoulou et al., 2005; Golbidi & 
Laher, 2014; Hulver et al., 2002; Kim, Cho, Kang, Choi, & Park, 2012; Klimcakova et 
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al., 2006; Kondo, Kobayashi, & Murakami, 2006; R. R. Kraemer et al., 2003; R. R. 
Kraemer & Castracane, 2007; Marcell, McAuley, Traustadottir, & Reaven, 2005; 
Markofski et al., 2014; Miyazaki et al., 2010; Polak et al., 2006; Ryan, Nicklas, Berman, 
& Elahi, 2003; Saunders et al., 2012a; Shadid, Stehouwer, & Jensen, 2006; Taksali et 
al., 2008; Van Berendoncks et al., 2011; Yatagai et al., 2003). The current study 
hypothesized that a supervised resistance training program and a structured hypocaloric 
macronutrient scheduled diet would result in a greater increase in adiponectin then 
through diet alone. This hypothesis assumed that adiponectin would increase in the diet 
and exercise group due to the greater weight loss achieved previously through combined 
diet and exercise interventions as opposed to diet in isolation (Ballor, 1994). 
Furthermore, adiponectin was expected to increase as a result of chronic exercise. 
Resistance training exercise results in metabolic adaptations, including increased muscle 
mass, greater cardiovascular fitness and improved insulin sensitivity, all of which are 
associated with improvements in adiponectin (Hakkinen et al., 2002; Ritchie, Wright, & 
Dyck, 2014). 
TNF-α is an inflammatory cytokine that is inversely related to adiponectin and positively 
associated with the degree of adiposity (Hivert et al., 2010; Hotamisligil, Arner, Caro, 
Atkinson, & Spiegelman, 1995). TNF- α is also inversely related to insulin sensitivity, 
and has been recognized as a relevant clinical biomarker for diabetics (Chaldakov, 
Stankulov, Hristova, & Ghenev, 2003). Weight loss achieved through diet and exercise 
has shown mixed results with respect to changes in TNF-α (Dandona et al., 1998a; 
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Plaisance & Grandjean, 2006a). What is broadly accepted is that TNF-α is reduced with 
weight loss as well as with participation in physical activity (Greiwe, Cheng, Rubin, 
Yarasheski, & Semenkovich, 2001).  It is proported that exercise, and specifically 
resistance training, may offset TNF-α related chronic inflammation and muscle atrophy 
(Greiwe et al., 2001). Resistance training has been shown to reduce TNF-α even when 
no change in weight or body composition was has taken place, indicating an independent 
effect outside of weight loss (Phillips et al., 2012).   
The effect of diet on TNF-α has not yet been fully elucidated. What is known is that the 
macronutrient composition of food intake can attenuate obesity related adipose tissue 
dysregulation and circulating TNF-α concentration (Cassani, Fassini, Silvah, Lima, & 
Marchini, 2015). Therefore, the current study employs resistance training in conjunction 
with a diet emphasizing a specific macronutrient content of meals consumed at frequent 
intervals as compared to the diet intervention alone. This approach was chosen to 
determine whether weight loss achieved via exercise combined with diet has a greater 
impact on TNF-α than diet in isolation.  
Appetite regulating hormones leptin and ghrelin also show mixed results with respect to 
their response to diet and exercise. Leptin is strongly associated with body fat and is 
reduced during weight loss, however, it has shown inconsistent responses to exercise 
(Ozcelik, Celik, Ayar, Serhatlioglu, & Kelestimur, 2004; Polak et al., 2006). The 
majority of studies indicate that leptin reduces with weight loss regardless of the method 
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by which it is achieved (Ozcelik et al., 2004; Polak et al., 2006). As a result, the current 
study hypothesized a greater decrease in leptin following the exercise and diet 
intervention as opposed to the diet alone due to the greater weight loss expected due to 
increased energy expenditure from exercise in the combined intervention.  
Ghrelin plays an important role in energy regulation and increases during weight loss, in 
particular as a response to caloric restriction (Cummings, 2006). Ghrelin has been shown 
to respond differently to energy intake depending on the macronutrient content of meals 
(Erdmann et al., 2004; Overduin, Frayo, Grill, Kaplan, & Cummings, 2005; Tannous dit 
El Khoury, Obeid, Azar, & Hwalla, 2006). Additionally, ghrelin has shown an 
independent response to the increased energy expenditure associated with exercise 
(Schubert, Sabapathy, Leveritt, & Desbrow, 2014). These increases in ghrelin could 
contribute to an increased energy intake, thereby hindering weight loss due to physical 
activity. The current study utilized a high intensity supervised resistance training 
program, designed to increase energy expenditure to a greater extent then traditional 
resistance training (Vingren 2010), as well as a dietary approach which emphasised 
frequent feeding and macronutrient ratios previously shown to augment ghrelin 
concentration. It was hypothesized that the exercise and diet intervention would result in 
a greater increase in ghrelin concentration as compared to diet alone due to the greater 
energy demand created by physical activity as well as the greater weight loss expected 
from the combined intervention. In addition to weight loss, resistance training has been 
shown to increase lean body mass and improve basal metabolism (Okay et al., 2009). 
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These exercise related changes are hypothesized to result in an increase in ghrelin to 
compensate for the associated increase in metabolism and energy expenditure (Bajer, 
Vlcek, Galusova, Imrich, & Penesova, 2015). If demonstrated, this would illustrate the 
importance of assessing energy regulating hormones in the treatment of obesity and 
support further research in this area.  
Testosterone is a steroid hormone that is responsible for muscle protein synthesis and 
which reduces muscle protein degradation, while playing a significant role in energy 
expenditure (Tajar et al., 2012). Specifically, testosterone enhances lipolysis and reduces 
triglyceride uptake in human abdominal adipose tissue (Tajar et al., 2012). A reciprocal 
relationship exists between obesity status and testosterone, where elevated testosterone 
helps prevent weight gain and lowered testosterone helps promote weight gain 
(Grossmann, 2011). Additionally, increases in visceral fat, a patterning associated with 
male obesity, elevates circulating TNF-α, insulin and leptin, all of which may 
downregulate the hypopituitary gonadal axis, resulting in reductions in testosterone 
(Sharman & Volek, 2004). Changes in basal testosterone concentration during resistance 
training have been inconsistent, showing increases in some studies (Hakkinen, 
Pakarinen, Alen, Kauhanen, & Komi, 1988a; Hakkinen, Pakarinen, Alen, Kauhanen, & 
Komi, 1988b; W. J. Kraemer et al., 1999; Marx et al., 2001; Staron et al., 1994), while 
others have shown no change (Alen, Pakarinen, Hakkinen, & Komi, 1988; Hakkinen et 
al., 1988b; Hakkinen & Pakarinen, 1994; Hakkinen, Pakarinen, Kraemer, Newton, & 
Alen, 2000a; Hickson, Hidaka, Foster, Falduto, & Chatterton, 1994; McCall, Byrnes, 
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Fleck, Dickinson, & Kraemer, 1999).  Testosterone is believed to be augmented by 
exercise prescription variables, including volume, intensity and duration of exercise 
(Hakkinen et al., 1988a; Hakkinen et al., 1988b).  
The impact of diet on circulating testosterone has not been investigated extensively. This 
investigation controlled for diet in order to determine if there was an independent effect 
of exercise on fasting testosterone concentration. The exercise protocol employed in the 
current study was similar to other interventions previously shown to elicit changes in 
energy regulating hormones (Gotshalk et al., 1997; Hakkinen, Pakarinen, Kraemer, 
Newton, & Alen, 2000b; R. R. Kraemer et al., 2003; W. J. Kraemer et al., 1998; W. J. 
Kraemer et al., 1999; Linnamo, Pakarinen, Komi, Kraemer, & Hakkinen, 2005; Migiano 
et al., 2010). Therefore, one objective of this research was to determine the exercise and 
diet associated changes in testosterone during weight loss in a population susceptible to 
obesity-associated decrease in androgens. Additionally, changes in regional adiposity 
were investigated to determine whether testosterone concentration was associated with 
fat patterning in an overweight and obese (body mass index (BMI) between 25-35 
kg/m2) male cohort.   
In summary, the current investigation into the adiponectin response to weight loss 
achieved through structured supervised resistance training and a hypocaloric 
macronutrient scheduled diet versus a hypocaloric macronutrient scheduled diet alone 
may provide greater understanding into the behaviour of this adipokine in overweight 
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and obese, aging males.  Investigation into the response of our secondary energy 
regulating hormones, leptin, ghrelin, TNF-α, and testosterone may also provide a better 
understanding of their response to weight loss accomplished using diet and exercise 
versus diet alone. Additional analysis of biochemical measures and metabolic risk 
factors, physical fitness and anthropometry adds insight into the effectiveness of 
resistance training and diet in this overweight and obese male cohort.  Finally, the 
exploratory analysis into the relationship between regional adiposity and energy 
regulating hormones provides additional understanding of how fat influences the 
endocrine system and body fat topography. 
To our knowledge, this is the first study to compare a weight loss program involving 
supervised resistance training interventions in conjunction with a hypocaloric 
macronutrient scheduled diet versus a hypocaloric macronutrient scheduled diet alone to 
investigate it’s impact on energy regulating hormones in an overweight and obese, 35-55 
year old male population. This diet and exercise prescription could provide practitioners 
with an effective intervention for weight loss and obesity management in aging males in 
both clinical and non-clinical settings.  
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Hypotheses and Objectives 
Primary Objective – To determine the influence of supervised resistance training in 
conjunction with a hypocaloric macronutrient scheduled diet as opposed to the influence 
of a hypocaloric macronutrient scheduled diet alone on fasting adiponectin concentration 
in overweight and obese men ages 35-55. 
Hypothesis 1 – Adiponectin concentration will be inversely associated with body fat and 
will increase to a greater extent as a result of weight loss achieved through supervised 
resistance training and a hypocaloric macronutrient scheduled diet rather than through 
weight loss achieved by a macronutrient scheduled diet alone.  
Secondary Objective – To determine how both supervised resistance training in 
conjunction with a hypocaloric macronutrient scheduled diet, and a hypocaloric 
macronutrient scheduled diet alone effects fasting energy regulating hormones TNF-α, 
leptin, ghrelin and testosterone in overweight and obese men ages 35-55. 
Hypothesis 2 –TNF-α concentration will decrease with weight loss in both the Exercise 
+ Diet and Diet alone groups and TNF-α will decrease to a greater extent in the Exercise
+ Diet group due to the independent effect of physical activity.
Hypothesis 3 – Leptin concentration will decrease with weight loss in both the Exercise 
+ Diet and Diet alone groups, and TNF-α will decrease to a greater extent in the
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Exercise + Diet group due to the greater energy expenditure resulting from physical 
activity.  
Hypothesis 4 – Ghrelin concentration will increase with weight loss in both the Exercise 
+ Diet and Diet alone groups, and will increase to a greater extent in the Exercise + Diet 
group due to the greater energy expenditure resulting from physical activity.  
Hypothesis 5 – Testosterone concentration will increase with weight loss in both the 
Exercise + Diet and Diet alone groups, and will increase to a greater extent in the 
Exercise + Diet group due to the resistance training protocol.  
 
Exploratory Analysis – To determine the relationship between resting circulating 
concentrations of energy regulating hormones and regional adiposity including body fat 
topography.  
Hypothesis 6 – Weight loss will be greater as a result of supervised resistance training in 
conjunction with a hypocaloric macronutrient scheduled diet, rather that through a 
hypocaloric macronutrient scheduled diet alone. 
Hypothesis 7 – Measures of regional adiposity, including visceral fat, subcutaneous fat, 
as well as circumferential and DXA measures, will decrease to a greater extent as a 
result of weight loss achieved through supervised resistance training in conjunction with  
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a hypocaloric macronutrient scheduled diet, rather than weight loss achieved through a 
hypocaloric macronutrient scheduled diet alone. 
Hypothesis 8 – Measures of central adiposity, including visceral fat and abdominal 
subcutaneous fat, will be associated with fasting energy regulating hormone 
concentration.  
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Outline for Review of Literature  
Obesity and Body Fat Distribution will review obesity and obesity-related co-
morbidities, illustrate the impact of regional adiposity on general health, and will 
demonstrate the role played by energy regulating hormones.   
Weight and Health Management through Exercise will explore the effectiveness of 
exercise as a means of weight loss and treatment for obesity.  A specific focus will be 
placed upon the frequency, intensity, time, and types of exercise to determine the most 
appropriate use of physical activity for managing weight-loss.   
Weight and Health Management through Diet will discuss the effectiveness of 
various diets as a means of weight loss and treatment for obesity.  Specifically, this 
chapter will isolate the differences between fasting, caloric restriction, low-fat and 
feeding frequency diets, and will identify the current best practices for safe and effective 
diet induced weight loss for obese individuals.  
Weight and Health Management through Diet & Exercise will discuss the 
importance of diet and exercise for obese individuals who wish to archive weight loss 
and manage their health.  
The Role of Energy Regulating Hormones in Obesity and Weight-loss Through 
Diet and/or Exercise is the last section of the review. This chapter will discuss the 
association of energy regulating hormones adiponectin, TNF-α, leptin, ghrelin and 
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testosterone with obesity, and will investigate their impact and role in exercise and diet 
induced weight loss.  
The Summary of Literature Review will provide a succinct overview of the literature 
to show the logical steps taken to perform the current study which can address the 
hypotheses of this thesis.  In addition, a brief overview highlighting the specific study 
design considerations and rationale for this thesis will be provided.  
 
3.1 Obesity and Body Fat Distribution 
3.1.1 Overview of Obesity 
 Obesity is the result of a higher daily energy intake than the energy expenditure, 
achieved through excess caloric intake, insufficient physical activity or a combination of 
both (Oh et al., 2014). With the increased availability of high calorie, convenience foods 
coupled with a trend towards a more sedentary lifestyle, the energy balance is shifting to 
one which promotes weight gain and results in obesity (Kumanyika et al., 2008).  To 
date, the obesity epidemic affects over 500 million people globally including 18.3% of 
Canadians (Twells 2014). The rate of obesity in Canada has nearly doubled between 
1978 and 2008, rising from 13.8% to 24.3% (Raine et al., 2014).  In addition, there has 
been a disproportionate increase in people demonstrating severe obesity in Canada 
(Katzmarzyk & Mason, 2006). Specifically, the province of Newfoundland and 
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Labrador has the highest prevalence of obesity in the country with 29% and 40% of its 
population recognized as obese and overweight, respectively (Twells, Gregory, 
Reddigan, & Midodzi, 2014).  Numerous studies have demonstrated that obesity 
increases the risk of developing type 2 diabetes, hypertension and dyslipidemia (Bogl et 
al, 2016, Kaur, 2014, Kissebah & Perris, 1989, Oh et al., 2014).  In addition the social 
stigma often reported by individuals living with obesity can cause psychological stress 
(Bogl et al., 2016; Despres, 2007; Kaur, 2014; Kissebah & Peiris, 1989; Oh et al., 2014; 
P. Patel & Abate, 2013).  For example, type 2 diabetes comprises 90% of all diabetic 
cases and has become an ever increasing healthcare challenge as the number of people 
affected climbs concordantly with obesity to epidemic proportions (World Health 
Organization, 2015).  Moreover, the prevalence of type 2 diabetes is expected to reach 
over 438 million people globally by the year 2030 and, like most cardiometabolic 
diseases, carries with it a significant fiscal burden (Canadian Diabetes Association, 
2013).  
Obesity is a multifaceted condition resulting from a variety of physiological and 
environmental conditions, including education, income, social class, age, gender, 
ethnicity, and genetic predisposition (Dutton & McLaren, 2011; McLaren, 2007; Shields 
& Tjepkema, 2006; Y. Wang & Beydoun, 2007).  Males between the ages of 35-55, are 
at particular risk of developing obesity and represent 14.2% of Newfoundland and 
Labrador’s (NL) population (Twells et al., 2014).  The obese male population has a 
higher risk of developing cardiovascular disease, sleep apnea, and osteoarthritis, and 
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also has a greater risk of developing certain cancers than their normal weight 
counterparts (Glintborg 2014).  In fact, it has been suggested that obesity contributes as 
much as, if not more than, smoking to the onset of disease (Jia & Lubetkin, 2010), that it 
decreases quality of life, and that it increases the risk of premature death (Katzmarzyk & 
Mason, 2006).  Within the last decade, the direct and indirects costs of obesity in Canada 
has been estimated to be $4.3 billion (Katzmarzyk, Gledhill, & Shephard, 2000). This 
estimate includes the cost of hospital care, pharmaceuticals, and lost work days due to 
short and long-term disability (Katzmarzyk et al., 2000). Therefore, the rapid increase in 
obesity, where obesity rates have doubled in the last 20 years, is both a health and 
economic concern (Katzmarzyk et al., 2000).  Currently, there are no interventions 
shown to prevent the development of obesity, however, lifestyle modifications (such as 
increased physical activity, moderate weight loss, and eating behavior modifications) 
have been shown to attenuate the onset of obesity and obesity related conditions (World 
Health Organization, 2015).  
The functional relationship of energy regulating hormones with obesity and obesity-
related conditions is a significant and growing field.  At present, however, very little is 
understood regarding the role that energy regulating hormones play in obesity 
development, specifically how these hormones are affected by weight loss induced 
through lifestyle modifications.    
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3.1.2 Obesity and Energy Regulating Hormones 
Obesity has a very complex multidimensional etiology. Generally, obesity is the result 
of weight gain caused by a chronic positive caloric balance, where the total daily energy 
intake is greater than the total daily energy expenditure.  However, although a lack of 
activity and/or the increased accessibility/consumption of calorie dense foods are the 
primary factors which contribute to obesity development, genetics, diet composition and 
the environment also play important roles in the development of energy regulation and 
body weight maintenance (Cahill 2016).  For example, animal studies have shown that 
the genetically modified ob/ob or obese mouse is deficient in leptin, an energy 
regulating hormone that acts upon the hypothalamus to regulate energy expenditure and 
eating behavior (Y. Zhang et al., 1994). The administration of leptin to this phenotype of 
mice ameliorated the reduction of energy expenditure and excessive food intake (Halaas 
et al., 1995). Additionally, a study by Montague and Farooqi et al. which examined 
obese children found a very low circulating leptin concentration and that they were 
leptin deficient (Montague et al., 1997). The administration of recombinant leptin 
increased energy expenditure and significantly reduced food intake and body fat in these 
children (Montague et al., 1997).  
These studies provided the first evidence that genetics, and its subsequent influence on 
endocrinology, is an important factor in body fat management.  Furthermore, a study by 
Frayling et al. showed that a common variant of the FTO gene was significantly 
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associated with BMI in children and adults (Frayling et al., 2007).  The study found that 
adults who were homozygous for the risk allele weighed about three kilograms heavier.  
The researchers found that adults who were homozygous for the risk allele had 
significantly greater odds of being obese as compared with those without the risk allele.  
It appears that genetics can significantly affect endocrine function, and that the optimal 
performance of various energy regulatory pathways results in an increased susceptibility 
to weight gain (Figure 1 & 2 – role of energy regulating hormones in obesity).  
 
Figure 1: Impact of obesity on and from energy regulating and sex hormones: Obesity is 
characterized by changes in several hormones associated with energy regulation, metabolism and body 
composition. These include a proportional increase in leptin in association with increases in body fat, and a 
subsequent decrease in ghrelin to reduce food intake. Additionally, both leptin and adipose tissue result in 
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decreases in circulating testosterone through down regulation of the hypopituitary gonadal axis and the 
aromatization of testosterone to estrogen via adipose tissue respectively. Adiponectin is reduced under 
conditions of obesity resulting from increases in TNF- and mechanisms not fully elucidated. This 
subsequent decrease in adiponectin and increase in TNF- results in reduced insulin sensitivity which 
consequently increases the likelihood of additional weight gain.  
 
 
 
 
Figure 2: The impact of normal weight homeostasis on and from energy regulating and sex 
hormone: Normal weight homeostasis is characterized by the regulation of body weight via several 
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hormones associated with energy regulation, metabolism and body composition. These include leptin which 
is produced in proportion to body fat, and ghrelin which assists in both short and long term regulation of 
body weight through acute and chronic increases in appetite stimulation. Testosterone concentration is not 
augmented by body composition under conditions of normal weight due to the removal of inhibitory stimuli 
associated with the obese state. Adiponectin concentration is higher in normal weight versus obese 
individuals while TNF- is reduced leading to improved insulin sensitivity as compared to obese 
individuals.  
 
This can lead to obesity and obesity-related conditions.  Therefore, energy regulating 
hormones have significant influence over glucose/lipid metabolism and body weight 
homeostasis.  For example, some of the energy regulating hormones which enter 
circulation can act directly on the CNS, and can influence eating behavior (Konturek et 
al., 2005). These hormones include ghrelin, a gut-derived hormone which stimulates 
appetite in an attempt to regulate energy intake and restore body fat during weight loss 
(Ueda et al., 2009), glucagon like peptide one (GLP-1), which is secreted by the L-cells 
of the distal ileum in response to food intake to suppress hunger, and polypetide YY 
(PYY), another gut derived appetite suppressing hormone which inhibits gastrointestinal 
motility and pancreatic hormone secretion (Batterham 2002). In response to increases in 
body fat resulting from disturbances in energy balance, the inflammatory cytokine TNF-
α is elevated and promotes insulin resistance (Hotamisligil, Shargill, & Spiegelman, 
1993a). Furthermore, adipose tissue derived hormones adiponectin and leptin, when 
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released into circulation, can also significantly affect insulin sensitivity, energy 
expenditure, and eating behavior.  For instance, adiponectin has been shown to attenuate 
insulin resistance and effectively increase the disposal of circulating glucose (Hotta et 
al., 2001; Moreno-Aliaga, Lorente-Cebrian, & Martinez, 2010). Since adiponectin has 
been recognized as a significant insulin sensitizer it would be reasonable to anticipate 
that circulating adiponectin levels would be elevated in the presence of an insulin 
resistant state such as obesity.  However, the research to date suggests that adiponectin is 
inversely associated with both obesity (Arita et al., 2012; Cnop et al., 2003) and insulin 
resistance (Hotta et al., 2001; Yamauchi, Iwabu, Okada-Iwabu, & Kadowaki, 2014). The 
majority of cross-sectional studies show that circulating adiponectin is diminished 
among the obese population (Arita et al., 2012; Yang et al., 2001),  and is significantly 
promoted after weight reduction in cross-sectional studies (Christiansen et al., 2010; 
Yang et al., 2001). However, hormones like TNF-α have been observed to inhibit 
adiponectin release, while adiponectin has been shown to inhibit TNF-α in adipose 
tissue (N. Maeda et al., 2002). Adiponectin also reduces the expression of adhesion 
molecules in endothelial cells and elicits its anti-inflammatory properties by decreasing 
cytokine production from macrophages (Salmenniemi et al., 2004).  Furthermore, it 
promotes insulin sensitivity and inhibits the inflammatory mediators (Yang et al., 2001). 
Due to the significant influence of energy regulating hormones on metabolism, and their 
potential role in the development of adiposity and adiposity-related health conditions, 
the current study aims to investigate a number of these hormones to explore the benefits 
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of a weight loss program based on supervised resistance training and diet as opposed to a 
weight loss program based on diet alone. In addition, this study also aims to explore the 
relationship between body fat distribution and circulating energy regulating hormone 
concentration. Although exercise and diet are still the most recommended approaches 
for managing obesity, there remains a great deal of controversy regarding the most 
effective diet and exercise modalities for health improvement. These modalities are 
especially difficult to decipher when outcomes are primarily body-weight based, and 
often neglect to measure the success of the intervention on health-based outcomes.  
3.1.3 Body Fat Distribution and Health Outcomes 
 The majority of epidemiological studies/reports attempting to evaluate the 
association of cardiometabolic disease with obesity make the assumption that BMI can 
accurately predict adiposity.  Over the past few decades, however, the measurement of 
body fat distribution has demonstrated that BMI is a poor predictor of adiposity and 
obesity status (Kennedy, Shea, & Sun, 2009; Shea, Randell, & Sun, 2011; Shea, King, 
Yi, Gulliver, & Sun, 2012). More importantly, the current literature has demonstrated 
that BMI significantly over estimates the association of obesity with cardiometabolic 
disease (Bennasar-Veny et al., 2013; de Lima, Nobrega, & de Souza, 2012; Melmer et 
al., 2013). In addition, it was shown that despite a normal BMI, individuals with an 
elevated BF% are more susceptible to cardiometabolic disease (Kennedy et al., 2009; 
Shea et al., 2011; Shea et al., 2012).  Due to the poor predictability of BMI for adiposity, 
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an increasing number of studies have investigated the influence of more accurate and 
cost effective methods for assessing adiposity along with body fat distribution, to 
determine a more precise link between body fat accumulation and cardiometabolic risk 
factors (De Lorenzo et al., 2013). In addition, various low cost and easy to administer 
techniques such as predictive equations, girth measurements, and skin fold thickness 
measurements, have been employed to quantify these relationships.  Advances in 
technology have also led to a greater understanding of regional adipose tissue 
depositions, including dual-energy x-ray absorptiometry (DXA).  To date, few studies 
have attempted to explore the impact of both supervised resistance training and diet vs. 
diet alone on the changes in body distribution and its association with energy regulating 
hormones (Christiansen et al., 2010; Dutheil et al., 2010; Geliebter, Ochner, 
Dambkowski, & Hashim, 2014; Kelly et al., 2011; Kim et al., 2012; Mason et al., 2015; 
Ryan et al., 2003) and even fewer studies have included both insulin resistance and other 
cardiovascular disease risk factors such as HDL cholesterol, LDL cholesterol, and 
triglycerides (Bravata et al., 2003; Bueno, de Melo, de Oliveira, & da Rocha Ataide, 
2013; Mansoor et al., 2016). These biochemical risk factors are not only associated with 
total adiposity, but also with the region in the body where body fat is stored.  
 Central, or android, obesity has been associated with metabolic disorders such as 
hypertension, diabetes mellitus, hypertriglyceridemia, hypertension and mortality (Kaur, 
2014). Meanwhile, peripheral or gynoid obesity has a significantly lower risk of 
cardiovascular disease as compared with central deposits and in some cases is 
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considered cardio protective (Bogl et al., 2016; Samsell, Regier, Walton, & Cottrell, 
2014; Selyatitskaya, Pinkhasov, Karapetyan, & Kuz'minova, 2015).   The use of girth 
measurements, including waist and hip circumference, have been used to determine 
regional adiposity, particularly trunk fat (van der Kooy et al., 1993). Much of what is 
known regarding the relationship between central fat patterning and disease is due to this 
simple circumferential measure.  What girth measurements are not able to determine is 
whether central fat is stored in the subcutaneous or visceral compartment, both of which 
have unique physiological characteristics. 
 Elevated trunk fat is a characteristic of android obesity and is comprised of both 
subcutaneous and visceral fat (Kissebah&Peiris, 1989).  There is controversy about the 
functional role of these fat depots, particularly, their relationship with insulin resistance.  
It was initially thought that trunk subcutaneous fat content had a stronger correlation 
with insulin sensitivity than visceral fat among non-insulin dependent diabetic men 
(Goodpaster et al., 2005).  It was therefore believed that the stronger relationship 
between subcutaneous adipose tissue and insulin resistance observed in the non-diabetic 
population could be related to larger volumes of subcutaneous adipose tissue mass, 
which is estimated to be four to five times greater than visceral fat mass (Abate, Garg, 
Peshock, Stray-Gundersen, & Grundy, 1995a; Abate et al., 1996; Garg, 2004). Because 
of its larger volume, subcutaneous fat mass is considered to be a major contributor to 
systemic free fatty acid flux and therefore, to insulin resistance (Cnop et al., 2002).  
 Due to the advent of advanced imaging techniques, such as DXA, which 
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accurately assess the intra-abdominal fat compartment, it has been determined that the 
impact of visceral fat on metabolism is greater than was previously thought.  The 
majority of research now demonstrates that abdominal visceral fat has a stronger 
correlation with insulin resistance than to the subcutaneous fat compartment, in both 
diabetic and non-diabetic subjects (Cnop et al., 2003). Similarly, visceral adipose tissue 
and the centralization of adipose tissue is frequently correlated with a number of related 
metabolic variables, including plasma glucose and lipid concentrations (Abate et al., 
1995a; Bogl et al., 2016; Frayn, 2000; Smith et al., 2001).  Intraabdominal adipose tissue 
in the visceral compartment also has increased metabolic (both lipogenesis and lipolysis) 
activity as compared to subcutaneous fat.  
 Under the conditions of excess caloric intake resulting in increased adiposity, it 
is suspected that adipose tissue may become dysfunctional due to fat cell hypertrophy, 
decreased adipogenesis, and increased angiogenesis (Patel& Abate, 2013).  This is 
demonstrated by the inverse nonlinear relationships between glucose disposal and 
visceral fat and is independent of gender (Banerji, Chaiken, Gordon, Kral, & Lebovitz, 
1995). Visceral fat explains a significant portion (34%) of variance in the insulin-
mediated glucose disposal, whereas total or subcutaneous fat does not (Banerji et al., 
1995).  The negative implications of elevated visceral fat mass are further supported by 
the portal vein theory, which states that free fatty acids, as a product of lipolysis, directly 
enter the liver via the portal , causing increased lipid synthesis, gluconeogenesis, and 
insulin resistance.  This can result in hyperlipidemia, glucose intolerance, hypertension 
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and ultimately atherosclerosis (Garg, 2004). As well, excess circulating free fatty acids 
can inhibit skeletal muscle glucose uptake, leading to peripheral insulin resistance 
(Arnlov, Ingelsson, Sundstrom, & Lind, 2010). To demonstrate the aforementioned 
metabolic outcomes, this theory would require that the majority of free fatty acids would 
reside in the visceral compartment. However, visceral fat represents only a small 
proportion of total fat in men at ~15%–18% (Arnlov et al., 2010). It is therefore thought 
that other mechanisms must be involved which make visceral fat phenotypically unique 
as compared with other fat deposits. One such explanation is that adipose tissue is not 
merely a dormant fat storage site, as was once believed. Instead it is a complex, 
essential, and highly active metabolic and endocrine organ. It has been shown that in 
excess it can lead to systematic inflammation, assists in energy regulation and plays a 
significant role in reproduction.  
 Visceral fat has shown a consistent negative association with the insulin 
sensitizing hormone adiponectin (Yang et al., 2001).  In vitro studies show that visceral 
adipocytes have increased the expression of adiponectin as compared to subcutaneous 
adipose tissues (Fain, Madan, Hiler, Cheema, & Bahouth, 2004). The nature of the 
inverse relationship between adiponectin and visceral fat is believed to occur because 
adiponectin is down regulated by the inflammatory cytocine TNF-𝛼, whose primary 
production and secretion site is the visceral adipose tissue (Clement et al., 2004). As 
visceral fat increases, so does inflammation, resulting in a subsequent suppression of 
adiponectin. It has been shown that even small changes in visceral fat may influence 
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changes in TNF-α in both overweight and obese males (Kirwan, Krishnan, Weaver, Del 
Aguila, & Evans, 2001). These findings indicate that although the visceral compartment 
is relatively small in comparison with the larger subcutaneous depot, its role with respect 
to metabolism and energy regulation may be significantly greater than other fat depots.  
 The role played by visceral fat in metabolism is further supported by studies that 
contract central and peripheral obesity. It has been demonstrated that subjects with 
higher trunk fat, specifically visceral fat, are more insulin resistant than subjects with 
peripheral or lower body obesity (Bogl et al., 2016; Samsell et al., 2014; Selyatitskaya et 
al., 2015). Regardless of mechanism, be it energy regulating hormones or the portal vein 
transmission of fat to neighboring organs, what is certain is that trunk fat (visceral and 
subcutaneous fat) has a higher free fatty acid concentration than the peripheral 
gluteofemoral region. A study by Goodpaster et al found that thigh subcutaneous fat, as 
an indicator of fat deposition in peripheral tissue, can significant predict insulin 
sensitivity (Goodpaster et al., 2005). It is thought that gluteofemoral fat has a protective 
role, and that adipocytes in that region are relatively insensitive to lipolysis stimulus and 
sensitive to anti-lipolysis stimulus (Manolopoulos, Karpe, & Frayn, 2010).  
3.1.4 Chapter 1 Summary 
The traditional view of adipose tissue as a passive reservoir for energy storage is no 
longer valid. As early as 1987, adipose tissue was identified as an endocrine organ and a 
major site for the metabolism of sex steroids, as well as for energy regulating hormones.  
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As a result, adipose tissue is systemically involved in coordinating a variety of 
biological processes, including energy metabolism, growth and reproduction, in addition 
to immune function.   Research into the effects of diet and exercise on energy regulating 
hormones has revealed limited information on how these factors influence obesity. 
Furthermore, the relationships between energy regulating hormonal concentrations and 
regional adipose tissue is not well understood. Therefore, the current study provides an 
opportunity to examine the relationship between exercise, diet, and energy regulating 
hormones under conditions of weight loss, as well as the associations, if any, between 
these hormones and regional adiposity in an overweight and obese male cohort.  
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3.2 3 Weight and Health Management through Exercise 
The recommendation to participate in regular exercise and physical activity is one of the 
most broadly prescribed lifestyle modifications in the treatment of obesity.  Exercise has 
been defined as activity requiring physical effort, carried out especially to sustain or 
improve health and fitness (ACSM, 2014). If appropriate exercise is performed on a 
regular basis, physical activity can increase metabolism and reduce the risk of 
developing obesity and its co-morbidities. Exercise can also prevent the loss of lean 
body mass, improve cardiorespiratory fitness, and increase one’s overall feeling of well-
being (Okay et al., 2009). The impact of exercise on weight loss and health improvement 
is complex, which can be attributed, in part, to the effects of hormones responsible for 
insulin sensitivity, appetite and muscle anabolism. The following chapter will review 
exercise related weight loss and health benefits, and will give particular attention to the 
hormonal response to resistance training. 
3.2.1 Exercise Modalities: 
The terms “aerobic”, “anaerobic”, and “resistance training” do not have universal 
definitions throughout academic and popular media due to the broad variety of 
modalities which encompass these types of exercise. Aerobic exercise is commonly 
defined as exercise involving large muscle groups in dynamic activities, which can result 
in substantial increases in heart rate and energy expenditure (Powers, Howley, & Cox, 
1985). Anaerobic exercise, in contrast, is completed at very high intensities such that a 
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large portion of energy is provided by glycolysis and stored phosphocreatine.  
Resistance training is exercise that causes muscles to contract against an external 
resistance, with an expectation of increases in strength, tone, mass, and/or endurance 
(Howley, 2001). 
 
3.2.2 Weight Loss and Body Fat Distribution 
Exercise intervention studies show conflicting results with respect to weight loss. This is 
not surprising, given the broad spectrum of modalities that are considered exercise. The 
term exercise is often broadly used in physical activity research, where the differences 
between approaches such as cardiovascular training and resistance training are not 
always clearly identified (American College of Sports Medicine, 2009).  Due to the 
varied physiological and adaptive responses that occur as a result of different activities, 
it is important that the characteristics of the exercise intervention are clearly explained 
(American College of Sports Medicine, 2009).  Because of the uncontrolled nature of 
many exercise intervention studies, researchers are often unable to determine the 
participants’ energy expenditure during an exercise session (Conn et al., 2014). This 
difficulty is compounded by the standardization of training programs administered in 
research studies, which can result in individuals working at varying levels of intensity 
based upon physical fitness and exercise experience. Furthermore, the lack of 
supervision in many trials results in an over or under reporting of total activity 
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performed and does not control for possible modifications in exercise performance, 
including lower time under tension, increased rest intervals between sets, and a reduced 
range of motion (Ballor & Poehlman, 1994; Garrow & Summerbell, 1995; Miller et al., 
1997). 
In a meta-analysis on the effect of exercise on weight loss, participants who engaged in 
exercise lost an average of 2.4 kg more than the sedentary control groups (Wing & 
Phelan, 2005).  In six out of the ten studies reviewed, the difference in the amount of 
weight loss was significant, leading reviewers to conclude that exercise alone produces 
moderate weight loss (Wing & Phelan, 2005). However, the small sample sizes used in 
several of these studies limits generalizations for the larger population. The sample sizes 
for three out of the ten studies were as follows: five participants in the control and 
experimental group, n=10 (Verity & Ismail, 1989), 13 participants in both the control 
and experimental group, n=26 (Ronnemma,1988), and eight participants in the 
experimental group and four in the control group, n=12 (Hammer, 1989).  This meta-
analysis was pursued in order to increase the sample size and derive a more accurate 
picture of the relationship between exercise therapy and obesity.   
Although caloric restriction remains the most efficacious method for weight loss, 
exercise and physical activity are integral components of long-term weight maintenance 
and do lead to additional, although modest, weight loss when combined with diet. In a 
meta-analysis on weight loss approaches performed by Miller et al. weight loss achieved 
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through exercise in isolation resulted in only a 2.9 kg weight loss, where diet resulted in 
10.7 kgs, and diet combined with exercise resulted in 11 kg (Miller et al. 1997). When 
performed in isolation, the difference in weight loss between diet and exercise is 
substantial, therefore it is recommended that diet or diet and exercise be performed to 
achieve healthy body weight for obese patients (Miller et al. 1997). As significant 
heterogeneity exists within the definition of exercise the opportunity to determine 
effective approaches which provide additional weight loss when exercise is combined 
with diet would contribute to the current literature.  
The average energy deficits created by exercise are estimated at ~28% of daily energy 
intake (Ross et al., 2000).  When combined with caloric restriction, exercise results in 
additional benefit, demonstrating a 30% greater energy deficit than that observed in 
individuals who rely on dieting alone (Ross et al., 2000). Ross et al. concluded that more 
controlled studies are required whereby energy deficits induced by dieting and exercise 
are carefully matched to determine whether exercise alone is beneficial for weight loss 
(Ross et al., 2000). These previous investigations have helped define the current study’s 
approach towards the use of exercise and diet for weight loss.  
The increased energy expenditure achieved with exercise may be more important to 
weight loss outcomes then the modality of exercise itself (Sedlock, Fissinger, & Melby, 
1989).  In two out of the ten studies reviewed, energy deficits are approximately equal 
between exercise in isolation versus dieting alone (Ross et al., 2000; Sopko et al., 1983). 
56   
 
    
Sopko et. al found that weight loss for exercise in isolation is comparable to that of the 
diet only under conditions of matched energy deficits (Sopko et al., 1983). The authors 
believe that the magnitude of the energy deficit is a more important factor than the 
manner in which the energy deficit is achieved (Sopko et al., 1983).  Ross et. al  also 
found that body weight decreased by 7.5 kg  (8%) in both the diet and exercise groups 
when equal energy restrictions were administered, while total fat decreased by 1.3 kg 
more in the exercise only group (Ross et al., 2000).  Exercise itself, even without weight 
loss, has been shown to reduce specific regional adipose deposits including those in the 
visceral region (Ohkawara, Tanaka, Miyachi, Ishikawa-Takata, & Tabata, 2007). The 
reduction in visceral fat associated with exercise demonstrates specific benefits for men, 
as intra-abdominal fat is associated with a higher risk of metabolic disease, including 
diabetes, in this population (Smith et al., 2001). The preferential reduction in visceral fat 
associated with exercise indicates that visceral fat is more sensitive than subcutaneous 
fat to lipolytic stimulation and less is resistant to insulin suppression (Fried, Leibel, 
Edens, & Kral, 1993). In contrast, Egger et. al concluded that physical activity on its 
own is not effective for weight loss unless the individual is participating in 
approximately 3-3.5 hours of physical activity a day, which is an un-realistic expectation 
for most obese populations (Egger, 2008). However, exercise effectiveness can be 
improved via several prescription variables to yield effective interventions, while 
reducing overall time required for exercise (Ross et al., 2000).  It is clear that more 
research is needed to employ evenly matched energy restrictions in order to determine 
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the effects of exercise in isolation on weight loss. Also, studies need to take a broader 
view on physiological responses to exercise that are not limited to weight loss, such as 
the biochemical and hormonal variables specific to the obese phenotype (D. L. 
Williamson & Kirwan, 1997).  
Exercise can lead to weight loss. However, the type and intensity of the activity dictates 
the degree (Ross et al., 2000; Wing & Phelan, 2005). Structured exercise is a complex 
arrangement of movements where numerous variables can be modified to elicit a variety 
of training effects ranging from strength to endurance. The practitioner must 
differentiate between the benefits of aerobic, anaerobic, and resistance training, as well 
as between low, moderate, and high intensity training regimens in order to accomplish 
the desired training effect (Howley, 2001).  
The literature focusing on the weight loss effects of exercise often considers all exercise 
to be equivalent.  The incorporation of exercise prescription principles in the 
development of exercise interventions aimed at weight loss would help reduce the 
heterogeneity in exercise interventions currently existing in the literature. The current 
investigation incorporates a series of important training specificity variables into its 
resistance training protocol prescription.  
Research involving exercise as a means of weight loss must carefully consider the 
prescription of resistance training programming. In order to optimize training effect, 
recommendations for exercise should include attention to contraction speed, sufficient to 
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recruit fast twitch muscle fibers, the use of a variety of contraction types, and an 
assortment of closed chain, multi-joint free weight exercises. Although these exercise 
prescription principles have been well established in younger athletic populations, their 
benefit for aging and overweight/obese populations is not clear.  
3.2.3 Physiological and Biochemical Changes 
Approximately 20 years ago, the importance of exercise as a therapy was investigated by 
a panel of experts representing the National Heart, Lung, and Blood Institute as well as 
the National Institute of Diabetes and Digestive and Kidney Disease in an attempt to 
identify, evaluate, and treat overweight and obese adults (Wing & Phelan, 2005). Since 
those seminal studies, exercise has played an important role in the treatment of weight 
gain in the general and clinical population. 
It is well established that acute energy expenditure attained via exercise is not the only 
effect of physical activity. Chronic exercise results in metabolic adaptation, increased 
muscle mass, cardiovascular fitness and insulin sensitivity, all of which impact obesity 
(Hakkinen et al., 2002; Ritchie et al., 2014). Therefore, studies that focus solely on 
energy expenditure during exercise are limited, and may lack a larger view of exercise 
adaptation. 
Resistance training as an exercise modality for cardiovascular disease risk factors has 
shown success with improving cholesterol (Kukkonen-Harjula, Borg, Nenonen, & 
59   
 
    
Fogelholm, 2005) and triglycerides (Cornelissen, Fagard, Coeckelberghs, & Vanhees, 
2011). Additionally, resistance training may slightly improve diastolic blood pressure 
(Cornelissen et al., 2011; Pattyn, Cornelissen, Eshghi, & Vanhees, 2013), waist 
circumference (Christiansen et al., 2010; Lemes et al., 2016) and glucose disposal 
(Roberts, Hevener, & Barnard, 2013).  
Exercise-associated improvements in insulin sensitivity and glucose tolerance have been 
found in a variety of populations, including younger individuals (Poehlman, Dvorak, 
DeNino, Brochu, & Ades, 2000) and older individuals (Zachwieja, Toffolo, Cobelli, Bier, 
& Yarasheski, 1996), those with hypertension (Reynolds, Supiano, & Dengel, 2004) and 
people who have type II diabetes (Ishii et al., 2001). 
Resistance training, regardless of prescription has shown consistent evidence that it 
improves insulin sensitivity (Roberts et al., 2013). However, there were two identified 
studies involving resistance training that failed to achieve significant changes. The first 
study showed an increase of ~10% and did not achieve statistical significance (P<0.06) 
(Davidson et al., 2009) and the second used 60 minutes of physical activity per week, 
suggesting that a minimum level of activity is warranted to elicit change (Ryan et al., 
2001). The latter study supports guidelines from exercise physiology governing bodies, 
which recommend 60 minutes of physical activity per day. It is therefore not surprising 
that with only 60 minutes per week, no significant change in insulin sensitivity was 
detected (ACSM, 2014).  
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Resistance training can show health benefits in the absence of weight loss (Klimcakova et 
al., 2006). In obese, middle-aged men, a 24% increase in glucose disposal rate, without 
any change in body weight, fat mass or VO2max, was demonstrated (Klimcakova et al., 
2006). Other research noted a modest increase in insulin sensitivity, which occurred in the 
absence of changes in total body, subcutaneous or visceral fat (Poehlman et al., 2000).  
In summary, a recent systemic review of 20 studies found that supervised resistance 
exercise training improved glycemic control and insulin sensitivity in a wide variety of 
study groups (Gordon, Benson, Bird, & Fraser, 2009). However, without supervision, 
resistance training compliance and glycemic control are generally less, suggesting either 
the need for supervision or additional motivation to maximize training-induced benefits. 
Lastly, the addition of a calorically restricted diet, as was employed in the current study, 
improves insulin sensitivity in exercise participants to a greater degree than exercise in 
isolation (Gordon et al., 2009).  
3.2.4 Energy Regulating Hormones 
 Exercise is capable of altering hormones responsible for insulin sensitivity, 
metabolism, appetite and muscle anabolism. The insulin sensitizing adipokine, 
adiponectin, the primary hormone of interest in the current study, has been the focus of 
several studies (Boudou et al., 2003; Christiansen et al., 2010; Dutheil et al., 2010; 
Esposito et al., 2003; Hulver et al., 2002; Ryan et al., 2003; Yatagai et al., 2003). These 
studies have used various modalities, frequencies and intensities of exercise in a variety 
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of populations. To date, however, there is a relatively small amount of research using the 
current study population of overweight and obese aging males (Simpson & Singh, 2008). 
 The adiponectin response to exercise has been unpredictable. Where some studies 
show an increase in adiponectin (Saunders et al., 2012b), others show no changes 
(Yatagai et al., 2003), or in one example, an adiponectin decrease (Christiansen et al., 
2010).   
The inflammatory cytokine TNF-α increases under conditions of obesity and decreases 
with regular participation in physical activity (Plaisance & Grandjean, 2006b). Research 
has also shown that regular physical activity can negate or reverse TNF-α’s association 
with obesity status, which reduces the health risk associated with both obesity and 
inflammation (Mattusch, Dufaux, Heine, Mertens, & Rost, 2000). The physical activity 
associated with increases in insulin sensitivity is accomplished, in part, by suppressing 
TNF-α, which in turn upregulates the production/secretion of the insulin sensitizing 
hormone adiponectin (Kasapis & Thompson, 2005). The exercise induced reduction in 
circulating concentrations of TNF-α is not limited to chronic exercise, but is also acutely 
reduced following a single exercise session (Mattusch et al., 2000).   
Weight loss also reduces the size and number of TNF-α producing fat cells, which 
demonstrates the importance of exercise in creating a decrease in energy balance 
(Hotamisligil, Shargill, & Spiegelman, 1993b).  Currently, there is limited research as to 
which modes of exercise are the most effective at reducing chronic inflammation 
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resulting from TNF-α. This gap in the literature provides an opportunity for 
investigations into specific exercise prescriptions and their effect on obesity related 
inflammatory hormones.   
The appetite regulating adipokine leptin has been observed to decrease in response to 
exercise. However, these findings have been inconsistent. It is well established that 
leptin is directly correlated to adiposity status and, as a result, the majority of research 
indicates that exercise associated changes in leptin are in response to weight loss 
resulting from exercise, rather than exercise itself (Ozcelik et al., 2004; Polak et al., 
2006). Studies showing the independent effects of exercise on leptin have involved 
various modalities and intensities of exercise, often in an uncontrolled setting, leading to 
uncertainties about the true impact of exercise on leptin. There is a need for highly 
controlled, supervised exercise research using well defined protocols which can provide 
definite answers about leptin’s relationship with physical activity.   
Ghrelin, an energy and appetite regulating hormone, has been observed to increase in 
response to weight loss (Leidy et al., 2004). Similar to leptin, ghrelin consistently fails to 
show an independent change in circulating concentrations in response to chronic 
exercise (Foster-Schubert et al., 2005; R. R. Kraemer & Castracane, 2007; Leidy et al., 
2004; Schubert et al., 2014; Thomas et al., 2012; Ueda et al., 2009). Due to the energy 
demands of exercise, ghrelin has shown an acute post exercise increase, which is 
believed to stimulate energy intake which restores the energy depleted during exercise 
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(Schubert et al., 2014). Additionally, ghrelin is thought to increase in response to the 
secondary benefits of exercise, in particular, the lower inhibitory effects of leptin 
associated with weight loss, and the increased energy demand from improvements in 
lean body mass (Schubert et al., 2014). It is well established that exercise protocols lead 
to food cravings and increased appetite due to the increased energy demands of exercise 
activity, and that ghrelin stimulates these responses (Thomas et al., 2012).  
Testosterone is an androgen hormone which plays an important role in muscle protein 
synthesis (W. J. Kraemer et al., 1998). Changes in resting testosterone concentrations 
during resistance training have been inconsistent. Testosterone concentrations have 
shown increases in some studies (Hakkinen et al., 1988a; Hakkinen et al., 1988b; W. J. 
Kraemer et al., 1999; Marx et al., 2001; Staron et al., 1994) while others have shown no 
change (Alen et al., 1988; Hakkinen et al., 1988b; Hakkinen & Pakarinen, 1994; 
Hakkinen et al., 2000a; Hickson et al., 1994; McCall et al., 1999). Additionally, the 
majority of research involves younger individuals, or subjects who are highly trained 
(Hakkinen & Pakarinen, 1993; L. Hansen, Bangsbo, Twisk, & Klausen, 1999; Linnamo 
et al., 2005). The goal of the current investigation is to determine whether protocols 
previously shown to increase testosterone in more athletic populations result in similar 
changes for overweight and obese aging male population.  
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3.2.5 Chapter 2 Summary 
It has been shown consistently that exercise without dietary restrictions does not show 
significant weight loss in obese individuals (Ross et al., 2000). However, this connection 
is subject to limitations, and must be interpreted cautiously. Studies that prescribe 
adequate intensity, duration and loading of exercise has been shown to elicit a greater 
weight loss and training adaptation (Ross et al., 2000).  In eight out of the ten studies 
reviewed, the negative energy balance created through the amount and intensity of 
exercise prescription was small, to the point where results showed that large weight 
losses are not attainable (Ross et al., 2000). Additionally, exercise interventions must 
focus on outcomes outside of weight loss including both biochemical and physical 
changes in cardiovascular risk factors. In particular studies must investigate the changes 
in energy regulating hormones, many of which are associated with the aforementioned 
changes in adiposity and cardiovascular risk factors. The current investigation 
implemented a structured, supervised resistance training protocol, based on those 
previously shown to augment energy regulating hormones while providing sufficient 
metabolic demand to elicit weight loss, in an overweight and obese aging male 
population.  Finally, exercise has been shown to be most effective when combined with 
caloric restriction (Miller et al., 1997). The following chapter highlights the most current 
approaches for effective weight loss through diet, and discusses the impact of nutrition 
on weight loss, health risk reduction and energy regulating hormones.  
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3.3 Weight and Health Management through Diet 
Dietary restriction remains the most common method of weight loss prescribed by 
physicians (D. F. Williamson, Serdula, Anda, Levy, & Byers, 1992). However, no single 
diet plan has been universally successful at achieving weight loss and improving 
clinically relevant health measures (Matarese & Pories, 2014). In fact, there is a 
surprising lack of consistent weight loss outcomes associated with dietary restriction. 
Diets emphasizing reduced calorie intake typically characterize most approaches; 
however, the exclusion of various nutrients including low fat or low carbohydrate diets 
add complexity to dietary prescriptions. Additionally, the unique characteristics of the 
various macronutrients, specifically saturated versus unsaturated fats and complex 
versus simple carbohydrates, have been considered to be important factors when 
determining the impact of diet on energy regulating hormones, including adiponectin 
(Esposito et al., 2003), leptin (Barkoukis et al., 2007; Bouche et al., 2002; Ebbeling et 
al., 2012; Niwano et al., 2009)., ghrelin (Erdmann et al., 2004; Overduin et al., 2005; 
Tannous dit El Khoury et al., 2006), and TNF-α (Kelly et al., 2011). The following 
chapter reviews the weight loss, health, and energy regulating hormone outcomes shown 
in previous research and provides the rationale behind the hypocaloric macronutrient 
scheduled diet employed in the current study.  
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With a growing emphasis on weight loss in society stemming from an increased 
awareness of obesity related health risks, significant efforts have been made to validate 
the best approach to achieving and maintaining a healthy body composition. The past six 
decades have led to several distinct approaches to weight loss via diet, all of which vary 
in effectiveness, macronutrient content or quantity and health impact. 
The very low calorie diet (VLCD), which was popularized in the 1980s, promotes the 
ingestion of liquids which are low in energy (Kaplan, Miller, & Anderson, 1992). 
Although an effective modality for weight loss, the practicality of these diets is limited 
due to the strict guidelines which leads to a lack of patient adherence (Miller et al., 
1997). Within one year after dieting, 75% of dieters were shown to re-gain the weight 
lost and, after two years over 90% were unsuccessful (Safer, 1991). VLCD diets 
typically provide 20% of their energy from protein, 20% from fat, and 60% from 
carbohydrates and limit individuals to only 400-800 calories a day, which is a 
significantly lower caloric intake in comparison to normal eating habits (Cowburn, 
Hillsdon, & Hankey, 1997). For these reasons, the use of the VLCD was not employed 
in the current study. 
In contract to pure caloric restriction, the reduction of certain macronutrients has been 
investigated extensively. These diets are commonly known as the low fat and low 
carbohydrate diets (Bravata et al., 2003; Bueno et al., 2013; Matarese & Pories, 2014).  
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The low fat diet has been the most commonly prescribed weight loss approach with 
respect to caloric restriction (Matarese & Pories, 2014). The popularity of this approach 
is thought to be related to the reduction in caloric intake due to the higher caloric content 
of dietary fat versus protein and carbohydrate.  
Low carbohydrate diets promote a reduced or restricted carbohydrate intake that leads to 
a ketogenic state (Bravata et al., 2003; Bueno et al., 2013).  This approach provides 
more nourishment as compared to VLCD, while still leading to significant weight loss 
(Brehm, Seeley, Daniels, & D'Alessio, 2003; Tay, Brinkworth, Noakes, Keogh, & 
Clifton, 2008). Consuming a low carbohydrate diet redirects substrate utilization from 
glucose to ketone bodies in an attempt to fuel the central nervous system due to the 
inability of the brain to metabolize fatty acids in the absence of glucose (Bueno et al., 
2013). What is known is that the low-carbohydrate diet decreases appetite, even during 
periods of caloric restriction and weight loss (Gibson et al., 2015). It has been proposed 
that the state of ketosis is partly responsible for this decrease in hunger (Gibson et al., 
2015). It has been well established that the macronutrient content of meals can influence 
energy intake in the post meal period, with protein exerting a stronger satiety influence 
over appetite than carbohydrates (Blundell, Stubbs, Hughes, Whybrow, & King, 2003). 
The low-carbohydrate approach may inadvertently benefit from a disproportional intake 
of protein, which may lead to reduced hunger (Gibson et al., 2015).  
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The understanding of the role of the various macronutrients with respect to energy 
metabolism, as well as the understanding of the importance of frequent feeding, has led 
to effective and sustainable approaches to weight loss via diet without excessive 
macronutrient or caloric restriction.  Moderate energy restriction typically recommends 
that caloric intake be limited to approximately 1,200 calories a day. However, these 
restrictions allow for increases or decreases in energy intake depending upon body size, 
metabolic needs, activity levels, gender, and age (Cowburn et al., 1997). Due to the 
known effect of various macronutrients on weight loss and satiety, the efficacy of 
“calorie counting” may be oversimplified and requires attention with respect to 
macronutrient scheduling and type (Frost, 2007). Although macronutrients have a 
specific caloric content that can be measured, they exert different effects on satiety 
independent of their caloric value (Matarese & Pories, 2014). Furthermore, the 
assumption that all individuals function equally under the same caloric restriction is 
highly variable. The traditional calorie counting approach has been shown to 
underestimate the amount of energy required by each individual, leading to lower 
adherence due to increased appetite resulting from reduced nutrient intake (Frost, 2007).  
It has been shown that the most effective approach for moderate caloric restriction 
should be no more than 500 kcal below their estimated energy expenditure (James, 
1983). This is the approach that was employed in the current study.  
Although it is well established that the amount of calories ingested is a crucial variable 
in the effectiveness of a weight loss diet, it is not the only consideration. In particular, 
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within moderate energy restriction diets there are several variables which can be adapted 
to optimize caloric intake including feeding frequency and quality of macronutrients, 
such as the glycemic index of carbohydrates and the proportion of saturated versus 
unsaturated fats in food sources (Schoenfeld, Aragon, & Krieger, 2015). The glycemic 
index (GI) is a measure of the ability of individual foods to elevate blood sugar over two 
hours compared to eating a simple sugar such as glucose and has been hypothesized to 
impact the satiety of an individual during caloric restriction (Sacks et al., 2014). High-GI 
foods digest rapidly and have various negative health effects while low-GI foods digest 
slower and are believed to be beneficial to our health (Sacks et al., 2014). In a review by 
Niwano, the GI was investigated to determine its impact on appetite, hunger and satiety 
(Niwano et al., 2009). It was found that high-GI foods were generally found to increase 
hunger and lower satiety over the short term, possibly due to a resulting state of 
hypoglycemia (Niwano et al., 2009). Consequently, high-GI test meals resulted in 
individuals eating more at subsequent meals (Ball et al., 2003; Ludwig et al., 1999; 
Warren, Henry, & Simonite, 2003). 
Understanding the role of various nutrients, their combinations, as well as the 
recommended timing of nutrient intake are all important variables in the prescription of 
diet. The following sections summarize the impact of these various dietary approaches 
on outcomes of interest investigated in the current study, including weight loss, 
cardiovascular risk factors and energy regulating hormones.  
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3.3.1 Weight Loss and Body Composition 
The degree of weight loss achieved through caloric restriction varies greatly depending 
upon the approach employed. The average weight loss results with VLCD range 
anywhere from 1.5-2.5 kg/week within the first six to ten months; however, it is broadly 
recommended that ranges of 0.5-1.0 kg/week are safe and desirable for long term weight 
loss (Weinsier, Wilson, & Lee, 1995). As time passes, the rate at which people lose 
weight on VLCD diminishes, owing to a reduction in basal metabolic rate by an average 
of 15% (Cowburn et al., 1997).  
With respect to macronutrient restriction, low fat diets emphasize reduced caloric intake 
through the avoidance of high calorie dietary fats, and demonstrate significant weight 
loss. However, low fat diets are generally considered to be less effective than other 
caloric restriction approaches (Ajala, English, & Pinkney, 2013).  Randomized control 
trials which prescribe low fat and high carbohydrate interventions show a mean weight 
loss ranging between 0 and 10 kg (Astrup, Toubro, Raben, & Skov, 1997). Meanwhile, a 
recent systematic review in human obesity and dietary fat consumption found that a 
reduction of 10% in dietary fat intake results in a reduction in weight of 16g/d, 
corresponding to a weight loss of 2.9 kg over six months (Bray & Popkin, 1998). To 
determine the impact of restricting dietary fat, Ebbeling et al. evaluated the effects of 
different macronutrient diet compositions of diets on energy expenditure during weight 
loss (Ebbeling et al., 2012). They developed a three-way crossover study of overweight 
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and obese young adults (n = 21) which included a run-in phase in which calories were 
restricted to achieve a 10% to 15% weight loss (Ebbeling et al., 2012). The diet was 
composed of 45% carbohydrate, 30% fat, and 25% protein and subjects were randomly 
assigned iso-caloric diets for four weeks: either a low fat, high–glycemic load (60% 
carbohydrate, 20% fat, 20% protein); low–glycemic index (40% carbohydrate, 40% fat, 
20% protein); or a very-low-carbohydrate, low–glycemic load (10% carbohydrate, 60% 
fat, 30% protein) diet (Ebbeling et al., 2012). During each phase energy expenditure was 
measured. The researchers found that the reduction in both resting and total energy 
expenditures was highest in the low-fat group, indicating that weight loss was more 
difficult (Ebbeling et al., 2012). 
Additionally, low carbohydrate diets gained popularity following research showing that 
when obese individuals consumed a high-fat, high-protein diet, they experienced 
significant weight loss, even when there was no negative caloric balance (Foster et al., 
2003). In contrast, recent comparisons of the low carbohydrate diet to other caloric 
reducing diets, have shown that macronutrient composition is not the sole determining 
factor in the effectiveness of losing weight when energy intake is also decreased 
(Matarese & Pories, 2014). It is therefore assumed that the weight loss observed 
amongst low carbohydrate dieters is mainly due to a reduction in energy intake rather 
than macronutrient composition (Dansinger et al., 2005; Foster et al., 2003; Morgan et 
al., 2009; Yancy, Olsen, Guyton, Bakst, & Westman, 2004). In general, low 
carbohydrate diets are not associated with significantly greater weight loss then other 
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diets. However, all diets that have a long duration and a high caloric restriction result in 
greater weight loss then those with of shorter duration and less caloric restriction 
(Mansoor et al., 2016).  
With respect to body composition, an increased frequency of feeding (three meals and 
three snacks per day versus three meals per day) is positively associated with reductions 
in fat mass and body fat percentage, as well as with an increase in lean body mass 
(Schoenfeld et al., 2015). Lean body mass has been shown to be maintained or increased 
with greater feeding frequency, as protein synthesis and growth are heightened when 
protein-containing meals are consumed frequently throughout the day (Moore et al., 
2012). The ingestion of protein scheduled every three hours has been determined as the 
most beneficial frequency for increasing net protein balance, in particular following 
resistive exercise (Moore et al., 2012). These findings are relevant for overweight 
populations, as many weight loss interventions combine both diet and exercise, in 
particular resistance training (Moore et al., 2012). The increase in anabolism that results 
in increases in lean mass would conceivably aid in weight management due to 
enhancements in resting metabolic rate (Areta et al., 2013).  
 Changes in body composition are not the only clinically relevant outcomes of 
dietary restriction. Changes in physiological and biochemical measures resulting from 
caloric restrictions have made diet an appealing therapy for metabolic disease and 
lifestyle related illnesses.  
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3.3.2 Physiological and Biochemical Changes 
Dietary restriction has led to both positive and negative health effects. Diets 
emphasizing excessive caloric restriction have led to warnings from governing medical 
associations, and are therefore not recommended for individuals seeking a healthy 
approach towards weight loss (Miller, et al., 1997). For example, a common risk factor 
with rapid weight loss resulting from VLCD is cholelithiasis (the formation of 
gallstones), partly due to patients losing more than 1.5 kg/week (Weinsier et al., 1995). 
In addition, VLCDs include significant challenges around patient adherence, loss of lean 
body tissue and weight regain following cessation (Miller et al., 1997).   
With respect to positive health benefits, the low fat diet is an appealing approach as it 
encourages low saturated fat intake which results in a decreased risk of elevated 
cholesterol and triglycerides (Mansoor et al., 2016). Alternately, studies using the 
combination of a high fat and a low carbohydrate diet have been associated with a 
greater weight loss, as well as a greater reduction of both total cholesterol and 
triglycerides and increased HDL cholesterol, compared with their low fat diet 
counterparts (Bravata et al., 2003; Bueno et al., 2013). However, these studies also show 
a signiﬁcant increase or lack of reduction in LDL cholesterol, which is credited to the 
high fat content of the low carbohydrate diet (Bueno et al., 2013; Nordmann et al., 2006; 
Schwingshackl & Hoffmann, 2013a; Schwingshackl & Hoffmann, 2013b; Tay et al., 
2008). High LDL cholesterol can be harmful, as it is an important risk factor for CVD 
74   
 
    
morbidity and mortality (Krauss & Siri, 2004). Therefore, concerns have been raised 
about the use of a low carbohydrate diet that does not discourage the excessive 
consumption of saturated fats, especially by patients with known CVD, type 2 diabetes, 
dyslipidemia and/or hypertension, many of which fall into the category of overweight 
and obese individuals seeking to lose weight (Bravata et al., 2003). It is therefore 
essential to identify the form of fat consumed during a low carbohydrate diet and to 
reduce the consumption of saturated fats, while maintaining higher levels of mono and 
polyunsaturated fats which have been shown to benefit those patients (Bravata et al., 
2003; Bueno et al., 2013).  
Significant research has been conducted regarding the use of low glycemic index 
carbohydrates in place of simple carbohydrates for the control of blood glucose.  After a 
low-GI breakfast, adolescents ate less lunch than those eating a high-GI breakfast due to 
the lowering of the post prandial insulin response from the low-GI meal (Warren et al., 
2003). The response to a rapid increase in blood glucose is an increased insulin action 
(Warren et al., 2003). Therefore individuals ingesting a high-GI food are more likely to 
experience mild hypoglycemia (Warren et al., 2003). As blood glucose drops below the 
person’s base level, satiety ends and appetite returns. Therefore, the greater glycemic 
control offered by low-GI foods provides a greater opportunity for stable blood sugar as 
compared with high-GI food. For example, various forms of low glycemic 
carbohydrates, including fructose, glucose, sucrose and maltodextrins serve to suppress 
appetite, and reduce the later intake of energy by approximately the same amount of 
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calories that was ingested (Astrup, 1999). For this reason, low-GI foods have been 
promoted for the treatment of obesity, and are included frequently in current dietary 
recommendations. Low-GI foods were therefore employed in the current study.  
In a five week study, which included moderately overweight men undergoing a low-GI 
diet, subjects effectively ameliorated some plasma lipid parameters, decreased total fat 
mass and tended to increase lean body mass without changing body weight (Bouche et 
al., 2002). These authors proposed possible mechanisms to explain why the lower GI 
diet induced a selective decrease in fat and an increase in lean body mass, including the 
difference in nitrogen balance and protein metabolism (Bouche et al., 2002). Due to the 
negative nitrogen balance associated with the high GI diet, it was suggested that fat 
tissue is oxidized to a lesser degree and muscle to a greater degree with the high-GI diet 
(Bouche et al., 2002). Another possible mechanism they proposed is that a low-GI diet 
utilization, which reduces carbohydrate oxidation and increases fat oxidation (Bouche et 
al., 2002). 
To date, the results of long-term studies showed varying responses of appetite/satiety to 
foods of various glycemic indices, and there is inadequate evidence to support the 
widespread use of low-GI foods in the treatment of obesity (Kelly et al., 2011). 
Specifically, long-term studies do not show that low-GI diets reduce appetite or hunger 
unless, there is a definite change in blood glucose level (Kelly et al., 2011). Therefore, 
the current study aims to clarify the use of low glycemic index carbohydrates in 
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conjunction with scheduled feeding and food log supervision in overweight and obese 
males.  
In addition, the benefit of feeding frequency, moderate energy restriction and a low GI 
diet extends to more than cardiovascular risk factor improvement and changes in body 
composition, but also to changes in energy regulating hormones (Bowen, Noakes, & 
Clifton, 2006). Hormonal response to specific dietary approaches is not a novel concept, 
and has been the focus of significant study due to the relationship between energy 
regulating homrones, obesity, and weight loss.  
3.3.3 Energy Regulating Hormones 
Energy regulating hormones show a variety of responses to nutritional intake. The 
adipose tissue derived hormone adiponectin showed a significant improvement in 
adiponectin concentration following a comprehensive multidisciplinary approach 
towards nutrition, employing whole grains, mono and poly unsaturated fats, and a 
balanced macronutrient intake (Esposito et al., 2003). Other hormones respond directly, 
both acutely and chronically, to total energy intake as well  to the quality of 
macronutrients.  
Post prandial increases in insulin and glucose stimulate the release of leptin (Barkoukis 
et al., 2007). As a result, the consumption of low glycemic index carbohydrates and their 
impact on leptin have been studied extensively, with the majority of studies showing that 
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low glycemic index meals result in a post prandial environment that is favorable to 
satiety and which increases leptin post prandially (Barkoukis et al., 2007; Bouche et al., 
2002; Ebbeling et al., 2012; Niwano et al., 2009).  
The benefits of increased feeding frequency can be impacted by the macronutrient 
content of meals, in particular when considering the appetite stimulating hormone 
ghrelin. It is well established that the type of macronutrient ingested dictates the 
magnitude of ghrelin suppression (Erdmann et al., 2004; Overduin et al., 2005; Tannous 
dit El Khoury et al., 2006) where carbohydrates demonstrate the greatest satiety, 
followed by protein and fat respectively (Tannous dit El Khoury et al., 2006). Ingestion 
of carbohydrates and proteins decreases ghrelin by approximately 70% during the post 
prandial period, while fats result in an approximate decrease of 50% (Bowen et al., 
2006). The higher concentration of ghrelin associated with dietary fat intake is one of the 
proposed mechanisms of weight gain related to high fat diets due to the reduced humoral 
signal to consume additional calories (Tannous dit El Khoury et al., 2006).  Therefore, 
meals which contain higher protein or complex carbohydrates ingested at regular 
intervals have been shown to maintain the post prandial elevation of ghrelin, potentially 
assisting in the inhibition of additional feeding and the maintenance of diet adherence.  
A low-glycemic index diet has also been shown to reduce the inflammatory adipokine 
TNF-α in older, obese adults and it is believed that the normalization of plasma glucose 
resulting from a low GI diet can help halt the cycle of hyperglycemia, which contributes 
78   
 
    
to insulin resistance, adipose tissue dysfunction, and pro-inflammatory cytokine 
production (Kelly et al., 2011). Researchers confirmed that a low glycemic index diet 
improved glucose tolerance, and that a low-GI diet can reduce the inflammation that is 
associated with obesity (Kelly et al., 2011). These findings are supported by longer-term 
dietary interventions, which suggest that carbohydrate intake modification may 
influence the protein or mRNA expression of inflammatory markers in adipose tissue 
(Kirwan et al., 2001).  Of particular significance in prescription of diet is that increasing 
age leads to an exacerbated response of the inflammatory cytokine TNF-α to 
hyperglycemia and hyperinsulinemia resulting from high glycemic index carbohydrates, 
which has been shown to reduce insulin sensitivity (Kirwan et al., 2001). Therefore the 
relevance of the low GI dietary approach for older individuals becomes an important 
consideration during the design of dietary restrictions for overweight and obese 
populations (Kirwan et al., 2001).  
Based on this promising evidence, future studies should investigate the impact of low-GI 
foods, frequent feeding and a balanced macronutrient intake on weight loss, long term 
health, and obesity related energy regulating hormones.   
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3.3.4 Chapter 3 Summary 
In summary, the evolution of dietary protocols aimed at weight loss has undergone a 
variety of iterations since its initial mainstream adoption over five decades ago. 
Countless dietary approaches have since been developed, which have yielded significant 
insights into strategies involving various caloric intakes, macronutrient ratios and timing 
of food intake. These approaches have shown both benefits and risks for individuals, and 
in some cases have yielded significant weight loss while also constituting significant 
health risks (Miller et al., 1997). Other approaches have shown improvements in body 
composition, while demonstrating significant long term health benefits relevant to 
overweight and obese populations seeking meaningful outcomes from weight loss 
(Miller et al., 1997). The current study has adopted the approach of utilizing a moderate 
calorie restriction focused on reduced carbohydrate intake in the form of low GI and 
high fiber sources, coupled with a low saturated fat intake and characterized by frequent 
feedings. Significant work is still required to determine more refined dietary approaches, 
in particular the development of strategies that lead to long term weight loss, and of how 
these strategies can impact energy regulating hormones in an overweight and obese 
aging male population.  
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3.4 Weight and Health Management through Diet & Exercise 
There is a growing understanding in the field of health and wellness that even small 
amounts of weight reduction can lead to increased health benefits (Bajer et al., 2015; 
Herring, Wagstaff, & Scott, 2014; Mansoor et al., 2016; Stuart et al., 2016). A weight 
loss of 10% is associated with marked reductions in the risk for chronic diseases 
associated with obesity (Christiansen et al., 2010). As a result, health practitioners are 
promoting small and gradual change to lifestyle, including the addition of exercise and 
improving eating habits. Safer et al concluded that those who do not combine a 
restrictive diet with an exercise routine as in, they only participate in one or the other 
tend to increase the amount of weight lost for the first two years, but decrease weight 
maintenance after three to five years versus individuals who incorporated both exercise 
and diet together into their lifestyle (Safer, 1991).  
Even when effective diet and exercise approaches are employed adherence remains a 
challenge. The application of behaviour change theory (BCT) has been shown to 
improve the effectiveness of exercise and diet interventions in obese and overweight 
individuals. In a meta-analysis, Olander et al. aimed to identify which BCTs increase 
individual’s self-efficacy and physical activity behaviour of obese adults (Olander et al., 
2013). They found that the BCTs that were associated with significant increases in these 
variables included; action planning, reinforcing of effort or progress towards behaviour, 
and provided instruction. It appears that some BCT approaches were more effective with 
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obese populations than others therefore it was concluded that to develop effective 
lifestyle interventions it may be important to consider tailoring intervention techniques 
to this population  (Olander et al., 2013). These approaches include that goal setting, 
compliance tracking and logging of food intake and exercise participation are effective 
means at improving healthy lifestyle adherence (Samdal, Eide, Barth, Williams, & 
Meland, 2017). Additionally, the degree of support provided to an individual dictates 
weight loss success (Conn, Hafdahl, Phillips, Ruppar, & Chase, 2014). Supervised 
exercise complimented with generic nutrition advice, including information on weight 
loss delivered via booklets, brochures, weight loss manuals, or even by a one-time 
personal session with a dietitian, did not result in successful weight loss (Conn et al., 
2014). It appears that exercise and diet require regular monitoring and ongoing support, 
as unsupervised education results in negligible outcomes with respect to weight loss as 
compared to higher attention interventions (Franz et al., 2007; Herring, Wagstaff, & 
Scott, 2014; Yoshida et al., 2010). In a systematic review by Samdal et al. two 
theoretical themes emerged of importance in the maintenance of lifestyle change; BCTs 
facilitating behaviour self-regulation, including skills and functional aspects of 
behaviours (“how to”), combined with a communication style that addresses the 
underlying nature of motivation (“the why”) in order to maintain the new behaviour over 
time (Samdal et al., 2017). It was highlighted that these perspectives are not opposites, 
but complement each other. Without the first, there would be lack of competence. 
Without the second, there is lack of meaning, value, and satisfaction of psychological 
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needs. Therefore addressing behaviour change as part of a diet or exercise intervention is 
an important aspect of any intervention in order to maintain positive behaviour over time 
(Samdal et al., 2017). The current study employed several of these established BCT 
approaches to ensure adherence and compliance in the exercise and diet interventions.  
Those following a moderate diet in combination with exercise have the best results, with 
more weight loss occurring after two years than through dieting alone. Those who 
continue to exercise regularly have the best weight loss maintenance after six years 
(Safer, 1991). In one study completed by Katahn et al.,  forty-four people who were 
considered massively obese (approximately 82.5% over their ideal weight) were 
administered a six month treatment program which included guidance in nutrition and 
reversing undesirable eating habits, along with information pertaining to a physically 
active lifestyle (Wallston, McMinn, Katahn, & Pleas, 1983). Results demonstrated that 
participants lost 28.1 pounds during the treatment and gained other significant health 
benefits such as a reduction in blood pressure and increased cardiorespiratory endurance 
(Wallston et al., 1983). This behavior education/modification technique of combined 
diet and exercise was considered successful, as long-term follow up results showed that 
twelve to eighteen months later, the majority of subjects involved were able to maintain 
the weight loss (Wallston et al., 1983). The researchers found that the combination of 
both diet and exercise was important as those who only followed the diet modification 
regained at least 40% of the weight they had lost during the treatment (Wallston et al., 
1983).  In another study completed by Svendsen, Hassager, and Christiansen (1994), 
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half of the participants followed a moderate energy restriction diet of 1,200 calories, and 
the other half followed an exercise routine along with a 1,200 calorie diet. With the diet 
alone, participants maintained a 6.6 kg weight loss after nine months. Participants who 
followed the diet and exercise routine, in contrast, maintained a weight loss of 10.6 kg. 
Previous research has demonstrated that using dieting techniques alone has not shown 
conclusive efficacy. Therefore, it has been proposed that in order to successfully lose 
weight and maintain weight loss, multiple lifestyle changes, including both diet and 
physical activity levels, must occur (Svendsen, Hassager, & Christiansen, 1995).  There 
are more effective means of exercise than others to improving health and fitness, and the 
application of these prescription principles may be a means to improve the outcomes of 
future weight loss studies. 
The beneficial impact of exercise on weight loss becomes more apparent when 
investigating its effectiveness in combination with diet. Individuals show greater long-
term weight loss with diet and exercise in combination as compared to either exercise or 
diet in isolation (Franz et al., 2007). Furthermore, the combined approach of diet and 
exercise indicates that individuals maintain weight loss for longer periods of time as 
compared to the use of weight reducing diet alone (Curioni & Lourenco, 2005).  
Reduction of weight by as little as 10% is associated with significant health benefits for 
individuals, particularly when that weight loss is the result of decreased adipose storage 
in the visceral compartment (Christiansen et al., 2010). 
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As obesity rates continue to increase, it is clear that a better understanding of the impact 
of diet on weight loss is required. Studies that implement dietary restrictions without the 
incorporation of exercise regimens have not provided strong evidence for long term 
weight loss within obese patients (Franz et al., 2007). In addition, more long-term 
studies using moderate energy restriction diets that have been shown to benefit clinically 
significant outcomes are necessary (Mancini, Filion, Atallah, & Eisenberg, 2016). While 
weight loss can average up to 1.5-2.5 kg/week on very low calorie diets, there is 
mounting evidence to suggest that 0.5-1.0 kg/week is a safe and maintainable weight 
loss goal (Weinsier, Wilson, & Lee, 1996). Moderate energy restriction diets can lead to 
this degree of weight loss, and were found to be easier to adhere to (Wadden et. al, 
1994). Therefore, moderate energy restriction which accounts for individual differences 
in energy requirements based on one’s age, sex, and physical activity level should be 
considered as an effective and safe approach for those seeking weight loss (Frost, 2007). 
Exercise and physical activity assist in controlling obesity, and can significantly reduce 
the risk of developing co-morbidities associated with excess adiposity (Okay, 2009). 
However, results have varied as to whether exercise is recommended for use in weight 
loss on its own (Wing, 1999, Ross, Freeman, &Jannsen, 2000, Sopko et. al, 1995, & 
Egger et. al, 2008 ). When aerobic training is compared to strength training, subjects in 
strength training groups generally do not decrease their body weight or fat free mass but 
have significant decreases in percentage of body fat, while participants in aerobic 
training groups tend to have decreases in body weight and fat free mass, but no 
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differences in percentage of body fat (Ballor, 1996, &Geliebter et. al, 1997). Body 
composition is not the only clinically relevant end point and research into the 
effectiveness of exercise training should include clinically relevant biomarkers into their 
outcome measures (Okay et. al, 2009).  
3.4.1 Chapter 4 Summary 
        Previous studies suggest that a one dimensional approach to weight loss has not 
been effective (Tyler, Johnston, &Foreyt, 2007). It is recommended that people aim to 
lose weight by focusing on lifestyle modifications in diet and exercise to promote weight 
loss maintenance (Tyler, Johnston, &Foreyt, 2007). Individuals who are given education 
and training in moderate energy restriction diets in combination with exercise routines 
have shown the best weight loss management over six year periods (Safer, 1991). 
Adopting lifelong habits conducive to weight control and overall health rather than 
temporary measures for weight loss should be emphasized in patients seeking a long 
term weight loss solution (tyler, Johnston, &Foreyt, 2007). For these reasons, the current 
study compared Diet + Exercise to Diet Alone to determine their various impact on 
weight loss, health outcomes and energy regulating hormones in overweight and obese 
aging males.                                                                                                                                      
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3.5 Role of Energy Regulating Hormones in Obesity and Weight-loss Through Diet 
and/or Exercise 
Exercise and dietary intervention effectiveness has typically involved a general 
assessment of anthropometric and body composition measures. The current study 
acknowledges the relevance of weight loss and changes in body composition due to diet 
and exercise and expands on these outcome measures to include the assessment of 
specific molecular health variables. Molecular measures including cholesterol, blood 
glucose and triglycerides have been well established biomarkers of health associated 
with diet and exercise interventions (Bravata et al., 2003; Bueno, de Melo, de Oliveira, 
& da Rocha Ataide, 2013; Mansoor et al., 2016), however, there has been limited 
investigation as to the impact of these interventions on hormones associated with body 
composition, metabolism and food intake (Simpson & Singh, 2008).  
The classification of hormones as energy regulating has traditionally been reserved for 
those hormones which control appetite through the promotion or inhibition of energy 
intake (Williams 2016). In the current study, the definition of energy regulating 
hormones has been expanded to not only include those hormones considered to be 
responsible for appetite regulation, namely leptin and ghrelin, but also include hormones 
involved in metabolism; specifically, those impacted by obesity that have been shown to 
be altered by exercise and diet. These candidate hormones include adiponectin, TNF- 
and testosterone.  
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The following chapter will discuss the interplay of these hormones with diet and 
exercise and their relevance to the current study population. For example, adiponectin is 
inversely associated with obesity (S. Bluher et al., 2014; Boudou, Sobngwi, Mauvais-
Jarvis, Vexiau, & Gautier, 2003; Bruun, Helge et. Al 2006; Christiansen et. Al 2010; 
Esposito et al., 2003; Fatouros et al., 2005; Giannopoulou et al., 2005; Golbidi & Laher, 
2014; Hulver et al., 2002) while leaner individuals demonstrate elevated concentrations 
of adiponectin that are believed to improve insulin sensitivity and metabolism (Weyer et 
al., 2001). TNF- is positively correlated with degree of adiposity, inversely associated 
with insulin sensitivity and is believed to down regulate adiponectin (Hivert et al., 2010; 
Hotamisligil, Arner, Caro, Atkinson, & Spiegelman, 1995). Specifically, the visceral fat 
depots, characteristic of overweight and obese men, have been shown to exhibit higher 
TNF- concentration (Clement et al., 2004). Appetite regulating hormone leptin shows a 
strong positive association with degree of adiposity and in animal models has been 
considered to control long term energy intake (Bouassida et al., 2010). Ghrelin, a gut 
derived peptide hormone, controls short term regulation of energy intake and shows a 
subsequent inverse relationship with obesity and increases during weight loss in an 
attempt to promote increased food intake and weight regain (Foster-Schubert et al., 
2005). Lastly testosterone, which is has shown a reciprocal relationship with obesity 
status in men and decreases with age, is involved with lipolysis and muscle anabolism, 
two important outcome variables of the current study (Camacho, 2013). Additionally, 
testosterone has been shown to be improved during high intensity resistance training 
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protocols like those employed in the current study (Hakkinen et al., 1988a; Hakkinen et 
al., 1988b; W. J. Kraemer et al., 1999; Marx et al., 2001; Staron et al., 1994) and 
preferentially reduce visceral fat (Camacho et al., 2013; Tajar et al., 2012). 
 
3.5.1 Adiponectin 
Adiponectin is an adipose tissue derived adipokine. Adiponectin was 
independently characterized in 1995 and 1996 by four groups using different methods, 
and given alternative names of apM1 (adipose most abundant gene transcript 1), Acrp30 
(adipocyte complement-related protein of 30 kDa), adipoQ, and GBP28 (gelatin binding 
protein of 28 kDa) (Kershaw & Flier, 2004). Adiponectin is a protein hormone that 
modulates a number of metabolic processes, including glucose regulation and fatty acid 
catabolism (Chandran, Phillips, Ciaraldi, & Henry, 2003). This hormone plays an 
important role in the suppression of metabolic illnesses that can result in type 2 diabetes, 
obesity, artherosclerosis, non-alcoholic fatty liver disease and an independent risk factor 
for metabolic syndrome (You, Arsenis, Disanzo, & Lamonte, 2013). Although 
adiponectin is exclusively secreted from adipose tissue into the blood stream, and is 
abundant in plasma relative to many hormones, circulating concentrations are inversely 
correlated with body fat percentage in adults (Kershaw & Flier, 2004). There appears to 
be a gender specific difference in circulating levels between men and women, with 
females displaying a higher basal concentrations than males. As stated, adiponectin is 
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inversely associated with insulin resistance and as a result, is markedly lower in diabetics 
than non-diabetics. However, weight reduction can increase levels in this population and 
others (Chandran et al., 2003).  
Adiponectin is found in circulation in several multimeric forms, which have different 
physiological actions (Waki et al., 2003; Wang et al., 2006). These include High, 
Medium and Low–molecular weight (HMW) adiponectin. It is believed that HMW 
adiponectin is the biologically active form and is a stronger predictor of metabolic 
parameters then total adiponectin (Hara et al., 2006). Several studies have reported an 
association between HMW adiponectin and insulin sensitivity (Bobbert et al., 2005; 
Lara-Castro, Luo, Wallace, Klein, & Garvey, 2006), however, whether HMW is a 
stronger predictor of insulin sensitivity than total adiponectin is still debated (Bluher et 
al., 2006; Christiansen, Paulsen, Bruun, Pedersen, & Richelsen, 2010). 
Changes in the adiponectin multimeric complexes have shown varied responses to diet-
induced weight loss (Polak et al., 2007). It is unknown whether this heterogeneity in the 
research is due to unexplained biological actions of adiponectin or methodological 
challenges with the small number of studies investigating adiponectin isoforms during 
weight loss. Of relevance to the current study, Bluher et al. did not detect any clinically 
significant difference between HMW adiponectin and total adiponectin at predicting 
insulin sensitivity and metabolic variables following an exercise treatment program 
(Bluher et al., 2006). In agreement, Christiansen et al. found that changes in the three 
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adiponectin complexes were comparable in all groups undergoing an exercise and diet 
intervention (Christiansen et al., 2010). Therefore, based on the heterogeneity in the 
research, the current investigation did not investigate these different isoforms but instead 
relied on the assessment of total adiponectin. 
 Adiponectin exerts itself centrally via the brain in conjunction with its upstream 
partner leptin (Kershaw & Flier, 2004). Adiponectin binds to its own specific receptors, 
which are inversely correlated with insulin. In animal models, these receptors are found in 
lower numbers in the skeletal muscle and adipose tissue of diabetic mice (Yamauchi et 
al., 2003). Investigations into varying degrees of glucose tolerance demonstrated that 
hypo-adiponectinemia is strongly associated with insulin resistance (Weyer et al., 2001). 
Adiponectin replacement therapy has been shown to dramatically reverse insulin 
resistance and glucose intolerance in obese, diabetic mice (Arita et al., 2012) and in 
adiponectin-knock out mice (K. Maeda et al., 2012). Adiponectin replacement therapy for 
humans has not yet been studied, and current methods to increase circulating adiponectin 
levels involve patient lifestyle intervention. Simple lifestyle interventions aimed at 
decreasing excess body fat and restoring a healthy body weight have been shown to be 
effective at increasing circulating levels of adiponectin and improving insulin resistance 
(Yang et al., 2001). This indicates that lifestyle change is an appealing, safe and long term 
solution to controlling the morbid effects of hypoadiponecetinemia.  
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3.5.1.1 Adiponectin and Obesity 
Despite being produced by adipose tissue, adiponectin concentration is inversely 
correlated to body fat and is lower in obese patients as compared to normal weight 
individuals (Esposito et al., 2003). The mechanism responsible for this down regulation in 
the obese has not been fully elucidated. It could be assumed that increased volumes of 
adipose tissue would be related to increased adipokine production; however, this is not 
the case with adiponectin.  
Although some studies have not shown a significant change in circulating 
adiponectin levels in obese subjects (Hotta et al., 2001), research indicates that following 
weight loss, adiponectin concentration is improved significantly and demonstrates an 
inverse relationship with circulating leptin as compared to pre-weight loss values 
(Calvani et al., 2004). Reports investigating the magnitude of this relationship have 
shown that weight loss influences leptin to a greater degree than adiponectin (Shand, 
Scott, Elder, & George, 2003). Both are strongly correlated to the degree of adiposity and 
its location in the body, especially the visceral and subcutaneous abdominal deposits 
(Shand et al., 2003). Furthermore, hypoadiponectinemia is associated with 
hyperinsulinemia and is an independent risk factor for type 2 diabetes (Lindsay et al., 
2002; Spranger et al., 2003). 
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Alterations in adiponectin pulsatility may also be associated with the 
Hypothalamic-Pituitary Axis (HPA). The action of these counter regulatory hormones has 
been shown to be over active in obese individuals, potentially limiting adiponectin release 
(Rosmond & Bjorntorp, 1998). Furthermore, it has been hypothesized that swollen fat 
cells produce and secrete quantities of the inflammatory cytokine TNF-α, which interacts 
with adiponectin by mutually inhibiting each other’s production in adipose tissue (K. 
Maeda et al., 2012). 
 Adiponectin has several specific roles within the body, one of which is its effect 
on endothelial cell function. Adiponectin has also been shown to reduce the expression of 
adhesion molecules in these endothelial cells, and results in an anti-inflammatory 
response by decreasing cytokine production from macrophages (Salmenniemi et al., 
2004). It is well established that adiponectin promotes insulin sensitivity (Yang et al., 
2001) and that circulating concentrations have been found to decline concurrently with 
the development of insulin resistance. Additionally, and of relevance to the current study, 
adiponectin decreases in obese middle-aged subjects to a greater extent than in younger, 
leaner individuals (Hotta et al., 2001).  
 
3.5.1.2 Adiponectin and Exercise 
 Exercise has historically been used as a tool for sport performance or weight loss, 
However, its role in improving health status is now broadly recognized. Individuals 
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suffering with illnesses ranging from diabetes to cardiovascular disease are universally 
encouraged to engage in regular physical activity as part of their treatment (Kaur, 2014). 
With this new acceptance in the medical community comes confusion regarding the 
efficacy of different modes of exercise. It is apparent that the medical community will 
require validated exercise and nutrition prescriptions to ensure health benefits for patients. 
 The ability of exercise to alter adiponectin has been the focus of several studies 
(Boudou et al., 2003; Christiansen et al., 2010; Dutheil et al., 2010; Esposito et al., 2003; 
Hulver et al., 2002; Ryan et al., 2003; Yatagai et al., 2003). Studies have used various 
modalities, frequencies and intensities of exercise in a variety of populations. To date, 
however, there is a relatively small amount of research using overweight and obese aging 
males (Simpson & Singh, 2008).  
 The studies reported in the adiponectin literature thus far have shown inconsistency, 
with some showing that plasma adiponectin levels can increase (Saunders et al., 2012b), 
remain the same (Yatagai et al., 2003), or decrease (Christiansen et al., 2010) in response 
to exercise. Yatagai et. al attempted to elucidate the effect of exercise on adiponectin by 
controlling for weight reduction, and by using an active cohort who did not experience a 
decrease in body fat (Yatagai et al., 2003). This approach, although effective for 
controlling weight loss, lacks the pragmatic nature of evaluating adiponectin response to 
exercise interventions due to its well established relationship with increased body fat and 
reduced insulin sensitivity. Therefore, investigators must take a more practical approach 
to the impact of lifestyle on adiponectin including both diet and exercise whenever 
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possible. Both diet and exercise behaviors have been shown to exhibit the most robust 
decreases in body fat and increases in adiponectin when used in tandem. (Simpson & 
Singh, 2008). 
 In a well-designed lifestyle intervention undertaken by Faturouros et. al, 
adiponectin increased in response to diet and exercise in elderly individuals (Fatouros et 
al., 2005). Specifically, these participants demonstrated an increase in adiponectin in 
response to the exercise prescription in a dose response manner. These results have been 
mirrored in a recent study using mice, suggesting that there is a dose effect for exercise 
training intensity (Garekani et. al 2011). Exercise intensity may be an important factor 
when investigating the adiponectin response to physical activity. Similarly, when 
investigating non-diabetic obese adults, nineteen weeks of diet and exercise showed an 
improvement in total body fat, visceral fat, and insulin resistance as well as increased 
adiponectin (Shadid et al., 2006). Of the adipokines measured, only adiponectin was 
consistently related to insulin sensitivity and body fat distribution (Shadid et al., 2006). 
Conversely, resistance training was employed for a span of twelve weeks with obese male 
subjects. Exercise training was conducted using a progressive training model that 
increased intensity over the intervention relative to the individual’s baseline strength tests 
(Klimcakova et al., 2006). After training, total body mass and adiponectin remained the 
same even in the presence of improved insulin resistance and reduced leptin. It is possible 
that the small sample size of only twelve individuals was an explanation for the lack of 
change in adiponectin (Klimcakova et al., 2006). Furthermore, as adiponectin appears to 
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follow a dose response, the progression of exercise which began with a single set for each 
exercise may not have been sufficient to result in a significant training effect. Similarly, 
in obese but elderly men and women, twelve weeks of aerobic training improved overall 
fitness, insulin resistance and reduced fat mass in both the subcutaneous and visceral 
regions. Humoral markers, including leptin, reduced; however, there was no statistically 
significant change in adiponectin (O'Leary et al., 2006).   
Adiponectin has also been shown to decrease in response to exercise, even when suitable 
intensity is achieved (Christiansen et al., 2010). Christiansen et al., found a decrease in 
adiponectin during weight loss resulting from exercise by using a randomized sample of 
overweight and obese individuals on a hypocaloric diet who engaged in high intensity 
aerobic exercise (Christiansen et al., 2010). It was shown that not only was significant 
weight loss achieved of greater than 10% of body weight, but there was a significant 
decrease in adiponectin as a result of exercise (Christiansen et al., 2010). This decrease 
in adiponectin was not seen in the diet only group of the study, indicating that there is an 
exercise-mediated effect on adiponectin via a mechanism that has not yet been 
elucidated.  
3.5.1.3 Nutrition and Adiponectin 
 In a review of popular diets by Freedman et al., it was demonstrated that only 10% 
of dieters maintain their specific “popular diet” program of choice (Freedman et al., 
2014). This high attrition rate coupled with the confusion and broad definition of nutrition 
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recommendations in popular media warrants important attention while developing dietary 
protocols, particularly where adiponectin is concerned. 
 Esposito et al’s study (2003) showed a significant improvement in adiponectin 
concentration following a comprehensive multidisciplinary approach towards lifestyle 
including structured exercise and nutrition guidelines proposed by the Mediterranean Diet 
(Esposito et al., 2003).  Results demonstrated an increase in adiponectin and a reduction 
in markers of vascular inflammation and insulin resistance (Esposito et. al 2003). 
Additionally, adiponectin increased in response to a diet and exercise intervention in 
subjects with metabolic syndrome (Dutheil et al., 2010). It was highlighted that although 
this intervention was successful, compliance to the new healthy lifestyle was not optimal 
and the intervention still constituted significant challenges for the clinical population, 
who may not be motivated to modify diet and incorporate exercise into their daily 
schedule (Dutheil et al., 2010). The need for rigorously designed investigations that 
involve a multidisciplinary approach and which utlize effective and documented 
interventions would help clarify the potential impacts of diet on adiponectin in 
overweight and obese cohorts. These interventions must utilize techniques which are not 
only scientifically founded, but are pragmatic enough in application to be useful to the 
medical community and general population in day to day life. 
 
97   
 
    
3.5.1.4 Summary of Adiponectin 
 Adiponectin and its relationship to obesity and insulin resistance has been 
extensively investigated (Kershaw & Flier, 2004; Chandran et al., 2003). However, the 
way in which weight loss achieved through exercise and diet impacts adiponectin 
remains unclear (Boudou et al., 2003; Christiansen et al., 2010; Dutheil et al., 2010; 
Esposito et al., 2003; Hulver et al., 2002; Ryan et al., 2003; Yatagai et al., 2003). Recent 
investigations have provided greater insight into the response of adiponectin to various 
modalities and intensities of physical activity, indicating that the nature of exercise 
intervention is a relevant factor. Additionally, a greater understanding of the impact of 
diet on adiponectin, including the approach utilized in the current investigation shows 
that weight loss achieved through caloric restriction yields positive results (Esposito et. 
al 2003). Therefore, the goal of the current study is to determine the influence of 
supervised resistance training and a hypocaloric macronutrient scheduled diet as 
compared to a hypocaloric macronutrient scheduled diet alone on fasting adiponectin 
concentration in overweight and obese men ages 35-55. 
 
3.5.2 TNF-α 
Tumor necrosis factor alpha (TNF-α), a proinflammatory cytokine, is expressed and 
secreted into circulation by a variety of cells (Mohan et al., 2002).  TNF-α has been 
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shown to be positively associated with adiposity (Warne, 2003), and significantly higher 
levels of circulating TNF-α have been found amongst obese individuals compared to 
normal weight individuals (Kern, Ranganathan, Li, Wood, & Ranganathan, 2001).  
TNF-α gene expression is greater in the adipose tissue of obese individuals then in 
normal-weight individuals and, more specifically, this expression is much higher in 
visceral adipose tissue than subcutaneous adipose tissue (Kern et al., 2001). In fact, 
among obese individuals, macrophage-infiltrated visceral fat is one of the primary sites 
of TNF-α production (Clement et al., 2004). TNF-α is also positively correlated with the 
degree of obesity and the level of hyperinsulinemia (Hotamisligil et al., 1993a; 
Hotamisligil et al., 1995). Diabetic patients have also been shown to have a much higher 
level of TNF-α activity both in circulation and in skeletal muscles (Saghizadeh, Ong, 
Garvey, Henry, & Kern, 1996) Accumulating data suggests that the prevalence of insulin 
resistance increases concordantly with circulating TNF-α concentrations in the blood, 
and is inversely associated with circulating adiponectin (Hivert et al., 2010). 
 
3.5.2.1 TNF-𝛼 and Obesity 
In obese individuals there are marked increases in the secretion of pro-inflammatory 
adipokines like TNF-𝛼, and a decreased production of anti-inflammatory adipokines 
such as adiponectin (de Carvalho, Colaco, & Fortes, 2006). This change in adipokine 
balance is a key component of pathogenic metabolic and immune responses and impacts 
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angiogenesis, blood pressure and lipid metabolism, all of which are linked with 
cardiovascular disease (de Carvalho et al., 2006). Accumulating data suggests that 
during high lipolytic activity, more fatty acids are released from visceral adipose tissue 
than subcutaneous adipose tissue (Katsuki et al., 2003b). This is may be due to the 
higher metabolic rate and increased susceptibility of lipolytic enzymes in visceral 
adipose tissue (Wajchenberg et al., 2002). TNF-𝛼 has been shown to stimulate fatty acid 
uptake while simultaneously attenuating fatty acid oxidation (Wajchenberg et al., 2002).  
During stages of adiposity development it has been theorized that adipocyte 
degeneration begins with a significant increase in TNF-𝛼 levels (Chaldakov et al., 2003).  
Therefore, persistent chronic inflammation and increased levels of TNF-𝛼 play a role the 
development of obesity and obesity-related commodities (Chaldakov et al., 2003).   
 
3.5.2.2 TNF- α and Exercise 
Over the past ten years, a growing body of evidence has shown that TNF-α is positively 
associated with obesity status and inversely associated with physical activity (Plaisance & 
Grandjean, 2006b). Research has also shown that regular physical activity can attenuate, 
or even ameliorate, this association with obesity and its subsequent negative health 
effects (Mattusch et al., 2000). For example, it has been shown that physical activity 
increases insulin sensitivity by suppressing the reduction of resting levels of TNF-α, 
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which in turn augments the production/secretion of insulin sensitizers like adiponectin 
(Kasapis & Thompson, 2005). In addition, overall exercise induced weight loss is 
effective in reducing circulating concentrations of inflammatory markers, where even 
acute episodes of physical activity can have strong positive influence (Mattusch et al., 
2000).  Weight loss through exercise decreases the volume/number of adipocytes as well 
as the number of endothelial and macrophage cells that produce TNF-α (Hotamisligil et 
al., 1993b).  However, very little is currently known about which modes of exercise are 
the most effective at attenuating/ameliorating chronic inflammation due to biomarkers 
such as TNF-α.  Therefore, investigations such as this thesis, are important to further 
understand the role that diet and exercise plays in body fat management and the related 
management of obesity related health risks.  In fact, a study by Timmerman et al. 
revealed that the combination of a moderate to high intensity aerobic and resistant 
training program was able to significantly reduce TNF-α (Timmerman, Flynn, Coen, 
Markofski, & Pence, 2008). The exercise program was twelve weeks (three days/week) 
in duration, and consisted of 20 min of aerobic exercise at 70–80% of heart-rate reserve, 
and resistance exercise training (eight exercises, two sets) at 70–80% of maximal effort 
(Timmerman et al., 2008). Interestingly, a study by Balsucci et al. found that resistance 
training is only able to reduce circulating TNF-α in combination with aerobic exercise 
(Balducci et al., 2010). In this study 23 participants, underwent 40 min of aerobic 
exercise at 70-80% Vo2 max, and 20 min of resistance training at 80% of their 
maximum effort.  Neither low intensity aerobic exercise alone or high intensity aerobic 
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exercise alone were able to effect TNF-α levels. This would suggest that resistance 
training may be the more important mode of physical activity to help reduce the chronic 
inflammation caused by TNF-α in the obese.  Resistance training may also be so 
effective in attenuating TNF-α that even a change in weight or body composition is not 
necessary.  Eleven participants underwent a twelve week resistance training program 
(three sets, 8-12 repetitions, for 10 exercises, three times per week), and although they 
did not see any significant changes in body composition, TNF-α was significantly 
reduced (Phillips et al., 2012). This is a novel finding which supports a growing body of 
literature which states that resistance training may have more physiological and lifestyle 
benefits then traditional aerobic exercise programs.  This is especially true for those in 
aging populations, where muscle atrophy is a serious issue.  
The reduction in muscle strength and endurance is one of the most deleterious effects on 
the quality of life for men (McGregor, Cameron-Smith, & Poppitt, 2014). It is believed 
that resistance training may offset TNF-α related chronic inflammation and muscle 
atrophy (Greiwe et al., 2001). Muscle TNF-α mRNA and protein levels significantly 
decreased in those elderly individuals who undertake resistance training exercise as 
opposed to those who do not (Greiwe et al., 2001).  These findings also later supported 
by a study from Bruunsgaard et al., which revealed that baseline TNF-α was inversely 
associated with an increase in muscle strength after twelve weeks of resistance training 
(Bruunsgaard, Bjerregaard, Schroll, & Pedersen, 2004). Overall, recent studies have 
established that resistance training has significant benefits for building muscle strength 
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and assisting in weight management, especially for the aging population (Winett & 
Carpinelli, 2001).  However, it would appear that resistance training may have a more 
direct impact on circulating TNF-α than aerobic exercise, which may also be 
independent of significant weight loss.   
 
3.5.2.3 TNF-α and Nutrition  
 Obesity and insulin resistance are strongly associated with metabolic 
dysregulation and chronic inflammation (Kaur, 2014). A proper diet that maintains or 
decreases body weight may provide a strong stimulus for improving both issues 
(Dandona et al., 1998b). Although a reduction in body weight amongst obese individuals 
results in significant reductions in TNF-α production, and the amelioration of insulin 
resistance (Dandona et al., 1998b), very little is known about whether diet induced 
weight loss has the same positive influence on inflammation and circulating TNF-α 
(Dandona et al., 1998b).  
A study by Moller et al. placed 42 obese men and women on an eight week diet, which 
resulted in a loss of body weight (~ 7 kg) and a reduction in circulating TNF-α (Moller 
et al., 2016). However, a study by Rosc et al., did not find any change in TNF-α for diet 
induced weight loss amongst morbidly obese men and women (Rosc et al., 2015). 
Although the investigators discovered significantly higher levels of TNF-α in the 
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morbidly obese subjects (BMI > 40 kg/m2) compared to their normal-weight (BMI < 24 
kg/m2) subjects at baseline, there was not a significant change in TNF-α after a 9.4% 
reduction in body weight. Investigators hypothesized that the reduction in body weight 
may not have been great enough to elicit the restoration of normal adipocyte function.  
This would suggest that there is a specific set point regarding weight loss and the 
reduction in TNF-α production.   
Investigations into the dietary approaches indicate that the macronutrient composition of 
food intake may be the critical factor regarding the attenuation/reversal of adipose tissue 
dysregulation (Cassani et al., 2015).   A study by Cassani et al found that while 
circulating TNF-α was significantly reduced (25%) after 42 days on a low carbohydrate 
diet, those who also ingested 60g of flaxseed powder per day saw a much great 
reduction in TNF-α (46%)  (Cassani et al., 2015). Although weight loss should 
eventually attenuate adipose tissue dysregulation, it would appear that the composition 
of one’s diet could be more effective then weight loss in achieving this goal.  Overall, 
diet induced weight loss plays an important role in circulating TNF-α, and there is a 
significant need to further investigate the impact of nutritional composition.  
3.5.2.4 Summary of TNF-α 
Adipose tissue clearly plays a critical role in the inflammatory process. The clinical 
objective of identifying lifestyle factors that may affect the obesity-immune system 
dynamic is therefore very important.  Although physical activity and nutrition are very 
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well known lifestyle factors for weight loss/management, very little is currently known 
about how these factors influence the deleterious inflammatory profile for the 
overweight and the obese.  Ultimately, both aerobic and resistance exercise may be 
effective in attenuating obesity related inflammation, in addition to having significant 
implications to preventing obesity.  Mechanistic studies in humans demonstrate that 
moderate exercise exerts an inhibition of TNF-α  (N. Maeda et al., 2002). Moreover, 
indirect anti-inflammatory effects of exercise may be mediated via improvements in 
body composition.  It should be emphasized that physical activity and proper nutrition 
constitute a natural, strong, anti-inflammatory and metabolism-improving strategy with 
minor side effects.  TNF-α may be an important co-factor to consider in response to the 
primary question of this thesis. The alterations in circulating adiponectin amongst obese 
individuals may also be directly associated with the expression/circulation of TNF-α 
(Rosmond & Bjorntorp, 1998).  This hypothesis would suggest that TNF-α interacts with 
adiponectin by inhibiting both its production and secretion from adipose tissue (N. 
Maeda et al., 2002).  Since adiponectin plays a role in both the attenuation of insulin 
resistance and inflammation it may be possible that the presence of TNF-α could 
potentially exacerbate these affects amongst obese males, while also negatively affecting 
the role adiponectin plays in the reversal of insulin resistance and inflammation during 
weight loss due to exercise.  Therefore, the current investigation aims to determine the 
influence of supervised resistance training and a hypocaloric macronutrient scheduled 
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diet versus a hypocaloric macronutrient scheduled diet alone on TNF-α in overweight 
and obese men ages 35-55.   
3.5.3 Appetite Regulating Hormones 
The control of food intake is complex and consists of neural and hormonal signals 
between the pancreas, gut and central nervous system. In additional hormones related to 
adipose tissue volume, as well as individual genetic factors are involved with energy 
regulation and the signal to consume nutrients. These hormones act within key brain areas 
such as the hypothalamus and brainstem which adjusts food intake accordingly (Simpson 
& Bloom, 2010).  
3.5.3.1 Leptin 
Leptin, is one of the first identified adipocytokines, and is produced in proportion to 
body fat. Leptin demonstrates higher concentrations in obese individuals, and is 
associated with energy balance, appetite and adiposity status in both animals and 
humans (Bouassida et al., 2010). The role of leptin was first discovered in the ob/ob 
mouse model (Campfield, Smith, Guisez, Devos, & Burn, 1995). The gene coding for 
leptin, having been mutated in this animal model, resulted in an obese phenotype. This 
work eventually led to an understanding of leptin’s involvement in appetite suppression 
(M. Bluher, 2013).  Later studies demonstrate that the administration of recombinant 
106   
 
    
leptin reduces body weight by decreasing food intake and increasing energy metabolism 
in animals (Reseland et al., 2001).   
Human studies investigating leptin have identified that obese individuals generally have 
high leptin concentrations (Teerds, de Rooij, & Keijer, 2011).  Since leptin’s primary 
function appears to be the suppression of hunger for body weight regulation, elevated 
leptin in the presence of obesity may indicate that a resistance to leptin is occurring 
(Thong, Hudson, Ross, Janssen, & Graham, 2000).  The concept of leptin resistance has 
been supported by the administration of recombinant leptin in humans, which has led to 
weight loss and decreased food intake in only a small subset of obese patients with 
genetic leptin deficiency (Savage & O'Rahilly, 2002).  Leptin has also been associated 
with insulin and insulin resistance in both animals and humans, and demonstrates a 
consistent relationship with improved insulin sensitivity during weight loss (M. Bluher, 
2013).   
 
3.5.3.1.1 Leptin and Obesity 
Leptin concentration increases during weight gain and decreases during weight loss 
(Teerds et al., 2011). Leptin has also shown regionally specific expression, with 
subcutaneous adipocytes expressing greater concentrations when compared with visceral 
adipocytes (Taksali et al., 2008). It has been shown that the decrease in leptin associated 
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with visceral fat reflects an unfavorable metabolic profile characterized by higher insulin 
resistance and lower adiponectin (Taksali et al., 2008).  These regional characteristics 
are of particular importance in the current study population who are characterized by 
greater visceral adipose deposits as compared to female and younger male populations 
(Fain et al., 2004; Polak et al., 2006).  
In circumstances of weight loss, leptin concentration is reduced in proportion to weight 
loss. Although leptin concentration is diminished in weight loss, its anticipated 
inhibitory effect on satiety in humans does not consistently translate into reducing food 
intake, as will be discussed in the following sections (Bouassida et al., 2010).  
3.5.3.1.2 Leptin and Exercise 
Leptin has been shown to decrease in response to exercise. However, these findings are 
inconsistent. The majority of research indicates that exercise associated changes in leptin 
are in response to weight loss resulting from exercise, rather than in response to exercise 
itself (Ozcelik et al., 2004; Polak et al., 2006). Studies showing the independent effects 
of exercise on leptin involve various modalities and intensities of exercise, often in an 
uncontrolled setting, leading to uncertainties about the true impact of exercise on leptin.  
In obese females, for example, leptin has been shown to consistently decrease after 
aerobic training. However, leptin remains strongly correlated to decreases in fat mass, 
and demonstrates no independent effect from exercise (Ozcelik et al., 2004; Polak et al., 
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2006). Similar results have been shown in overweight men following a one year exercise 
program (Miyatake et al., 2004). These men had a reduced circulating leptin 
concentration in accordance with their percentage body fat. Again the investigators 
concluded that there was no independent effect on circulating leptin resulting from 
exercise (Miyatake et al., 2004). Older men, ages 65-78, were divided into one of four 
resistant training groups, consisting of a control group as well as a low, moderate and 
high intensity training group (Fatouros et al., 2005). It was found that measures of 
physical fitness improved in all exercise groups, as did anthropometric values including 
subcutaneous skinfold measures and BMI. The greatest decrease in leptin occurred in the 
highest intensity training group. However, that group also experienced the greatest 
decrease in body fat (Fatouros et al., 2005). The authors concluded that leptin may have 
a dose response to exercise. Due to the strong correlation with changes in body 
composition, however, it would appear that, similar to others, leptin decreases in 
proportion to weight loss.   
In summary, exercise training has disparate effects concerning leptin concentration. 
Exercise training protocols that result in reduced fat mass are generally accompanied by 
lower leptin concentrations. Reductions in leptin levels have also been attributed to 
alterations in energy balance, insulin sensitivity and lipid metabolism. However, the 
majority of research indicates that leptin concentration is correlated to the amount of 
body fat the individual possesses. It is possible that the dose response regarding exercise 
intensity may elicit the independent leptin response as proposed by Fatouros (Fatouros et 
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al., 2005). Concurrently, the types of exercise and training programs must be carefully 
considered, and researchers should build on previous studies that focus on well designed 
exercise intervention research.  
3.5.3.1.3 Leptin and Nutrition 
The true impact of leptin on food consumption may be overestimated in overweight and 
obese individuals (Thong et al., 2000). Due to high levels of circulating leptin which 
occur in most cases of obesity in humans, as well as rodents fed a high-fat diet, it is 
likely that a state of leptin resistance is occurring (Thong et al., 2000). As a result, the 
effect of leptin on satiation may be minimal unless leptin sensitivity is improved through 
either weight loss or change in energy balance. It has been hypothesized that adipocytes 
can detect energy balance. Therefore, hypocaloric diets can be expected to demonstrate 
augmented leptin in overweight and obese individuals (Considine, 1997).  
Post prandial increases in insulin and glucose stimulate the release of leptin (Barkoukis 
et al., 2007). As a result the consumption of low glycemic index carbohydrates and their 
impact on leptin has been studied extensively, with the majority of studies showing that 
low glycemic index meals result in a post prandial environment that is favorable to 
satiety and which increases leptin post prandially (Barkoukis et al., 2007; Bouche et al., 
2002; Ebbeling et al., 2012; Niwano et al., 2009). In a long term study investigating 
moderately overweight men, a low glycemic index diet resulted in the improvement of 
blood lipid concentrations, reduced body fat and improved lean  body mass (Bouche et 
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al., 2002). Leptin decreased in accordance with body fat, but food intake was not altered 
(Bouche et al., 2002). The role of leptin in humans appears to be very modest in adults 
who are overweight or obese. Although leptin concentration appears to be improved 
during hypocaloric diets that are low in fat and which consist of low glycemic index 
carbohydrates, leptin’s strong relationship with adiposity status appears to be the 
determining factor in its circulating concentration. 
3.5.3.1.4 Summary Leptin 
Leptin is strongly correlated to body fat and is suppressed during weight loss in a variety 
of populations (Teerds et al., 2011). Leptin’s role with respect to appetite suppression is 
well established in animal models, but elevated circulating concentrations in obese men 
and women indicates that leptin resistance occurs in humans (Thong et al., 2000). Diet 
and exercise have shown inconstant effects on leptin unless accompanied by a change in 
body fat mass, indicating that irrespective of how weight loss is achieved, leptin follows 
obesity status (Ozcelik et al., 2004; Polak et al., 2006). However, promising insights 
regarding the role of low glycemic diets indicate that a diet that controls for insulin 
response to feeding and which maintains glucose homeostasis results in beneficial 
changes with respect to both leptin and body fat in overweight and obese individuals 
(Barkoukis et al., 2007; Bouche et al., 2002; Ebbeling et al., 2012; Niwano et al., 2009). 
Consequently, the current investigation will determine the influence of supervised 
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resistance training and a hypocaloric macronutrient scheduled diet versus a hypocaloric 
macronutrient scheduled diet alone on leptin in overweight and obese men ages 35-55. 
 
3.5.3.2 Ghrelin 
Ghrelin is the only known circulating orexigen which is implicated in both the short 
term control of food intake and the long term control of body weight (Foster-Schubert et 
al., 2005). Circulating ghrelin has been shown to increase in response to weight loss 
resulting from hypocaloric diets, cancer cachexia, anorexia nervosa, and chronic failure 
of the heart, kidneys and liver (Foster-Schubert et al., 2005). 
3.5.3.2.1 Ghrelin and Obesity 
Body weight is maintained within a narrow, individualized range by a process known as 
“energy homeostasis” (Cummings, 2006). In an attempt to maintain body weight, 
hormones such as ghrelin are engaged to improve or reduce appetite in response to both 
caloric restriction, and caloric surplus, respectively (Cummings, 2006). Weight loss has 
been shown to trigger an increase in circulating ghrelin concentrations as part of an 
adaptive response to energy deficits (Crujeiras et al., 2010). The associated increase in 
ghrelin has been associated with changes in leptin which are diminished when levels 
drop in accordance with fat loss (Crujeiras et al., 2010). Furthermore ghrelin levels have 
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been shown to increase in response to resistance training and exercise to compensate for 
associated increases in energy expenditure. 
Ghrelin is a meal patterning hormone which triggers acute food intake. Additionally, 
there is growing evidence which suggest that it plays a significant role in obesity. 
Circulating ghrelin consistently correlates negatively with measures of adiposity, and 
demonstrates low concentrations in overweight individuals (Cummings, 2006; Ravussin, 
Tschop, Morales, Bouchard, & Heiman, 2001; Tschop et al., 2001).  
Ghrelin has been said to impact all aspects of energy regulation in order to achieve 
weight gain for the individual. This has been evidenced by the consistent increase in 
ghrelin during weight loss. Obese individuals who achieve a 5% decrease in body 
weight demonstrate significant increases in ghrelin (T. K. Hansen et al., 2002).  It has 
been hypothesized that this relationship may not be entirely associated with adiposity, 
and instead may be linked to the nutrient restriction related to weight loss (T. K. Hansen 
et al., 2002).  
3.5.3.2.2 Ghrelin and Exercise 
Ghrelin has been shown to increase in response to weight loss achieved through 
exercise. However, physical activity has not consistently shown an independent effect on 
circulating concentration (Foster-Schubert et al., 2005; R. R. Kraemer & Castracane, 
2007; Leidy et al., 2004; Schubert et al., 2014; Thomas et al., 2012; Ueda et al., 2009). 
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Exercise has been shown to acutely suppress post workout ghrelin. There appears to be a 
compensatory effect in ghrelin stemming from the increased energy expenditure 
resulting from exercise. Additionally, exercise may result in chronic changes in ghrelin 
due to the lower inhibitory effects of leptin associated with weight loss, and the 
increased energy demand from improvements in lean body mass (Schubert et al., 2014). 
It is well established that exercise protocols lead to food cravings and increased appetite 
due to the increased energy demands of these activities (Thomas et al., 2012)  
Chronic changes in circulating ghrelin concentrations have not mirrored acute post 
workout responses. Leidy et al. demonstrated only a modest and non-clinically 
significant increase in ghrelin during twelve weeks of exercise training without changes 
in body weight for women (Leidy et al., 2004). Additionally, Foster-Schubert failed to 
show exercise-associated changes in ghrelin where increases in circulating 
concentrations were related to weight loss alone (Foster-Schubert et al., 2005). 
Conversely, a study by Markofski et al. showed the independent effects of exercise on 
ghrelin concentrations. This investigation showed elevated ghrelin when no significant 
changes in body composition had occurred, indicating that the change was related to the 
intensity of the exercise intervention (Markofski et al., 2014). One of the challenges with 
exercise intervention studies is monitoring adherence, especially during subject self-
reporting (Wing & Phelan, 2005). In the aforementioned study, exercise participants 
were exercising unsupervised and at a self-selected intensity, which limits the reliability 
of the results due to self-reporting (Timonen et al., 2002).  
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A recent systematic review of the effects of exercise on appetite regulation indicates that 
what is currently missing are studies which investigate the impact of long-term (greater 
than six weeks) exercise on appetite-related hormones, and which determine how any 
changes observed relate to weight loss and prevention of weight regain in response to 
exercise in the obese population. We feel this study helps answer this gap in the 
literature.  
3.5.3.2.3 Ghrelin and Nutrition 
Diet and nutrition have a clear impact on ghrelin. Previous work has demonstrated 
that ghrelin suppression occurs post-prandially when specific ratios of macronutrients are 
consumed (Erdmann et al., 2004; Overduin et al., 2005; Tannous dit El Khoury et al., 
2006). High protein diets have been shown to promote weight loss as compared with high 
fat diets. The suppressive effect of protein on ghrelin is considered to be an important 
factor in the success of high protein, hypocaloric diets (Bowen et al., 2006). Furthermore, 
due to a 3-4 hour feeding frequency, the diet protocol used in both groups of the current 
study was designed to reduce ghrelin concentration between feedings. This reduction was 
expected to take place in the presence of weight loss as well.  
Ghrelin response to dietary restriction has shown conflicting results. However, studies 
which have employed nutrition protocols that control for timing and the macronutrient 
content of meals have better demonstrated a decrease in ghrelin, as they address post 
prandial responses by suppressing ghrelin release (Bowen et al., 2006; Bowen et al., 
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2006).  Specifically, carbohydrates demonstrate the greatest suppressive effect on 
ghrelin, followed by protein and fat, respectively (Erdmann et al., 2004; Overduin et al., 
2005; Tannous dit El Khoury et al., 2006) The lack of ghrelin suppression demonstrated 
by fat intake is hypothesized as one of the causes of weight gain associated with high fat 
diets (Tannous dit El Khoury et al., 2006). Furthermore, diets which are higher in low 
glycemic index carbohydrates and lean protein sources have shown encouraging results 
with respect to weight loss (Ajala et al., 2013; Mancini et al., 2016; Nordmann et al., 
2011; Rees et al., 2013; Sofi et al., 2008). It is likely that the reduction in ghrelin 
following the feeding of these nutrients helps with hunger during periods of weight loss 
and caloric restriction which typically results in increased ghrelin and subsequent hunger 
(Bowen et al., 2006). Therefore, ghrelin release appears to occur in response to the 
ingested macronutrients and, as a result, helps dictate subsequent hunger and food 
intake. Ghrelin also shows strong relationships with adiposity status in overweight 
individuals, and appears to respond acutely to weight loss specifically achieved through 
caloric restriction.  
3.5.3.2.4 Ghrelin Summary 
Ghrelin concentration is increased during weight loss in an attempt to maintain energy 
intake and preserve body fat stores (Cummings, 2006). This relationship has been 
demonstrated in a variety of populations, and is considered an important factor in weight 
maintenance and weight loss (Cummings, 2006; Ravussin et al., 2001; Tschop et al., 
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2001). Ghrelin has not been shown to be effected by exercise itself, but rather through 
the weight loss achieved through increases in caloric expenditure (Foster-Schubert et al., 
2005; R. R. Kraemer & Castracane, 2007; Leidy et al., 2004; Schubert et al., 2014; 
Thomas et al., 2012; Ueda et al., 2009). Nutrition has shown a much more consistent 
impact on ghrelin. Higher carbohydrate and protein intake, relative to fat intake, has 
shown a measurable reduction in circulating ghrelin concentration, as has frequent 
feedings every 3-4 hours (Bowen, Noakes, & Clifton, 2006; (Erdmann et al., 2004; 
Overduin et al., 2005; Tannous dit El Khoury et al., 2006). Ghrelin increases to 
encourage food intake with even small decreases in body fat, and therefore plays an 
important role in body weight regulation (T. K. Hansen et al., 2002). The current study 
investigates the response of ghrelin to both exercise and diet compared to diet alone in 
order to determine the ghrelin response to weight loss achieved through these 
approaches in aging overweight and obese males.  
3.5.3.3 Insulin 
Insulin is a peptide hormone produced by beta cells of the pancreatic islets and is an 
anabolic hormone whose functions are manifested during the fed state. Insulin is secreted 
in response to meals and acts on its key target tissues, skeletal muscle, liver, and adipose 
tissue, to stimulate the uptake of glucose and to store calories predominantly in the form 
of glycogen and fat. Circulating insulin also affects the synthesis of proteins in a wide 
variety of tissues (Kaur, 2014) and are proportional to degree of adiposity (Rocha et al., 
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2011). Animal studies have shown that exogenous administration of insulin in rodents 
reduces food intake and body weight (Air, Benoit, Blake Smith, Clegg, & Woods, 2002). 
Insulin works to suppress food intake and maintain energy balance similar the adipokine 
leptin (Garcia-San Frutos et al., 2007). Insulin has been found to stimulate the synthesis 
and secretion of leptin from white adipose tissue through the adipoinsular axis (Kieffer & 
Habener, 2000). As insulin is increased during obesity, chronically high circulating 
concentrations of insulin can lead to insulin resistance (Adam et al., 2009). As a result it 
has been hypothesized that obesity is a product of insulin resistance and not the cause of 
insulin resistance (Morrison, Huypens, Stewart, & Gettys, 2009). 
Insulin is believed to impact food intake through insulin receptors located in the central 
nervous system. It is well established that, in addition to a sufficient supply of insulin to 
the brain, insulin receptor function is vital for energy homeostasis (Figlewicz, 2003). 
Insulin has been considered to be a potential regulator of leptin, because plasma insulin 
concentrations decrease during fasting and increase after refeeding in parallel with plasma 
leptin levels (Kolaczynski et al., 1996). Current evidence suggests that insulin plays a 
chronic role in the regulation of leptin gene expression and production by white adipose 
tissue and that hyperinsulinemia increases plasma leptin levels and gene expression in 
both rodents and humans (Kolaczynski et al., 1996). As fat stores increase, rising plasma 
leptin concentrations reduce insulin levels, in an attempt to direct less energy to the 
formation of adipose tissue. In the event that adipose stores diminish, falling plasma 
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leptin levels would permit increased insulin production, thereby resulting in the 
deposition of additional fat. Therefore, it has been hypothesized that leptin helps regulates 
insulin levels based on the extent of adiposity. This interplay with insulin is reciprocal in 
nature as part of a bidirectional adipoinsular axis (Kieffer, Heller, & Habener, 1996).  
3.5.3.4 Glucagon-like Peptide-1 
Glucagon-like peptide-1 (GLP-1), a 30-amino acid peptide hormone secreted from the L-
cells of the distal ileum (Holst, Schwartz, Lovgreen, Pedersen, & Beck-Nielsen, 1983), 
GLP-1 is released into circulation in response to food intake in proportion to the amount 
of calories consumed (Verdich et al., 2001a). GLP-1 is lowest in the fasted state, while 
the concentration rises postprandially in response to feeding (Wadden et al., 2013).  
GLP-1 binds to its own receptors that are present in a variety of tissues which help 
facilitate the glucose dependent release of insulin from the pancreatic beta-cells (Meier & 
Gressner, 2004), decrease appetite and decrease gastric motility (Wadden et al., 2013).  
GLP-1 has been associated in many chronic metabolic diseases and thought to be 
involved in obesity as morbidly obese subjects demonstrate a decreased diurnal L-cell 
secretion (Holst et al., 1983). Fasting GLP-1 has shown inconsistencies in its relationship 
with obesity but has been found to be lower in obese diabetic patients as compared to 
healthy controls (Greenfield et al., 2009). Morbidly obese individuals have a lower 
postprandial secretion of GLP-1 that improves after weight loss (Naslund et al., 1998).  
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Although previous studies have suggested that obese individuals have a lower GLP-1 
secretion as compared to lean individuals (Holst et al., 1983; Mannucci et al., 2000; 
Naslund et al., 1998; Verdich et al., 2001b). Research has shown no significant difference 
in fasting GLP-1 concentration between overweight/obese and normal weight subjects. 
Wadden et al. found that no significant relationship between baseline GLP-1 
concentration and markers of adiposity including BMI and percent body fat in normal 
weight and obese 19-29 year old males (Wadden et al., 2013).  In an attempt to determine 
the relationship between overfeeding and weight gain in this population it was found that 
the rise in GLP-1 concentration resulting from caloric challenge was independent of 
adiposity status in these normal weight and overweight/obese groups (Wadden et al., 
2013). Gynoid obesity was the only measure of adiposity that was associated with a 
change in GLP-1 at baseline in the overweight/obese group. In general, women are more 
likely to have greater gynoid fat distribution, and having this distribution is thought to 
oppose cardiovascular diseases through more efficient fat storage/lipoprotein lipase 
functionality (McCarty, 2003). 
As recent evidence suggests that GLP-1 is more closely related to caloric intake then 
adipose tissue the current study did not assess this energy regulating hormone however it 
is clear that GLP-1 plays a significant role in appetite regulation during periods of caloric 
restriction and overfeeding.  
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3.5.3.5 PYY 
Peptide YY (PYY), a 36-amino acid appetite suppressing gut hormone, is secreted from 
the L-cells of the gastrointestinal tract. Circulating PYY increases satiety and decreases 
food intake via gut-brain communication (Batterham et al., 2002; Chaudhri, Small, & 
Bloom, 2006; Karra & Batterham, 2010), inhibits gastrointestinal motility (Imamura, 
2002) and pancreatic hormone secretion (Pfluger et al., 2007; Yang, 2002). PYY plays 
an integral part in maintaining energy homeostasis (P. C. Konturek, Konturek, 
Czesnikiewicz-Guzik, Brzozowski, Sito, & Konturek, 2005b; S. J. Konturek, Konturek, 
Pawlik, & Brzozowski, 2004) but its role in obesity development and its relationship 
with adiposity has shown contrasting evidence (Boggiano et al., 2005; Cahill et al., 
2013).  
Appetite is an important factor in energy homeostasis and hormones including PYY 
significantly influences the regulation of body weight (Boggiano et al., 2005). Therefore 
investigating appetite regulating hormones, such as PYY, may provide valuable insight 
into the underlying mechanisms responsible for weight loss intervention effectiveness.  
Animal studies have shown that PYY knockout mice developed significant hyperphagia 
(an abnormal increased appetite for food) and that that exogenous replacement of PYY 
significantly ameliorated this condition (Batterham et al., 2002; Batterham et al., 2003). 
These initial investigations indicated that PYY was inversely associated with obesity-
related phenotypes (Batterham et al., 2002). These studies demonstrated that a deficiency 
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in circulating PYY could be a significant contributing factor toward the promotion of 
increased food intake and subsequent weight gain. However, many successive PYY 
knockout (Boey et al., 2006; Wortley et al., 2007), studies have failed to reproduce the 
strong association of PYY with appetite and diet-induced obesity or demonstrate any 
significant association between circulating PYY and adiposity (Cahill et al., 2013; Kim, 
Cho, Kang, Choi, & Park, 2012; Pfluger et al., 2007).  
Current research has investigated the association of circulating PYY concentration with 
obesity and body composition, measured by dual-energy x-ray absorptiometry, in a large 
population adjusting for major confounding factors. Cahill et. al investigated whether 
PYY was associated with obesity classification and body composition by comparing 
fasting serum PYY between normal-weight (NW), overweight (OW) and obese (OB) men 
and women. They found that that serum PYY is not negatively associated with obesity 
status defined by BMI or %BF as was currently accepted (Cahill 2013). Additionally, an 
extensive review in 2005, exploring the anorexigenic effect of PYY, revealed 84% studies 
produced among 41 independent research groups were unable to reaffirm the claim 
proposed by the initial investigations (Batterham et al., 2003).  Data from human studies 
are limited, inconsistent, contain small sample sizes and have utilized less accurate 
obesity measures (such as BMI) in place of more accurate measures of body fat such as 
DXA. Therefore the inaccurate measurement of adiposity and the misclassifications of 
obesity status could be the factor attributing to the contradictory reports concerning the 
association of PYY with obesity. Cahill et al found that circulating PYY was not 
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significantly different among normal-weight, overweight and obese participants and these 
findings were consistent whether obesity status was defined either by %BF or BMI. With 
over 2000 subjects, these results indicate that circulating PYY concentration is not likely 
a significant factor affecting obesity status at the population level (Newfoundland), in 
particular with respect to men (Cahill 2013).  
Due to the apparent lack of relationship between adiposity status, in particular with men, 
PYY was not investigated in the current study as normal, overweight and obese 
individuals do not demonstrate differing circulating concentrations of PYY. 
3.5.5 Testosterone 
The aging overweight and obese male population is at significant risk of developing 
cardiovascular disease, sleep apnea, osteoarthritis, certain cancers and gonadal 
dysfunction (Glintborg et al., 2014).  Specifically, the androgen hormone testosterone 
naturally decreases with age following full maturity in men, and this decline is further 
amplified by obesity (Allan, Strauss, Burger, Forbes, & McLachlan, 2008; Allan & 
McLachlan, 2010; Camacho et al., 2013; Glass, Swerdloff, Bray, Dahms, & Atkinson, 
1977; Wu et al., 2012). Due to testosterone’s involvement in the promotion of muscle 
protein synthesis, and that it is reduced by the obese state, its response to weight loss 
achieved through resistance training exercise is of particular relevance to our current 
study population (Camacho et al., 2013).  
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3.5.5.1 Testosterone and Obesity 
Obesity’s role in lowering testosterone was evidenced by the Massachusetts Male Aging 
Study (MMAS), which demonstrated that moving from a non-obese to an obese state 
resulted in a decline of testosterone levels comparable to that of advancing ten years in 
age (Travison, Araujo, Kupelian, O'Donnell, & McKinlay, 2007). Conversely, obesity 
may also be compounded by low testosterone levels. Testosterone enhances lipolysis 
and reduces triglyceride uptake in human abdominal adipose tissue. There is a reciprocal 
relationship between obesity status and testosterone where elevated testosterone helps 
prevent weight gain, and lowered testosterone helps promote weight gain (Grossmann, 
2011). Testosterone is also susceptible to conversion into estrogen by excess adipose 
tissue via the fat derived enzyme aromatase (Camacho et al., 2013). Additionally, 
increases in visceral fat which is a fat storage pattern associated with male obesity, also 
increases circulating TNF-α, insulin and leptin, all of which may down regulate the 
hypopituitary gonadal axis and result in reductions in testosterone (Sharman & Volek, 
2004).  
Testosterone has been shown to increase with both lifestyle intervention and surgical 
approaches, though the latter yields more significant results (Botella-Carretero et al., 
2013; Corona et al., 2013; Hakkinen et al., 1988b; Hammoud et al., 2009; W. J. Kraemer 
et al., 1999; Marx et al., 2001; Staron et al., 1994). During these interventions, the 
degree of weight loss was predictive of testosterone response, with the largest percent of 
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body weight lost yielding the greatest increase in testosterone (Camacho et al., 2013). It 
is believed that the magnitude of weight loss required to augment testosterone levels 
must amount to 15% of one’s body weight. As typical weight loss interventions yield 
between a 6-17% decrease in body weight, only the weight loss interventions which 
yield the greatest results are successful at augmenting testosterone (Camacho et al., 
2013). 
3.5.5.2 Testosterone and Exercise 
Changes in resting testosterone concentrations during resistance training have been 
inconsistent. Testosterone concentrations have shown increases in some studies 
(Hakkinen et al., 1988a; Hakkinen et al., 1988b; W. J. Kraemer et al., 1999; Marx et al., 
2001; Staron et al., 1994) while others have shown no change (Alen et al., 1988; 
Hakkinen et al., 1988b; Hakkinen & Pakarinen, 1994; Hakkinen et al., 2000a; Hickson 
et al., 1994; McCall et al., 1999). It is believed that the current state of lean body mass 
corresponds to resting concentrations of testosterone in that increases or decreases may 
occur depending upon both the volume and the intensity of exercise performed 
(Hakkinen et al., 1988a; Hakkinen et al., 1988b).  
Resistance exercise and its corresponding acute testosterone response have been the 
focus of several investigations (Gotshalk et al., 1997; Hakkinen et al., 2002; Izquierdo et 
al., 2006; R. R. Kraemer et al., 2006; W. J. Kraemer et al., 1998; Linnamo et al., 2005). 
Acute elevations in testosterone have been attributed to adrenergic stimulation, lactate-
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stimulated secretion, and potential adaptations in the testosterone synthesis of leydig 
cells in the testes (Durand et al., 2003). Hormonal response to resistance training is 
dependent upon several variables including volume, number of sets, order of exercise, 
intensity, rest intervals, and choice of exercise.  
Exercises which encompass large muscle groups including Olympic lifts (W. J. Kraemer 
et al., 1998), deadlifts (Heavens et al., 2014), squats and squat jumps (Volek, Kraemer, 
Bush, Incledon, & Boetes, 1997) demonstrate the highest acute testosterone response. 
The addition of large muscle group exercises at the beginning of a resistance training 
routine has been shown to increase the hormonal response from smaller muscle group 
exercises, which would not typically elicit an acute testosterone response had the larger 
exercise not been performed initially (L. Hansen et al., 1999). Therefore the design of 
structured resistance training programs aimed at producing increases in circulating 
testosterone should incorporate the use of large muscle exercises at the start of an 
exercise sessions.  
In order to stimulate a testosterone response from exercise there appears to be a required 
level of intensity which must be achieved. This intensity is closely tied to training 
volume. Low intensity exercise which is characterized by loads that are less than 50% of 
an individual’s one repetition maximum and a low number of repetitions, have not been 
shown to elicit a testosterone response (W. J. Kraemer & Ratamess, 2005).  Kreamer 
demonstrated that when total volume is unchanged, a reduction in training intensity can 
126   
 
    
prompt a lower testosterone response (W. J. Kraemer & Ratamess, 2005). Similarly, 
when repetitions are kept constant, higher load and the resulting higher volume exercise 
protocols bring about a greater testosterone release post exercise (Hakkinen & 
Pakarinen, 1993). It has been shown that working at or close to an individual’s repetition 
maximum yields the highest testosterone response. However, there appears to be a 
ceiling on intensity. Hakkinen showed that ten sets was needed to increased testosterone; 
however, increasing the number of sets to twenty did not significantly increase 
testosterone levels indicating that there is a ceiling effect with resistance exercises 
(Hakkinen & Pakarinen, 1993). 
3.5.5.3 Testosterone and Nutrition 
The impact of diet on testosterone is unclear. It appears that reducing total fat intake and 
drastically increasing polyunsaturated to saturated fat intake ratios results in a decrease 
in total testosterone in women (Allen, Appleby, Davey, & Key, 2002). Whether men 
respond accordingly, however, has not yet been investigated to our knowledge. It is also 
unclear how diet related decreases in total testosterone influences muscle mass, if at all. 
It has been recommended that to improve testosterone, 25% of dietary calories should be 
in the form of protein, which allows for adequate carbohydrate intake to provide energy 
during resistance-training sessions and adequate fat to maintain circulating testosterone 
levels (Lambert et al., 2004). The impact on testosterone as a result of reducing dietary 
saturated fat must be balanced with the potential beneficial effects of these changes on 
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cardiovascular risk factors (Lambert et al., 2004). Clearly, more research on these 
relationships needs to be conducted.  
3.5.5.4 Testosterone Summary  
In summary, resistance training programs seeking to improve testosterone in overweight 
and obese aging males should incorporate methodologies from previous research which 
demonstrates improvements in androgens. This would include the use of large full body 
movement exercises, performed at a high relative load for upwards of ten sets, with 
moderate to low rest intervals. This exercise, coupled with a caloric restriction diet 
aimed at reducing body weight, may foster a physiological environment which promotes 
improved testosterone in a population susceptible to its decline. Lastly, it is expected 
that weight loss achieved through resistance exercise would not only promote 
testosterone as a result of physical activity, but would also reduce the inhibitory effects 
of counter regulatory hormones TNF-α, leptin and insulin. Therefore, we believe that the 
assessment of testosterone in the current investigation is an important biomarker in the 
current study cohort due to testosterone’s relationship with other energy regulating 
hormones, obesity and resistance training.  
3.5.5 Energy Regulating Hormones Summary 
Obesity is a complex condition that is controlled in part by adipose tissue related 
hormones which play an important role in energy regulation (Fasshauer & Bluher, 
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2015). Adipose tissue produces, interacts with, and augments these hormones, which in 
turn effects insulin sensitivity (Chandran et al., 2003), inflammation (de Carvalho et al., 
2006), appetite (Schubert et al., 2014) and protein synthesis (Camacho et al., 2013). 
Traditional approaches to assessing weight loss intervention effectiveness have focused 
on weight loss, with some approaches addressing changes in biochemical and 
physiological health (Simpson et al. 2008). Recent advances in the understanding of 
adipose tissue as an endocrine organ have led to an improved understanding of the 
impact of weight loss on energy regulating hormones (Fasshauer & Bluher, 2015). This 
research has also demonstrated that where fat is stored also impacts these hormones and 
causes resulting health risks (P. Patel & Abate, 2013). Therefore, the objective of this 
research is to determine the influence of supervised resistance training and a hypocaloric 
macronutrient scheduled diet vs a hypocaloric macronutrient scheduled diet alone on the 
fasting energy regulating hormones adiponectin, TNF-α, leptin, ghrelin and testosterone 
in overweight and obese men ages 35-55. Additionally, this research will investigate the 
relationship between these energy regulating hormones and body fat topography, 
including total and regional adiposity.  
4. Methods  
This chapter outlines the eligible study population, the study sample including the 
setting for the study and the primary sample size, the intervention and control, 
N=5
1 
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definitions of outcomes of interest (primary and secondary), data analysis, and ethical 
considerations.  
4.1 Ethics Statement 
This study was approved by the Health Research Ethics Authority (HREA), Memorial 
University of Newfoundland and Labrador (#11.327).  All subjects provided written 
informed consent prior to participation in the research study. HREA approval letter 
(including renewal application), and consent form are included in Appendix 9 and 10. 
4.2 Study Design 
This was a randomized control trial (RCT) that lasted twelve weeks. Subjects were 
randomized to either a Resistance Training and Diet (Exercise + Diet) or Diet (Diet 
Alone) intervention group.  Individuals in the Exercise + Diet group underwent strength 
training sessions at a local fitness facility (Definitions Health and Wellness) supervised 
by a certified kinesiologist for the duration of the intervention (see below for details). 
The kinesiologist was provided with comprehensive training by the primary investigator 
and a manual (Appendix 1 – Research Assistant Handbook) to ensure that he 
understood the exercise intervention as well as the study protocols and processes 
surrounding their role in the research. To ensure that exercise sessions were 
implemented correctly, the primary investigator reviewed workout logs and met with the 
kinesiologist weekly. All subjects in both groups met with a registered dietitian (RD) in 
130 
order to review the dietary guidelines of the intervention and to provide food logs, as 
well as to take home information regarding nutrition planning.  
As part of the RCT design, blinding was ensured whenever possible. Subjects, as well as 
the certified kinesiologist and registered dietitian (RD) directly involved with the 
intervention were aware of group allocation due to the nature of the study, which 
required structured exercise for some (Exercise + Diet) and not others (Diet Alone). The 
primary investigator was not aware of group allocation to avoid potential measurement 
bias during skinfold and girth measurement assessment. Assessment of fitness testing 
was performed at the School of Human Kinetics and recreation by the resident 
laboratory kinesiologist who was unaware of group allocation, however the kinesiologist 
performing the physical training was unable to be blinded due to their involvement with 
the training. Similarly, the RD who audited food logs was required to be aware of group 
allocation due to the various timing of nutrients pre and post exercise for the Exercise + 
Diet group. The RD was not involved with any data collection this did not impose any 
bias in the assessment of diet using the food intake questionnaire (Appendix 12) and the 
diet assessment (Appendix 13) provided at the Complex Diseases Laboratory at 
Memorial University.  
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Figure 3: Study design: Randomized trial to either the Exercise + Diet or Diet Alone intervention groups 
Each stage of the exercise training was designed based on previously established 
protocols shown to elicit muscular hypertrophy in similar populations (Vingren et al., 
2010).  All subjects underwent nutritional education and submitted weekly food logs 
which were monitored for compliance to the nutrition protocol (see below for details).  
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4.3 Study Population  
Fifty-one 35-55 year old males participated in this study.  Inclusion criteria 1) male; 2) 
BMI in the overweight (BMI > 25 < 30); or obese category I (BMI ≥ 30 < 35); 3) 35-55 
years of age; 4) not currently engaging in physical activity. Physical activity was self-
reported and had to describe their activity level as sedentary and not currently 
participating in structured or intentional physical activity (i.e. walk regularly, play 
sports, go to gym) were excluded.  Subjects were recruited through at businesses in the 
city of St. John’s (NL, Canada) and surrounding areas. These businesses were in a 
variety of locations and included blue and white collar workplaces to ensure a variety of 
potential subjects. Potential subjects were verbally informed on the upcoming study and 
if interested were sent a recruitment email which outlined enrollment and inclusion 
criteria (Appendix 11). Recruitment for the initial phase of the research (initial 30 
subjects) took approximately four weeks, from the beginning of November to start of 
December 2013 and, during the second phase of the research, recruitment occurred 
much more quickly with the second phase of recruitment (n=21) taking only a week. The 
second phase of recruitment occurred the same time the following year, consisting of the 
first week of November 2014. Seventy-eight individuals volunteered for the study, 
however, 27 were excluded for various reasons including: having a pre-existing 
metabolic condition, a BMI of either below the overweight BMI category (BMI < 30) or 
greater than the obese class I category (BMI>34.99), or inability to attend the full twelve 
week intervention in succession. 
133   
 
    
 
4.4 Study Interventions  
4.4.1 Resistance Training Protocol 
Participants were instructed to follow the Canadian Society for Exercise Physiology 
(CSTF 1995) preliminary instructions (no smoking, caffeine or alcohol) prior to exercise 
(CSTF 1995).  Subjects in the Exercise + Diet group underwent supervised (certified 
kinesiologist) strength training sessions three times per week for twelve weeks. The 
kinesiologist was trained by the primary investigator, and was provided with a 
standardized research assistant manual (Appendix 1) developed by the primary 
investigator. The manual provided guidance on proper workout facilitation and 
coaching.  Exercise was divided into three separate, four week progressive resistance 
training programs.  The initial four week protocol involved three sets of fifteen 
repetitions of eight different exercises (Appendix 2) including an exercise for each of 
the following muscle groups: full body compound movement, chest, back, legs, biceps, 
triceps, shoulders and core.  All eight exercises were performed in succession with a 
sixty second break following the eighth exercise.  The second phase of resistance 
training involved nine sets of twelve repetitions of three body parts, such as chest, back, 
and core, shoulders, legs, and core, and triceps, biceps and core.  Exercises were divided 
into groups of two that involved opposing muscle groups, and were performed in 
succession with a sixty second rest interval between sets.  A total of nine exercises were 
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performed each day (three for each primary muscle group and three for the core) 
(Appendix 3).  During the final phase individuals performed ten sets of ten repetitions 
for two body parts per day. Examples of these routines are as follows; chest & back – 
bench press, latissimus dorsi pulldown. shoulders & legs – shoulder press, barbell squat; 
and biceps & triceps – dumbbell curls, db triceps extensions.  One set of each exercise 
was performed in succession, which was followed by a sixty second rest period.  This 
was repeated until all ten sets were completed for both exercises in the routine 
(Appendix 4).  Tempo was controlled by the kinesiologist, and included a three second 
eccentric movement, a one second pause and a one second concentric movement.  All 
workouts were tracked and recorded in order to progressively overload the subjects and 
improve strength over the course of the training. Subjects booked all of the exercise 
sessions through the kinesologist using a fitness facilities booking system 
(Mindbody.com). Workout attendance for the Exercise + Diet group was tracked by the 
primary investigator via the online booking system to ensure that all participants 
completed their required exercise training. At the end of twelve weeks, it was 
determined that all Exercise + Diet subjects completed their prescribed workouts and 
completed the protocol.  Subjects who missed scheduled exercise sessions were 
provided with an alternative time during the same week to make up for the missed 
session. Verbal encouragement was also provided to all participants during exercise 
sessions.  
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4.4.2 Diet Protocol 
Baseline energy requirements were determined from 24-hr diet recalls and a thirty day 
dietary inventory.  Participants were instructed to consume approximately sixteen 
hundred calories per day (hypocaloric diet), and to adhere to a macronutrient 
contribution of  30% protein, 30% fat, and 40% carbohydrates to mimic guidelines 
shown to be effective in weight loss studies, and which impact energy regulating 
hormones (Bowen et al., 2006; Niwano et al., 2009; Tannous dit El Khoury et al., 2006).  
Subjects were encouraged to eat three meals and three small snacks each day.  A 
nutrition education session was completed with each subject, where macronutrients, 
timing of food intake and recommendations for meal selection were taught by a 
registered dietitian. The primary investigator was also in attendance to answer questions 
surrounding food log requirements.   This one hour session included a take home and 
online education manual that clearly outlined healthy options and recommended dietary 
selections for each period of the day, in order to ensure a balance of nutrients at each 
meal (Appendix 5 – Meal Planner).  All subjects participated in the nutrition 
intervention; however the Diet Alone was encouraged to follow the nutrition guidelines 
while maintaining their previous level of physical activity during the course of the study. 
This separation was reinforced by restricting fitness facility access to only those in the 
Exercise + Diet group.  Exercise avoidance was assessed as part of the food log, which 
required subjects to record all physical activity or exercise during the week. Food logs 
required individuals to record meals and snacks for each day of the week (3 meals and 3 
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snacks/day). As part of this reporting foods were recorded under a specific 
macronutrient category that represented the primary macronutrient that the food 
consisted of (e.g. Peanut butter = fat, fish = protein, apple = carbohydrate). Lists of food 
categories and their respective serving sizes were included in the education manual and 
this ongoing education and macronutrient awareness created through food tracking was 
an intentional design of the study in an attempt to re-enforce RD coaching (Appendix 5). 
These food logs were subjective in nature and did not utilize a validated measurement 
tool. Therefore, no data analysis was performed on these tracking sheets, rather they 
were used to coach subjects to dietary change.  
All subjects from both the Exercise + Diet and Diet Alone groups received a handbook 
following the education session with key nutrition principles, recipes and sample meal 
plans. As part of the research design, the dietitian was aware of group allocation of all 
subjects during the education session in order to reinforce maintenance of physical 
activity levels in the Diet Alone group. All nutrition education sessions and submitted 
food log reviews were conducted by the same Registered Dietitian during the course of 
the study.  
4.4 Randomization 
Subjects were block randomized in groups of 8 via sealed envelope to that were 
prepared and shuffled by the primary investigator. Subjects chose an envelope following 
baseline testing with the kinesiologist in the Human Kinetics and Recreation Physiology 
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Lab. Regardless of group allocation, all subjects were booked to meet with the RD to 
undergo diet education. Subjects allocated to the Exercise + Diet group were also 
provided instructions on exercise training and booked their initial session in the fitness 
facility using the online booking tool (mindbody.com). 
4.5 Study Outcomes 
Anthropometric, body composition, physical and biochemical measurements were 
collected, at baseline and after twelve weeks, following a twelve hour fast.  Each subject 
completed a questionnaire to obtain baseline information regarding lifestyle and physical 
activity.  Girth measurements and skin fold thickness measurements were assessed the 
following day at baseline and after twelve weeks by the primary investigator, who was 
blinded to group allocation. Variables and their assessment scales are included in Table 
1 and testing and the data collection process is included in Figure 4. All subjects 
completed the intervention, and were tested at baseline and after twelve weeks. There 
were no drop outs or missing data from the subjects at either baseline or follow-up.  
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Figure 4. Baseline and post intervention testing was performed at the Complex Diseases Laboratory in the 
School of Medicine and Physiology Laboratory at the School of Human Kinetics and Recreation at 
Memorial University. Trained laboratory technicians conducted DXA and anthropometric measures, 
blood collection, sample analysis, dietary questionnaires at the Complex Diseases Laboratory. Subjects 
then went to the Human Kinetics and Recreation Physiology Laboratory where they participated in fitness 
testing, skin fold and girth measurements.  
  
	 15	
 
Table 1. Variable Definitions and Measurement Scales 
 
Body Composition Characteristics Variable Type Assessment Method 
Age (yr) Objective Recall 
Height (m) Objective Medical scale 
Weight (kg) Objective Medical scale 
Waist (cm) Objective Measuring tape 
Hip (cm)  Objective Measuring tape 
Total Body Fat (kg) Objective DXA 
Total Lean Tissue (kg) Objective DXA 
Body Fat (%) Objective DXA 
Trunk Fat (% ) Objective DXA 
BMI (kg/m2) Objective Predictive equation 
Visceral Fat (kg) Objective DXA 
Metabolic Characteristics      
HDL Cholesterol (mmol/L) Objective Blood sample 
LDL Cholesterol (mmol/L) Objective Blood sample 
Total Cholesterol (mmol/L) Objective Blood sample 
Triacylglycerol (mmol/L) Objective Blood sample 
Insulin (pmol/L) Objective Blood sample 
HOMA-IR Objective Predictive equation 
HOMA-β Objective Predictive equation 
Glucose (mmol/L) Objective Blood sample 
Systolic Blood Pressure (mmhg) Objective Blood pressure cuff 
Diastolic Blood Pressure (mmhg) Objective Blood pressure cuff 
Heart Rate (bpm) Objective Blood pressure cuff 
Energy Regulating Hormones      
Adiponectin (ug/ml) Objective Blood sample 
Leptin (ug/ml) Objective Blood sample 
TNF-α (pg/ml) Objective Blood sample 
Total Testosterone (pg/ml) Objective Blood sample 
Free Testosterone (pg/ml) Objective Blood sample 
Ghrelin (pg/ml) Objective Blood sample 
Fitness Tests     
Pushups Objective Standardized fitness test 
Sit and Reach Objective Standardized fitness test 
Partial Curl-Up Objective Standardized fitness test 
Back Extension Objective Standardized fitness test 
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4.5.1 Serum Hormone and Biochemical Measurements 
All hormonal blood measurements and analysis were performed by a trained laboratory 
technician in the Complex Diseases Laboratory, located in the Faculty of Medicine at 
Memorial University.  
Fasting serum was collected from subjects in the morning between 9 am and 11 am 
following a twelve hour fast, and was stored at -80 °C for subsequent analysis.  
Adiponectin, (EMD Millipore, Austin, TX, USA), and testosterone (Phoenix 
Pharmaceuticals, Belmont, California) were measured in duplicate utilizing, enzyme-
linked immunosorbent assays.  Leptin, ghrelin, and TNF-α were also measured in 
duplicate using a magnetic bead-based quantitative immunoassay via the MAGPIX 
system (EMD Millipore, Austin, TX, USA).  The intra-assay CV for adiponectin (n=3, 
average of Plate 1, Plate 2 and Plate 3 = 2.8 + 3.8 + 3.1) was 3.2% while the  
inter-assay CV (n=3, Average of High and Low control 7.1% and 1.2%) was 4.2%. The 
TNF-α intra-assay CV (n=3, Average of Plate 1, Plate 2 and Plate 3 = 6.9%, 5.5% and 
5.6%) was 6.0% and the inter-assay CV (n=3, Average of High and Low control = 5.3% 
and 5.2%) was 5.3%. Leptin demonstrated an intra-assay CV (n=3. Average of Plate 1, 
Plate 2 and Plate 3 = 6.7%, 5.7% and 5.4%) of 5.9% and an inter-assay CV (n=3, 
Average of High and Low control = 7.4% and 2.7%) of 5.1%. Ghrelin showed an intra-
assay CV (n=3, Average of Plate 1, Plate 2 and Plate 3 = 6.6%, 5.6% and 4.4%) of 5.3% 
and an inter-assay CV (n=3, Average of High and Low control = 6.1% and 4.1%) of 
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5.1%. The intra-assay CV of total testosterone (n=3, Average of Plate 1, Plate 2 and 
Plate 3 = 3.6%, 2.9% and 3.4%) was 3.3% while the inter-assay CV (n=3, Average of 
High and Low control = 1.4% and 3.6%) was 2.5% 
Serum insulin concentrations were measured with the use of an immunoassay analyzer 
(Immulite; DPC, Los Angeles, CA).  The homeostasis model assessment (HOMA) was 
used to measure insulin resistance and β-cell function (Matthews et al., 1985). 
 
 
The homeostatic model assessment (HOMA) is a method used to quantify insulin 
resistance and beta-cell function. It was first described under the name HOMA by 
Matthews et al. (Matthews et al., 1985) 
Serum concentrations of glucose, triacylglycerols (TG), high-density lipoprotein 
cholesterol (HDLc) and total cholesterol were measured by an Lx20 analyzer (Beckman 
Coulter Inc, Fullerton, CA).  Low-density lipoprotein cholesterol (LDLc) was calculated 
with the following formula which is reliable in the absence of severe hyperlipidemia.  
LDLc = [Total Cholesterol(mmol/L) – HDL Cholesterol (mmol/L) – (Triacylglycerol 
(mmol/L/2.2)] 
)5.22/])/[cos_]/[_(( LmmoleGluFastingmlUInsulinFastingIRHOMA  
))5.3]/[cos_/(]/[_20((  LmmoleGluFastingmlUInsulinFastingHOMA 
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The samples were analyzed in batches at the end of the study. Upon the completion of 
the study the samples are thawed and analyzed. All of the samples were measured in 
batches were as many participant samples, both pre and post, could be measured on a 
single plate. For example, when doing ELISA on a 96 well plate 16 wells were used to 
build the standard curve in duplicate and another 4 wells were used for 2 standard 
controls. Since both the pre and post samples were measure in duplicate on the same 
plate 4 wells were required per subject. Therefore 19 subjects (with both pre and post 
samples) were measured on each ELISA plate. Sample analysis for glucose, triglycerides 
and lipids was performed in a similar fashion following the completion of the study at 
the Memorial University Medical School biochemistry laboratory run by Dr. Edward 
Randell. 
 
4.5.2 Anthropometric and Body Composition Measurements 
Height (nearest 0.1 cm) and weight (nearest 0.1 kg) measurements were collected, 
repeated twice, and averaged for subjects who were wearing a standard hospital gown 
without footwear, using a platform balance weigh scale (Health O Meter, Bridgeview, 
IL). BMI was calculated as weight divided by height squared (kg/m2) from these 
measurements.  Obesity status has been grouped as overweight (BMI 25.00–29.99), and 
obese (BMI ≥ 30-34.99), as recommended by the World Health Organization (WHO) 
(World Health Organization, 2015).  Percent trunk fat was measured utilizing dual x-ray 
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absorptiometry (DXA) (Lunar Prodigy, GE Medical Systems, Madison, WI, USA).  
Measurements were performed on subjects in a supine position after the removal of all 
metal accessories.  The enCORE software package (version 12.2, GE Medical Systems, 
Madison, WI, USA) was used for DXA data acquisition.   
Skin fold and girth measurements were taken following the American College of Sports 
Medicine’s (ACMS) guidelines for fitness testing (ACSM, 2014).  Skin fold sites 
included the chest, triceps subscapularis, mid-axillary, suprailiac, abdominal and thigh.  
Girth measurements included the biceps (flexed and relaxed), neck, chest, waist, hip, and 
thigh. The specific standardized protocols of skin fold/girth measurements are included 
in Appendix 6. All measurements were taken in triplicate and averages of the scores 
were recorded as the site value.  
The sum of the skin fold’s body fat percentage was calculated using the Jackson Pollock 
7 site skin fold protocol that determines body fat using the various skin fold sites listed 
above. This protocol was developed from the research of Dr. Andrew Jackson and M. L. 
Pollock (Jackson & Pollock, 2004). The primary investigator, who was blinded to group 
allocation, took all anthropometric measurements, and is certified by the Canadian 
Society of Exercise Physiology to perform these tests.  
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4.3 Fitness Testing 
Fitness testing was completed according to the Canadian Society of Exercise 
Physiology’s (CSEP) guidelines for fitness testing and included tests for muscular 
strength, endurance and flexibility. This testing was performed at the Human Kinetics 
and Recreation laboratory at Memorial University by the resident certified kinesiologist. 
These tests included a push up test, partial curl-up, back extension, and sit and reach 
flexibility (fitness testing protocols included in Appendix 7). All baseline and post 
intervention fitness testing was performed by the kinesiologist. 
4.6 Sample Size and Statistical Analysis  
Preliminary sample size calculation was based on the Fatourous study which measured 
the adiponectin response to high intensity exercise training (Fatourous et al., 2005). 
Therefore, using a mean difference of 18% in adiponectin, shown to be statistically 
significant by the Fatourous study, and a mean total adiponectin concentration of 8.1 
ug/ml with a SD of 2 ug/ml, an alpha of 0.05, and a power set to 0.8, a total of 15 
subjects were needed in the intervention group.  
Following completion of the initial study an interim analysis was performed. Based on 
preliminary data analysis it was decided to to increase the sample size. This resulted in 
additional recruitment of subjects and a re-running of the study. The final sample size 
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was determined from a power calculation on adiponectin from the initial fifteen subjects 
who were recruited in each group.   
When setting the minimum mean difference to 25% for the Exercise + Diet group 
(n=15) with the Standard Deviation (SD) of the adiponectin measurement from the 
interim analysis of 13.1 ug/ml , an alpha of 0.05, and a power set to 0.8, a total of 26 
people are needed. Therefore, we recruited eleven more subjects for this group.  
When setting the minimum mean difference to 25% for the Diet Alone group (n=15), 
with the Standard Deviation of the adiponectin measurement from the interim analysis 
of 12.0 ug/ml, an alpha of 0.05, and a power set to 0.8, a total of 22 people are needed. 
In total, 11 more subjects were recruited to the Exercise + Diet group and, due to the 
block randomization approach employed in the current study, 10 additional subjects 
were recruited to the Diet Alone group.  
Data are presented as means ± SD, unless otherwise stated.  Before any statistical 
analysis was performed, data that were not normally distributed were logarithmically 
transformed (TG, insulin, HOMA-IR and HOMA-β) to approximate normal distribution.  
Baseline values between the two groups were analyzed using an independent student’s  
t-test and a Bonferonni adjustment was used to control for multiple comparisons. Within 
groups analysis in response to the Exercise + Diet and Diet Alone groups was performed 
using a student paired t-test to ensure similarity between groups. Differences in variables 
between the two groups were analyzed using a two-way repeated measures analysis of 
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variances test (ANOVA).  The Main Effect P-value was reported along with interaction 
(Intervention * Group) P-Value if it was found to be significant (p < 0.05).  An 
interaction effect is a change in the simple main effect of one variable over levels of the 
second.  For example, if the differences (due to the interventions) describing the simple 
main effects are not parallel, an interaction would exist.  Therefore, a simple main effect 
can be found without differential influences from the two interventions.  Pearson's 
correlation analysis was also performed to identify potential factors related to the 
variables of interest. Additionally, two correlation analyses were performed as follows: 
1) Adiponectin, leptin, TNF-α, testosterone, and ghrelin at baseline were compared with 
all physical and biochemical phenotypes at baseline 2) Adiponectin, leptin, TNF-α, 
testosterone, and ghrelin at baseline were compared with changes in physical and 
biochemical phenotypes in response to the interventions.  A two-way ANCOVA 
analysis was also performed while controlling for variables which may influence the 
response of adiponectin, leptin, TNF-α, testosterone, and ghrelin regarding the 
interventions.   SPSS software version 20.0 (SPSS Inc, Chicago, IL, USA) was used for 
all analyses.  Statistical analyses were 2-sided and p < 0.05 was considered to be 
statistically significant.  
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5 Results 
5.1 Study Baseline Characteristic and Adherence: 
Of the seventy eight individuals who responded to the study advertisements, twenty 
seven did not meet inclusion criteria. Six were excluded because of serious metabolic 
conditions, twelve had a BMI that was not within the overweight or obese class I range, 
and eight were excluded due to age, as they were either below the 35 year old minimum 
or above the 55 year old maximum (Figure 5- subject flow diagram demonstrating 
recruitment, group randomization and follow-up).  
Fifty-one males, aged 35-55 years old, classified by BMI as either overweight or obese, 
who self-reported as physically inactive (not engaging in regular or structured physical 
activity) and not suffering from a serious metabolic, cardiovascular, or endocrine disease 
met the inclusion criteria (Figure 5).  Of the fifty one subjects recruited to the study 
twenty six were randomized to the Exercise + Diet group and twenty five were 
randomized to the Diet Alone group.  All subjects completed the intervention, and were 
tested at baseline and after twelve weeks and the study was stopped after all subjects 
completed their respective interventions (Figure 5).  There were no significant 
differences between groups at baseline for any anthropometric or biochemical 
measurements (Table 2).   
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Figure 5: Study flow diagram: Include a flow diagram that would also show the disposition of subjects 
into the two arms, and how many completed each time point. 
Body Composition Characteristics Mean SD  Mean SD p     Sig 
Age (yr) 43.45 ± 5.8 45.73 ± 7.1 0.217 NS 
Height (m) 179.00 ± 6.5 176.68 ± 5.1 0.164 NS 
Weight (kg) 102.90 ± 13.4 99.00 ± 17.2 0.372 NS 
Waist (cm) 111.99 ± 10.2 110.22 ± 11.8 0.579 NS 
Hip (cm) 109.83 ± 8.8 108.09 ± 11.5 0.56 NS 
Total Body Fat (kg) 34.28 ± 10.0 31.56 ± 10.3 0.344 NS 
Total Lean Tissue (kg) 64.99 ± 6.3 64.25 ± 8.8 0.731 NS 
Body Fat (%) 32.83 ± 6.0 31.23 ± 5.0 0.306 NS 
Trunk Fat (%) 40.28 ± 5.8 38.29 ± 5.5 0.216 NS 
BMI (kg/m2) 32.09 ± 3.6 31.62 ± 4.7 0.689 NS 
Visceral Fat (kg) 2.13 ± 0.8 1.89 ± 0.8 0.318 NS 
Metabolic Characteristics
HDL Cholesterol (mmol/L) 1.13 ± 0.2 1.11 ± 0.2 0.798 NS 
LDL Cholesterol (mmol/L) 3.61 ± 0.9 3.89 ± 0.9 0.258 NS 
Total Cholesterol (mmol/L) 5.42 ± 1.1 5.83 ± 1.1 0.188 NS 
Triacylglycerol (mmol/L) 1.50 ± 0.7 1.57 ± 0.7 0.735 NS 
Insulin (pmol/L) 59.36 ± 35.9 76.43 ± 40.1 0.129 NS 
HOMA-IR 2.15 ± 1.4 2.84 ± 1.8 0.143 NS 
HOMA-ß 86.53 ± 54.7 110.43 ± 75.0 0.225 NS 
Glucose (mmol/L) 5.61 ± 0.8 6.04 ± 2.6 0.451 NS 
Systolic Blood Pressure (mmhg) 128.27 ± 9.0 130.22 ± 15.5 0.601 NS 
Diastolic Blood Pressure (mmhg) 84.96 ± 6.0 86.78 ± 12.0 0.516 NS 
Heart Rate (bpm) 67.35 ± 7.0 69.43 ± 12.3 0.478 NS 
Table.2 - Body Composition and Metabolic Characteristics for the Exercise +  Diet and Diet Alone Groups 
at Baseline (n=51)
Baseline 
Exercise + Diet (n=26) Nutrition (n=25) 
Baseline 
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5.2 Physical Fitness Response to Intervention: 
All fitness test scores improved within both the Exercise + Diet and Diet Alone groups. 
The magnitude of these differences was in favor of the Exercise + Diet group. The 
Exercise + Diet group demonstrated a significantly greater increase in fitness testing 
scores (p<0.001) including push-ups (# of repetitions), partial curl-ups (# of repetitions), 
sit and reach flexibility (distance in cms), and back extensions (time holding position), 
with improvements of 22%, 30%, 51%, 40%, respectively (Table 4&5). The Diet Alone 
group also showed significant improvements of 6%, 11.5%, 34.5%, and 22%. Flexibility 
improved the most in the Diet Alone group, which could be a result of changes in 
regional adiposity, specifically that of the trunk. These changes could lead to a greater 
range of motion due to a reduction in fat mass (Table 3).  
5.3 Nutritional Intake Response to Intervention: 
The average caloric intake per day at baseline was 2171.3 ± 705.2 kcal, where average 
protein intake was determined to be 97.6 ± 42.4 g, carbohydrate intake was 274.6 ± 96.1 
g (fiber at 22.6 ± 10.8 g), total fat intake was 75.0 ± 29.0 g;, saturated fats intake was 
21.5 ± 11.2 g. This constitutes a macronutrient intake ratio of approximately 18% 
protein, 55% carbohydrate, and 31% fat.  Following the nutrition education session, both 
groups had their food intake re-assessed at twelve weeks, and showed a decrease of 30% 
in total calories and a 40% reduction in carbohydrate intake per day (g) (Table 6&7).  
As a result the macronutrient intake was 26% and 27% protein, 42% and 44%  
Body Composition Characteristics Mean SD Mean SD p   Sig Mean SD Mean SD p   Sig
Age (yr) 43.45 ± 5.8 -- -- -- -- 45.73 ± 7.1 -- -- -- --
Height (m) 179.00 ± 6.5 -- -- -- -- 176.68 ± 5.1 -- -- -- --
Weight (kg) 102.90 ± 13.4 98.13 ± 12.1 0.000 SIG 99.00 ± 17.2 94.83 ± 16.9 0.000 SIG
Waist (cm) 111.99 ± 10.2 105.75 ± 10.6 0.000 SIG 110.22 ± 11.8 105.89 ± 12.8 0.001 SIG
Hip (cm) 109.83 ± 8.8 105.31 ± 8.8 0.000 SIG 108.09 ± 11.5 104.80 ± 11.0 0.017 SIG
Total Body Fat (kg) 34.28 ± 10.0 28.34 ± 9.7 0.000 SIG 31.56 ± 10.3 27.43 ± 10.1 0.000 SIG
Total Lean Tissue (kg) 64.99 ± 6.3 66.16 ± 6.9 0.000 SIG 64.25 ± 8.8 64.39 ± 8.0 0.629 NS
Body Fat (%) 32.83 ± 6.0 28.35 ± 6.6 0.000 SIG 31.23 ± 5.0 28.07 ± 5.6 0.000 SIG
Trunk Fat (% ) 40.28 ± 5.8 35.11 ± 7.3 0.000 SIG 38.29 ± 5.5 34.54 ± 6.6 0.000 SIG
BMI (kg/m2) 32.09 ± 3.6 30.62 ± 3.3 0.000 SIG 31.62 ± 4.7 30.30 ± 4.6 0.000 SIG
Visceral Fat (kg) 2.13 0.8 1.52 ± 0.8 0.000 SIG 1.89 ± 0.8 1.53 ± 0.8 0.001 SIG
Metabolic Characteristics 
HDL Cholesterol (mmol/L) 1.13 ± 0.2 1.15 ± 0.2 0.498 NS 1.11 ± 0.2 1.19 ± 0.2 0.114 NS
LDL Cholesterol (mmol/L) 3.61 ± 0.9 3.22 ± 0.7 0.011 SIG 3.89 ± 0.9 3.61 ± 0.8 0.086 NS
Total Cholesterol (mmol/L) 5.42 ± 1.1 4.87 ± 0.8 0.005 SIG 5.83 ± 1.1 5.60 ± 1.1 0.214 NS
Triacylglycerol (mmol/L) 1.50 ± 0.7 1.10 ± 0.5 0.001 SIG 1.57 ± 0.7 1.60 ± 0.9 0.771 NS
Insulin (pmol/L) 59.36 ± 35.9 58.92 ± 32.2 0.939 NS 76.43 ± 40.1 70.69 ± 49.5 0.404 NS
HOMA-IR 2.15 ± 1.4 2.07 ± 1.2 0.674 NS 2.84 ± 1.8 2.57 ± 1.6 0.251 NS
HOMA-β 86.53 ± 54.7 101.46 ± 66.1 0.236 NS 110.43 ± 75.0 79.99 ± 46.5 0.009 SIG
Glucose (mmol/L) 5.61 ± 0.8 5.42 ± 0.7 0.199 NS 6.04 ± 2.6 6.24 ± 2.5 0.251 NS
Systolic Blood Pressure (mmhg) 128.27 ± 9.0 121.06 ± 9.0 0.001 SIG 130.22 ± 15.5 132.13 ± 17.6 0.607 NS
Diastolic Blood Pressure (mmhg) 84.96 ± 6.0 78.40 ± 7.6 0.000 SIG 86.78 ± 12.0 85.91 ± 10.1 0.196 NS
Heart Rate (bpm) 67.35 ± 7.0 62.18 ± 9.2 0.005 SIG 69.43 ± 12.3 63.30 ± 11.3 0.006 SIG
Energy Regulating Hormones 
Adiponectin (ug/ml) 24.05 ± 13.1 21.34 ± 12.2 0.304 NS 23.51 ± 12.0 25.93 ± 16.8 0.422 NS
Leptin (ug/ml) 7.43 ± 4.5 4.77 ± 3.7 0.002 SIG 7.09 ± 6.1 5.56 ± 4.9 0.023 SIG
TNF-α (pg/ml) 5.83 ± 3.6 5.07 ± 3.0 0.108 NS 6.73 ± 3.8 6.69 ± 3.8 0.931 NS
Total Testosterone (pg/ml) 8.32 ± 5.6 7.63 ± 3.7 0.497 NS 6.49 ± 4.6 7.26 ± 4.3 0.312 NS
Free Testosterone (pg/ml) 8.02 ± 4.2 8.97 ± 5.5 0.386 NS 7.54 ± 3.4 8.89 ± 5.7 0.106 NS
Ghrelin (pg/ml) 47.41 ± 46.4 49.76 ± 35.7 0.749 NS 60.13 ± 38.7 41.91 ± 23.8 0.063 NS
Table. 3 - Differences With-In The Exercise + Diet and Diet Alone Groups - Body Composition, Metabolic Characteristics and Energy Regulating Hormones Differences (n=51)
Pre Post Pre Post
Exercise + Diet (n=26) Diet Alone (n=25)
Mean SD Mean SD p Sig Mean SD Mean SD p Sig
Curl-Ups (repetitions) 36.53 ± 7.4 47.53 ± 9.6 0.001 SIG 25 ± 6.41 40.76 ± 6.36 0.001 SIG
Push-Ups (repetitions) 19.65 ± 7.8 23.94 ± 9.5 0.001 SIG 24 ± 7.78 18.65 ± 8.15 0.001 SIG
Flexibility (cm) 15.12 ± 5.1 22.88 ± 7.7 0.001 SIG 16 ± 5.2 20.24 ± 8.15 0.001 SIG
Back Extension (seconds) 41.71 ± 13.7 58.41 ± 19.1 0.001 SIG 35 ± 12.4 52.29 ± 14.9 0.001 SIG
Post Pre Post
Exercise + Diet (n=26) Diet Alone (n=25)
T-Test
Table. 4 - Fitness Measure Differences Within Groups (n=51)
Pre T-Test
p			 Sig p			 Sig
0.001 SIG 0.001 SIG
0.001 SIG 0.001 SIG
0.001 SIG 0.001 SIG
Curl-Ups (repetitions) 
Push-Ups (repetitions) 
Flexibility (cm) 
Back Extension (seconds) 0.001 SIG 0.001 SIG
Table. 5 - Fitness Measure Differences Between Groups ANOVA (n=51)
Two-Way	ANOVA
Main	Effect Interaction
Mean SD Mean SD p Sig Mean SD Mean SD p Sig
Total Calories 2135.1 ± 750 1555.21 ± 162 0.001 SIG 2208.9 ± 669 1512.1 ± 161 0.001 SIG
Protein (grams) 98.12 ± 49.4 100.4 ± 24.6 0.48 NS 97.06 ± 34.6 101.9 ± 28.8 0.57 NS
Carbohydrates (grams) 266.89 ± 104 164 ± 30.1 0.001 SIG 282.72 ± 88.1 168.7 ± 26.9 0.001 SIG
Dietary Fiber (grams) 22.35 ± 10.6 20 ± 8.5 0.71 NS 22.91 ± 11.3 21 ± 5.32 0.65 NS
Fat (grams) 65.95 ± 29.7 54.4 ± 16.7 0.74 NS 64 ± 28.7 45.9 ± 13.4 0.63 NS
T-TestPost
Exercise + Diet (n=26) Diet Alone (n=25)
T-Test
Table. 6 - Nutritional Intake Differences Within Groups (n=51)
Pre Post Pre
p			 Sig p			 Sig
0.021 SIG 0.222 NS 
0.527 NS 0.648 NS 
0.001 SIG 0.135 NS 
0.167 NS 0.661 NS 
Total Calories 
Protein (grams) 
Carbohydrates (grams) 
Dietary Fiber (grams) 
Fat (grams) 0.683 NS 0.505 NS 
Table. 7 -  Nutritional Intake Differences Between Groups (n=51)
Two-Way	ANOVA
Main	Effect Interaction
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carbohydrates and 30% and 27% fat intake for the Exercise + Diet and Diet Alone 
groups, respectively.  As a result no statistically significant differences were found 
between groups with respect to total calories per day, as well as with respect to total 
protein, carbohydrate, saturated fat and dietary fiber (g) intake at baseline and twelve 
weeks.  These results suggest that the intervention was adhered to equally by both 
groups (Table 6&7).  Adherence to the nutrition program was monitored by the 
registered dietitian, who received weekly food logs from all participants. Food logs were 
submitted an average of eleven times over twelve weeks, and no subjects went longer 
than one week without submitting a food log. There was no statistically significant 
difference in participation between groups with both the Exercise + Diet and Diet Alone 
groups submitting food logs 90% of the time (Table 8).  
5.4 Physical & Biochemical Response to Intervention 
Although the Exercise + Diet group had two interventions that could cause weight loss 
as opposed to the single intervention experienced by the Diet Alone group, both groups 
lost a similar amount of weight after twelve weeks (~5 kg and ~ 4 kg, respectively).  
This modest weight loss was significantly lower than baseline (p<0.001) for each group, 
but there was no statistically significant difference between the groups after twelve 
weeks.   
Exercise + Diet 
(n=26)
Diet Alone        
(n=25)
Week 1 25 24
Week 2 24 20
Week 3 24 22
Week 4 22 20
Week 5 22 22
Week 6 24 24
Week 7 23 23
Week 8 22 21
Week 9 24 23
Week 10 23 23
Week 11 24 24
Week 12 26 24
91% 90%
Table 8. Food Log Compliance during 12 Week Intervention (n=51)
Group
Body Composition p   Sig p   Sig
Weight (kg) 0.000 SIG 0.601 NS
Waist (cm) 0.000 SIG 0.191 NS
Hip (cm) 0.000 SIG 0.424 NS
Total Body Fat (kg) 0.000 SIG 0.137 NS
Total Lean Tissue (kg) 0.002 SIG 0.016 SIG
Body Fat (%) 0.000 SIG 0.135 NS
Trunk Fat (% ) 0.000 SIG 0.209 NS
BMI (kg/m2) 0.000 SIG 0.692 NS
Visceral Fat (kg) 0.000 SIG 0.050 SIG
Metabolic Characteristics 
HDL Cholesterol (mmol/L) 0.080 NS 0.318 NS
LDL Cholesterol (mmol/L) 0.003 SIG 0.627 NS
Total Cholesterol (mmol/L) 0.004 SIG 0.235 NS
Triacylglycerol (mmol/L) 0.007 SIG 0.025 SIG
Insulin (pmol/L) 0.483 NS 0.547 NS
HOMA-IR 0.235 NS 0.507 NS
HOMA-β 0.352 NS 0.009 SIG
Glucose (mmol/L) 0.926 NS 0.084 NS
Systolic Blood Pressure (mmhg) 0.179 NS 0.024 NS
Diastolic Blood Pressure (mmhg) 0.000 SIG 0.041 SIG
Heart Rate (bpm) 0.000 SIG 0.992 NS
Energy Regulating Hormones 
Adiponectin (ug/ml) 0.942 NS 0.197 NS
Leptin (ug/ml) 0.000 SIG 0.266 NS
TNF-α (pg/ml) 0.207 NS 0.251 NS
Total Testosterone (pg/ml) 0.946 NS 0.253 NS
Free Testosterone (pg/ml) 0.093 NS 0.765 NS
Ghrelin (pg/ml) 0.187 NS 0.039 SIG
Table. 9 - Differences Between Exercise + Diet and Diet Alone Groups - Body 
Composition, Metabolic Characteristics and Energy Regulating Hormones
Two Way ANOVA
Interaction   Main Effect
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This trend continued for circumferential measurements of the waist (p<0.001) and hips 
(p<0.001), which reduced by ~5 cm and ~4 cm respectively in both groups.   
Measurement of adiposity including total body fat (in kg), body fat percentage (%BF), 
trunk fat percentage (%TF), and BMI also reduced (p<0.001), all of which was expected 
given the similar reduction in weight for both groups. The Exercise + Diet group 
displayed a moderate increase in lean body mass of 1.2 kg (p=0.016) most likely as a 
result of the resistance training intervention. Additionally, visceral fat, which decreased 
in both groups, showed a 42% greater reduction in fat mass in the Exercise + Diet group 
as compared to the Diet Alone group (p=0.05) (Table 9).  
In addition to weight loss and anthropometric changes, cardiovascular and blood lipid 
measurements demonstrated overall and intervention specific responses within and 
between groups (Table 9&10) 
Baseline and follow-up assessment was conducted to determine the total number of 
subjects in the study, and in each intervention group, who possess diabetes, hypertension 
and dyslipidemia (Table 10). With respect to blood pressure, 9 subjects in the study 
were normotensive, 31 were pre-hypertensive and 7 subjects were classified as 
hypertensive at baseline. Following the twelve week interventions the total number of 
normotensive individuals increased from 9 to 19, where the Exercise + Diet group saw 
an increase in normotensive individuals from 4 at baseline to 14 at follow-up. The Diet 
Alone group showed 5 individuals who were classified as normotensive at baseline and  
Table.10 - Blood pressure, glucose and lipid risk classifications of study participants (n=51) ts (n=51)
Pre Post Pre Post Pre Post
Normal 9 19 4 14 5 5
Prehypertension 31 21 18 11 13 10
Hypertension 7 7 3 0 4 7
Pre Post Pre Post Pre Post
Normal 41 38 22 23 19 15
Prediabetic 5 8 3 2 2 6
Diabetic 3 3 1 1 2 2
Pre Post Pre Post Pre Post
Normal 17 28 11 19 6 9
Boarderline 15 12 8 4 7 8
Dyslipidemia 16 8 7 3 9 5
Blood Pressure
Normal	=	Systolic	Blood	Pressure	<	120	mm	Hg
Prehypertension	=	Systolic	Blood	Pressure	121	-	139	mm	Hg
Hypertension	=	Systolic	Blood	Pressure	>	140	mm	Hg
Dyslipidemia	=	LDL	>	4.1	mmol/L
Entire Cohort Exercise
Blood Glucose
Entire Cohort Exercise Nutrition
Normal	=	Fasting	Blood	Glucose		<	6.0	mmol/L
Prediabetic	=	Fasting	Blood	Glucose	6.0	-	7.0	mmol/L
Diabetic	=	Fasting	Blood	Glucose	>	7.0	mmol/L
Entire Cohort
Nutrition
Blood LDLc
Exercise Nutrition
Normal	=	LDL	<	3.3	mmol/L
Boarderline	=	LDL	3.3	-	4.1	mmol/L
Table.11 - Differences in Energy Regulating Hormones Between Exercise + Diet and Diet Alone Groups Analyzed by BMI Classification (n=51)
Mean	 SD Mean	 SD Mean	 SD
Pre 25.35 ± 7.4 Pre 5.18 ± 4.1 Pre 3.32 ± 1.6
Post 26.06 ± 8.9 Post 3.73 ± 3.1 Post 3.09 ± 1.7
Mean	 SD Mean	 SD Mean	 SD
Pre 25.64 ± 16.6 Pre 7.17 ± 4.3 Pre 4.27 ± 2.4
Post 21.78 ± 11.7 Post 6.63 ± 3.9 Post 2.22 ± 1.0
Mean	 SD Mean	 SD Mean	 SD
Pre 23.66 ± 14.5 Pre 6.02 ± 3.5 Pre 8.72 ± 4.4
Post 19.92 ± 12.9 Post 5.48 ± 2.9 Post 5.31 ± 4.1
Mean	 SD Mean	 SD Mean	 SD
Pre 22.09 ± 8.1 Pre 6.41 ± 3.6 Pre 8.96 ± 7.1
Post 28.70 ± 19.4 Post 6.73 ± 3.8 Post 7.78 ± 5.1
Mean	 SD Mean	 SD
Pre 81.61 ± 77.3 Pre 11.34 ± 7.1
Post 60.61 ± 49.6 Post 10.40 ± 5.6
Mean	 SD Mean	 SD
Pre 84.38 ± 39.3 Pre 7.30 ± 4.2
Post 47.02 ± 29.0 Post 6.86 ± 4.6
Mean	 SD Mean	 SD
Pre 34.25 ± 19.6 Pre 7.42 ± 4.9
Post 45.59 ± 30.3 Post 6.80 ± 2.5
Mean	 SD Mean	 SD
Pre 42.50 ± 28.3 Pre 5.89 ± 5.0
Post 38.19 ± 19.9 Post 7.55 ± 4.3
Diet	Alone	(n	=	10)
Testosterone
p	=	0.115
Interaction	=	p	=	0.631
p	=	0.936
Interaction	=	0.896
Obese	
Exercise	+	Diet	(n	=	6)
Testosterone
Overweight	
Exercise	+	Diet	(n	=	6)
Testosterone
Diet	Alone	(n	=	10)
Testosterone
Overweight	
Adiponectin
Exercise	+	Diet	(n	=	6)
Diet	Alone	(n	=	10)
Adiponectin
Overweight	
Exercise	+	Diet	(n	=	6)
TNF-α
Diet	Alone	(n	=	10)
TNF-α
Obese	
Exercise	+	Diet	(n	=	6)
Adiponectin
Diet	Alone	(n	=	10)
Adiponectin
Obese	Obese	
Overweight	
Exercise	+	Diet	(n	=	6)
Leptin
Diet	Alone	(n	=	10)
Leptin
Overweight	
Exercise	+	Diet	(n	=	6)
Ghrelin
Diet	Alone	(n	=	10)
Ghrelin
Interaction	=	p	=	0.742
p	<	0.001
Interaction	=	p	<	0.004
Exercise	+	Diet	(n	=	6)
Ghrelin
Diet	Alone	(n	=	10)
Ghrelin
Exercise	+	Diet	(n	=	6)
Leptin
Diet	Alone	(n	=	10)
Leptin
Exercise	+	Diet	(n	=	6)
TNF-α
Diet	Alone	(n	=	10)
TNF-α
Interaction	=	p	=	0.113
P	=	0.326
Interaction	=	P	=	0.249
p	=	0.123
Interaction	=	p	=	0.162
p	<	0.03
Interaction	=	p	=	0.120
P	=	0.954
Interaction	=	P	=		0.301
p	=	0.973
p	=	0.201
Interaction	=	p	=	0.296
p	=	0.422
Obese	
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5 who classified as normotensive at follow-up. The number of individuals classified as 
pre-hypertensive also decreased from baseline to twelve weeks, dropping from 31 pre-
hypertensive subjects to 21 following the interventions. The Exercise + Diet group 
dropped from 18 individuals at baseline to 11 individuals at twelve weeks who were pre-
hypertensive, while the Diet Alone group saw a decrease from 13 to 10 individuals 
following the study. The number of subjects with hypertension remained the same from 
baseline to follow-up, however, it was characterized by a decrease of 3 to 0 individuals 
in the Exercise + Diet group while the Diet Alone group saw an increase of subjects with 
hypertension increasing from 4 to 7 individuals at twelve weeks.  
With respect to diabetes 41 subjects were considered to have normal fasting glucose, 
while 7 were considered pre-diabetic and 3 were classified as diabetic at baseline. 
Following the respective interventions, the total number of individuals with normal 
fasting blood glucose dropped to 40. The Exercise + Diet group saw an increase in 
individuals classified as normal blood glucose, increasing from 22 subjects at baseline to 
23 at twelve weeks. The diet alone group had 2 less individuals classified as normal 
blood glucose at twelve weeks dropping from 19 to 17 subjects in this category. The 
number of individuals classified as pre-diabetic increased at twelve weeks, from 7 
subjects at baseline to 8 following the interventions. Of these the Exercise + Diet group 
dropped from 3 individuals at baseline to 2 individuals at twelve weeks while the Diet 
Alone group saw an increase from 4 to 6 individuals following the study. The number of 
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subjects with diabetes remained the same from baseline to follow-up where 1 individuals 
in the Exercise + Diet group and 2 individuals in the Diet Alone group had diabetes. 
Seventeen subjects in the study displayed normal blood cholesterol, 15 were classified as 
borderline dyslipidemia, while 16 were considered to have dyslipidemia. Following the 
respective interventions, the total number of individuals with normal cholesterol was 28, 
where the Exercise + Diet group saw an increase from 11 subjects at baseline to 19 at 
twelve weeks. The diet alone group went from 6 to 9 individuals at twelve weeks who 
displayed normal blood lipids. The number of individuals classified as borderline 
hyperlipidemia decreased at twelve weeks, dropping from 15 subjects at baseline to 12 
following the interventions. Of these, the Exercise + Diet group dropped from 8 
individuals at baseline to 4 individuals at twelve weeks while the Diet Alone group saw 
an increase from 7 to 8 individuals following the study. The number of subjects with 
dyslipidemia dropped from 16 at baseline to 8 at follow-up, where 3 individuals in the 
Exercise + Diet group had dyslipidemia post study as compared to 7 at baseline and the 
Diet Alone group had 5 individuals with dyslipidemia following the study as compared 
to 9 at baseline.  
Between baseline and follow-up, equivalent reductions in heart rate of approximately ~5 
and ~6 bpm (p=0.006), LDL cholesterol of between ~11% and ~7% (p=0.011), and total 
cholesterol of ~10% and ~4% (p<0.005) were shown in both the Exercise + Diet and 
Diet Alone groups, respectively. Although results showed a significant difference within 
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groups, they did not show between groups differences when compared using an 
ANOVA. However, the Exercise + Diet group demonstrated a significant reduction in 
both diastolic and systolic blood pressure (mm Hg) of ~6 mm/hg (p<0.001) and ~7 
mm/hg (p<0.001) respectively, which can be considered to be of clinical benefit, in the 
presence of no change in either value for the Diet Alone group.  
Similarly, fasting triacylglycerol was reduced in the Exercise + Diet group by 
approximately 27% (p<0.001), while the Diet Alone group intervention showed no 
effect. With respect to insulin resistance, HOMA-IR did not respond to either the 
Exercise + Diet or Diet Alone protocols even under conditions of significant weight loss. 
HOMA-β was significantly reduced in the Diet Alone group by nearly 28% (p=0.009), 
however, the Exercise + Diet group saw an unexpected non-significant increase of ~15% 
under conditions of similar weight loss, suggesting that nutrition in isolation improved 
Beta cell function, while exercise in conjunction with diet (Exercise + Diet) resulted in 
no statistically significant change (Table 3).  
5.5 Primary Outcome 
5.5.1 Adiponectin response to the intervention 
The primary outcome of this study was to determine the adiponectin response to an 
Exercise + Diet intervention as compared to a Diet Alone intervention. Student paired t-
tests revealed that adiponectin did not change significantly in response to the twelve 
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week intervention for either the Exercise + Diet or the Diet Alone groups (Table 3). 
Furthermore, ANOVA demonstrated there was no significant difference between groups 
in response to either the Exercise + Diet or Diet Alone intervention (Table 9) indicating 
that neither a twelve week Exercise + Diet or Diet Alone intervention elicited a change 
in adiponectin for overweight and obese 35-55 year old males. Adiponectin results were 
graphed in a forest plot for the entire cohort (Figure 6) the Exercise + Diet group 
(Figure 7), and the Diet Alone Group (Figure 8). 
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Figure 6: Adiponectin Response to intervention by subject for entire cohort 
 Black - Baseline adiponectin by subject  
 Red - Post intervention adiponectin by subject  
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Figure 7: Adiponectin Response to intervention by subject for Exercise + Diet group 
 Black - Baseline adiponectin by subject 
 Red - Post intervention adiponectin by subject 
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 Figure 8: Adiponectin Response to intervention by subject for Diet Alone group 
 Black - Baseline adiponectin by subject 
 Red - Post intervention adiponectin by subject 
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5.6 Secondary Results 
5.6.1 Adiponectin’s relationship with Anthropometric and Biochemical Measures: 
To determine adiponectin’s relationship with anthropometric (e.g. %BF, %TF, waist 
circumference) and biochemical measures (e.g. Glucose, LDL, HDL) associated with 
obesity and metabolic disease, a correlation analysis was conducted.  Baseline fasting 
adiponectin demonstrated an inverse association with visceral fat percentage %VF 
(p=0.04), which is a key adipose storage site with respect to metabolic health. Baseline 
assessments also showed an inverse relationship between adiponectin and biochemical 
measures, including triacylglycerol (p<0.001), (a known risk factor for diabetes and 
stroke), and the glucose mediating hormone insulin (p=0.003) (Table 13). Furthermore, 
HOMA-IR (p=0.003) showed a strong correlation with adiponectin at baseline, 
indicating that adiponectin may interplay with insulin resistance in overweight and obese 
populations (Table 13). With respect to humoral variables (adiponectin, TNF-α, leptin, 
ghrelin, testosterone), our results demonstrated a statistically significant inverse 
relationship between TNF-α and adiponectin at baseline (p=0.02), indicating that this 
hormone may be associated (Table 14).  
Additionally, subgroup analysis was performed to determine if overweight and obese 
subjects responded differently to either the Exercise + Diet and Diet Alone interventions. 
This subgroup analysis divided by subjects with a BMI in the overweight or obese 
category indicated that adiponectin as well as other hormones of interest responded to  
r     P r     P r     P r     P r     P
Age (yr) 0.95 NS -0.10 NS 0.25 NS -0.35 0.01 -0.01 NS
Height (cm) 1.00 NS 0.12 NS -0.09 NS 0.16 NS -0.16 NS
Weight (kg) -0.09 NS 0.58 0.00 -0.21 NS -0.08 NS -0.42 0.01
Waist (cm) 0.12 NS 0.67 0.00 -0.22 NS -0.12 NS -0.48 0.00
Hip (cm) 0.01 NS 0.65 0.00 -0.28 NS -0.06 NS -0.45 0.01
Total Body Fat (kg) 0.03 NS 0.69 0.00 -0.29 0.04 -0.11 NS -0.36 0.03
Total Lean Tissue (kg) 0.10 NS 0.27 NS -0.02 NS -0.02 NS -0.40 0.01
Body Fat (%) 0.00 NS 0.67 0.00 -0.31 0.03 -0.13 NS -0.31 NS
Trunk Fat (%) 0.04 NS 0.63 0.00 -0.28 0.04 -0.15 NS -0.32 NS
BMI (kg/m2) -0.06 NS 0.62 0.00 -0.20 NS -0.17 NS -0.44 0.01
Visceral Fat (kg) 0.02 0.04 0.42 0.00 -0.04 NS -0.34 NS -0.43 0.01
Ghrelin
Table. 12 - Baseline Pearson Correlation of Body Composition Characteristics with Circulating Adiponectin, Leptin, TNF-α, Total Testosterone, and Ghrelin (n=51)
Adiponectin Leptin TNF-α Total Testosterone
r     P r     P r     P r     P r     P
0.05 NS 0.15 NS
-0.34 NS
-0.02 NS
-0.11 NS
-0.21 NS -0.35 0.04
-0.36 0.01
-0.20 NS
0.17 NS
0.10 NS
0.26 NS
-0.28 NS
0.05 NS
0.07 NS
0.23 NS -0.44 0.01
-0.31 0.03 0.50 0.00 - -0.55 0.00
-0.31 0.03 0.41 0.00 - -0.55 0.00
0.36 0.01
-0.04 NS -
0.38 0.01
0.17 NS -
HDL Cholesterol (mmol/L)
LDL Cholesterol (mmol/L)
Total Cholesterol (mmol/L)
Triacylglycerol (mmol/L)
Insulin (pmol/L)
HOMA-IR
HOMA-β
Glucose (mmol/L)
Systolic Blood Pressure (mmhg)
Diastolic Blood Pressure (mmhg)
Heart Rate (bpm)
-0.15 NS
0.05 NS
-0.09 NS
0.00 NS
-0.18 NS 0.30 0.04
0.04 NS
0.10 NS
0.11 NS
0.17 NS
0.00 NS
0.07 NS
0.07 NS
-0.18 NS
-0.21 NS
-0.20 NS
-0.09 NS
-0.10 NS
-0.20 NS
0.02 NS
0.07 NS
-0.15 NS
-0.18 NS
-0.23 NS
-0.19 NS
-0.19 NS
-0.16 NS
-0.21 NS
Ghrelin
Table. 13- Baseline Pearson Correlation of Metabolic Characteristics with Circulating Adiponectin, Leptin, TNF-α, Total Testosterone, Free Testosterone and Ghrelin (n=51)
Adiponectin Leptin TNF-α Total Testosterone
r     P r     P r     P r     P r     P
-0.14 NS -0.32 0.02 0.07 NS 0.28 NS
-0.13 NS 0.09 NS -0.40 0.02
-0.38 0.01-0.13 NS
0.09 NS -0.38 0.01
-0.24 NS
0.08 NS
Adiponectin (ug/ml)
Leptin (ug/ml)
TNF-α (pg/ml)
Total Testosterone (pg/ml)
Ghrelin (pg/ml)
-0.14 NS
-0.32 0.02
0.07 NS
0.28 NS -0.40 0.02 -0.24 NS 0.10 NS
Ghrelin
Table. 14 - Baseline Pearson Correlation of Circulating Adiponectin, Leptin, TNF-α, Total Testosterone, Free Testosterone and Ghrelin (n=51)
Adiponectin Leptin TNF-α Total Testosterone
Exercise + Diet (n=26) r     P r     P r     P r     P r     P
Weight (kg) 0.01 NS -0.41 0.04 0.02 NS 0.00 NS 0.20 NS
Waist (cm) -0.21 NS -0.07 NS -0.06 NS -0.12 NS 0.42 NS
Hip (cm) -0.01 NS -0.02 NS -0.08 NS -0.11 NS 0.52 0.03
Total Body Fat (kg) -0.12 NS -0.15 NS 0.07 NS -0.04 NS 0.24 NS
Total Lean Tissue (kg) 0.28 NS -0.19 NS -0.11 NS 0.34 NS 0.29 NS
Body Fat (%) -0.19 NS 0.10 NS -0.01 NS -0.14 NS -0.06 NS
Trunk Fat (%) -0.24 NS 0.15 NS -0.05 NS -0.19 NS 0.35 NS
BMI (kg/m2) 0.06 NS -0.41 0.04 0.00 NS 0.02 NS 0.33 NS
Visceral Fat (kg) -0.05 NS 0.07 NS 0.19 NS 0.04 NS 0.27 NS
Weight (kg) 0.00 NS -0.23 NS 0.36 NS -0.12 NS -0.11 NS
Waist (cm) 0.00 NS 0.03 NS -0.03 NS 0.01 NS -0.07 NS
Hip (cm) 0.00 NS -0.15 NS 0.30 NS -0.10 NS -0.20 NS
Total Body Fat (kg) 0.00 NS -0.22 NS 0.18 NS -0.05 NS 0.11 NS
Total Lean Tissue (kg) 0.00 NS -0.22 NS 0.19 NS -0.28 NS -0.07 NS
Body Fat (%) 0.00 NS -0.07 NS 0.08 NS -0.02 NS 0.37 NS
Trunk Fat (%) 0.00 NS 0.03 NS 0.09 NS 0.02 NS -0.24 NS
BMI (kg/m2) 0.00 NS -0.24 NS 0.39 NS -0.13 NS -0.33 NS
Visceral Fat (kg) -0.16 NS -0.47 0.02 -0.01 NS 0.03 NS 0.11 NS
Ghrelin
Table. 15 - Pearson Correlation of Change in Body Composition with Baseline with Circulating Adiponectin, Leptin, TNF-α, Total Testosterone, and 
Ghrelin (n=51)
Diet Alone (n=25)
Adiponectin Leptin TNF-α Total Testosterone
Exercise + Diet (n=26) r     P r     P r     P r     P r     P
0.12 NS 0.09 NS 0.53 0.01
0.12 NS 0.12 NS
0.20 NS 0.14 NS
0.26 NS
-0.07 NS
-0.12 NS
-0.22 NS
0.09 NS -0.46 0.02
0.24 NS -0.55 0.00
-0.38 NS
0.41 0.04
-0.32 NS
0.26 NS
0.19 NS
0.15 NS
0.23 NS
0.21 NS
0.04 NS
0.01 NS
0.29 NS 0.51 0.03
0.16 NS 0.20 NS
HDL Cholesterol (mmol/L)
LDL Cholesterol (mmol/L)
Total Cholesterol (mmol/L)
Triacylglycerol (mmol/L)
Insulin (pmol/L)
HOMA-IR
HOMA-β
Glucose (mmol/L)
Systolic Blood Pressure (mmhg)
Diastolic Blood Pressure (mmhg)
Heart Rate (bpm) 0.06 NS
-0.19 NS
-0.17 NS
-0.16 NS
-0.10 NS
-0.05 NS
-0.14 NS
0.23 NS
0.34 NS
0.13 NS
0.21 NS
-0.54 0.01
0.13 NS
0.29 NS
-0.08 NS
0.28 NS
0.18 NS
-0.15 NS
-0.20 NS
-0.12 NS
-0.35 NS
0.15 NS
0.14 NS
-0.23 NS
-0.04 NS -0.01 NS
0.26 NS
0.07 NS
0.17 NS
0.24 NS
-0.36 NS
0.08 NS
-0.15 NS
-0.42 NS
-0.61 0.00-0.01 NS
0.15 NS
-0.39 NS
0.50 0.02
-0.66 0.00
0.01 NS
-0.39 NS
0.18 NS -0.52 0.01
HDL Cholesterol (mmol/L)
LDL Cholesterol (mmol/L)
Total Cholesterol (mmol/L)
Triacylglycerol (mmol/L)
Insulin (pmol/L)
HOMA-IR
HOMA-β
Glucose (mmol/L)
Systolic Blood Pressure (mmhg)
Diastolic Blood Pressure (mmhg)
Heart Rate (bpm)
-0.24 NS
-0.19 NS
-0.27 NS
-0.28 NS
0.03 NS
0.03 NS
0.13 NS
-0.34 NS
0.07 NS
0.02 NS
0.17 NS
-0.24 NS
0.25 NS
0.25 NS
0.24 NS
-0.05 NS
0.26 NS
-0.03 NS
0.03 NS
-0.12 NS
-0.05 NS
-0.36 NS
-0.09 NS
-0.26 NS
-0.19 NS
-0.05 NS
-0.12 NS
-0.06 NS
0.02 NS
0.21 NS
0.42 NS
0.19 NS
0.39 NS
0.01 NS
-0.26 NS
-0.37 NS
0.16 NS
Ghrelin
Table. 16 - Pearson Correlation of Change in Metabolic Characteristics with Baseline Circulating Adiponectin, Leptin, TNF-α, Total Testosterone, 
and Ghrelin (n=51)
Diet Alone (n=25)
Adiponectin Leptin TNF-α Total Testosterone
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both the Exercise + Diet and Diet Alone interventions similarly regardless of BMI 
classification and reflect the results of the combined (overweight and obese) group 
analysis (Table 11). 
To determine the relationship between baseline adiponectin and the changes in physical 
and biochemical characteristics due to the interventions, correlation analysis was 
performed (Table 15, 16 & 17).  Subgroup investigation revealed that fasting baseline 
adiponectin was positively associated with a change in glucose (p<0.04), which was 
expected. As well, it appears that baseline adiponectin is negatively associated with a 
change in adiponectin within the Exercise + Diet group (p<0.05), indicating that those 
with lower adiponectin at baseline experience the greatest increase in adiponectin in 
response to exercise and diet ,while higher baseline adiponectin results in a smaller 
increase in adiponectin in response to the intervention (Table 15 & 16).  In the Diet 
Alone group, baseline adiponectin was not associated with changes in any of the 
physical (Table 15) or biochemical characteristics (Table 16 & 17). 
 
  
Exercise + Diet (n=26) r     P r     P r     P r     P r     P
Adiponectin (ug/ml) -0.39 0.05 0.38 NS -0.32 NS 0.05 NS -0.12 NS
Leptin (ug/ml) 0.06 NS -0.56 0.003 0.09 NS 0.11 NS 0.42 NS
TNF-α (pg/ml) -0.01 NS 0.00 NS -0.45 0.02 0.21 NS 0.13 NS
Total Testosterone (pg/ml) 0.04 NS 0.13 NS 0.19 NS -0.71 0.00 -0.30 NS
Free Testosterone (pg/ml) -0.02 NS -0.08 NS 0.21 NS -0.44 0.03 -0.44 NS
Ghrelin (pg/ml) 0.26 NS 0.26 NS 0.38 NS -0.15 NS -0.52 0.03
Adiponectin (ug/ml) -0.14 NS 0.31 NS 0.11 NS -0.02 NS -0.25 NS
Leptin (ug/ml) -0.04 NS -0.60 0.00 -0.15 NS -0.31 NS 0.09 NS
TNF-α (pg/ml) 0.29 NS -0.03 NS -0.24 NS -0.29 NS -0.10 NS
Total Testosterone (pg/ml) 0.38 NS -0.12 NS -0.18 NS -0.57 0.00 0.02 NS
Free Testosterone (pg/ml) 0.02 NS 0.03 NS -0.05 NS -0.33 NS -0.21 NS
Ghrelin (pg/ml) 0.00 NS 0.25 NS 0.10 NS -0.01 NS -0.68 0.00
Ghrelin
Table. 17 - Pearson Correlation  of Change in Adiponectin, Leptin, TNF-α, Total Testosterone, and Ghrelin with the Baseline Energy Regulating 
Hormones (n=51)
Diet Alone (n=25)
Adiponectin Leptin TNF-α Total Testosterone
Skin Folds r     P r     P r     P r     P r     P r     P
Pectoralis 0.04 NS 0.42 0.001 -0.47 0 0.25 NS 
Tricep 0.06 NS 0.27 NS 0.50 0.001
Sub 0.46 0.001 0.22 NS 
Mid 0.54 0.001 0.26 NS 
Supra 0.28 NS 0.19 NS 
Umb 0.19 NS 0.19 NS 
Quad
-0.02 NS 
-0.11 NS 
-0.02 NS 
-0.02 NS 
0.12 NS 0.35 0.01
-0.04 NS 
0.04 NS 
-0.28 NS 
-0.09 NS 
-0.23 NS 
-0.04 NS 
-0.09 NS 
-0.36 NS 
-0.20 NS 
-0.11 NS 
-0.19 NS 
-0.19 NS 
-0.22 NS 
-0.06 NS 
-0.30 NS 
-0.27 NS 
-0.25 NS 
-0.03 NS 
-0.01 NS 
-0.16 NS 0.17 NS 
Girth Measurements
Right Bicep Flex 0.00 NS 0.33 0.02 -0.27 NS 0.01 NS 
Left Bicep Flex 0.04 NS 0.37 0.01 -0.37 0.01 0.16 NS 
Right Bicep 0.09 NS 0.29 0.04 -0.37 0.01 0.08 NS 
Left Bicep 0.06 NS 0.42 0.001 -0.40 0.001
-0.20 NS
-0.26 NS 
-0.11 NS 
-0.26 NS 0.19 NS 
Neck 0.56 0.001 -0.22 NS -0.39 0.02 0.48 0.001
Shoulders 0.49 0.001 -0.30 0.04 -0.31 NS 0.29 NS 
Chest
-0.05 NS 
-0.13 NS 
-0.21 NS 0.51 0.001 -0.40 0.02 0.28 NS 
Waist - 0.74 0.001
-0.24 NS 
-0.13 NS -0.51 0.001 0.44 0.001
Hip - 0.69 0.001 -0.36 0.01 0.35 0.02
Right Thigh 0.11 NS -0.43 0.001 0.15 NS 
Left Thigh
0.13 NS 
0.05 NS 
0.12 NS 
0.12 NS 0.16 NS -0.39 0.01
-0.07 NS
-0.02 NS 
-0.07 NS 
-0.02 NS 
0.23 NS 
-0.14 NS 
-0.15 NS 
-0.08 NS 
0.06 NS 
0.19 NS 
0.15 NS 
-0.33 0.05
0.11 NS 
-0.01 NS 0.21 NS 
Insulin
Table 18. Baseline Pearson Correlation Skinfold Measurements with Circulating Adiponectin, Leptin, TNF-α, Total Testosterone, and Ghrelin (n=51)
GhrelinAdiponectin Leptin TNF-α Total Testosterone
Table. 19 - HOMA-β & HOMA-IR For Non-Diabetic Normal-Weight, Overweight, and Obese Men (Ages 35-55) From The General Population (n=317)
Mean SD Mean SD Mean SD Mean SD
HOMA-β 120.76 ± 66.3 88.48 ± 48.7 109.72 ± 55.6 158.04 ± 73.0
HOMA-IR 2.60 ± 1.7 1.80 ± 1.6 2.38 ± 1.2 3.51 ± 1.9
Entire Cohort NW OB
(n = 317) (n = 71) (n = 143) (n = 103)
OW
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5.6.2 Exercise associated and energy regulating hormonal response to intervention 
Student paired t-tests were performed to determine if the twelve week Exercise + Diet or 
Diet Alone interventions resulted in a change in fasting TNF-α, testosterone, leptin and 
ghrelin (Table 3).  
Paired t-test revealed that energy regulating hormone leptin decreased in response to 
both the Exercise + Diet (36.5%) (p=0.002) and Diet Alone (21.6%) (p=0.023) 
interventions and after conducting ANOVA it was demonstrated that there were no 
significant differences between the groups. This indicated that other factors may be 
responsible for the change in leptin outside of Exercise + Diet (Table 9). Similarly, 
ANOVA was conducted between groups for ghrelin, testosterone and TNF-α, which 
determined that there were no differences between groups as a result of the intervention 
(Table 9). Leptin, ghrelin, testosterone and TNF-α did not respond differently to the 
Exercise + Diet, and Diet Alone interventions.  
Baseline anthropometric and biochemical variables were compared with our secondary 
hormone measures to determine if pre-established or novel associations were present 
(Table 12, 13, 14). To increase statistical power in all baseline correlations, subjects 
from both groups were pooled at baseline for Pearson's Correlation analysis.  
As expected, baseline fasting leptin was found to be positively correlated with several 
anthropometric variables related to obesity. These variables included global measures of 
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obesity including weight (p<0.001), total body fat (p<0.001) and body fat percentage 
(p<0.001). Of particular interest to this study were regional measures of adiposity, 
specifically those representative of central fat patterning  including trunk fat % 
(p<0.001), visceral fat % (p<0.001), waist circumference (p<0.001), and hip 
circumference (p<0.001), which all showed a statistical association. Leptin showed the 
highest correlation with anthropometrics compared to any other hormone, indicating that 
leptin is strongly related to adiposity. 
Biochemical markers of insulin sensitivity including insulin (p<0.001), HOMA-IR 
(p<0.001), and HOMA-β (p<0.01), all of which showed moderate correlations with 
leptin at baseline. Additionally, systolic blood pressure (p=0.01) and heart rate (p=0.04) 
also showed statistically significant correlations (Table 13).  
When compared to changes in anthropometric and biochemical markers following the 
twelve week intervention, baseline leptin was negatively associated with a change in 
weight (p=0.04) and BMI (p=0.04) in the Exercise + Diet group. These results suggest 
that leptin is not just related to bodyweight and BMI at baseline, but also during changes 
occurring as a result of weight loss achieved through exercise. Furthermore, leptin was 
correlated to insulin (p=0.02) and HOMA-IR (p=0.04), but only in the Exercise + Diet 
group. Regardless of group, baseline leptin was inversely correlated with the change in 
leptin (Table 17). Finally, for the Diet Alone group, baseline leptin was associated with 
a change in %VF (p=0.02) (Table 15).   
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Baseline fasting ghrelin was found to be negatively correlated with several 
measurements related to adiposity and body composition, including weight (p=0.01), 
waist circumference (p<0.001), hip circumference (p=0.01), %TF (p=0.03), and %VF 
(p=0.01) (Table 12). These results were expected due to ghrelin’s inverse relationship 
with obesity. As hypothesized, metabolic variables related to energy metabolism 
including insulin (p=0.04) and HOMA-IR (p=0.01), also demonstrated inverse 
relationships with ghrelin. Moreover, biochemical variables of total cholesterol 
(p<0.001), and tricylglycerol (p<0.001) were correlated to ghrelin for the entire cohort 
(Table 13). In the Exercise + Diet group, baseline ghrelin was positively associated with 
changes in hip circumference (p=0.03) and systolic blood pressure (p=0.03) (Table 15, 
16). Baseline ghrelin, however, is predictive of change in ghrelin in both the Exercise + 
Diet (p=0.03) and Diet Alone (p<0.001) groups where higher baseline ghrelin indicates a 
smaller change in ghrelin when weight loss is achieved (Table 17). 
Total testosterone was negatively associated with age (p=0.01) (Table 12). Additionally, 
baseline testosterone is inversely related to TNF-α (p=0.01), which was predicted due to 
its well established reciprocal relationship with testosterone status (Table 14).   
Baseline total testosterone was inversely associated with changes in insulin (p<0.001) 
and HOMA-IR (p<0.001), as well as with systolic blood pressure (p=0.01) in the Diet 
group only. It was expected that these results would be present in both cohorts due to 
their similar weight loss (Table 16).  Similar to the other measured hormonal variables 
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in our study, baseline testosterone predicted the change in testosterone resulting from the 
Exercise + Diet protocol (p=0.05). However, this correlation was not present in the Diet 
Alone group (Table 16). 
Lastly, it was hypothesized that baseline fasting TNF-α would be negatively associated 
with adiposity. Results suggest that baseline total body fat (p=0.04), %BF (p=0.03), and 
%TF (p=0.04) support this hypothesis (Table 12). Furthermore, as stated previously, the 
hormones adiponectin (p=0.02) and total testosterone (p=0.01) were both correlated with 
TNF-α (Table 14). Baseline TNF-α was positively associated with the change in HDL 
cholesterol due to Exercise + Diet (p=0.01) and negatively associated with the change in 
systolic blood pressure (p=0.01), which confirms the previously identified associations 
between TNF-α and cardiovascular health. (Table 16). Baseline TNF-α was only 
positively associated with the change in glucose in the Diet Alone group (p=0.02), 
(Table 13) which, along with the lack of correlation with HOMA-IR, did not show the 
anticipated relationship with insulin resistance.  
5.6.3 Exploratory Analysis of Endocrine Response to Intervention: 
An analysis of covariance (ANCOVA) was performed, controlling for percentage or 
trunk fat at baseline, which is an established confounding variable for adiponectin 
(Cahill et al., 2013). The ANCOVA suggests that adiponectin significantly decreased in 
the Exercise + Diet group and increased in the Diet Alone group (p < 0.036) (Table 9).  
Additionally, we conducted an ANCOVA on TNF-α, which controlled for percentage of 
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trunk fat. The ANCOVA revealed that TNF-α significantly decreased in both the 
Exercise + Diet and Diet Alone groups between baseline and twelve weeks by a similar 
magnitude. However, there was no difference between the groups.   
To control for the impact of changes in body composition, specifically the increase in 
lean body mass in the Exercise + Diet group, on the energy regulating hormone ghrelin, 
an ANCOVA was performed.  Lean body mass has been shown to be a confounder for 
ghrelin (Bajer et al., 2015). This analysis revealed that ghrelin decreased significantly in 
the Diet Alone group (p=0.05) compared to the Exercise + Diet group (p=0.04) when 
controlling for increases in lean body mass (Table 9). 
5.6.4 The Association of Baseline Adiponectin, Leptin, Ghrelin, Total Testosterone, 
and TNF-α Concentration with Adiposity Characteristics 
To investigate the possible association between endocrine variables and regional 
adiposity, Pearson correlations were performed between hormones and regional 
measurements of girth, as well as for regional subcutaneous skin fold thickness (Table 
18).  
Leptin, shown to be elevated in conditions of obesity and reduced when decreases in 
adiposity occur during weight loss, was associated with several skinfold sites including 
the pectoralis (p<0.001), mid-axillary (p<0.001), subcapularis (p<0.001), the quadriceps 
(p<0.001), and all girth measurements (p<0.05) except thighs. Leptin was also 
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associated with %BF (p<0.001), BMI (p<0.001), TF% (p<0.001), and VF% (p<0.001), 
as mentioned previously. Due to leptin’s previously established relationship with 
regional adiposity, all skinfold and girth measurements were used in the analysis (Table 
18). 
Ghrelin was shown to be inversely associated with the pectoralis skinfold as well as with 
girth measurements for the chest, waist and hips, and was negatively associated with 
BMI and VF% when a correlation analysis was performed (Table 18).  
Correlation analysis revealed that sex hormones showed no significant association with 
subcutaneous skinfold sites, girth measurements or regional body fat measures.  Skinfold 
and girth measurement sites related to gynoid and android obesity were chosen for 
analysis with testosterone to reduce the potential number of comparisons, and to 
maintain statistical power. These included the triceps, pectoralis, suprailiac, umbilical 
and quadriceps skin fold sites, as well as arm, waist, hip and thigh girth measurements 
(Table 18). 
Correlation analysis was also performed for adiponectin, which did not show a 
relationship with skinfold sites. However, as previously reported, adiponectin was 
negatively associated with percentages of visceral fat (p=0.04) determined by DXA. 
TNF-α failed to demonstrate correlations with any regional skinfold or girth 
measurements, but it did show a positive association with the TF% and BF% determined 
by DXA. Skin fold and girth measurements associated with gynoid fat patterning were 
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also chosen for analysis, including the subscapularis, mid axillary, suprailliac and 
umbilical skinfold sites, the waist and hip girth measures, and DXA measures of 
adiposity (Table 18).  
5.6.5 The Association of Baseline Adiponectin, Leptin, Ghrelin, Total Testosterone, 
and TNF-α Concentration with the Change in Adiposity Characteristics 
Insulin was positively associated with the triceps skinfold site, as well as several DXA 
measures of adiposity including BF%, TF%, and visceral fat in our correlation analysis 
(Table 18). 
In an attempt to determine if the change in adiposity measures, either through skin fold, 
girth or DXA measures, were associated with baseline endocrine concentration, a 
correlation analysis was performed. Due to the lack of change in several endocrine 
variables in the presence of significant changes in adiposity, the correlation analysis 
failed to show any significant associations between changes in adiposity variables and 
baseline hormones (Table 18).  
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6 Discussion 
The obesity epidemic affects over 500 million people globally (Center for Disease 
Control, 2016). The prevalence of obesity in Canada is nearly 20%, and Newfoundland 
and Labrador is the most significantly impacted, with an estimated 29-40% of the 
population affected (Twells et al., 2014). Middle aged overweight and/or obese males 
possess specific risk factors for metabolic disease, including hypertension, coronary heart 
disease, stroke, type 2 diabetes and certain cancers (Camacho et al., 2013). To mitigate 
obesity and its comorbidities, diet and exercise interventions have been extensively 
employed; however, there is inconsistency in their adherence and training prescription, 
leading to heterogeneity in the research. 
 
This research sought to investigate the benefits of structured exercise and nutrition 
(Exercise + Diet) on increasing levels of adiponectin and metabolic risk factors such as 
obesity and energy regulating hormones (specifically TNF-α, leptin, ghrelin and 
testosterone). The relationship between such energy regulating hormones and regional 
adiposity as a result of structured exercise and nutrition was also explored. Specifically, 
the primary goal of this study was to compare the effectiveness of a twelve week 
structured exercise and nutritional-intervention program (Exercise + Diet) to a program of 
nutritional intervention alone (Diet Alone) on adiponectin levels. 
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Several hypotheses were considered throughout this study. The primary 
hypothesis was that adiponectin levels would increase as a result of weight loss from a 
combined modification of Exercise + Diet rather than through Diet Alone. Additionally, it 
was hypothesized that the Exercise + Diet group would have greater improvements in 
energy regulating hormones, such as ghrelin and testosterone, and a decrease in both 
leptin and TNF-α, compared to modification of Diet Alone. Lastly, it was hypothesized 
that central adiposity, as determined by DXA, would have a significant relationship with 
energy regulating hormones, while skin-fold thickness, determined by callipers, would 
not demonstrate a similar relationship.  
 
6.1 Body Composition and Biochemical Response to Intervention: 
At baseline, anthropometric and body composition was determined in participating 
middle aged males (44.59 ± 6.45yrs), indicating that they were overweight and/or obese 
(BMI – 31.85 ± 4.1), yet free from metabolic disease with respect to elevated 
cholesterol, blood pressure, glucose and insulin resistance.  Following the twelve week 
intervention, body weight decreased by 4.5% in both the Exercise + Diet and Diet Alone 
groups.  In addition, waist circumference, hip circumference, BMI, total mass, fat mass, 
trunk fat, visceral fat and percent body fat all decreased between 3-9% in both groups.  
Changes in weight are affected by the amount of energy expended versus the amount of 
energy consumed (Swift, Johannsen, Lavie, Earnest, & Church, 2014). Overall, the 
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changes in weight in response to exercise training without caloric restriction are highly 
heterogeneous and individual differences can span weight gain to clinically significant 
weight loss (Swift et al., 2014). Based on the present literature, unless the overall volume 
of exercise training is very high, clinically significant weight loss is unlikely to occur 
(Swift et al., 2014). The current exercise intervention was considered high intensity and 
resulted in approximately 1800 calories in exercise expenditure per week, however, this 
may have been insufficient to result in additional weight loss.  
Wing et al. reported that, although exercise training and caloric restriction together may 
promote greater weight loss compared to caloric restriction alone, the differences in 
weight loss are not statistically significant (Wing & Phelan, 2005). Miller et al. 
performed a meta-analysis of weight loss interventions and determined that rate of 
weight loss was similar after exercise training and caloric restriction (1.0 kg/week) and 
caloric restriction alone (0.98 kg/week) (Miller, Koceja, & Hamilton, 1997). Thus, the 
present study supports the majority of literature which indicates that the weight loss 
from combined exercise and caloric restriction can be attributed to caloric restriction 
(Wing & Phelan, 2005). Although body weight was also reduced regardless of 
intervention, the Exercise + Diet group experienced the greater improvement in fitness, 
lean body mass, and metabolic profile. Exercise may offset potential weight loss because 
of its tendency, as demonstrated in the current study, to build lean body mass. This 
increase in muscle resulting from exercise would result in less weight loss, however is 
beneficial for long term health and fitness (Wing & Phelan, 2005). 
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Metabolic measures including LDL, total cholesterol, triglycerides, systolic and diastolic 
blood pressure all decreased in the Exercise + Diet group but were not altered in the Diet 
Alone group. With respect to insulin resistance, HOMA- improved by 28% in the Diet 
Alone group but not the Exercise + Diet group. The relevance of this measure is 
demonstrated by others who have shown that defects in islet -cell function is predictive 
of the development of type 2 diabetes and is present long before the diagnostic criterion 
for diabetes has been met (Matthews, 1996; Pimenta et al., 1995).  
Typically, the western diet, which is characterized by an increased proportion of dietary 
fat and lower amounts of carbohydrates negatively impacts -cell function (Rosenbaum 
& Leibel, 2010). A shift to a diet lower in fat and higher in carbohydrates has been 
shown to ameliorate this dysfunction function (Rosenbaum & Leibel, 2010). These 
results were mirrored in the current study where significant decrease in HOMA- as a 
result of the 12-week Diet Alone intervention. It is possible that the reduced intake of 
saturated fats and simple carbohydrates associated with the Diet Alone protocol was 
responsible for this change. This improved -cell function was not shared by the 
Exercise + Diet group. This finding was unexpected given exercises established benefit 
to insulin sensitivity (Babraj et al., 2009; Potteiger, Jacobsen, Donnelly, Hill, & Midwest 
Exercise Trial, 2003; Whyte, Gill, & Cathcart, 2010).  ). In comparison to non-diabetic 
normal weight, overweight and obese men ages 35-55 years old from the general 
population of Newfoundland the Diet Alone groups baseline HOMA-β more closely 
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resembled that of the overweight category while the Exercise + Diet group baseline 
value was closer to that of a normal weight population (Table 19). This baseline 
difference, although not statistically significant may explain the lack of change in 
HOMA-β in the Exercise + Diet group. Additionally, the lack of change in HOMA- is 
likely due to the absence of insulin resistance among the study population who were 
generally metabolically healthy, where 22 of the 26 subjects in the Exercise + Diet group 
displayed normal blood glucose. These conclusion are based on speculation the 
explanation as to why the Exercise + Diet group did not respond similarly to Diet Alone 
group after both undergoing the same dietary protocol is unanswered and warrants 
further investigation.  
The results indicate that the two interventions were largely similar in terms of weight loss 
and change in regional adiposity, but that there were statistically significant differences in 
metabolic parameters, fitness and lean body mass within the Exercise + Diet group.  
Although greater quantities of lean body mass has been associated with improved insulin 
sensitivity and glucose disposal when comparing men and women, it is unlikely that the 
modest change in lean body mass in the Exercise + Diet group would have demonstrated 
an increased insulin sensitivity (Rattarasarn, Leelawattana, & Soonthornpun, 2010).  
Although resistance training shows a positive impact on lean body mass, 
cardiovascular risk factors and insulin sensitivity, a recent meta-analysis suggest that in 
subjects with a BMI ≥25 kg/m2, aerobic exercise is more efficient in reducing measures 
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of obesity including body weight, waist circumference and fat mass as well as in 
increasing VO2max uptake when compared to resistance training (Schwingshackl et. al., 
2013). 
Furthermore, the meta-analysis results provide evidence that a combined 
intervention seems to be the most promising tool for management of overweight and 
obesity (Schwingshackl 2013). Combined aerobic and resistance training was more 
powerful in reducing anthropometric risk factors like body weight, waist circumference, 
fat mass and increasing lean body mass when compared to exercise training (either 
aerobic or resistance training) in isolation (Schwingshackl 2013). The American College 
of Sports Medicine recommends either moderate-intensity aerobic physical activity for a 
minimum of 30 min on five days each week or vigorous-intensity aerobic activity for a 
minimum of 20 min on three days each week for healthy adults (ACSM 2014). In 
addition, these authorities encourage regular resistance training (RT) for a minimum of 
two days per week performing 8 exercises with eight to twelve repetitions (ACSM 2014). 
The goal of this research was to investigate whether the high intensity supervised 
resistance training program utilized in this study and designed to increase energy 
expenditure to a greater extent than traditional resistance training was sufficient to 
achieve the same impact as combined aerobic and resistance training. Additionally, due to 
the equipoise which remains regarding the impact of resistance training on the hormones 
of interest which relate to energy metabolism, body composition and energy intake, the 
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current study used a single exercise approach to clearly delineate the exercise mediated 
impact on these hormones.  
The current study did not find a difference in degree of weight loss between 
groups despite suspected increased energy demands in the structured Exercise + Diet 
group. It is likely that the frequency of exercise sessions was not sufficient to create a 
large enough energy deficit that could translate into greater weight loss between the 
Exercise + Diet and Diet Alone groups.  Although the sample size calculation was based 
on similar work (Simpson & Singh, 2008) and increased based on interim analysis, the 
small sample size may help explain the lack of hypothesized change between groups, and 
the difference between baseline and twelve weeks.   
 
6.2 Primary Outcome: The response of adiponectin to a structured fitness and 
nutrition program compared to nutrition alone  
6.2.1 Adiponectin: Obesity 
Although the adiponectin response to weight loss as a result of diet and exercise in 
humans is uncertain, adiponectin has been shown to be inversely related to obesity status 
in a large number of studies (Blüher, 2014; Fasshauer & Bluher, 2015; Hui, Lam, 
Vanhoutte, & Xu, 2012; Kern, Di Gregorio, Lu, Rassouli, & Ranganathan, 2003; Kishida, 
Funahashi, & Shimomura, 2014a; Lindsay et al., 2002; Selyatitskaya et al., 2015; 
Yamauchi et al., 2014). In addition, levels of adiponectin have increased in the presence 
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of significant weight loss (Varady, Tussing, Bhutani, & Braunschweig, 2009; Yang et al., 
2001).  
This study’s hypothesis assumes that adiponectin would be inversely associated 
with body fat, and would increase in response to decreases in adiposity resulting from a 
highly controlled Exercise + Diet intervention. The current study failed to find an 
association between adiponectin and any of the obesity-related body composition 
measurements.  However, adiponectin was negatively associated with triacylglycerol, 
insulin, insulin resistance, and TNF-α at baseline.  The lack of association and change in 
adiponectin in the presence of significant reductions in total and regional body fat in the 
current study was unexpected. Several studies have examined changing adiponectin 
concentrations in response to weight reduction with contradictory results. Some groups 
showed no concordance between adiponectin status and change in adiposity (Cahill et al., 
2013; Cnop et al., 2003), whereas others demonstrated that adiponectin levels 
significantly increased after weight reduction (Varady et al., 2009; Yang et al., 2001). The 
degree of weight loss in the current investigation was modest at ~5% and ~4% for the 
Exercise + Diet and Diet Alone groups, respectively. This result was similar to other 
studies using exercise in overweight and/or obese populations (M. Bluher, 2013; Boudou 
et al., 2003; Fatouros et al., 2005; Giannopoulou et al., 2005; Hara et al., 2005; Marcell et 
al., 2005; Oberbach et al., 2006; O'Leary et al., 2006; Polak et al., 2006; Ryan et al., 
2003). Not only was weight loss expected in both groups, the current study hypothesized 
a greater degree of weight loss in the Exercise + Diet group due to increases in energy 
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expenditure. Weight loss and change in regional adiposity was similar between groups, 
with only lean body mass showing a physiologically significant difference in the Exercise 
+ Diet group.  
Only total adiponectin was measured in the current study. The choice to measure total 
adiponectin was due to the inconclusive response of different isoforms of adiponectin to 
weight loss achieved via diet and exercise. Weight loss by caloric restriction appears to 
be associated with an increase in HMW adiponectin (Acharya, Brooks, Evans, Linkov, 
& Burke, 2013; Bobbert et al., 2005). Regarding exercise alone, one study showed that, 
irrespective of any associated weight loss, there was a shift in the adiponectin multimer 
distribution toward LMW (Auerbach et al., 2013); two other studies showed no changes 
in HMW adiponectin after exercise training (Ando, Hosaka, Suzuki, & Yamagata, 2009; 
Christiansen et al., 2010); yet, another study showed that HMW adiponectin 
concentration increased (Kelly et al., 2012). Thus, with current evidence, we could not 
determine whether exercise training and caloric restriction induced weight loss have 
different effects on adiponectin multimer complex composition a decision was made not 
to measure adiponectin multimer distribution in this study. However, because HMW 
adiponectin may be more closely associated with insulin resistance than total plasma 
adiponectin concentration (Hara et al., 2006b), it would have been prudent to measure 
this as part of the current study’s methodology. It is likely that the inconsistent findings 
from the current and previous studies is related to the lack of assessment of the 
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adiponectin multimer distribution changes in response to interventions and is a limitation 
of the current research.  
The degree of weight loss between groups was expected to be greater in the 
current study, due to the increased energy demand from the structured exercise protocol, 
but this was not the case. It has been proposed that to increase circulating adiponectin, a 
weight loss of at least 10% of one’s initial body weight is needed (Christiansen et al., 
2010). Although the current study’s weight loss was statistically significant (4.5%), and 
the population was overweight and/or obese, it may not have been realistic for these 
individuals to achieve the magnitude of weight loss necessary to impact adiponectin 
within the twelve week study period. Furthermore, studies which have shown increases in 
adiponectin in response to weight loss have done so by using a more obese population 
than subjects who displayed a BMI of between 25-35 kg/m2 (Hulver et al., 2002; Kondo 
et al., 2006; Polak et al., 2006). 
Several modalities have been employed to demonstrate changes in adiponectin in 
obese individuals, including the use of a very low calorie diet (VLDL) (Hotta et al., 2001; 
Manigrasso et al., 2005), exercise (Brekke et al., 2005; Giannopoulou et al., 2005; Hsieh 
& Wang, 2005; Hulver et al., 2002; Marcell et al., 2005; Oberbach et al., 2006) and 
gastric bypass surgery (Faraj et al., 2003; Hulver et al., 2002). The current study utilized 
moderate-to-high intensity resistance training exercise, which may not be achievable or 
safe for morbidly obese subjects (Gotshalk et al., 1997). As a result it was most 
appropriate to use overweight and obese subjects in this study. Although it is likely that 
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morbidly obese subjects may have been more capable of losing weight in twelve weeks as 
compared to the study sample population, the resistance training exercise intervention 
was more appropriate to an overweight and obese population.  
Due to the intensity and energy requirements of the resistance training protocol, 
the nutrition protocol, which used a moderate decrease in caloric intake of approximately 
25% of total calories, was determined to be most appropriate for subjects. An overly 
restrictive diet, such as those employed by other VLDL studies (Christiansen et al., 2010; 
Hotta et al., 2001; Manigrasso et al., 2005), was not considered to be adequate to meet 
exercise demands, as it could limit exercise adaptation and foster an energy restricted 
state which would confound the exercise programs effectiveness. Studies using 
individuals sharing a similar obesity profile as the current investigation’s subjects have 
shown that adiponectin can be altered with weight loss (Balagopal, George, Yarandi, 
Funanage, & Bayne, 2005; Christiansen et al., 2010; Fatouros et al., 2005; Marcell et al., 
2005). It is possible that there are differences in sample populations, and degrees of 
adiposity that could explain differences in adiponectin response between studies. In the 
current investigation, however, under conditions of moderate and clinically significant 
weight loss combined with highly controlled interventions, a statistically or clinically 
significant difference in adiponectin concentration was not observed in either group.  
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6.2.2 Adiponectin: Response to Exercise 
Adiponectin levels have been studied extensively in exercise-related research 
(Bajer et al., 2015; Geliebter et al., 2014; Herring et al., 2014; W. J. Kraemer et al., 1998; 
Linnamo et al., 2005; Oliver et al., 2015). Based on previous reports, it was hypothesized 
that adiponectin would improve in response to a progressive, highly controlled resistance 
training protocol in combination with diet (Exercise + Diet), as compared to diet in 
isolation (Diet Alone). 
The twelve week intervention failed to demonstrate a measurable change in 
adiponectin from baseline in the presence of a significant weight loss of 5% in the 
Exercise + Diet group, and 4% in the Diet Alone group. Despite these conflicting results, 
some studies have found similar results when using obese but otherwise healthy 
populations (Kondo et al., 2006; Ryan et al., 2003).  The majority of studies which have 
shown an increase in adiponectin in overweight and obese populations have typically 
been performed on subjects who have glucose intolerance or insulin resistance, but who 
may not necessarily be diabetic (M. Bluher, 2013; Hsieh & Wang, 2005; Oberbach et al., 
2006). 
 
The effect of exercise on adiponectin is still unclear, with some studies showing 
that exercise improves adiponectin (Fatouros et al., 2005; Marcell et al., 2005) while 
others show no change (Kondo et al., 2006; Ryan et al., 2003) or a decrease (Christiansen 
et al., 2010; Christiansen et al., 2010; Yatagai et al., 2003). The lack of clearly defined 
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exercise protocols involves a variety of modalities, including aerobic training 
(Christiansen et al., 2010; Hsieh & Wang, 2005; Kondo et al., 2006; Oberbach et al., 
2006) anaerobic training (Fatouros et al., 2005), supervised training (Boudou et al., 2003; 
Fatouros et al., 2005; Giannopoulou et al., 2005; Hara et al., 2005; Marcell et al., 2005) 
and unsupervised training (Hsieh & Wang, 2005; Yatagai et al., 2003). These modalities 
have all resulted in diverse findings.  Furthermore, secondary outcome variables 
including weight/adipose tissue change, regional adipose location, impact of diet and the 
effects of other cytokines are not measured in many studies, making interpretation 
challenging, and comparisons difficult.   
A systematic review by Simpson et al. highlighted the need for more studies 
which directly compare responses in healthy, sedentary, lean, obese, and clinical cohorts 
to clarify whether subject characteristics define exercise adaptation (Simpson & Singh, 
2008). This exercise intervention study sought to address this issue, and based the 
resistance training protocol on previously established guidelines involving exercise 
progression models (Issurin, 2010). This approach prepared the study’s inactive subjects 
for high intensity resistance exercise shown to result in improved fitness (Vingren et al., 
2010). High intensity exercise was chosen for the structured exercise portion of this 
study, as both aerobic and anaerobic high intensity exercise demonstrates consistent 
findings with respect to improving adiponectin levels (Fatouros et al., 2005). It has also 
been shown that adiponectin changes resulting from high-intensity exercise are not lost 
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with short-term detraining, suggesting that a small amount of training may have a positive 
effect on adiponectin (Fatouros et al., 2005).  
Sample populations may be a factor in the discrepancy between these results and 
those of others who have demonstrated an increase in adiponectin. Although adiponectin 
responses have been observed in populations with characteristics similar to the current 
study’s subjects, it appears that no study has used such a population with a moderate to 
high intensity resistance training intervention (Ferguson et al., 2004; R. R. Kraemer et al., 
2003; St-Pierre, 2006; Yatagai et al., 2003).  
The specificity of the exercise intervention has been identified as an important 
study metric, as demonstrated in two contrasting studies.  Fatourous et al. randomized 
subjects to four different exercise conditions: sedentary control, low intensity, moderate 
intensity and high intensity resistance training exercise, all of which lasted 24 weeks 
(Fatouros et al., 2005). A similar study used an intervention that lasted 16 weeks, and 
which included moderate and intense exercise as compared to sedentary controls (Marcell 
et al., 2005). Similar to this study, Fatourous incorporated baseline fitness testing that was 
used to determine training intensity for each subject during the intervention. This 
approach to tailored prescription was not used by Marcell, who measured baseline aerobic 
capacity with a generalized aerobic prescription, not accounting for baseline performance 
(Marcell et al., 2005). Furthermore, it is recommended that a variety of exercises be 
incorporated into an exercise progression model that increases the volume and intensity of 
training while matching strength improvements of the subjects (Budnar, Duplanty, Hill, 
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McFarlin, & Vingren, 2014; Hakkinen & Pakarinen, 1995; Klimcakova et al., 2006; W. J. 
Kraemer et al., 1998; Linnamo et al., 2005). The determination of training intensity 
provides insights into exercise prescription responses between exercise sessions, which is 
a significant benefit for individuals undergoing monitored training. Although the current 
study’s intervention was similar to the aforementioned studies with respect to intervention 
and outcome measures, a change in adiponectin concentration was not identified. It is 
likely that differences in population demographics, in particular age as well as training 
duration could be a factor in the disagreement between these findings and those of others.  
The interplay between nutrition and exercise may also play a role in adiponectin 
response to a specific intervention. For example, the lack of caloric restriction and 
resulting weight loss by Fatourous (1.2-1.7% over 24 weeks) could be a factor. In 
addition, several studies have not reported regional adiposity and lean mass, either due to 
a lack of imaging assessment or because they chose not to report these variables (Fatouros 
et al., 2005). An important finding of this intervention was the increase in lean body mass 
which results from resistance training. As muscle is a powerful regulator of insulin 
resistance, it would have been valuable to compare the change in lean body mass with 
previous studies to determine its impact on insulin sensitivity during exercise 
participation.  
The length of the training intervention was shorter than some studies, which 
potentially impacted the adiponectin response and adaptations observed by others. The 
majority of exercise studies showed an improvement in adiponectin, which suggests that 
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training lasting longer than two months, that employs a sufficient exercise volume 
(frequency, intensity, and duration), results in a reduction in body weight, and improves 
insulin sensitivity increases adiponectin (Simpson & Singh, 2008). These criteria were 
applied to the study design; however, longer exposure to the exercise stimulus may have 
been necessary in the currents study’s population. Although this study was twelve weeks 
in duration, and the supervised Exercise + Diet intervention was adequate in intensity, 
and resulted in improvements in muscle mass, fitness measures and a modest yet 
statistically significant weight loss, it is likely that the weight loss was not significant 
enough to demonstrate the hypothesized changes. Another possible explanation for why 
this cohort did not demonstrate a change in adiponectin is because they were not insulin 
resistant at baseline. However, this hypothesis requires further investigation involving the 
use of populations with and without insulin resistance. 
A recent study by Christiansen et al. demonstrated a decrease, rather than an 
increase, in circulating adiponectin with exercise (Christiansen et al., 2010). They used a 
similar randomized sample size, involving a population of overweight and obese 
individuals, and also employed imaging techniques to capture anthropometric data 
(Christiansen et al., 2010) . Differences between the current study design and 
Christiansen et al. are evidenced by the protocols employed. The Christiansen group used 
aerobic training rather than resistance training and incorporated the use of a very low 
calorie diet (VLDL) of approximately 1/3 of the subject’s baseline caloric intake 
(Christiansen et al., 2010). The goal of their intervention was to achieve weight loss 
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through the manipulation of energy balance, resulting from increases in energy 
expenditure from aerobic exercise and decreases in energy intake as a consequence of 
restricted caloric intake (Christiansen et al., 2010). Results demonstrated a weight loss of 
11% (p<0.05) and a 19% (p<0.1) increase in adiponectin in the diet only group and a non-
significant adiponectin reduction of 6% (p=0.1) in the combined exercise and diet group 
(Christiansen et al., 2010). In comparison with the aforementioned study, the intention of 
the present exercise protocol was two-fold: to increase energy expenditure, and to elicit 
muscular hypertrophy through the employed resistance training program. Unlike the 
Christiansen et al. study, this study also aimed to show improvements in the androgen 
hormone testosterone. The dramatically reduced caloric intake resulting from a VLDL 
used by Christiansen et al. was not applicable to this study’s population, as it would not 
have provided necessary energy intake for hypertrophic adaptation to the resistance 
training intervention. Furthermore, it is possible that this high volume aerobic training 
program may have placed different physiological demands on subjects than a resistance 
training program, with respect to energy systems and training effect (Christiansen et al., 
2010). The mixed gender cohort of subjects may also help explain the discrepancy 
between results, as it is well documented that men and women respond differently to 
exercise, particularly resistance exercise (Lewis, Kamon, & Hodgson, 1986). Gender 
differences may also help explain discrepancies in adiponectin levels in response to 
weight loss through controlled diet and exercise. It is also likely that the modest decrease 
in body weight (~4-5%) observed in the current study, as compared to the Christiansen, 
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group (>10%) could help explain the inconsistencies in these findings. As opposed to the 
current study, these studies may have achieved the required magnitude of weight loss 
necessary to elicit an increase in adiponectin (Simpson & Singh, 2008). Interestingly, 
under conditions of exercise adiponectin unexpectedly decreases, while under conditions 
of diet in isolation adiponectin increases (Christiansen et al., 2010). After adjustment for 
trunk fat using an analysis of covariance, the current study’s results demonstrated that, 
similar to Christiansen et al., there was a statistically significant increase of adiponectin in 
the Diet Alone group and a corresponding decrease of adiponectin in the Exercise + Diet 
group.  
Adiponectin is a significant insulin sensitizer that is more concordant with 
changes in glucose metabolism and insulin resistance than changes in adiposity (Weyer et 
al., 2001).  Several studies have reported that the use of insulin-sensitizing agents 
markedly increase adiponectin concentrations, even in the absence of, or after adjustment 
for changes in weight (Fasshauer & Bluher, 2015; K. Maeda et al., 2012). The current 
study‘s baseline results demonstrate a relationship between adiponectin and insulin 
resistance, rather than adiposity, which is consistent with previous findings (Cnop et al., 
2003; Hotta et al., 2001; Weyer et al., 2001). Similar weight loss interventions increase 
circulating levels of adiponectin; however, these changes occur in the presence of 
improved insulin resistance (Yang et al., 2001).  
 The present study’s cohort was made up of overweight and/or obese, but 
otherwise healthy, individuals with normal insulin sensitivity and cardiovascular health. It 
198   
 
    
is important to recognize that obesity classification does not necessarily indicate the 
health of an individual.  It is well established that obesity is associated with insulin 
resistance, inflammation and metabolic disease; however, it is estimated that 10-30% of 
the obese population is considered to be metabolically healthy obese (MHO) (M. Bluher, 
2014). Although these MHO individuals have excess fat mass, they are insulin sensitive, 
normotensive and display a healthy blood lipid profile (Roberson et al., 2014). It is likely 
that there was little insulin sensitivity to be gained through the modest weight loss 
achieved by the current study’s subjects. The assumption that adiposity status is 
predictive of health status may be a contributing factor to the gap in the literature 
regarding the adiponectin response to weight loss interventions. 
 
6.2.3 Adiponectin: Exploratory Analysis 
To explore whether regional adiposity was a confounding factor in the adiponectin 
response, an exploratory analysis was performed after controlling for trunk fat. A 
statistically significant (p<0.002) paradoxical response between interventions was 
discovered, where adiponectin was lowered in the Exercise + Diet group by ~12% and 
elevated in the Diet Alone group by ~8% (Christiansen et al., 2010). 
The decrease in adiponectin demonstrated in the Exercise + Diet group relative to 
the Diet Alone group suggests that when controlling for the impact of regional adiposity 
physical activity suppresses adiponectin.  Furthermore, it was demonstrated that only 
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diet-induced weight loss in the absence of exercise (Diet Alone group) increased 
adiponectin among overweight/obese subjects. These findings are in agreement with 
Christiansen et al., who found that adiponectin concentration was reduced whether weight 
loss was achieved through exercise alone or in combination with dieting, and that it 
increased when weight loss was achieved through diet without exercise (Christiansen et 
al., 2010).  
To isolate the impact of exercise on adiponectin and determine its independent 
effect, one study controlled for weight reduction by using an active, normal-weight cohort 
who would not experience a significant decrease in body fat as a result of exercise 
training (Yatagai et al., 2003). This group used a smaller sample size of twelve non-obese 
subjects between the ages of 18-33 who were free of diabetes and not on any medications 
(Yatagai et al., 2003). Researchers conducted a six week intervention involving cycle 
ergometer aerobic training without caloric restriction (Yatagai et al., 2003). Body fat was 
measured using hydrostatic weighing and did not determine regional adiposity, unlike the 
DXA technique used in the current study. Investigators determined insulin sensitivity at 
baseline, sixteen hours following the subject’s final exercise session, and one week after 
the final exercise session (Yatagai et al., 2003)   After six weeks of lactate threshold 
ergometer exercise training, researchers discovered that insulin sensitivity improved 
independent of adiponectin, and that adiponectin levels decreased slightly as a result of 
this training (Yatagai et al., 2003) They concluded that adiponectin was suppressed due to 
an acute improvement in insulin action resulting from exercise (Yatagai et al., 2003). The 
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post-testing protocol involved blood collection that occurred forty-eight to seventy-two 
hours following the participants’ final exercise session. It is therefore likely that enhanced 
insulin action as a result of exercise was not detected. This was previously supported by 
other studies, and found to be correlated with suppressed adiponectin levels (Christiansen 
et al., 2010). Therefore, future research using a similar cohort to those in this study would 
benefit from a close examination of the relationship between insulin and adiponectin 
shortly after exercise participation. 
Another possible explanation for the suppression of adiponectin seen in exercise, 
was identified by Christiansen et al., who also measured the mRNA expression of 
adiponectin and its receptors in adipose tissue and muscle tissue, respectively. They found 
that diet-induced weight loss increased the mRNA expression of adiponectin in adipose 
tissue and increased adiponectin receptors in muscle tissue, but found that introducing 
physical activity soley resulted in an increase in adiponectin receptors in muscle tissue 
(Christiansen et al., 2010). Despite suggesting that mRNA expression could be 
responsible for the reduction of adiponectin through exercise and diet, this study did not 
provide evidence that changes in the expression of adiponectin receptors was associated 
with changes in the receptor protein and/or its subsequent biological effects. Similar to 
the current study’s findings, it was determined that adiponectin is not concordant with 
adiposity but instead with other factors, some of which are related to exercise 
(Christiansen et al., 2010). 
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The results of the exploratory analysis of adiponectin were not pre-specified and 
relied on subgroups. Therefore, these results must be considered tentative rather than 
definitive, despite being statistically significant. Although results were adjusted for 
multiple comparisons and remained statistically significant, this was a post-hoc, 
unplanned analysis, and further investigations should be made into the relationship 
between specific regional adiposity and the adiponectin response to weight loss achieved 
through Exercise + Diet. 
 
6.2.4 Association between regional adiposity and adiponectin: 
Adiponectin’s relationship to insulin sensitivity is well established. However, its 
association with adiposity remains uncertain within the literature (Cahill et al., 2013; 
Cnop et al., 2003). Visceral fat has shown a consistent negative association with 
adiponectin (Yang et al., 2001), as in vitro studies show that visceral adipocytes have 
increased the expression of adiponectin as compared to subcutaneous adipose tissues 
(Fain et al., 2004). The current study’s findings show that adiponectin concentration is not 
associated with subcutaneous adipose tissue measured via skinfold thickness, but rather is 
negatively associated with visceral fat as measured by DXA. These findings reaffirm the 
findings of previous studies, which show that an elevation in visceral fat depresses 
adiponectin secretion (Cnop et al., 2003). Based on the literature, there was little 
expectation to see as strong of a relationship with regional subcutaneous fat as is observed 
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with visceral deposits. However, the lack of association with any skin fold sites was 
unexpected due to the understanding that adiponectin is associated with adiposity (Galic, 
Oakhill, & Steinberg, 2010; Guerre-Millo, 2004; Kern et al., 2003).  
Although an easy to perform, skin fold caliper test that predicts adiponectin 
concentration could provide novel insights into its relationship with regional adiposity, a 
biochemical analysis is necessary to predict changes (Fasshauer & Bluher, 2015). Of 
relevance is that adiponectin has an acute and chronic response to rapid changes in body 
weight, and increases during periods of rapid weight gain in an attempt to improve energy 
regulation (Cahill et al., 2013). Therefore, adiponectin may be difficult to predict due to 
its response to various acute lifestyle scenarios associated with obesity (Cahill et al., 
2013). It may be valuable to investigate adiponectin changes with respect to regional 
body fat distribution in a cohort diagnosed with insulin resistance, as the relationship 
between insulin resistance to body fat and adiponectin has been well established (Haluzik, 
Parizkova, & Haluzik, 2004; Kaur, 2014; Kishida, Funahashi, & Shimomura, 2014b; 
Lindsay et al., 2002; Spranger et al., 2003). It could be hypothesized that changes in 
adipose tissue may reflect changes in adiponectin. However, this speculation would most 
likely be due to changes in insulin sensitivity, rather than the interplay between 
adiponectin and body fat. 
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6.2.5 Adiponectin: Summary and Interim Conclusions 
 
The present study’s results indicate that the adiponectin response to the Exercise + Diet 
intervention is dependent upon insulin resistance rather than adiposity status. Although 
the current study was able to demonstrate significant changes in total and regional 
adiposity, it did not show an associated change in adiponectin, without controlling for 
regional adipose depots.  Furthermore, the lack of change in insulin, insulin resistance 
and adiponectin in response to the intervention reinforces the relationships between 
these variables. In agreement with others (Christiansen et al. 2010), post hoc analysis 
revealed a reciprocal response of adiponectin in the intervention groups, where Exercise 
+ Diet reduced and Diet Alone increased circulating concentration. Both groups 
displayed similar weight loss and the Exercise + Diet group demonstrated addition 
cardiovascular health benefits. Therefore, the current study indicates that the assessment 
of adiponectin may be irrelevant in the prediction of health improvement resulting from 
exercise, in a population which is not insulin resistant. Therefore, future research should 
clearly identify subjects with impaired insulin resistance when investigating the impact 
of diet and exercise on adiponectin.  
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6.3 Energy Regulating Hormones and Cytokines 
 
The concentration of cytokine/hormones TNF-α, leptin and ghrelin are influenced 
by energy balance, and maintain homeostasis under conditions of reasonable food intake, 
energy consumption and normal metabolic rate (Considine, 1997; Golbidi & Laher, 2014; 
Kelly et al., 2011; R. R. Kraemer & Castracane, 2007; Leidy et al., 2004; Martins, 
Robertson, & Morgan, 2008; Ueda et al., 2009).  Conversely, conditions of obesity 
resulting from excessive energy intake leads to a disruption of these energy regulating 
hormones/cytokines (Castaneda, Tong, Datta, Culler, & Tschop, 2010; Fasshauer & 
Bluher, 2015; Oh et al., 2014; Selyatitskaya et al., 2015; Tschop et al., 2001).  Obese 
individuals express elevated basal concentrations of the adipokine leptin, which has been 
associated with the inhibition of food intake and increases in energy for both animals and 
humans (Bouassida et al., 2010), and TNF-α, which is associated with inflammation and 
decreased insulin sensitivity (Nikseresht, Sadeghifard, Agha-Alinejad, & Ebrahim, 2014).  
In addition, the gut peptide hormone ghrelin, which increases food intake and reduces fat 
metabolism, decreases in response to increases in adiposity (Hill, Murphy, & Singer, 
2012). The behaviour of these hormones is associated with adiposity status as well as 
with changes in body composition under conditions of weight loss (Considine, 1997; 
Sharman & Volek, 2004; Tschop et al., 2001; Varady et al., 2009). As a result, this study 
investigated the response of TNF-α, leptin and ghrelin to weight loss achieved through an 
Exercise + Diet intervention in overweight and obese middle aged males, a population 
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which possesses significant risk for obesity related health conditions such as energy 
regulation and metabolism.  
 
6.3.1 TNF-α 
 TNF-α has been shown to exhibit higher circulating levels in obese individuals, 
potentially promoting insulin resistance by inhibiting adiponectin release (Rosmond & 
Bjorntorp, 1998).  Although physical activity and nutrition are well established lifestyle 
factors for weight loss/management, very little is known about how these factors 
influence the inflammatory profile for overweight and obese men, particularly the impact 
of structured, supervised, high intensity resistance training. Therefore, it was 
hypothesized that circulating TNF-α concentrations would reduce with weight loss in 
both the Exercise + Diet and Diet alone groups and that TNF-α would decrease to a 
greater extent in the Exercise + Diet group due to participation in physical activity.  
 
6.3.1.1 TNF- α: Obesity 
The current study’s findings show a statistically significant, inverse relationship 
between TNF-α and total adiposity (p<0.03), as well as with trunk fat (p<0.04) at 
baseline. This inverse association supports the findings of others who state that even 
modest changes in adiposity may influence changes in TNF-α in overweight and obese 
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males (Kirwan, Kohrt, Wojta, Bourey, & Holloszy, 1993) and that the primary site related 
to increases in TNF-α  production and secretion is the abdominal/visceral adipose tissue 
(Clement et al., 2004). 
In both the Exercise + Diet and Diet Alone groups, TNF-α was inversely 
associated with adiponectin (p<0.02) as is currently understood in the literature (Hivert et 
al., 2010). This relationship with adiponectin is an important factor in the pathogenic 
impact of TNF-α on angiogenesis, blood pressure and lipid metabolism, all of which are 
linked with cardiovascular disease (Golbidi & Laher, 2014). Furthermore, it has been 
proposed that poor weight management could potentially promote an increase in TNF- α 
concentration, which can lead to chronic insulin resistance (Diehl, 2004). The current 
study population was not diabetic and did not demonstrate a significant change in insulin 
resistance in either the Exercise + Diet or Diet Alone group. Therefore, this intervention 
may have failed to demonstrate a change in TNF-α, because the subject’s baseline health 
status did not include impaired insulin resistance, or because the intervention resulted in 
no difference in insulin resistance parameters, and only resulted in modest weight loss. 
Another possible consideration for the lack of change in TNF-α is the age of the subjects. 
It has been shown that plasma TNF-α increases with advancing age; however, the 
magnitude of this effect has not been clearly established (Kirwan et al., 2001). Thus, there 
exists a growing body of literature investigating the relationships between aging, glucose 
tolerance, changes in body composition, and modulatory factors such as TNF-α, 
particularly with respect to overweight and obese aging males. 
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6.3.1.2 TNF- α: Response to Exercise 
The current study detected an inverse association between the baseline TNF-α 
concentration and the change in TNF-α concentration resulting from the Exercise + Diet 
intervention.  An inverse relationship between the plasma levels of inflammatory 
adipokines and the amount of physical activity was found (Dutheil et al., 2010).  Exercise 
has been shown to be protective against TNF- α  induced insulin resistance while also 
increasing anti-inflammatory substances such as adiponectin (Plaisance & Grandjean, 
2006b).  This is of particular relevance to the current study population, as the expression 
of TNF- α in adipose tissue is highest in obese subjects (Kern et al., 2001), and that TNF- 
α interacts with adiponectin by inhibiting its production and secretion from adipose tissue 
(N. Maeda et al., 2002). No change in TNF-α levels was observed after the Exercise + 
Diet intervention, indicating that there is no apparent independent effect of high intensity 
resistance training in this overweight/obese male cohort.  
  
6.3.1.3 TNF- α: Response to Nutrition 
TNF-α did not change in response to the Diet Alone intervention in the current 
study. This finding was unexpected and contradicts other results, which show that TNF-α 
responds favourably to nutrition interventions aimed at weight loss (Kallio et al., 2008; 
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Kelly et al., 2011; Kirwan et al., 1993; Qi et al., 2006). Investigations into the use of a 
low-glycemic index diet, similar to the one employed in this study, show that TNF-α 
reduces in older, obese adults (Kelly et al., 2011). It is believed that the consumption of a 
low-glycemic index diet and its resulting normalization of plasma glucose can halt the 
cycle of hyperglycemia, which contributes to insulin resistance, adipose tissue 
dysfunction, and pro-inflammatory cytokine production (Kelly et al., 2011). Using a 
highly controlled dietary intervention, researchers confirmed that a low glycemic index 
diet improved glucose tolerance and provided novel evidence that diet can reduce obesity 
associated inflammation (Kelly et al., 2011). These results are supported by longer-term 
dietary interventions, which suggest that carbohydrate intake modifications may influence 
the protein or mRNA expression of inflammatory markers in adipose tissue (Kirwan et 
al., 2001).  Because this study’s population did not suffer from insulin resistance or 
impaired glycemic control, and demonstrated TNF-α concentrations that were inverse to 
those typically expressed in males suffering from obesity, these findings are not 
unexpected.  In order for weight loss resulting from diet and exercise to reduce TNF-α, a 
baseline inflammatory profile may be necessary, which may not have been present in this 
cohort.  Of particular significance is the impact of increasing age, which leads to an 
exacerbated TNF-α response to hyperglycemia and hyperinsulinemia resulting from high 
glycemic index carbohydrates (Kirwan et al., 2001). When compared with a group of 
healthy young men (22 ± 1 yr), older men (67 ± 2 yr) show a “normal” suppression in 
TNF-α production under post-prandial-like conditions, supporting the role of TNF- α as a 
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modulator of insulin-mediated glucose metabolism (Kirwan et al., 2001). TNF- α may be 
a factor in the decline in insulin action observed among older men, due to the relatively 
greater total body and abdominal fat mass witnessed in this population (Kirwan et al., 
2001). The measurement of post-prandial TNF-α would be a valuable addition for future 
research employing the current study’s dietary protocol, due to its effectiveness in 
reducing total adiposity and visceral fat in both the Exercise + Diet and Diet Alone 
groups.  
The employed nutrition protocol not only involved the consumption of low 
glycemic carbohydrates, but encouraged their consumption in the form of whole grains, 
including dietary fiber. It was found that fiber intake was associated with lower 
inflammatory markers in both diabetic and non-diabetic individuals (Qi et al., 2006). It is 
possible that the inhibition of inflammation by whole grain and cereal fiber may be 
secondary to their effects of lowering glycaemia (Qi et al., 2006). This is supported by the 
observation that dietary glycemic index is positively related to inflammatory markers, as 
was also noted in a previous study among nondiabetic subjects similar to ours (Kallio et 
al., 2008). 
 
6.3.1.4 Association between regional adiposity and TNF-α: 
TNF- α is elevated in obese individuals, and is associated with systematic 
inflammation and insulin resistance (Cawthorn & Sethi, 2008).  Although associated with 
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subcutaneous fat mass, the visceral adipose compartment is credited as the major source 
of TNF-α production and secretion (Clement et al., 2004).  TNF-α concentration has been 
predicted by anthropometric measures including BMI, waist circumference and percent 
trunk fat, as determined by DXA (Clement et al., 2004).  TNF-α did not show a 
significant relationship to any regional skin fold or girth measurements. However, it did 
show a positive association with total body fat, trunk fat percentage and body fat 
percentage as determined by DXA in the current study. This data does not reflect the 
relationship between TNF-α and adipose tissue, which consistently demonstrates a greater 
fasting concentration of TNF-α which is positively associated with visceral adipose tissue 
mass in obese humans (Clement et al., 2004). Of particular relevance is that most TNF-α 
release is due to non-fat cells, but shows an enhanced release by adipocytes isolated from 
subcutaneous adipose tissue of massively obese individuals (BMI of 45) as compared to 
their leaner counterparts (Ruan & Lodish, 2003). The study population of overweight and 
obese participants may not have met the necessary obesity threshold to demonstrate the 
previously established TNF-α relationship with subcutaneous adipose tissue (Fain et al., 
2004). Furthermore, the relevance of skinfold caliper assessments for morbidly obese 
individuals becomes less relevant due to the lack of sensitivity associated with larger skin 
fold thickness measurements. These findings indicate that the use of skinfold thickness as 
a possible predictor of fasting TNF-α concentrations is unlikely to be of value during 
obesity management. It appears that the population who may best demonstrate the 
necessary resolution between TNF- α and subcutaneous skinfold thickness is likely those 
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who are obese. However, the use of this measurement technique is not accurate for these 
populations. 
 
6.3.2 Leptin and Ghrelin:  
6.3.2.1 Leptin, Ghrelin and Obesity 
Leptin is an appetite regulating hormone produced in proportion to body fat, 
demonstrating higher concentrations in obese individuals (Bouassida et al., 2010). In 
circumstances of weight loss, circulating leptin concentration is reduced, which 
diminishes its inhibitory effect on satiety and leads to an increase in appetite and feeding 
(Bouassida et al., 2010). Therefore, it was hypothesized that circulating leptin levels 
would reduce with weight loss in both the Exercise + Diet and Diet Alone groups and that 
leptin would decrease to a greater extent in the Exercise + Diet group due to the increased 
energy expenditure resulting from physical activity.  
The association between leptin and adiponectin observed at baseline was not 
maintained after weight loss, most likely because of the demographics of the study 
population. As stated previously, the baseline characteristics of the study population 
confirms that while subjects were overweight or obese according to the BMI scale and 
demonstrated various elevated measurements of regional adiposity as compared with their 
normal weight counterparts, their overall metabolic profile did not resemble that of those 
suffering from obesity associated metabolic conditions including hypertension, 
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hyperlipidemia or diabetes. It is likely that the significant change in adiposity, without a 
change in insulin resistance, is responsible for the uncoupling of the adiponectin-leptin 
relationship demonstrated at baseline. These results further reinforce the understanding 
that leptin is strongly associated with adiposity in humans (Teerds et al., 2011), while 
adiponectin is more closely related to insulin resistance than the degree of adiposity 
(Weyer et al., 2001). Interestingly, the fasting leptin concentration at twelve weeks 
maintained its relationship with insulin and insulin resistance after weight loss, although 
not as strongly. Neither of these variables demonstrated significant changes in response to 
either the Exercise + Diet or Diet Alone interventions. Another possibility for the lack of 
association between leptin and adiponectin may be due to the study power. However, 
sample size was addressed in the study design of the current experiment and was 
determined to be sufficient for demonstrating the relationships in this study’s primary 
variables. It is more likely that these results mirror those of previous studies, which show 
that weight loss influences leptin to a greater degree than adiponectin, even though both 
are strongly associated with adiposity (Shand et al., 2003; Stefanyk & Dyck, 2010) . 
Leptin receptors are also present in testicular tissue, and it is believed that leptin 
may exert a direct negative action on androgen production and play a role in the reduction 
of androgens among obese males (Isidori et al., 1999). The relationship between leptin 
and testosterone was not found at baseline or after twelve weeks for either the Exercise + 
Diet or Diet Alone groups (Table 11). The lack of change in total testosterone in the 
presence of both decreased leptin and weight loss may be a result of the relatively small 
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degree of weight loss or, more likely, the lack of obesity related derangement in sex 
hormones at baseline for these subjects. Baseline analysis revealed that subjects did not 
suffer from hypogonadism. Therefore, it would be expected that the inhibitory effects of 
leptin did not significantly impact sex hormones and, consequently, are not susceptible to 
improvements or changes resulting from either the Exercise + Diet or Diet Alone 
intervention. 
Ghrelin is a peptide hormone, and is one of the only hormones known to increase 
appetite (Ahima, 2006; Nakazato, 2003). Unlike most other gut-derived, meal patterning 
peptides, ghrelin increases food intake and reduces fat utilization, and is therefore 
associated with long term body weight regulation (Foster-Schubert et al., 2005). Weight 
loss has been shown to trigger an increase in circulating ghrelin concentrations as part of 
an adaptive response to energy deficits (Cummings, 2006). It was therefore hypothesized 
that ghrelin would increase in response to weight loss and demonstrate greater positive 
change in the Exercise + Diet group, due to the high intensity exercise and its associated 
increase in energy expenditure. 
The current study’s results did not show a statistically significant change in 
ghrelin in response to either the Exercise + Diet or Diet Alone protocols. In the Diet 
Alone group, ghrelin demonstrated a statistically significant inverse association with 
anthropometric measures of obesity including weight (p<0.01), waist circumference 
(p<0.001), hip circumference (p<0.001) and total body fat (p<0.003). Of particular 
relevance is that this relationship between ghrelin and adiposity was not maintained 
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following weight loss for either the Exercise + Diet or Diet Alone groups. The current 
study suspected that the nature of the intervention that controlled for macronutrient 
content of meals and only required a reduction of daily caloric intake of approximately 
25% for subjects is a factor in the discrepancies in the results and those of others who 
have shown an increase in ghrelin with weight loss (R. R. Kraemer & Castracane, 2007; 
Leidy et al., 2004; Markofski et al., 2014; Schubert et al., 2014; Thomas et al., 2012).  As 
stated previously, ghrelin has an inverse relationship with leptin in both circulating 
concentrations and function, and is related to adiposity status, increasing appetite in order 
to restore energy balance during periods of weight loss (Hill et al., 2012). However, 
baseline associations were not maintained following both interventions in the current 
study. Both ghrelin and leptin have the same regulating system, and both inform the 
central nervous system about acute and chronic energy balance (Castaneda et al., 2010). 
Results from the current investigation indicate that ghrelin may be more closely linked to 
nutritional intake and energy balance than leptin, which is more strongly correlated with 
adiposity (Castaneda et al., 2010).. 
 
6.3.2.2 Leptin and Ghrelin: Response to Exercise 
  
Previous studies have shown that leptin decreases independently in response to exercise 
(Pasman, Westerterp-Plantenga, & Saris, 1998; Sakurai et al., 2012). These studies lack 
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methodological rigor, and have involved various modalities and intensity of exercise, 
often in an uncontrolled setting (Pasman et al., 1998; Sakurai et al., 2012). In the current 
study, both Exercise + Diet and Diet Alone groups displayed similar, modest weight loss. 
It was anticipated that changes in leptin concentration would only be apparent in the high 
intensity exercise training if significant weight loss was achieved. Studies have reported 
that fasting concentrations of leptin may decline with endurance and/or resistance training 
(Sakurai et al., 2013). However, the majority of investigations point to the inverse 
relationship of leptin with adiposity, and show no apparent impact from exercise 
(Bouassida et al., 2010; Golbidi & Laher, 2014; Markofski et al., 2014; Mason et al., 
2015). The inability of previous studies to detect an independent effect of exercise on 
leptin concentration may be due to the exercise prescription itself and/or the lack of 
training supervision, which ensures that exercise intensity is maintained during activity 
sessions. A highly controlled exercise prescription could elicit a change in circulating 
leptin independent of the weight loss achieved through nutrition intervention alone, due to 
leptin’s relationship with energy regulation and the sympathetic nervous system. Results 
from previous exercise studies have been hindered by their inability to disassociate the 
effects of exercise itself from the confounding effects of energy balance (Fatouros et al., 
2005). Although intensity and hours of exercise have claimed to have independent effects 
on leptin, the strong association between adiposity and leptin makes interpretation of the 
change mechanisms difficult (Fatouros et al., 2005; Pasman et al., 1998). Findings of this 
study mirrored those of others, which have shown that weight loss, independent of 
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modality, results in an associated decrease in leptin, and that leptin does not change in 
response to long term exercise training when controlling for adiposity status (Bouassida et 
al., 2010; Kim et al., 2012; Sakurai et al., 2012). 
With respect to ghrelin, there was an increase in the Exercise + Diet group of 
approximately 5% and a decrease in the Diet Alone group of ~30% between baseline and 
twelve weeks. However, these results were not statistically significant, and do not provide 
evidence that either intervention affected circulating ghrelin concentrations. These results 
provide further insight into the impact of exercise on ghrelin concentrations, as research 
to date has been inconclusive. Ghrelin has shown an acute suppressive response to the 
concentric action of resistance training. However, ghrelin does not change in response to 
running or cycling in humans (Takano et al., 2005).  In an attempt to identify the role of 
chronic exercise on ghrelin, Markofski et. al controlled for body fat loss and showed 
significant increases in circulating ghrelin and adiponectin, as well as a trend towards 
reduced leptin following exercise training (Markofski et al., 2014). Study design 
considerations, such as lack of supervision and self-selected exercise intensity may 
explain the difference in outcomes from the current study. The fact that the highly 
controlled Exercise + Diet and Diet Alone prescriptions were supervised by a certified 
kinesiologist and registered dietitian in this study provides greater control over possible 
confounding variables, including exercise adherence and caloric intake.  Furthermore, the 
assessment of adiposity using skin fold calipers used by Markofski et al., in lieu of gold 
standard adiposity imaging such as DXA, further reduces the reliability of subcutaneous 
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body fat measurements, and does not allow for the assessment of important regional 
adiposity sites including visceral fat. With respect to the Exercise + Diet group, it was 
hypothesized that the increase in ghrelin is related to the greater energy requirements of 
enhanced baseline lean muscle tissue, coupled with the increase in energy demanded by 
the resistance training protocol. 
Ghrelin has shown a significant increase during weight loss via exercise, where 
those individuals with the highest degree of weight loss exhibit the greatest increase in 
ghrelin (Foster-Schubert et al., 2005; Leidy et al., 2004). One review concluded that in 
the absence of weight loss, exercise has no significant impact on the fasting plasma levels 
of ghrelin (R. R. Kraemer & Castracane, 2007). Of particular relevance is the current 
investigation’s unplanned exploratory analysis that when controlling for lean body mass 
demonstrated a higher fasting ghrelin concentration in the Exercise + Diet group at twelve 
weeks compared to baseline. This finding supports a minority consensus in the literature 
that ghrelin is elevated in response to exercise to compensate for associated increases in 
energy expenditure (Bajer et al., 2015). 
 
6.3.2.3 Leptin and Ghrelin: Response to Nutrition 
With respect to nutrition, leptin concentration is associated with dietary reductions 
in total energy and dietary fat intake under conditions of caloric restriction and weight 
loss (Reseland et al., 2001). Lifestyle changes, including diet and exercise are similar to 
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those in this randomized trial, and have been reported to improve carbohydrate 
metabolism, reduce insulin resistance and improve metabolic profile (Erdmann et al., 
2004; Overduin et al., 2005; Tannous dit El Khoury et al., 2006). Results from the present 
study indicate that there is a significant change in leptin after twelve weeks, however this 
was not independent of group. Both the Exercise + Diet and Diet Alone groups underwent 
a hypocaloric diet designed to promote weight loss and improve satiety through the use of 
a low glycemic index, high protein and low saturated fat nutrition protocol that has been 
shown to impact appetite regulating hormones (Mason et al., 2015; S. X. Zhang, Guo, 
Wan, & Xue, 2011). A study by Considine et. al. hypothesized that changes in energy 
intake or expenditure may be detected by adipocytes, which in turn influence the 
synthesis of leptin (Considine, 1997). Nutrition guidelines were provided to subjects by a 
registered dietitian, which included particular emphasis on the selection of low glycemic 
index (GI) foods. The relationship between glycemic response and leptin has been 
specifically investigated with respect to appetite control and satiety (Barkoukis et al., 
2007; Bowen et al., 2006). One group reported that low glycemic meals promote a 
postprandial metabolic environment that is favourable for reduced food consumption in 
young, healthy volunteers (Barkoukis et al., 2007). In a separate five week study, using 
moderately overweight men undergoing a low-GI diet, subjects effectively ameliorated 
some plasma lipid parameters, decreased total fat mass and tended to increase lean body 
mass without changing body weight (Bouche et al., 2002). Similar to the current study, 
the decrease in fat mass was accompanied by a significant decrease in leptin; however, 
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the decrease in food intake was not confirmed (Bouche et al., 2002). These authors 
proposed possible mechanisms to explain why the lower GI diet induced a selective 
decrease in fat and an increase in lean body mass, including the difference in nitrogen 
balance and protein metabolism (Bouche et al., 2002). It was suggested that fat tissue was 
oxidized to a lesser degree and muscle to a greater degree with the high-GI diet due to the 
greater negative nitrogen balance associated with the high GI diet (Bouche et al., 2002). 
Another possible mechanism they proposed is a shift in substrate utilization for a low-GI 
diet which reduces carbohydrate oxidation and increases fat oxidation (Bouche et al., 
2002). It is possible that the increase in lean mass observed in the Exercise + Diet group 
was enhanced by these proposed mechanisms. However, this theory is speculative, and 
warrants further investigation.  
Diet and nutrition have a much clearer impact on ghrelin than leptin. It is well 
established that the type of macronutrient ingested dictates the magnitude of ghrelin 
suppression, with carbohydrates demonstrating the greatest suppressive effect, followed 
by protein and fat, respectively (Erdmann et al., 2004; Overduin et al., 2005; Tannous dit 
El Khoury et al., 2006). Ingestion of carbohydrates and proteins decreases ghrelin by 
approximately 70% during the post prandial period, while fats demonstrate an 
approximate decrease of 50% (Bowen et al., 2006). The higher post-prandial circulating 
concentration of ghrelin that is associated with dietary fat intake, as compared to 
carbohydrate or protein, is one of the proposed mechanisms of weight gain associated 
with high fat diets due to ghrelin’s resulting stimulation of appetite (Tannous dit El 
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Khoury et al., 2006).  Therefore, ghrelin release appears to occur in response to the 
ingested macronutrients and, as a result, helps dictate subsequent hunger and food intake. 
Both the Exercise + Diet and Diet Alone groups were required to ingest macronutrient 
ratios outlined by previous work that have demonstrated post-prandial ghrelin suppression 
(Erdmann et al., 2004; Overduin et al., 2005; Tannous dit El Khoury et al., 2006). Higher 
protein diets have been shown to promote weight loss more effectively than higher fat 
diets, and the implications is that the suppressive effect of protein on ghrelin is considered 
an important factor in the success of high protein, hypocaloric diets (Bowen et al., 2006). 
Because of the feed frequency that occurred every 3-4 hours, both the Exercise + Diet and 
Diet Alone protocols were designed to reduce ghrelin concentration between feedings, 
even in the presence of weight loss.  
When controlling for lean body mass at baseline, ghrelin showed a statistically 
significant decrease (p<0.001) in the Diet group of ~30% and an increased in the Exercise 
+ Diet group of ~5%. Although the post-prandial suppression of ghrelin has been 
established by previous work, the chronic effect of dietary protocols leading to decreased 
fasting ghrelin, as evidenced by the Diet Alone group in the current study, could be 
considered to be a novel finding. These results conflict with the results of others, which 
have shown that ghrelin is elevated in response to weight loss (Leidy et al., 2004). It 
should be noted that this was an exploratory analysis and although the result remains 
significant, even when adjusting for multiple comparisons, this was a post-hoc, unplanned 
analysis. This result therefore warrants further investigations into the relationship 
221   
 
    
between lean body mass and ghrelin under conditions of weight loss achieved through 
diet and exercise. 
Of particular relevance is the lack of change or slight increase in circulating 
ghrelin, and the associated drop in leptin for the Exercise + Diet group. These results may 
create a scenario which fosters negligible weight loss and potential weight regain 
following exercise cessation.  It has been established that restrained eaters, or successful 
dieters, are efficient at reducing energy intake in response to the elevated energy 
expenditure associated with exercise. Unrestrained eaters, or unsuccessful dieters, on the 
other hand, respond to increased energy expenditure by compensating with elevated 
energy intake (Geliebter et al., 2014; Mason et al., 2015).  In lifestyle prescription, 
adherence to exercise and nutrition protocols is a limiting factor in intervention 
effectiveness (Anderson, Konz, Frederich, & Wood, 2001; Curioni & Lourenco, 2005; 
Franz et al., 2007; Martins et al., 2008; Mason et al., 2015; Poirier & Despres, 2001; 
Swift, Johannsen, Lavie, Earnest, & Church, 2014). With a decrease in satiety resulting 
from lowered leptin, coupled with the appetite stimulating characteristics of ghrelin, 
restrained eating may be more difficult for those in the Exercise + Diet group as 
compared to the Diet Alone group.  Therefore, the results of the current study indicate 
that there may be a benefit to establishing restrained eating behaviours similar to those in 
the Diet Alone group prior to starting high intensity exercise. Although both groups 
showed high compliance in the current study, this may be due to the supervision aspect of 
the interventions, and may not be the case for individuals outside of the research setting.  
222   
 
    
As weight loss was comparable between the Exercise + Diet and Diet Alone groups over 
the twelve week intervention, and ghrelin was only reduced in the Diet Alone group, 
participants may display greater adherence to a hypocaloric dietary protocol in the 
absence of increased energy demands from exercise. Once initial weight loss is achieved 
and restrained eating is habitual, it may be beneficial to implement exercise to achieve the 
benefits of physical activity, particularly the cardio-protective attributes of the resistance 
training protocol employed in the current study. There are a lack of studies investigating 
the impact of long-term (greater than six weeks) exercise on appetite-related hormones 
which show how changes observed in these hormones relate to weight loss or prevention 
of weight regain in the obese population (Schubert et al., 2014). This study reveals 
important insights with respect to appetite regulating hormones associated with exercise 
and diet, which must be considered when prescribing lifestyle interventions to overweight 
and obese aging male patients, particularly where adherence and susceptibility to weight 
regain dictate long term success. 
The weight loss threshold needed to elicit a change in fasting ghrelin has yet to be 
established. However, previous research has shown it is individuals experiencing the 
highest degree of weight loss that ghrelin concentration increases most profoundly (Kim 
et al., 2012; Markofski et al., 2014; Mason et al., 2015).  The present research indicates 
that the adiposity-ghrelin relationship may be uncoupled by nutrition protocols designed 
to increase satiety and reduce post-prandial ghrelin.  This Diet Alone protocol may have a 
protective effect for weight loss through its suppression of ghrelin in the absence of 
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increased energy expenditures resulting from exercise.  Further investigation is therefore 
warranted into the potential beneficial impact of ghrelin concentration on appetite 
resulting from diet and exercise prescriptions for this demographic of 35-55 year old 
overweight and obese males. 
 
6.3.2.4 Association between Regional Adiposity and Leptin and Ghrelin: 
Leptin signals the central nervous system with respect to adiposity status and 
energy regulation (Blüher, 2014). The larger, subcutaneous fat deposits, rather than 
visceral fat deposits, have collectively been associated with leptin concentration and 
expression (Taksali et al., 2008). This relationship was demonstrated in the current study 
between leptin and skin fold measures, where statistically significant correlations were 
found for the pectoralis (p<0.001), mid-axillary (p<0.001), subscapularis (p<0.001), and 
the quadriceps (p<0.01). Additionally the current study also observed a strong association 
between visceral fat mass and leptin (p<0.001). It is believed that subcutaneous deposits, 
and not visceral fat, may be responsible for leptin signally to the CNS (Taksali et al., 
2008). In the current study, both subcutaneous and visceral adipose deposits displayed 
statistically significant associations with leptin, where all of the subcutaneous skin fold 
sites showed a marginally stronger relationship with leptin. These results indicate that 
leptin changes with overall adiposity, and is not associated with any specific 
subcutaneous skin fold sites. That said, the overall measure of percent body fat, 
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determined by skinfold thickness, may be a useful tool for the predicting circulating leptin 
concentrations during weight loss.  
Ghrelin has been shown to be associated with BMI. However, the majority of 
research indicates that it has a stronger relationship with leptin and nutritional intake, both 
of which are implicated in adiposity status (Bowen et al., 2006; Havel, 2001; Popovic & 
Duntas, 2005; Ueno, Dube, Inui, Kalra, & Kalra, 2004). The current investigation’s 
results indicate a negative association between several measures of adiposity and ghrelin, 
including BMI (p<0.01), waist (p<0.02) and hip circumference (p<0.001), as well as with 
total body fat (p<0.03) and visceral fat mass (0.01) as determined by DXA. Of particular 
interest is ghrelin’s statistically significant, inverse relationship with lean body mass 
(p<0.01), and its resulting, potential implications for energy regulation and metabolism. 
Research on energy expenditure increases achieved through exercise has been 
inconclusive with respect to its impact on ghrelin concentration. However, the increased 
basal and exercise associated energy demands related to increased lean body mass may 
show the promising, predictive capabilities of ghrelin (Kojima & Kangawa, 2008; 
Muccioli et al., 2004; A. D. Patel et al., 2006). The current study shows an inverse 
correlation with lean body mass that is stronger than ghrelin’s relationship with total fat 
mass. As ghrelin informs the CNS about acute and chronic energy balance, the positive 
association of ghrelin with lean body mass provides important insights into the 
relationship between body composition and ghrelin (Castaneda et al., 2010).  This is an 
important finding in the prescription of diet and exercise for obese populations, as 
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individuals who possess greater lean body mass at baseline, or who gain lean body mass 
as the result of lifestyle intervention, may be predisposed to increased appetite. Coupled 
with an inverse relationship with leptin, a scenario which fosters weight regain may 
become apparent. The assessment of lean body mass, either through imaging or through 
predictive equations such as skin fold caliper methods, may prove useful in the 
counselling of individuals with respect to caloric intake during weight loss and in 
populations with higher relative lean body mass irrespective, of obesity status. 
Furthermore, the lack of an association between ghrelin and regional skin fold thickness 
is likely not significant, particularly in the presence of several well established adiposity 
measures such as girth measures and body fat imaging. The secondary benefits of 
determining lean body mass using low cost assessment tools, such as skinfold thickness 
equations, may be more insightful than traditional BMI measures, which fail to determine 
body composition. 
 
6.3.2.5 Summary of Energy Regulating Hormone Findings: 
In summary, weight loss resulting from caloric restriction, with or without the 
increases in energy expenditure or improved lean body mass achieved through exercise, 
results in an associated decrease in circulating leptin for overweight and obese middle-
aged men. Comparatively, ghrelin concentrations may be impacted by the nature of the 
weight loss intervention and their relationship with lean body mass.  With respect to 
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inflammatory adipokines, it appears that either the Exercise + Diet or Diet Alone 
protocols failed to produce a change in TNF-α, in the absence of improvements to insulin 
sensitivity. Furthermore, it is likely that weight loss was not substantial enough to result 
in modified TNF-α in the current study.  These results are therefore inconclusive with 
respect to others who have found that short term changes in inflammatory markers and 
energy-restricted low-fat and low-carbohydrate diets are primarily related to weight loss, 
rather than dietary intervention (Sharman & Volek, 2004). However, baseline 
relationships between adiposity, in particular visceral adiposity, indicate that the 
employed intervention may be an effective strategy at improving inflammatory profile if 
significant weight loss is achieved.  
It appears that exercise has no significant effect on circulating TNF-α or leptin 
under the conditions of long term resistance training in this population, and that the 
demonstrated decrease in circulating leptin is weight loss-induced and associated with a 
reduction in adipose tissue. In addition, the reduction in ghrelin, coupled with the lower 
leptin concentration observed under conditions of caloric restriction in the Diet Alone 
group, indicates that current understandings of the ghrelin-obesity, ghrelin-leptin 
relationship may be disrupted through nutrient timing and the macronutrient content of 
meals. Leptin has been shown to suppress the secretion of ghrelin, and increases in 
ghrelin levels have been reported during diet-induced weight loss in obese individuals, 
suggesting that ghrelin contributes to appetite, responding to energy restriction and lower 
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leptin levels (Ueno et al., 2004). However, the current study’s findings did not see the 
predicted associated increase in ghrelin under conditions of lowered leptin.  
It is believed that the timing and macronutrient content of meals used in the 
employed nutrition protocol may have augmented this association. The significant 
reduction in ghrelin in the Diet Alone group coupled with the significant change in both 
measures of adiposity and leptin, indicates that the current nutrition protocol was 
successful in mitigating the previously established leptin-obesity-ghrelin relationship. 
6.3.3 Testosterone: 
6.3.3.1 Total Testosterone: Obesity 
 Testosterone is a steroid hormone that is responsible for muscle protein synthesis 
and which reduces muscle protein degradation, while playing a significant role in energy 
expenditure (Tajar et al., 2012). Testosterone circulates in the bloodstream, bound mostly 
to the sex hormone binding globulin and, to a lesser extent, serum albumin and 
corticosteroid-binding globulin (Tajar et al., 2012).  
Previous research demonstrates that testosterone is impacted by several variables, 
and reduces in response to increasing obesity, and increases in response to exercise (Tajar 
et al., 2012) . Therefore, the current study hypothesized that weight loss achieved through 
diet and exercise would demonstrate an increase in total testosterone for the inactive, 
overweight and obese, middle aged male cohort. 
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The current study was unable to detect a measurable response to either the 
Exercise + Diet or Diet Alone interventions between baseline and twelve weeks.  These 
preliminary results were not anticipated due to the inverse association between obesity 
and testosterone that has been well established in the literature (Camacho et al., 2013; 
Glass et al., 1977; Wu et al., 2012). However, upon further investigation into the baseline 
circulating testosterone levels observed in the current study’s subjects, as well as the 
degree of weight loss, the explanation for the lack of change becomes evident. Obesity is 
associated with an 8.7 fold increase in the relative risk of hypogonadism (testosterone < 
10.5mml and normal LH) and to date, the most significant predictor of low testosterone is 
obesity status (Frost, 2007; Tajar et al., 2012) .  Additionally, obesity status is one of the 
major contributors to age-associated decline in testosterone levels in men (Tajar et al., 
2010).  In an obese state, adipose tissue expresses aromatase, which converts testosterone 
into estrogen. Furthermore, the increases in visceral fat associated with male pattern 
obesity promote increased TNF-α, insulin and leptin, all of which may down regulate the 
HPT axis (Sharman & Volek, 2004). Although the current study’s population was 
classified as obese or overweight, and displayed elevated visceral fat stores in comparison 
to their normal weight counterparts, they did not demonstrate hypogonadism, as the mean 
total testosterone values fell within normal ranges for age matched males. Therefore, the 
lack of change in testosterone, although hypothesized to improve in response to weight 
loss and exercise, is not unexpected because of the baseline testosterone concentration, 
which fell within a normal range. 
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In humans, the degree of weight loss is predictive of testosterone response with 
individuals who experience the largest percent of body weight lost yielding the greatest 
increase in testosterone (Camacho et al., 2013). Weight loss of greater than 15% of body 
weight has shown a favorable impact on testosterone levels in overweight males. 
However, typical weight loss interventions using a hypocaloric diet results in between a 
6-17% reduction in body weight (Camacho et al., 2013). The current study showed an 
average weight loss of 4.5% in the intervention groups within the twelve week period, 
which may not have been sufficient to result in any significant changes in fasting total 
testosterone.  
 
6.3.3.2 Exercise and Testosterone: 
Total testosterone response to resistance training is dependent upon several 
variables including volume, number of sets, order of exercise, intensity, rest intervals, 
choice of exercise and pre/post workout nutrition (Vingren et al., 2010). Based on 
previous research, resistance training protocols were employed that have been shown to 
consistently improve total testosterone in a variety of populations including young, old, 
active and inactive individuals (Beaven, Gill, & Cook, 2008; Beaven, Cook, & Gill, 2008; 
Budnar et al., 2014; W. J. Kraemer et al., 1998; Linnamo et al., 2005; Vingren et al., 
2010). It was expected that these resistance exercise protocols would elicit a similar 
response in an overweight and obese, but otherwise healthy male cohort, as demonstrated 
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in similar non-obese populations (Hakkinen et al., 1988a; Hakkinen et al., 1988b; W. J. 
Kraemer et al., 1999; Marx et al., 2001; Staron et al., 1994). The basis for this hypothesis 
was twofold; first, it was anticipated that the training effect of the Exercise +Diet 
intervention would be amplified by the previously inactive status of the subjects, and 
secondly, it was anticipated that weight loss resulting from the Exercise +Diet protocol 
would have a beneficial and complimentary impact on total testosterone. However, this 
did not occur in the current study. 
Contractile loading of skeletal muscle through resistive-type exercise and protein 
ingestion acts as a strong stimulus for muscle protein synthesis and, when combined can 
induce a net positive protein balance and muscle hypertrophy, as witnessed by the 
increase in lean body mass in the Exercise + Diet group of the current study. This 
investigation utilized protocols more suitable for an older population, where contraction 
can be manipulated. The study used moderate-load weight lifting to stimulate rates of 
muscle protein synthesis to a level comparable to traditional high-loads, which is an 
approach with important implications for older adults interested in undertaking resistance 
exercise (Breen & Phillips, 2012). The resulting increase in lean body mass, coupled with 
the improved muscle cross sectional area of the Exercise +Diet group, indicates that 
hypertrophy occurred. Although the fasting total testosterone did not change in response 
to the intervention, the goal of muscular hypertrophy was achieved in a population who 
has been shown to possess specific challenges with respect to improved muscle protein 
synthesis due to obesity and age (Camacho et al., 2013). Changes in acute total 
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testosterone may be responsible for this hypertrophic response in the Exercise +Diet 
group. However, the lack of acute post exercise measurement makes this hypothesis 
speculative, and should be addressed in future studies.   
 
6.3.3.3 Testosterone and Nutrition: 
Testosterone response to dietary intake and the effect of specific macronutrients on 
androgens has yet to be extensively investigated. It is also unclear how diet related 
decreases in total testosterone influences muscle mass. The results of this study indicate 
that a hypocaloric diet, with or without resistance training exercise that results in modest 
but statistically significant weight loss, does not impact total testosterone in the studied 
population. These results must be interpreted with caution, as the relatively small degree 
of weight loss and the lack of significant change in weight between groups was a 
limitation for determining whether a change in circulating total testosterone concentration 
took place as a result of diet.  
 
6.3.3.4 Testosterone and Regional Adiposity: 
Testosterone is inversely associated with obesity status (Allan & McLachlan, 
2010). The impact of massive obesity on testosterone is well established; however, the 
impact of mild to moderate obesity on the hypopituitary gonadal axis is less clear (Tajar 
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et al., 2012). According to the Massachusetts Male Aging Study, testosterone 
concentration correlates with a number of abdominal fat parameters (Travison et al., 
2007). It was therefore hypothesized that total testosterone was negatively associated with 
fat mass, in particularly the visceral compartment.  
Results of the current study showed that testosterone concentration demonstrated 
the predicted statistically significant (p<0.01) inverse relationship with visceral fat. This 
finding is in agreement with other research, which has shown that circulating testosterone 
is negatively correlated with DXA measures of intra-abdominal fat in middle-aged men 
with BMIs ranging from 18-43 kg/m2 (Camacho et al., 2013; Tajar et al., 2012). Visceral 
fat has a high density of androgen receptors that, when exposed to testosterone, up-
regulates in number (Blouin, Boivin, & Tchernof, 2008). This up-regulation inhibits the 
expression of free fatty acid uptake in the omental, but not subcutaneous, adipose tissue 
(Bjorntorp, 1997). The significance of this interaction is lipid mobilization, resulting in a 
reduction of visceral fat mass and a decrease in omental adipocyte size, as well as a 
decrease in leptin expression (Bjorntorp, 1997). The effects of testosterone on adipocyte 
metabolism would be expected to markedly inhibit triglyceride uptake and stimulate their 
mobilization as witnessed in in vivo studies in men, suggesting that testosterone is an 
important regulator of central and peripheral adipose tissue in human males 
(Wajchenberg et al., 2002). 
Although no novel findings with respect to testosterone’s relationship with 
subcutaneous adipose deposits were found, the addition of further research supporting the 
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inverse relationship between visceral fat mass and total testosterone adds to an 
understanding of obesity’s impact on androgens in a population susceptible for obesity 
related sex hormone derangement.  
6.3.3.5 Testosterone: Summary of Findings 
In summary, total testosterone does not demonstrate significant change in 
response to diet in isolation, or in combination with high intensity resistance training in 
previously inactive, aging, overweight and obese men. These results support the 
understanding that significant weight loss must be achieved in order to elicit an increase 
in basal testosterone. Previous studies using similar protocols, but of a longer duration 
and exhibiting greater weight loss, have shown an increase in testosterone (Ahtiainen, 
Pakarinen, Alen, Kraemer, & Hakkinen, 2003; W. J. Kraemer et al., 1999; Marx et al., 
2001; Staron et al., 1994). Obesity and its associated downregulation of the HPG axis is a 
powerful mechanism which appears to have a strong suppressive effect on androgens that 
cannot be controlled for through diet and physical activity unless significant weight loss 
is achieved or baseline androgen derangement is present.  In addition, the assessment of 
bioavailable testosterone would be an important measure to add to this research, and 
would help determine the impact of obesity on testosterone. Bioavailable testosterone 
should therefore be added to future research investigating exercise and diet interventions 
in overweight and obese men.  
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Obesity status may augment the testosterone response to resistance exercise in an 
overweight population as compared to leaner individuals. Based on the results, it can 
therefore be concluded that moderate weight loss resulting from a hypocaloric diet, with 
or without exercise training, does not improve fasting total testosterone in aging, 
overweight and obese men. 
 
6.4 Summary Regional Adiposity: Skin Fold Thickness 
It appears that regional adiposity, as determined by skinfold thickness, yields 
limited insights into fasting circulating levels of the energy regulating and exercise 
associated hormones measured in this study. The multiple comparisons with these 
hormones of interest yielded some statistically significant correlations; however, these 
correlations are most likely due to chance. The phenotypical characteristics of adipose 
tissue are complex, and although there appears to be some regional predictive capabilities 
when employing skin fold thickness, the majority of depot specific associations have been 
previously demonstrated via other more reliable measurement techniques. These 
relationships include the interaction between visceral fat deposits, insulin resistance and 
associated adipokines, as well as leptins association with total adipose tissue (regardless 
of location).  Furthermore, the application of skin fold testing during exercise training to 
predict changes in exercise related hormones, including testosterone, appears to be 
inconsequential.  However, skin fold calipers provide researchers with an easily 
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administered, sensitive measure of subcutaneous skin fold thickness which is low cost, 
and which yields a more reliable prediction of obesity status as compared to many widely 
used techniques, including prediction formulas such as BMI.  Although regional skin fold 
sites may not predict fasting circulating levels of hormones related to Exercise + Diet 
interventions, they do provide an effective means for assessing body composition outside 
of a clinical setting, which can be performed by a variety of allied health professionals in 
a standardized and easily replicable fashion. 
  
6.5 Association between Adiposity and Biochemical Measures 
Adiposity can be determined by a variety of techniques, including predictive 
equations, physical measurements and imaging techniques. As stated in the introduction, 
BMI is a widely debated means of assessing obesity. However, it has shown consistent 
reliability in the prediction of cardiovascular and metabolic risk factors. Regardless of the 
BMI measures limitations, the current study’s results mirror the results of others which 
show the BMI’s association with cardiovascular and diabetes risk, demonstrating a 
significant negative association with HDL cholesterol, and positive associations with 
insulin and insulin resistance. BMI is used frequently in population research, which was 
the basis for implementing it in the inclusion criteria in the current study. Based on 
previous research, the assumptions made during this study’s design were that individuals 
falling within the overweight or obese BMI categories would possess an increased 
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likelihood of insulin resistance (even in the absence of diagnosed metabolic condition), 
which is an important biochemical characteristic with respect to the endocrine interplay of 
energy regulating and exercise related hormones associated with obesity. Although the 
relationship between BMI and insulin resistance was demonstrated in this study’s 
population, it is likely that the use of solely obese individuals instead of those in the 
overweight category would have provided greater resolution with respect to changes in 
insulin resistance. Furthermore, it is possible that some subjects classified as overweight 
may have had body compositions which were characterized by greater lean body mass, 
which would elevate BMI and misclassify individuals as having excess adipose tissue.  
These results coincide with the results of previous works, and demonstrate a 
relationship between waist and hip circumference, cardiovascular markers and diabetes. 
Both waist and hip circumference showed a statistically significant negative association 
with HDL cholesterol, and positive associations with insulin and insulin resistance in the 
study cohort. 
Some studies demonstrate that abdominal subcutaneous fat has a stronger 
correlation with insulin resistance than the visceral fat compartment in both diabetic and 
non-diabetic subjects (Cnop et al., 2003). In agreement with other studies, these results 
show that DXA measurements, including total body fat percentage and visceral fat mass, 
have a strong positive association with insulin resistance and fasting insulin. Both waist 
and hip circumference, which are used to determine trunk fat non-invasively, 
demonstrated a negative association with HDL, while visceral fat, measured using the 
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gold standard DXA method, did not. Furthermore, subcutaneous skin fold thickness of the 
suprailiac and umbilical region also failed to demonstrate a significant correlation with 
cholesterol, indicating that it may be a combination of both visceral and subcutaneous fat 
deposits that result in the inverse association between HDL and the android obesity 
phenotype in this overweight, middle-aged male cohort. In addition, visceral adipose 
tissue and the centralization of adipose tissue is frequently correlated strongly with a 
number of related metabolic variables, including plasma glucose and lipid concentrations. 
However, statistical analysis did not demonstrate this relationship (Abate, Garg, Peshock, 
Stray-Gundersen, & Grundy, 1995b; Bogl et al., 2016; Frayn, 2000; Smith et al., 2001).  
This lack of association between adiposity and metabolic measures is likely the result of 
this study’s sample population, who were required to be absent of metabolic disease while 
being categorized as overweight or obese. This exclusion criteria introduces a significant 
selection bias when comparing the current study’s population to individuals of similar age 
and adiposity matched norms from studies without this rigorous exclusion criteria related 
to metabolic health (Roberson et al., 2014).  
Visceral fat has been correlated to a greater extent with insulin resistance then 
total and subcutaneous fat (Banerji et al., 1995). Conversely, it is believed that 
subcutaneous trunk adipose tissue may impact insulin resistance (Cnop et al.,2002). This 
relationship was demonstrated in this research, as the subscapularis was associated with 
insulin resistance. Subcutaneous skinfold thickness has been used historically to predict 
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metabolic health risk (Kissebah & Peiris, 1989), and these results show that skin fold 
thickness may remain a useful tool in the non-invasive assessment of insulin resistance.   
In previous comparisons between central and peripheral obesity, it has been 
shown that subjects with higher trunk fat are more insulin resistant than subjects with 
peripheral or lower body obesity (Bogl et al., 2016; Samsell et al., 2014; Selyatitskaya et 
al., 2015). Results from this study agree with these findings, as several measures of 
central obesity showed positive associations with insulin resistance in these middle aged 
overweight and obese males. The underlying mechanism is still vague, however it has 
been shown that trunk fat, including visceral and subcutaneous fat, has a higher free fatty 
acid concentration than the peripheral subcutaneous depots (Bogl et al., 2016). A study by 
Goodpaster et al found that thigh subcutaneous fat, as one indicator of fat deposition in 
peripheral tissue, is a significant predictor of insulin sensitivity (Goodpaster et al., 2005). 
Studies have found that the peripheral thigh subcutaneous fat compartment had no 
correlation with insulin sensitivity, while others show that thigh intramuscular fat, 
assessed using CT, had a negative correlation with insulin sensitivity (Fried & Kral, 1987; 
Karastergiou, Smith, Greenberg, & Fried, 2012). It is believed that gluteofemoral fat has a 
cardio-protective role, and that adipocytes in that region are relatively insensitive to 
lipolysis stimulus, and sensitive to anti-lipolysis stimulus (Manolopoulos et al., 2010). 
Although not measured in the current study, lipoprotein lipase (LPL) has an important 
role for free fatty acid uptake in circulation. Previous studies have found that femoral fat 
depot have a relatively high LPL activity and lower lipolysis-stimulated activity (Fried & 
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Kral, 1987). Therefore, the gluteofemoral fat depot may be more effective in releasing 
free fatty acid into circulation and tend to release less free fatty acid into the circulation 
(Fried & Kral, 1987). Gluteofemoral subcutaneous fat was negatively associated with 
HDL (p<0.03) in the current study, however unlike other subcutaneous sites it failed to 
demonstrate any significant relationship with insulin resistance.  The concept of 
gluteofemoral subcutaneous adipose tissue that is physiologically different from other 
subcutaneous adipose sites is controversial, and the current study was unable to detect any 
associations with these biochemical measures of interest. Interestingly, this study was 
able to demonstrate similar findings to others which determined that the peripheral skin 
fold thickness of the triceps and subscapularis regions are associated with fasting insulin 
resistance (Kissebah & Peiris, 1989). Furthermore, both the triceps and subscapularis skin 
fold sites showed a positive association with fasting triglycerides, while the subscapularis 
showed an association with fasting glucose concentration as well. The explanation as to 
why these associations exist may relate to the overall adiposity and storage of body fat in 
the subcutaneous compartment. As body fat is stored preferentially from central to 
peripheral depots in men, the increase in peripheral stores may act as an indicator of 
overall adiposity as suggested by the body build continuum (Mueller & Wohlleb, 1981). 
Exploratory analysis found a significant correlation between both the triceps and 
subscapularis skin fold sites with regards to several measures of overall adiposity. 
Therefore, unlike other regions of adipose depots including the gluteofemoral region and 
visceral compartment, which may have unique adipose tissue characteristics or behavior, 
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it is likely that the triceps and subscapularis sites are primarily indicators of overall 
adiposity and that they behave similarly to other measures of obesity including girth 
measurements and prediction formulas in the assessment of metabolic health.  
 
6.6 Limitations 
Intervention studies using volunteer subjects possess several inherent limitations and 
challenges. Sample size would have been a limitation in our study without our interim 
analysis, which demonstrated that an increase in the number of subjects was required in 
order to detect a difference in our primary outcome, adiponectin. 
The volunteer nature of our subject population is a limitation of the study, making it 
difficult to generalize the findings to the general population of overweight and obese 
males who fall within the 35-55 year old age range. The volunteers for this study were 
highly motivated, and were likely to possess a greater concern and awareness for their 
own health. Furthermore, participation in an exercise study may appeal more readily to a 
population who is familiar with exercise, especially resistance training.  
Subject demographic was an intentional limitation of the study, nonetheless, it further 
restricted comparisons to others falling within the same age range, gender and obesity 
classification. Our subjects were required to be free of metabolic disease, and were 
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considered metabolically healthy and overweight/obese. This subject demographic 
reduces application to those of other age groups, as well as to the female population.  
The small sample size of the study may be a factor in the negative findings of this 
investigation. Although interim sample size calculations were performed and additional 
subjects added, the variance in the adiponectin response was larger than expected, 
therefore the current study may be underpowered. 
An additional limitation of the research was the lack of blinding by the primary 
investigator as to the group allocation of the subjects during the post test period. 
Although blinded to group allocation, the participation of the primary investigator in 
many aspects of the study implementation is a limitation of the current work.  
With respect to the intervention, there is not yet a method for the accurate determination 
of dietary intake. Physical and psychological characteristics of study participants play an 
important role reporting bias and the degree of misreporting (Westerlep et al. 2002). A 
potential solution to unreliable reporting is to encourage subjects with earlier results of 
food reporting which occurred weekly in our intervention. The current study attempted 
to reduce this limitation by regular reporting of food logs to a registered dietitian which 
assists in diet coaching effectiveness. 
The exercise intervention posed significant challenges in maintaining uniform exercise 
intensity amongst the various subjects, who ranged in fitness levels and previous 
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experience with resistance training. The study attempted to reduce these challenges by 
performing baseline fitness testing, which was used to determine the appropriate load for 
exercises using predictive tables available through the American College of Sports 
Medicine (ACSM, 2014). Furthermore, fitness testing was performed by a certified 
kinesiologist to ensure consistency in pre and post exercise testing measures.  
Although a lengthier study may have allowed for great weight loss, the current study 
opted for a twelve week study due to cost and potential threats to subject adherence. 
Consideration of previous research helped determine the length of the study which 
indicated that this study was of sufficient length, but a longer intervention may have led 
to greater weight loss and a clearer signal with respect to the outcomes of interest related 
to weight loss.  
Study adherence was a challenge in this intervention study. Our subjects all completed 
the required interventions, but some changes in the scheduling of workouts were 
required and 10% of food logs were not submitted. Because adherence is a vital aspect 
of a study such as this, the research team placed significant effort on ensuring 
participation in both the nutrition and exercise components of the study, allowing all 
fifty one subjects to complete the intervention, and to complete baseline and follow-up 
testing as per the study protocol. 
The assessment of appetite regulating hormones PYY and GLP-1 would have 
contributed to this body of work due to their role in energy regulation. These hormones 
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in conjunction with ghrelin and leptin would have provided enhanced resolution on the 
role of Exercise + Diet and Diet Alone on the hormonal interplay of appetite regulation. 
Additionally the assessment of the various molecular weight adiponectin isoforms would 
have provided insight into the change of total adiponectin to its active form HWM in 
response to the current intervention.  
For our secondary outcomes, testosterone was chosen as a hormone of interest due to its 
relationship with resistance training. However, the interpretation of these findings is 
limited due to several considerations specific to testosterone assessment. Much of the 
decline in testosterone linked to overweight/obesity is due to the lower bound levels of 
the hormone while the bioavailable levels are often maintained. We did not measure the 
bio-available testosterone in the current investigation, which does not allow for full 
resolution on the impact of obesity on testosterone. Furthermore, although the diurnal 
variation of testosterone was addressed through standardized sample collection in the 
morning, testosterone has superimposed spikes every ninety minutes. Consequently, the 
rigorous way to measure testosterone is by taking samples on three separate mornings 
which are then averaged, or by taking three separate measurements on one morning that 
are averaged. Due to cost constraints and subject availability this testing was not 
employed, which limits the resulting interpretation of the testosterone findings.  
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A final limitation of the current study was the lack of previous research from which to 
base the intervention, particularly with respect to moderate-high intensity resistance 
training, for a non-athletic population.  
The lack of general population research utilizing highly controlled exercise interventions 
developed based on training specificity principles results in heterogeneity in ongoing 
research. Furthermore, no study to our knowledge has employed both periodized 
resistance training and a moderate caloric restriction diet to encourage weight loss in this 
overweight and obese population, while investigating energy regulating and exercise 
associated hormones.  
6.7 Generalizability 
This study provides greater insight into the response of hormones associated with body 
composition, metabolism and appetite to resistance training and diet in the aging (35-55 
years old) overweight and obese male population. The findings of this study agree with 
others that demonstrate that exercise in combination with diet does not result in greater 
weight loss then diet alone (Miller 1997). Exercise does, however, provide added health 
benefits including increased lean body mass, improved cholesterol, triglycerides and 
blood pressure. Therefore, overweight and obese 35-55 year old men seeking weight 
loss can achieve this through caloric restriction and diet while those looking for 
additional benefits including greater lean body mass and cardiovascular health risk 
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reduction should be encouraged to incorporate resistance training exercise into their 
lifestyle. 
7 Conclusions 
Weight loss in overweight and obese 35-55 year old males achieved through twelve 
weeks of structured resistance training and diet (Exercise +Diet) or through Diet Alone 
does not result in a significant change in circulating adiponectin.  The Exercise + Diet 
intervention led to a similar significant weight loss as the Diet Alone intervention and it 
appears that exercise has independent improvements in measures of cardiovascular 
health. The current study indicates that the assessment of adiponectin during weight loss 
in a non-insulin sensitive population may not provide any additional value or insight into 
health status Furthermore, the energy regulating hormones ghrelin and TNF-α, along 
with testosterone, do not change in response to weight loss achieved through Exercise 
+Diet and Diet Alone interventions, while circulating leptin concentration decreased in 
response to weight loss for all subjects, regardless of group assignment.  When fat in the 
trunk region, a known confounder for adiponectin, was controlled for, adiponectin 
elevated in response to weight loss achieved through diet in isolation and reduced in 
response to weight loss achieved through resistance training exercise. Our results mirror 
other studies which have utilized different exercise modalities, including cardiovascular 
training, to elicit this response (Christiansen et al., 2010, Yatagai et al., 2003).  
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Although the weight loss and cardiovascular measures demonstrated statistically 
significant changes, our outcomes suggest that the length of the study may not have been 
sufficient for demonstrating the hypothesized humoral change. Additional exposure to 
resistance training and/or diet may have resulted in further weight loss and opportunities 
to observe changes in energy regulating and exercise associated hormones. Research 
using the current study’s exercise and diet protocols should ensure a longer exposure of 
subjects to the respective interventions. Due to the small number of studies investigating 
the impact of structured resistance training on adiponectin and other humoral variables, 
this research indicates that short term exposure to resistance training is unlikely to 
impact this study’s hormones of interest when resistance training is employed.  
Well established relationships between circulating hormone concentrations and regional 
body composition were observed in this study. These included adiponectin, TNF-α’s and 
testosterone’s relationship with visceral fat, leptin’s association with total body fat, and 
ghrelin’s relationship with lean body mass.  
The current study suggests that subcutaneous skin fold sites do not share the predictive 
capability of regional body composition with respect to circulating adiponectin, TNF-α, 
leptin, ghrelin and testosterone.  This study is the first, to the best of our knowledge, to 
investigate the relationship between regional subcutaneous skin fold measures and 
circulating hormones on energy regulation and exercise. Although these results do not 
demonstrate any significant insights regarding subcutaneous skin fold thickness and 
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circulating hormone concentrations, our outcomes validate the skin fold caliper as an 
effective means for assessing body composition when imaging techniques are not 
available.  
Obesity is a multi-factorial condition that is impacted by both environmental and genetic 
conditions. Weight loss achieved through changes in physical activity and diet are 
important approaches to improving and maintaining health. Our study provides insights 
into the impact of structured resistance training on the middle aged overweight and 
obese male demographic. Furthermore, this work provides an exercise and diet 
intervention which leads to healthy moderate weight loss in a relatively short period of 
time, while demonstrating measurable improvements in cardiovascular health benefits in 
overweight and obese middle aged males.  
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Introduction: 
 
In order to organize all necessary components of the research project a comprehensive  
procedures manual has been develop to assist future research assistants. This manual will cover  
everything they need to know to be a successful research assistant for the study “Hormonal  
Adaptation to Lifestyle Interventions”. Please review this manual prior to engaging in any  
research activities and keep for reference when necessary during the course of your work.   
 
  
Starting out: 
Meet with the team at the training facility and the other researchers involved in the study 
• Attend meetings with key partners with the primary investigator 
Read and understand: 
• Study protocol available in the intelligencebank.ca website 
• Study consent forms 
• Nutrition Questionnaire 
• Previous subject files 
 
Important material 
 
The first important pieces of reading material you should make yourself aware of are the Thesis 
Protocol, and the Subject Handbook. The Thesis Protocol will inform you of the specifics for the 
study so you can have a strong grasp on the work you are completing. The Subject Handbook is 
the informational booklet that your test subjects will be reading and referencing concerning  
dietitian designed nutrition plan and their work outs. Therefore as their guide you should know 
everything in this book from front to back. There is a study e-mail that you will be using as your 
primary means of communication. The study e-mail is how you will contact all potential subjects 
and others involved in the study.  
 
 
 
Procedures that you should know about 
 
A DEXA Scan  
 
A DEXA scan is a scan taken at the Health Science that measures your bone density at the  
beginning and end of the study at a couple of locations in the body. This scan will show you  
what percentage of your body is bone, and what percent is fat.  The individual will have to fast  
for 12 hours before getting this scan done. While at the DEXA scan they will have a small  
sample of blood taken. They will then be brought to a room where a DEXA machine is located  
and will lie on the machine as it scans their body. The entire process should take no more than  1 
hour to complete.  
 
Meeting with Primary Investigator 
	
The subjects should have the option to meet with the primary investigator the same day as both 
the DEXA and the  blood test if at all possible. This ensures that the subject does not have to go 
out of their way to  travel to The fitness facility twice when all of this could have happened in 
one day. If however this is  too much for one day it is suggested that the client is given the option 
to make two trips and  fast twice. This means they will get the DEXA completed one day and 
fast, and then have to fast  again another day for their blood test and meet with the primary 
investigator that same day. When they meet with the primary investigator he will discuss with 
them proper nutrition, take their measurements, weigh them, and  test there different skin fold 
sites. The meeting with the primary investigator takes half an hour. At this point the primary 
investigator  will give the subjects all needed documentation to make sure that it is all ready 
before the  subject begins there first training session.  
 
Training Sessions 
	
There will be 3 training sessions per week for each subject lasting an hour. In this time 
frame they will do a light 5 minute warm up and dynamic stretching to prepare their body for the  
workout. The structured supervised strength training is a strict program that is designed to keep 
your body guessing to help increase weight loss. It finishes with a special type of workout called 
GVT or German Volume Training that will push the subjects to give them optimal results 
towards the end of the study. They will finish with a foam roll at the end performed by the trainer 
or they can foam roll themselves once they have been taught the proper technique. The entire 
process will last a total of 12 weeks.  
  
Adding Clients to the study 
 
Important forms and documents for the study participants   
 
There are certain forms that must be given to the subjects before they begin their first training 
session. The first of these forms is a consent form and is found in the study materials filing 
cabinet. This form requires the consent of the participant to take part in the study and explains to 
them what this entails. The next form is the PAR-Q which asks the participant to check yes or no 
to any medical concerns that could cause them to need a Doctor’s note. The remainder of the 
necessary forms include a Personal & Parental History Questionnaire, Physical Activity 
Questionnaire, a Food Groups and Serving Size Survey. Ensure that each client also has a 
Subject Hand book either e-mailed to them or given to them during their initial visits at the 
fitness facility. This will make the process much more efficient for everyone involved if they 
have something to refer to in the early stages.  
 
File Folders 
 
The next step is to make up a file folder for each client. There are blue folders located in the top  
shelf of the desk in the office. These folders are from previous or existing clients and you may  
need them for reference or you may need to add to the existing folders at some point. You can  
add your new folders by printing the individuals name clearly  on a white tab and store these in  
the file cabinet next to the others. Remember to double check these folders to make sure that  all 
needed forms are there. If all forms are not there you must make a list indicating what you  need 
and from which subject. The forms that must be in each folder are located in the “Needed  forms 
Checklist” sheet which is found in Appendix J .You can then go to your “Personal  Information 
“Excel sheet which will give you the subjects contact so you can notify them of the  forms you 
need. These files are then provided to the primary investigator for locked storage.  
 
Daily Follow up  
	
 Following up when dealing with the public is a VERY important part of a research assistants 
job. It is the responsibility of the work term student to get in contact with every person that is 
given to them at any point in time.  
 
E-mail Records Document  
	
The ``E-mail Records`` document, found in Appendix K, can be very helpful in organizing your 
e- mails. This document lets you know how many times you have sent an e-mail to a particular  
person. If you have e-mailed someone numerous times and there is no reply try to find a  
telephone number you can reach them at. This ensures that no one gets left behind in an over  
flux of e-mails.  
 
 
Structure of the first e-mail  
 
The first email must be very detailed identifying what personal information we need  from the 
subjects, what the study is all about, and what the requirements are as a subject. An e-mail 
template can be found in Appendix L. This e-mail must include all of the different tests 
explained in detail and what is needed for each one. For example a Doctor`s note is a necessity  
for participation in the study and fasting is required for both the DEXA scan and the blood test at 
the lab.  Also these e-mails must be simplistic, for example: some people may not know  where 
the lab is in the Health Sciences Center. You must assume they do not know anything about the 
information you are giving them, this will ensure  there are no surprises for the test subjects.  
 
Role as the Kinesiologist  
How to greet a client on their first day  
 
Greet them with a welcoming smile; explain to them what is going to happen within the next  
hour (for example you will be using a foam roller) , show them the change  rooms, offer them a  
glass of water at the beginning and provide them with a shake at the end.  Explain to them the  
importance of having protein by itself after a workout when trying to lose weight.  
 
	
	
	
Having good insight  
 
As a trainer you must be aware of the vulnerability that these men may be experiencing.  Some  
of them may have never exercised in their lives and others may have been strong athletes who  
are embarrassed to have reached this point. You must explain things in steps and with care. You  
can do this by thinking about the individual separate from the rest and explain things in a way  
that is easy to understand. 
 
Progress sheet 
 
You are responsible to fill in the portion of the Study Handbook that has the subject’s workouts.  
This includes how much weight each client is lifting at the beginning to how much they can lift  
by the end. This will also help you in tracking where each client is from week to week.  
 
Client and Trainer schedule 
 
You must also do up a schedule to be used by you, your clients, and others at the gym in case  
they need to schedule someone in for you. This schedule should be done weekly and sent to the 
primary investigator so is aware of who is at what stage of their training and how many sessions 
you are  doing each week. There is an example shown in Appendix N.  
 
Follow up at the end of the 12 weeks 
Following the 12 week intervention the subjects will be required to return for follow up 
measures including the outlined tests and questionnaires to determine activity status and 
lifestyle. All participants will receive results from tests and be informed about them once  they 
are extrapolated. Subjects will also be required to attend blood collection for an additional  12 
weeks following the end of the intervention to determine trends and adaptation associated  with 
decreases in activity. It is your responsibility to ensure that all of these tests are scheduled  in a 
time sensitive manor. You must refer to the personal training book indicating what stage  each 
participant is at so that once they get to the 11th and 12th week you can start arranging  there 
DEXA scan , Blood test, and meeting with the primary investigator. 
Conclusion: 
As a research assistant you must review all important material such as the “Thesis Protocol”  and 
make yourself familiar with all of the different procedures such as a Vo2max test. You must  
become efficient at organizing when adding clients to the study and following up daily to make  
sure everyone is aware of what is happening. It is important to have a solid foundation for the  
structure of your first e-mail as this is the client’s first impression of us as a company and the  
study as a project. We want the client to receive all of the information clearly at the beginning  to 
make sure they have a set path to follow. This will make organizing appointments such as the  
blood work at the Nexus clinic and DEXA scan at the Health Science run smoothly. We need to  
keep track of each client’s progress so we can be ready for all of the follow up appointments  that 
happen at the end of the 12 week period. This booklet will be a valuable reference for  
everything that you or your clients could need in terms of the study.  
Appendix 2
Resistance Training Phase 1
Appendix 2
Name: Fullbody Phase 1 Workouts
Category: Fullbody Intensity: 3 
Notes: a great medium intensity workout for gyms 
Exercise name: Goblet Squat 
Grouping: A Sets: 3 Reps: 10 Tempo: Medium Rest: 0
Muscles: Quadriceps 
Tools: DB
Description: Hold one Dumbbell by its end with the base of your two hands under your chin. It should look like you are taking about to take a drink 
out of a big goblet like glass using both hands. Descend into a deep squat while maintain an upright posture with your upper body - chin up the whole 
time. 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: DB Press 
Grouping: A Sets: 10 Reps: 10 Tempo: Medium Rest: 60
Muscles: Chest 
Tools: DB
Description: Lying on a flat bench. Press weights over chest until arms are extended. Lower until there is a stretch in the chest 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 
Date w R w R w R w R w R w R w R w R w R 
Set 10 
w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Cable Woodchop 
Grouping: B Sets: 3 Reps: 10 Tempo: Medium Rest: 0
Muscles: Abdominals 
Tools: DB
Description: Grab high cable with both hands. Keeping arms straight bring the cable from the upper part of your body to the lower, rotating the hips 
and legs slightly contracting abdominals 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 


Name: Fullbody Phase 1 Workouts
Category: Fullbody Intensity: 4 
Notes: 
Exercise name: Step Ups 
Grouping: A Sets: 3 Reps: 12 Tempo: Medium Rest: 40
Muscles: Quadriceps 
Tools: DB 
Description: Start with one foot on the step and the other foot on the ground 
Date 
Set 1 
W R 
Set 2 
W R 
Set 3 
W R 
Set 4 
W R 
Set 5 
W R 
Set 6 
W R 
Set 7 
W R 
Set 8 
W R 
Set 9 
W R 
Set 10 
W R ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: SB Leg Curl 
Grouping: A Sets: 3 Reps: 12 Tempo: Medium Rest: 40
Muscles: Hamstrings 
Tools: SB 
Description: Lie on your back with your heels and lower calves on a SB. First lift your hips up until your body forms a ramp 
Date 
Set 1 
W R 
Set 2 
W R 
Set 3 
W R 
Set 4 
W R 
Set 5 
W R 
Set 6 
W R 
Set 7 
W R 
Set 8 
W R 
Set 9 
W R 
Set 10 
W R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Lat Pulldown 
Grouping: A Sets: 3 Reps: 12 Tempo: Medium Rest: 40
Muscles: Back 
Tools: MA 
Description: Palms facing, narrower than shoulder width grip. Lean back as you pull the bar to the sternum. Return to the starting position at the 
dictated tempo. 
Date 
Set 1 
W R 
Set 2 
W R 
Set 3 
W R 
Set 4 
W R 
Set 5 
W R 
Set 6 
W R 
Set 7 
W R 
Set 8 
W R 
Set 9 
W R 
Set 10 
W R 


 Name: Fullbody Phase 1 Workouts 
Category: Fullbody Intensity: 3 
Notes: 
Exercise name: Leg Press 
Grouping: A Sets: 3 Reps: 12 Tempo: Medium Rest: 60 
Muscles: Quadriceps 
Tools: MA 
Description: Sit with back against the seat and feet place firmly on the pad. Legs should be at hips width and legs should be bent at 90 degrees. 
Press pad with heels until extended but don1 lock at the knees. 
Date 
Set 1 Set2 
w R w R 
Set3 
w R 
Sel4 
w R 
Sel5 
W R 
Sel6 Sel 7 Set8 Set9 Set 10 
w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Lat Pulldown 
Grouping: A Sets: 3 Reps: 12 Tempo: Medium Rest: 60 
Muscles: Back 
Tools: MA 
Description: Palms facing, narrower than shoulder width grip. Lean back as you pull the bar to the sternum. Return to the starting position at the 
dictated tempo. 
Date 
Set 1 Set 2 
w R w R 
Set 3 
w R 
Set 4 
w R 
Set 5 
W R 
Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Push Up 
Grouping: A Sets: 3 Reps: 12 Tempo: MediUm Rest: 60 
Muscles: Chest 
Tools: BW 
Description: Lie face down to the ground, with palms touching the ground and elbows at 90 degrees. Arms should be soulder width apart, then try to 
raise yourslef by pushing the ground. Legs and back shouls be straight for the whole movement with toes touching the ground. 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 


Appendix 3
Resistance Training 
Phase 2
Appendix 3
Name: Full Body Phase 2 Workouts
Category: Fullbody Intensity: 5 
Notes: 
Exercise name: Incline Flys 
Grouping: A Sets: 3 Reps: 12 Tempo: Slow Rest: 0
Muscles: Chest 
Tools: DB 
Description: While lying on an incline bench hold dumbells with palms facing each other and arms extended above the chest. Rotate the shoulders 
back until Upper arms are parallel to the body and there is a slight strech in the chest. Bring weights forward the opposite way and squeeze the chest 
during contraction. arms are slightly bent throughout the movement 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Push Up 
Grouping: A Sets: 3 Reps: 12 Tempo: Slow Rest: 0
Muscles: Chest 
Tools: BW 
Description: Lie face down to the ground, with palms touching the ground and elbows at 90 degrees. Arms should be soulder width apart, then try to 
raise yourslef by pushing the ground. Legs and back shouls be straight for the whole movement with toes touching the ground. 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
Date w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name; Dumbbell Bent Over Row 
Grouping: A Sets: 3 Reps: 12 Tempo: Slow Rest: 60 
Muscles: Back 
Tools: DB 
Description: Opposite foot forward, palm facing you while holding DB, pull the DB to the side of the waist. 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 


Name: Full Body Phase 2 Workouts
Category: Fullbody Intensity: 5 
Notes: 
Exercise name: BB Bench Press 
Grouping: A Sets: 3 Reps: 10 Tempo: Slow Rest: 0
Muscles: Chest 
Tools: BB 
Description: Grip bar less than shoulder width. Lower the bar to the sternum. 
Set 1 Set 2 Set 3 Set 4 Set 5 
Date w R w R w R w R w R 
Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: High Row 
Grouping: A Sets: 3 Reps: 10 Tempo: Slow Rest: 0
Muscles: Back 
Tools: MA 
Description: Using a seated row with the rope attachment, grab on to the rope with thumbs facing each other and palms down. Keeping the back 
straight and knees slightly flexed, pull your hands up towards your ears, flexing the tops of your shoulders and squeezing your shoulder blades 
together. Pause for a second on top and lower at dictated tempo. 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Seated Row 
Grouping: A Sets: 3 Reps: 10 Tempo: Slow Rest: 60
Muscles: Back 
Tools: CB 
Description: Lean forward to grab narrow grip, keeping a slight bend in the knees. Feet should be in contact with foot pads. Lean back while holding 
Narrow grip with straight arms. Pull the bar towards your stomach while maintaining a straight lower back. Return to position 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 



Name: Full Body Phase 2 Workouts
Category: Fullbody Intensity: 5 
Notes: 
Exercise name: Incline DB Press 
Grouping: A Sets: 3 Reps: 12 Tempo: Slow Rest: 0
Muscles: Chest 
Tools: DB 
Description: Incline an adjustable bench to between 30 and 60 degrees. Start with the DB's at your shoulders and press directly over your chest, 
perpendicular to the ground. Rotate the DB's from palms facing your feet in the bottom position to palms facing at the top. 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Lat Pulldown 
Grouping: A Sets: 3 Reps: 12 Tempo: Slow Rest: 0
Muscles: Back 
Tools: MA 
Description: Palms facing, narrower than shoulder width grip. Lean back as you pull the bar to the sternum. Return to the starting position at the 
dictated tempo. 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Lat Raise and Pour 
Grouping: A Sets: 3 Reps: 12 Tempo: Slow Rest: 60 
Muscles: Shoulders 
Tools: DB 
Description: Complete a standard side raise and at the top range of motion rotate thumbs from a neutral position to a downward pointed position 
and then return to the starting position and lower the arms to complete the reps. 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 



Appendix 4
Resistance Training 
Phase 3
Appendix 4
Name: Body Part Phase 3 Workouts
Category: Split-Arms Intensity: 5 
Notes: 
Exercise name: DB Shoulder Press 
Grouping: A Sets: 10 Reps: 10 Tempo: Slow Rest: 0
Muscles: Shoulders 
Tools: DB 
Description: Performed while standing, begin by taking 2 dumbbells at a 90 degree elbow position by the head and pressing them directly up 
through the full range of motion. 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Close Grip Benchpress 
Grouping: A Sets: 10 Reps: 10 Tempo: Slow Rest: 90 
Muscles: Triceps 
Tools: BB 
Description: Grip bar less than shoulder width (10-14"). Lower the bar to the st,ernum from a bench press position. Pause at the bottom and press 
back to the starting position quickly. 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 Set 10 
Date w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: DB Side Raises 
Grouping: B Sets: 3 Reps: 10 Tempo: Slow Rest: 0
Muscles: Shoulders 
Tools: DB 
Description: Hold dumbbells with palms facing your legs. Raise arms until upper arms are parallel to shoulders. Lower and repeat 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 Set 9 
Date w R w R w R w R w R w R w R w R w R 
Set 10 
w R 

Name: Body Part Phase 3 Workouts
Category: Split-ChestandBack Intensity: 5 
Notes: 
Exercise name: Wide grip Pull-up 
Grouping: A Sets: 10 Reps: 10 Tempo: Slow Rest: 0
Muscles: Back 
Tools: MA 
Description: Use a palms down, wider than shoulder width grip. Lean back as you pull the lower sternum to the bar. 
Date 
Set 1 
W R 
Set 2 
W R 
Set 3 
W R 
Set 4 
W R 
Set 5 
W R 
Set 6 
W R 
Set 7 
W R 
Set 8 
W R 
Set 9 
W R 
Set 10 
W R ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: DB Press 
Grouping: A Sets: 10 Reps: 10 Tempo: Slow Rest: 90 
Muscles: Chest 
Tools: DB 
Description: Lying on a flat bench. Press weights over chest until arms are extended. Lower until there is a stretch in the chest 
Date 
Set 1 
W R 
Set 2 
W R 
Set 3 
W R 
Set 4 
W R 
Set 5 
W R 
Set 6 
W R 
Set 7 
W R 
Set 8 
W R 
Set 9 
W R 
Set 10 
W R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Push Up 
Grouping: B Sets: 3 Reps: 10 Tempo: Slow Rest: 0
Muscles: Chest 
Tools: BW 
Description: Lie face down to the ground, with palms touching the ground and elbows at 90 degrees. Arms should be soulder width apart, then try to 
raise yourslef by pushing the ground. Legs and back shouls be straight for the whole movement with toes touching the ground. 
Date 
Set 1 
W R 
Set 2 
W R 
Set 3 
W R 
Set 4 
W R 
Set 5 
W R 
Set 6 
W R 
Set 7 
W R 
Set 8 
W R 
Set 9 
W R 
Set 10 
W R 

 Name: Body Part Phase 3 Workouts 
Category: Split-LegsandShoulders Intensity: 5 
Notes: 
Exercise name: Squats 
Grouping: A Sets: 10 Reps: 10 Tempo: Slow Rest: 0
Muscles: Quadriceps 
Tools: BB 
Description: Bend knees forward while allowing hips to bend back behind.knees should be in same direction as feet and back should be straight 
lower yourself until thighs are past parallel to the floor Extend legs pushing with the heels until legs are straight 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Seta Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Leg Curl 
Grouping: A Sets: 10 Reps: 10 Tempo: Slow Rest: 90 
Muscles: Hamstrings 
Tools: MA 
Description: Lying on the bench with knees slightly off, and lever pad in contact with the back of the ankles, lift the pad with the lower legs by flexing 
at the knee. 
Date 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Seta Set 9 Set 10 
w R w R w R w R w R w R w R w R w R w R 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
DD DD DD DD DD DD DD DD DD DD 
Exercise name: Lunges 
Grouping: B Sets: 3 Reps: 10 Tempo: Slow Rest: 0
Muscles: Quadriceps 
Tools: DB 
Description: With Feet shoulder width apart hold dumbells at side of the body. Step forward with one leg , landing on the heel of that leg, keeping 
the back leg extended and heel raised. Lower back knee to the floor as you bend the lead leg at 90 degrees in the knee. 
Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Seta Set 9 Set 10 

Appendix 5
Subject Handbook
Influence of Supervised Resistance Training and a Hypocaloric Macronutrient Scheduled Diet 
vs a Hypocaloric Macronutrient Scheduled Diet Alone on Energy Regulating Hormones in 
Overweight and Obese Men Ages 35-55.
Nutrition and Exercise Guidelines
WELCOME TO THE STUDY
As you already know the following research program requires your commitment to a healthy lifestyle 
including regular resistance training, cardiovascular training and proper nutrition.
Your training in the gym will be guided by the study’s certified kinesiologist and our registered dietitian as well 
as the primary investigator Mike Wahl. It is the rest of the time you will need guidance in and primarily in the 
area of nutrition and proper eating.
The following book will provide you with all of the information you need to succeed in nutrition and training. 
Please review the book in the following steps...
Then, read the nutrition section of this manual to give you the fundamentals of what nutrients do what and 
how to tackle healthy eating at meal and snack times.
Next, read the section on typical nutrition days for you as a study subject depending on your activity and 
review the sample meal plans at the back and we will provide you a food log book to take with you each day to 
record your meals.
You will also notice your workouts are included in the back of this manual and include your three phases of 
resistance training and cardiovascular activity incase you are unable to attend a training session at anytime.
We hope this information teaches you how to live healthy and remember that you can ask questions at 
anytime. The results of this research and the impacts it will have on those like yourselves will depend on you. 
We appreciate your dedication to this research and look forward to seeing the end result!
Yours in Health!
Micheal Wahl
Primary Investigator
Primary Researcher:
Mike Wahl
email: mikewahl@definitionsonline.com
cell phone: 709 746-3355
work phone 709 576-3339
Research Co-Ordinator:
Kayla Hemmens
email: study@definitionsonline.com
cell phone: 709 743-4573
work phone: 709 576-3339
Definitions Training Facility:
email: info@definitionsonline.com
Phone: 709 576-3339
CONTACT INFO
KEYS TO SUCCESS...
Resistance Training:
You are required to book times to train with the Research Assistant/Kinesiologist 3 times each week. She is 
available between 6am and 8pm mon- day to Friday and from 7 until 3 pm on Saturday.
If you are not in town or unable to make a session please follow the workouts provided at the end of this manual 
for you do on your own at Definitions or another gym. Videos on how to complete the exercises can be found 
on www.definitionsonline.com using your personalized login provided by Mike Wahl or the Research Assistant/
Kinesiologist
Nutrition:
You must follow the guidelines dictated by our registered dietitian in this manual in order to lose weight. The 
following section involves a very comprehensive outline of how to eat and record your nutrition in a daily log.
Research staff will review this log weekly to ensure you are on track however, please don’t hesitate to ask 
questions should they arise.
Protein
Protein stems from Greek origin, meaning “of primary 
importance.”  This is fitting, as protein plays a major role 
in building and maintaining of your body structure. It 
helps in:   
• Building Muscles, Blood Cells, Bones, Teeth, Skin,
Nails, and Internal Organs
• Composing Enzymes and Hormones
• Maintaining Blood Pressure
• Regulating Blood Sugar Levels
• Speeding Up Metabolism
Proteins are tiny chemical compounds composed of 
building blocks known as amino acids; it is the amino 
acids that the body utilizes to synthesize tissue. There 
are 20 amino acids in total, some are celled essential and 
some are called non-esential. Basically we need to eat 
some in our food and the rest we can make ourselves. 
Protein is the crucial nutrient for those exercising as 
over time our bodies wear down, muscle degrades and 
injuries form when protein is not ingested in appropri-
ate amounts.
Examples of Proteins…
• Fish
• Seafood
• Beef
• Ham
• Pork
• Turkey
• Chicken
• Wild game
• Beans (pulse crops)
• Dairy
• Eggs
• Whey protein
Notes for Eating Right...
Always have a lean protein source on hand 
for salad salads such tuna, turkey, chicken, 
chickpeas, cottage cheese, hardboiled eggs, 
almonds, chopped steak, etc.
Choose a protein source during each meal
When cooking casseroles or entrees make 
sure protein is at least 30% of content
Diversify protein offering so you are get-
ting the various benefits from the different 
sources 
To reduce costs choose large cuts of meat 
including roasts, hips, whole fish, turkeys and 
chickens and cook them in bulk for use in 
sandwiches, omelets, snacks and for “left-
over” meals.
MACRONUTRIENTS 101
Carbohydrates are sugars. There are good ones and 
there are bad ones and the bad ones taste better to 
most people. Unfortunately the carbohydrates which 
most people ingest are the bad ones and these are clas-
sified as simple sugars. Carbohydrates that are good for 
you are called complex sugars and are necessary in the 
following ways…
As a primary energy source - the brain can only use 
carbohydrates for fuel
To regulate blood sugar level (maintain energy) and 
increase fat burning in the body
Glycemic Index (GI)
Glycemic index (GI) refers to the ease at which car-
bohydrates from a food source can be digested into 
your cells. The GI index is a system ranking foods from 
1-100.
Lower numbers mean that the food breaks down 
slower in your body and is more favorable for sustain-
ing energy. Higher numbers approaching 100 mean the 
food does not take a lot of time to enter your system.
As a rule, foods with a lower GI are more desirable to 
eat than foods with a higher GI, as they are generally 
complex carbohydrates and can contain more fiber. 
The general rule in choosing carbohydrates to eat are 
that the most complex sources come from nature. 
These include fruits, vegetables and whole grains, and 
rices. 
On the next pages, are examples of common foods and 
their glycemic indexes. Remember the lower the num-
ber the better but some foods like potato chips, banana 
cake and chocolate although not high on the glycemic 
index are loaded with bad fats. This will take time to 
learn but any questions you have will be answered im-
mediately by your definitions representative…
CARBOHYDRATES
HIGH Glycemic Index Foods...
white breads, potatoes and sugars from 
foods like these break down very quickly 
and create energy faster than we can 
use it. If you can’t use it, you store it, 
which is why fast food causes weight gain.
LOW Glycemic Index Foods...
Fruit, veggies, whole grains and dairy con-
tain healthy carbohydrates that break 
down slowly in the body and give us a 
sustained release of energy. This energy 
release is slow enough for us to use all of 
the energy as it becomes available.  This 
means we aren’t tired and we won’t store 
fat like we would with High GI foods.
Star * Point…
***If your protein source isn’t bigger than 
your carbohydrate source than you are eat-
ing too much carbohydrates***
Vegetables should be consumed as much as possible 
with meals. Fruit contains fructose, a very complex sug-
ar which can offer sustained energy in periods between 
meals. This makes fruit a great option for snack time. 
Carbohydrate Sources:
Fruit – all kinds
Vegetables – all kinds
Breads, Grains and Rices
Veggies with the least amount of energy (carbs) are…
• Leafy vegetables (spinach, lettuce, cabbage)
• Flowering vegetables (broccoli, cauliflower)
• Colored Vegetables (peppers, tomato, carrots)
• Stalk vegetables (bok choy, celery, asparagus)
• Sprouts
• Onions
Highest energy (carb) content for vegetables are…
• Potato
• Yams/sweet potato
• Corn
• Peas
Bread, Grains and Rices…
• Multigrain
• Whole grain
• Whole wheat
• Oats
• Millett
• Brown Rice
• Basmati Rice
• Cuscus
• Steamed Rice (long grain)
Examples include…
• Whole wheat pasta
• Whole wheat/multi grain bread/wraps/pita’s/ba-
gels/English muffins
• cereals
• Are the preferred choices over white
• All bran
• Granola
• Fiber One
• Shredded Wheat
• Multi Grain Cheerios
• Muslix
• Whole Wheat Bread
• Multi Grain Bread
• Whole Wheat Bagels
• Whole Wheat English Muffins
• Oatmeal
• Porridge
While nobody wants to be fat, everybody needs to eat it. 
Good Fats - Essential Fats
Appearing on labels as Mono-unsaturated or poly-un-
saturated, or Omega 3, these fats are a part of a healthy 
diet and should be consumed in daily nutrition.
Essential fats function to…
Aid in metabolism
Transport oxygen from red blood cells to the tissues 
Promote brain development 
Prevent blood cells from clumping together (blood clots 
can be a cause of heart attacks and strokes, among oth-
ers) 
Act as an anti-inflammatory (rheumatoid arthritis, ul-
cerative colitis, Chron’s disease) 
Reduces blood pressure 
Regulate the inflow and outflow of substances to and 
from cells 
Direct hormones in the right direction
Support cardiovascular health 
Bad Fats – Saturated Fats
Saturated fats (animal fats and) are solid at room tem-
perature. Saturates fats in excess amounts, along with 
Trans fats can lead to many health problems including 
high cholesterol and hypertension which lead to even 
bigger problems. Saturated fats come in fatty cuts of 
meat (filet mignon, prime rib, bacon, and sausages), 
high fat cheeses, butter, coconut oil and palm oil. These 
fats although necessary to survival should be eaten in 
moderation and used sparingly when cooking. 
Trans fats (hydrogenated or partially hydrogenated) 
come in the form of vegetable shortening, crackers can-
dies and bars, baked goods, condiments, cereals, canned 
foods, and many others. The reason for their broad ap-
peal with food manufacturers is that they are used to 
preserve the food and add flavor. These fats should nev-
er be consumed in any amounts and all foods contain-
ing them should be removed from the food orders and 
the food line. The pose serious health risks to the crew 
and yourself. 
Notes for Eating Right...
Only use good fats to cook with and if you do 
use bad fats use them in moderation
Make fish a part of atleast one meal each 
day
Almonds or any nuts should be eaten as 
snacks but in moderation (16 nuts / serving)
Cook with canola oil (it has the highest heat 
threshold)
Extra virgin olive oil can be used for home-
made dressings and salads as it contains 
the most beneficial essential fats of any oil
Natural peanut butter should be used on 
toast instead of jam and in moderation... 
1tsp is enough
FATS
One of the most important things you can do for all of 
these conditions is to increase your intake of the ome-
ga-3 fats found in fish oil, and reduce your intake of 
omega-6 fats.
These two types of fat; omega-3 and omega-6, are both 
essential for human health. However, the typical Amer-
ican consumes far too many omega-6 fats in their diet 
while consuming very low levels of omega-3. The ide-
al ratio of omega-6 to omega-3 fats is 1:1. Our ances-
tors evolved over millions of years on this ratio. Today, 
though, our ratio of omega-6 to omega-3 averages from 
20:1 to 50:1! That spells serious danger for you, and as 
is now (finally!) being reported throughout even the 
mainstream health media. 
Star * Point
It is important to remember that essential 
fats are still better for people than satu-
rated or bad fats, so regardless of Omega 
3 or 6, make them available to the crew so 
they can attain maximum health
OMEGA 6 OMEGA 3
Nuts Salmon
Cereals Fish Oils
Whole Grain Breads Shrimp
Vegetable Oils Winter Squash
Poultry Sardines
Red Meat Herring
Almonds Mackerel
Flax Walnuts
Omega 3s, where they went, and why we need them…
Omega 3 Fatty Acids are amazing nutrients that are 
becoming extinct in modern nutrition. They aid in all 
metabolic processes in the body and actually prevent 
diseases such as heart disease, cancer, depression, and 
Alzheimer’s. Omega 3 has also been shown to treat 
rheumatoid arthritis, diabetes, ulcerative colitis, and 
Raynaud’s disease to name a few. The question remains 
what are they and what do they do?
Omega 3 essential fats are anti-inflammatory in the 
body meaning they stop inflammation, as well they…
• Increases fat burning
• Helps decrease sugar cravigs
• Make you think better
• Improves skin and hair quality
• Helps you sleep
• Keeps you lean by preventing causes of diabetes
Whole milk Skim milk
Condensed Milk Low-fat/fat-free condensed milk
Ice Cream Low-fat/fat-free yogurt, ice milk or Sorbet
Cheese Reduced-fat cheese
Pasta with cream based sauce Multi-grain pasta with tomato-based sauce
Bacon or sausage Turkey bacon, Canadian bacon, lean ham or 95% fat-free sausage
1 Large egg 2 large egg whites or 1/4 cup egg substitute
White flour Whole wheat flour
White bread Multigrain, whole wheat bread/ wraps/pita
Mayonnaise Reduced-fat /  Fat-free mayo or Mustard
Regular salad dressing Reduced-fat/calorie dressing
Creamed soups Broth-based soups
Butter or shortening Extra virgin olive oil, canola oil
Cream cheese Light or fat-free cream cheese
Sour cream Light or fat-free sour cream, Plain low-fat yogurt, or 1/2 cup cottage cheese 
blended with 1 1/2 tsp lemon juice
Whipped cream Chilled, whipped evaporated skim milk
White rice Long grain brown or wild rice
For New and Existing Recipes try these Guidelines...
1 egg
2 egg whites
1/4 cup milk
1/4 teaspoon vanilla extract
1/4 teaspoon ground cinnamon
dash nutmeg
8 slices whole wheat bread
Healthy Cinnamon French Toast
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Breakfast is truly the most important meal of the day.  A 
well balanced breakfast serves many purposes. Break-
fast helps avoid…
• Weight Gain
• Headaches
• Poor Concentration
• Mood Swings
• Poor Energy Levels
• Cravings and Snacking
• Increased Chance of Illness
Breakfast Ideas...
Proteins: 
• Egg white egg scrambled eggs combo (2 egg whites
to every egg)
• Egg/Egg white Omelets (veggies, low fat cheese)
• Hard boiled eggs
• Lean Breakfast Ham
Carbohydrates: 
• Oatmeal
• Steal cut oats
• Porridge
Star * Point
***Instead of f lavored oatmeal use cinna-
mon, honey, raisins, berries or maple and 
vanilla extract to f lavor oatmeal***
Or you could try from the Definitions Recipe Book…
• French toast with sugar free natural maple syrup
• Breakfast burrito’s
• Breakfast casserole
Cold Ideas....
• Fresh fruit
• Frozen berries
• Cottage Cheese
• Low Fat Cheese
• Low Fat Yogurt
Cereals and Breads…
• All Bran
• Granola
• Fiber One
• Shredded Wheat
• Multi Grain Cheerios
• Muslix
• Whole Wheat Bread
• Multi Grain Bread
• Whole Wheat Bagels
• Whole Wheat English Muffins
From the Fridge…
• Smoothies
• Definitions Bars
Healthier Condiments…
• Salsa
• Natural peanut butter
• Sugar free maple syrup
Star * Point
***All Other choices should have healthy in-
gredients to make them “better” although 
they may not be good enough to be a “Defi-
nitions Choice.”
For example French toast with whole wheat 
bread, hash browns baked not fried etc.
BREAKFAST
Frequent healthy meals are vital to individual’s en-
ergy and success.  Eating the right foods in the right 
amounts will allow you to maintain energy throughout 
the 2nd half of your day.  You must build your plate as 
they would for supper and as indicated on the follow-
ing pages
1/3 Protein, 1/3 Vegetables, 1/3 Carbohydrates
Lunch Ideas...
Protein (atleast one)
• Chicken
• Turkey
• Steak
• Fish
• Pork
• Lean cold meats
Vegetables any mix or salad every meal too!
Carbohydrate (Starch) (1 At least)
• Brown rice/wild rice
• Sweet potato
• Baked potato
• Whole wheat pasta
• Whole wheat bread
• Healthy mashed potato
Other choices for pre-made lunch meals are as follows 
and are in the recipe book (optional)
• Turkey burgers
• BLT wraps
• Spicy turkey cheddar melt
• Tuna melts
• Chicken curry in a hurry
A definitions soup as outlined in soup section
LUNCH
Dinner Ideas...
Protein (1 At least)
• Chicken
• Turkey
• Steak
• Fish
• Pork
• Lean cold meats
• etc - see best foods by category list
Vegetables any mix
Carbohydrate (Starch) (1 serving maximum or no 
starch at all)
• brown rice/wild rice
• sweet potato
• baked potato
• whole wheat pasta
• whole wheat bread
• healthy mashed potato
Or from the Definitions Recipe Book…(optional)
• Tuna casserole
• Grilled salmon
• Asian beef stir-fry
• Spaghetti and meatballs
• Vegetable stew with broiled chicken
• Turkey meatloaf
• Hot pepper steak stir fry
MANDARIN CHICKEN
SERVES 2
• 2 tbsp rice wine vinegar
• 1 tsp sesame seed oil
• 1/2 tbsp garlic, minced
• 1 tbsp light soy sauce
• 2 chicken breast, cooked and chopped
• 3/4 cup drained mandarin orange seg-
ments
• 1/4 cup blanched snow peas
• 1/4 cup drained water chestnuts
• 2 cup shredded lettuce
• 1 tsp toasted sesame seeds
Mix the vinegar, sesame oil, garlic, and soy 
sauce thoroughly. Add chicken and orange 
segments, marinate for about 10 minutes. 
Add snow peas and water chestnuts. P lace 
lettuce on plates, top with chicken mixture 
and sesame seeds. 
DINNER
A great way to start a meal. It is also a good way to get 
extra fiber, vitamins and minerals.
Salads ... you gotta eat them...
Make sureyou have greens for your salad (spinach is 
the best choice)
Make sure vegetables are fresh whenever possible
Use extra virgin olive oil and low fat condiments when 
preparing salads
It is ok to add protein (i.e. chicken, turkey, eggs, ham) 
to salads
Make sure you use low calories salad dressings  or 
balsamic vinegar and extra virgin olive oil (1tbsp olive 
oil in dressing)
Options for a tasty salad: 
•	 Olives
•	 Eggs
•	 Chicken
•	 Tuna
•	 Ham
•	 Crab
•	 Left over proteins from meals
•	 Peppers
•	 Mushrooms
•	 Dried bananas
•	 Nuts
•	 Almonds
•	 Sunflower seeds
•	 Onions
•	 Tomato
•	 Cucumber
•	 Broccoli
•	 Cauliflower
•	 Mixed cheese
•	 Pickles
•	 Cottage cheese
Definitions pre-made salads could also be available
•	 Mandarin chicken salad
•	 Warm spinach chicken salad
•	 Non Caesar Caesar salad
•	 Mediterranean chicken salad
•	 Salmon with spinach and mustard
SALADS
When cooking your own soups please focus on hearty 
soup with light broths. Include lots of vegetables, some 
seasoning and protein and try to stay away from cream 
based broths.
Definitions recipes are as follows:
• Chicken soup
• Oriental chicken linguine soup
• Broccoli soup
• Minestrone with whole wheat pasta
• Bean soup
• Pea soup with ham
Star * Point - For your own recipes…
***Add proteins to soup (i.e. 2 times the 
meat) Noodle soups use the whole wheat 
noodles. Add barley, brown/wild rice, beans 
and chick peas to soups***
EASY SOUP
• 1/2 pound chicken breast
• 1/2 cup minced carrots
• 1 cup chopped onions
• 1 cup corn
• 1/2 cup canned peeled tomatoes
• 1 tsp olive oil
• 2 cloves of garlic, minced
• 2 tbsp chopped basil or parsley
• 1 cup canned navy beans, drained
• 1/4 tsp ground black pepper
In a large saucepan over low heat, cook the 
chicken and onion in the oil for about 10 
minutes or until the onion is golden brown. 
Add the garlic and cook for 1 minute. Then 
add the stock, beans and carrots, bring to 
a boil. Finally add the corn and tomatoes 
(with juice) and cook for 15 minutes.
SOUPS

Snacks are critical in Power Living.  Hearty snacks are 
the key here as foods with hollow calories (i.e. simple 
sugars) such as crackers and jam lead to blood sugar 
drops, low energy, and obesity.  All snacks should be 
hearty and use natural ingredients and well rounded 
nutrient profiles (protein, fats and carbs) thus keeping 
energy up, fat burning and muscle building environ-
ments working in the body.
Typical Snacks should include…
•	 Wraps (approved protein source, veggies and low fat   
 condiments)
•	 Whole wheat sandwiches (same as wraps)
•	 Any fruit
•	 Definitions bars
•	 Definitions cookies
•	 Yogurt
•	 Cheese
•	 Nuts
•	 Chili
•	 Soups
Star * Point
For snack stations bring out and mark Diet 
Pop and water as Definitions Choices to en-
courage their consumption versus high sugar 
beverages
SNACKS
Definitions Cookies - For Emergencies only!
 
Non-stick cooking spray
1 cup firmly packed light or dark brown sugar
3/4 cup trans-fat-free soft tub margarine 
spread
2 large egg whites
1 cup chocolate protein powder
2 tsp. pure vanilla extract
1 can chick peas drained and rinsed
2 cups semisweet chocolate chips
3/4 cup chopped walnuts (optional)
3/4 cup raisins (optional)
2 cups f lour
1/2 cup oatmeal
1 tsp baking soda
1/4 tsp salt 
 
Preheat oven to 350F.  Coat a baking sheet 
with cooking spray.  In a large mixing bowl, 
beat the sugar and margarine with a wooden 
spoon or on medium speed with a mixer until 
smooth.  Beat in the egg whites and vanilla, 
then the chickpeas and chocolate chips.  Add 
the f lour, oats, baking soda, and salt, and 
mix on low speed until a thick dough forms. 
Drop the dough by the tablespoonful onto 
the baking sheet, spacing the cookies about 
2 inches apart.  Press gently with a fork to 
f latten.  Bake until the cookies are golden 
brown and just set, 11 to 13 minutes; do not 
over bake.  Transfer to a rack to cool.  Store 
in an airtight container for up to 3 days.
Snacks can be tricky so let’s remember on simple say-
ing when it comes to the sugary stuff.
Star * Point 
“You can’t turn straw into gold!”
This study does not encourage sugary snacks but at the 
same time realizes that people love their treats. That 
being said, if an individual chooses a well rounded 
meal including protein, carbohydrates and essential 
fats, their body has received the nutrients necessary 
to give them energy and rebuild their body until their 
next meal. If this individual chooses to have dessert 
several interesting things happen if they have eaten a 
well rounded meal first. 
•	 They have increased satiety from the healthy meal
•	 They have a properly elevated blood sugar so crav-
ings decrease
•	 They don’t have room for more than one dessert
•	 They understand that it is ok occasionally but their 
meal is where their nutrition comes from
It is imperative that you do not cheat on your nutrition 
by eating too much and the wrong types of foods... you 
can however make sure your snacks still give you the 
chance to be healthy and have taste
Definitions Desserts…
•	 Berry Parfait
•	 Definitions Bars (not before bed)
•	 Definitions Cookies (not before bed)
Most times we want you to stick to the snacks listed
in the previous section however as the study
runs 14 weeks you made need some of these
foods to help cravings for the sweet stuff.
Definitions Bars
 
2 cups chocolate protein powder
11/4 cups oatmeal
1/2 cup wheat germ
1 cup bran
1 cup peanut butter
1/2 cup honey
Mix and slowly add water as needed. 
Finished bars should have the consistency 
of an “Eatmore” bar. P lace in cookie tray 
and let set in fridge for 2 hours
 
SNACKS
Choosing the right type of nutrient based on the situ-
ation and your bodie’s needs is an important part in 
choosing the right foods. 
This will take some practice but the “Cheat Sheet” on 
the opposite page will help with this process. Learn 
what foods fall into what category and use the food 
planning sheets and you will be all set.
“Proteins” – Good Choices
Fish
Seafood
Beef
Ham
Pork
Turkey
Chicken
Wild game
Beans (pulse crops) 
Dairy
skim milk
yogurt
cottage cheese
low fat cheese
Eggs
Whey protein 
For complete list see opposite page
“Fats” – Good Choices
Salmon
Scallops
Shrimp
Nuts
Olive Oil
Winter Squash
Fish Oils
Avacado
For complete list see opposite page
“Carbs” – Definitions Choices
Fruit – all kinds
Vegetables – all kinds
Vegetables with minimal carbohydrates are…
•	 Leafy vegetables (spinach, lettuce, cabbage)
•	 Flowering vegetables (broccoli, cauliflower)
•	 Colored Vegetables (peppers, tomato, carrots)
•	 Stalk vegetables (bok choy, celery, asparagus)
•	 Sprouts
•	 Onions
Highest carbohydrate content for vegetables are…
•	 Potato
•	 Yams/sweet potato
•	 Corn
•	 Peas
•	 Beans (legumes and pulse crops)
•	 Turnip
Bread, Grains and Rices…
•	 Multigrain
•	 Whole grain
•	 Whole wheat
•	 Oats
•	 Millett
•	 Brown Rice
•	 Basmati Rice
•	 Cuscus
•	 Steamed Rice (long grain)
Examples include…
•	 Whole wheat pasta
•	 Whole wheat/multi grain bread/wraps/pita’s/bagels/
English muffins
•	 cereals
•	 Are the preferred choices over white
•	 All bran
•	 Granola
•	 Fiber One
•	 Shredded Wheat
•	 Multi Grain Cheerios
•	 Muslix
•	 Whole Wheat Bread
•	 Multi Grain Bread
•	 Whole Wheat Bagels
•	 Whole Wheat English Muffins
BEST FOODS BY CATEGORY
CHEAT SHEET
Smoothie Station
One snack station that can be set up all day long at 
home or at work is the smoothie station.  Smoothies 
made with protein powder are healthy snacks that can 
be had any time and only take seconds to create and the 
possibilities are endless.   All that is required is a blender 
and some ingredients that can be added to the smoothie 
and blender with several containers (the Magic Bullet 
works great due to the multiple cups that come with 
each blender).
That way you can customize your smoothie based on 
what you like (see list below for healthy options) place 
them in their cup with either milk or water, add pro-
tein powder and simply blend it up to create your own 
healthy snack.  Some basic smoothie recipes form the 
Definitions recipe book are on the following page to 
give examples to follow in order to create some of our 
most popular smoothies.
List of Healthy Smoothie Additions:
•	 Berries
•	 Rolled Oats (non cooked)
•	 Yogurt and Cottage Cheese
•	 Peanut Butter
•	 All Bran
•	 Low Fat Milk
•	 Protein Powder (Chocolate or Vanilla flavour)
Easy Breakfast Smoothie:
1/2 cup of milk1 cup of yogurt1 scoop of whey protein1 banana or 1/2 cup of berries4 ice cubes
Blend and enjoy...
Chocolate PB Banana Oatmeal 
Smoothie:
1 pack of peanut butter
1 cup of water
1 scoop of whey protein
1 banana
1/4 cup of dry oatmeal
4 ice cubes
Blend and enjoy...
Power foods are a staple for personal wellness. They 
come in many forms and can add significantly to a well 
rounded plate. These foods are some of the same foods 
that offer our key nutrients like protein, carbohydrates 
and fats but at the same time can hold special proper-
ties which lead to health risk reduction, metabolism or 
energy.
The goal of the Power Foods chapter is for you the food 
preparation team to apply these foods to recipes, din-
ners and snacks as much as possible and share you 
knowledge with the crew as to why they are beneficial. 
This is a fun element of the education that allows you 
to have that little extra bit of knowledge that can truly 
establish you as a specialized crew. 
Nuts: 
Nuts, especially almonds in their original form are a 
great snack; full of good essential fats that unclog ar-
teries, are high in protein, fiber, vitamins and minerals. 
Don’t be confused or sucked in by “salted”, “smoked”, 
“honey roasted” or other alternative forms of nuts, these 
are only glorified pieces of candy; eat them in the form 
that they grow.
Spinach and Green Vegetables:
Popeye ate spinach so why wouldn’t you? With lots of 
vitamins and minerals; spinach, lettuce, green peppers, 
brocholi (and other flowering vegetables), peas, Brus-
sels sprouts are the ultimate power food. High in im-
portant vitamins and minerals these foods help you 
stay and feel young while boosting the immune system, 
preventing cancer, heart disease, strokes etc. the bottom 
line is just eat your veggies. 
Eggs:
High in protein, vitamins A and B12, eggs are quick, 
healthy and an easy meal to make. The once thought 
of notion that eggs are high in cholesterol and obvi-
ously bad for you is wrong. In fact high cholesterol in 
the body is due to dietary fat and not as much to do 
with cholesterol in foods like once thought. Eggs are a 
fantastic power food; both whole and egg whites fill you 
up and keep you healthy. 
Lean Cuts of White Meat (Turkey, Chicken etc.):
Low fat, high protein iron and other vitamins and min-
erals not to mention filling lean cuts of meat are the ul-
timate power food; breakfast, lunch, dinner or snack. 
Protein is the base of any plan and the cleanest, healthi-
est most natural source is from lean cuts of meat such 
as turkey or chicken. Remember to remove any chicken 
or turkey skin before eating but after cooking (keeps the 
juices in for more tender meat).
Berries:
Raspberries, strawberries, blueberries etc. are extreme-
ly high in antioxidants, fiber and vitamin C that fights 
against heart disease, aging, prevent cravings and boost 
ones immune system. 
Fish:
Very high in protein, vitamins and minerals, omega 3 
fatty acids and is also low in saturated fats and choles-
terol. Species high in omega 3 fats and low in mercury 
include char, herring, mackerel, salmon, sardines and 
rainbow trout. 
Red Meat: 
Humans are meant to eat atleast some meat. Cavemen 
hunted, killed and feasted on animals and our con-
sumption should be no different. High in protein, iron, 
vitamin B12, red meat is the classic example of a mans 
power food. Take note red meat is high in saturated fat, 
cholesterol which can lead to heart disease and arthro-
sclerosis if over consumed and accompanied by an in-
active lifestyle.
POWER FOODS
Olive Oil (also canola, peanut and sesame oil):
High in good fats and olive oil raises testosterone levels, 
lowers cholesterol, burns fast and boosts the immune 
system. Don’t be confused with other oils such as hy-
drogenated vegetable oils, trans fatty acids or margarine.
Tomatoes:
Loaded with vitamins tomatoes prevent the risk of blad-
der, stomach and colon cancers. Ketchup DOES NOT 
count as eating tomatoes, for it is loaded down with 
sugar. 
Celery:
Celery has long been known in Chinese medicine to re-
duce blood pressure; a recent study found that eating 4 
sticks of celery a day drops blood pressure 13 percent, 
so it doesn’t take much.
Chicken Soup:
Who hasn’t heard that chicken soup is good for sooth-
ing colds, flu’s and other inflammatory properties? But 
is their any science behind your grandmother’s seem-
ingly random wisdom? A study concluded that ingredi-
ents in chicken soup shows that our conventional wis-
dom is actually right and chicken soup does help fight 
colds.
Probiotic Yogurt:
Low fat yogurt is high in calcium and protein needed 
for maintaining healthy bones and muscles. However 
probiotic yogurt is key because of the microorganisms 
that benefit our system when eaten. Essentially these 
live bacteria are within our large intestine that improves 
our digestive processes. Not all yogurts contain bacte-
rial culture so be sure to check for it. 
Spices are a great way to improve the taste of food with-
out sugary or fatty calorie dressings or sauces. Used for 
thousands of years, spices were once considered one of 
the most valuable trade goods spurring the discovery of 
North America in an attempt to find a quicker route to 
India. Aside from their unique flavors spices also have 
medicinal and wellness benefits. Although not as pow-
erful as real medicine some spices highlighted below are 
excellent additions to your recipes as they do aid in ev-
erything from minor to severe illness. 
Allspice: 
Potential Health Benefit: an aromatic stimulant helps to 
relieve indigestion and gas. 
Jamaican Jerk Recipe:
Ingredients:
1/2 cup ground allspice berries 
1/2+ cup packed brown sugar 
6 to 8 garlic cloves 
4 to 6 Scotch bonnet peppers (hot peppers)
1 tablespoon ground thyme or 2 tablespoons 
thyme leaves 
2 bunches green onions
1 teaspoon cinnamon 
1/2 teaspoon nutmeg 
Salt and pepper to taste 
2 tablespoons soy sauce to moisten 
Preparation:
P lace allspice, brown sugar, garlic, scotch 
bonnet peppers, thyme, scallions, cinnamon, 
nutmeg, salt, pepper, and soy sauce in a food 
processor and blend until smooth. 
Cardamon: 
Potential Health Benefit: strong, unique taste. Often 
used in Indian cooking and Scandinavian baking. Used 
medicinally to treat infections in teeth and gums, con-
gestion of the lungs, and digestive disorders. 
Cayenne pepper: 
Potential Health Benefit: Increases metabolism and fat-
burning ability by up to 25 per cent. 
Celery Seed: 
Potential Health Benefit: Used as a homeopathic extract 
as a diuretic. Believed to help clear toxins from the sys-
tem. Also used as a mild digestive stimulant. 
Chili Powder:
Potential Health Benefit: Relieves achy joints. Research 
shows that capsaicin, found in chili peppers, has an 
anti-inflammatory effect, which may help ease arthritic 
swelling and pain. 
Sprinkle a few shakes of chili powder and 
salt on baked sweet potato fries.
Cinnamon:
Potential Health Benefit: Protects against Type 2 dia-
betes and heart disease. A 2003 study found that about 
half a teaspoon lowered blood glucose, cholesterol, and 
triglyceride levels. 
Mix half a teaspoon of cinnamon into your 
coffee, or jazz up whipped cream with a cou-
ple of pinches. (it makes the whipped cream 
taste better but not healthy)
SPICES
Coriander:
(also known as cilantro and Chinese parsley)
Potential Health Benefit: Said to assist with clearing the 
body of lead, aluminum, and mercury. Also said to help 
relieve anxiety and insomnia. 
Curry Powder:
Potential Health Benefit: Safeguards your brain. The 
yellow curry pigment curcumin may fight Alzheimer’s 
by thwarting development of the disease’s signature am-
yloid brain plaques, says a study. 
Whisk 1 1/2 teaspoons mild curry powder into 
mayonnaise to dress up sandwiches
Garlic:
Potential Health Benefit: Improves your heart’s health. 
Brigham Young University researchers found that garlic 
consumption can lower total cholesterol and triglycer-
ide levels by an average of 10 percent. 
Add minced garlic and chopped cucumber to 
plain yogurt for a light dip or salad dressing.
Ginger: 
Potential Health Benefit: Can inhibit nausea and vomit-
ing that may accompany morning sickness or motion 
sickness. 
Horseradish: 
Potential Health Benefit: Used as a digestive stimulant. 
Mint: 
Potential Health Benefit: Traditionally, mint was used 
to treat stomach ache and chest pains. It is also a strong 
diuretic and digestive aid. 
Mustard: 
There are several kinds of mustard — not just the type 
you slather on your hot dogs and hamburgers. “Mustard 
packs” have been used for generations to help relieve 
respiratory problems. 
Rosemary: 
Potential Health Benefit: Acts as a stimulant and mild 
analgesic, and has been used to treat headaches and 
poor circulation. 
Saffron: 
Potential Health Benefit: Besides being the world’s most 
expensive spice, saffron has been used to treat depres-
sion in Persian traditional medicine. A 2005 study 
found that saffron may help in cases of mild to moder-
ate depression. 
Wasabi:
Potential health perk: Prevents ulcers. A 2004 South 
Korean study suggests Japanese horseradish can kill ul-
cer-causing Helicobacter pylori bacteria. Plant chemi-
cals may also prevent tooth decay.
Mix a smidgen of wasabi paste with mashed 
avocado for a snappier guacamole.
Fruits  (60 calories /serving) 
Apple    1 small 
Banana   1 small or 1/2 large 
Blueberries   3/4 cup 
Cantaloupe   1 cup cubed 
Cherries   1 cup 
Dates    3 
Grapefruit   1 small or 1/2 large 
Grapes    1/2 cup 
Honeydew melon  1 cup cubed 
Kiwi    1 large 
Mango    1/2 cup diced 
Mixed fruit   1/2 cup 
Nectarine   1 
Orange   1 medium 
Orange juice   1/2 cup 
Peach    1 large 
Pineapple   1/2 cup cubed 
Pear    1 small 
Plums    2 
Prunes    3 
Raisins    2 tablespoons 
Raspberries   1 cup 
Strawberries   1 1/2 cups whole 
Tangerine   1 
Vegetables  (50 calories/serving)
Asparagus   1 cup pieces 
Broccoli   2 cups florets 
Brussels sprouts  1 cup 
Carrots   1 cup sliced 
Cauliflower   2 cups florets 
Celery    2 cups diced 
Cherry or grape tomatoes 16
Cucumber   2 cups sliced 
Eggplant (cooked)  2 cups
Green beans   1 1/2 cup 
Green pepper   2 cups sliced 
Kale (cooked)   1 1/2 cup 
Lettuce   4 cups shredded 
Mushrooms   2 cups whole 
Onions   1 cup sliced 
Peas, green   2/3 cup 
Spinach (cooked)  2 cups 
Spinach (raw)   4 cups 
Squash (summer)  1 1/5 cup sliced 
Tomatillo   1 cup diced 
Tomato   2 medium 
Vegetable juice  8 ounces 
Starchy Carbohydrates  (140 calories 
in a serving) 
Bagel (whole-grain)   1 
Barley (cooked)   1cup 
Beans     1 cup 
Bread (whole-grain)   2 slices 
Bulgur (cooked)   1 cup 
Cereal (see best foods list)  1 cup 
Corn     1 cup 
Corn tortillas    1 
English muffin (whole-grain)  1
Garbanzos beans   2/3 cup 
Kasha (buckwheat groats, cooked) 1 cup 
Oatmeal (cooked)   1 cup 
Pasta (whole-grain, cooked)  1 cup 
Peas     1 1/2 cups
Pita bread (whole-grain)  1 circle 
Popcorn (air-popped, plain)  4 cups 
Pumpkin (cooked)   3 cups 
Rutabagas (cooked)   1 1/2 cups 
Rice (brown, cooked)   2/3 cup 
Roll (whole-grain)   1 medium
Rye wafer    2 triple crackers 
Shredded wheat   2 biscuits 
Squash (winter, cooked)  2 cups 
Sweet potato (baked)   1 medium 
Turnips (cooked)    1 cup 
Protein/Dairy  (220 calories/ serving) 
Beef (lean) 3 ounces 
Chicken 6 ounces 
Cheese (feta) 1/2 cup 
Cheese (low-fat) 3 ounces 
Cod 6 ounces 
Cottage cheese (1% or lower) 1 cup 
Crab 6 ounces 
Egg 2 medium 
Egg substitute  1 cup 
Egg whites  8  
Halibut 6 ounces 
Lamb, lean cuts no fat 5 ounces 
Lentils 1 cup 
Milk (skim or 1 percent fat) 2 cups 
Pheasant, duck (breast) 6 ounces
Venison 6 ounces 
Pork, lean cuts no fat  4 ounces 
Salmon 6 ounces 
Shrimp 6 ounces 
Tofu 1 cup 
Tuna (canned in water) 6 ounces 
Turkey 6 ounces 
Yogurt (fat-free or lite) 2 cups
Star * Point
***Weigh and measure all food until you 
are completely comfortable with what con-
stitutes a serving size. Eating too big of a 
serving is the number one way an individ-
ual will not lose weight so pay careful at-
tention with the scales and cups provided 
by the study team***
Fats  (90 calories/serving) 
Almonds 16 whole 
Avocado 1/3
Canola oil 2 teaspoons 
Cream cheese 2 tablespoons 
Olives 18 large 
Olive oil 2 teaspoons 
Margarine (olive oil/omega 3) 2 teaspoons
Peanut butter 1 tablespoon 
Peanuts 16 whole 
Sunflower seeds 2 tablespoon 
Walnuts or pecans  8 halves 
As you are undergoing a new training regimen it is nec-
essary to fuel your body. You have three types of days 
for your training, non-resistance training day, resis-
tance training day, and rest day. This section will out-
line your specific nutritional demands for your exercise 
habits. Follow these rules and you will see the potential 
of your training program. Nutrition is 80% of the battle, 
stick with it. 
 
A Typical Day of Healthy Eating 
 
Breakfast
 
It is vital to consume a balanced meal with breakfast 
to start the day. There are many nutrients that must be 
consumed with breakfast to provide you with proper 
energy throughout the day. First, low Glycemic Index 
carbohydrates are a must (see yellow choices on best 
foods by category). After sleeping (approx. 8 hours of 
fasting) your muscle glycogen (stored carbohydrate en-
ergy) becomes depleted through the night.  Because of 
this, your body releases the hormone cortisol which is 
responsible for breaking down stored muscle into glu-
cose for energy. By consuming low GI carbs at  break-
fast, you will improve glucose tolerance for the rest of 
the day. This will allow your body to properly use car-
bohydrates for energy without feeling lethargic or stor-
ing excess fat. 
Proteins are also a must at this meal. Individuals who 
exercise must consume a little more protein than the 
average individual because you are intentionally break-
ing down muscle by training (which is made up of pro-
tein) and therefore need excess in order to allow proper 
recovery. A high quality whey protein is a good choice 
as it is absorbed rapidly, which is needed after an 8 hour 
fast, as well as some solid food proteins to provide a 
steady stream of amino acids. 
Macronutrient breakdown: 
 
· Protein: 40 grams 
· Carbs: 50 grams of carbohydrates 
· Fats: 1 serving of essential fats
 
For example a great breakfast is: 
· 1/2 cup (dry) oatmeal (add water of course) 
· Serving of frozen berries (mixed into the oatmeal) 
 
With: 
4 egg whites and 1 whole egg 
2 omega-3 fish oil caps or cook eggs in olive oil
Mid-Morning Snack:
 
Pre determine mid morning snacks (the night before) 
and make sure you have them before you head out the 
door. Stock your bag full of good food. You can have 
bags of almonds or other nuts on hand, fruit or even 
some dairy products in your fridge at work. 
See the “Easy Eating document” (online in the intelli-
gence bank of definitions website) for some more ideas 
about snacks
 
•	 Tip	 make	 or	 buy	 snacks	 once	 a	 week	 (see	 recipes)	
package them, stock and bring them daily. Your week 
will go really smooth and you will see tremendous 
results always your nutrition handy 
 
•	Try	green	tea	instead	of	coffee	or	diet	pop.	It	has	anti-
oxidants and will boost your energy and act as a natural 
fat burner. 
 
•	 If	you	want	a	protein	shake	have	1	scoop	of	protein	
with water. That will give you 20 grams of protein with 
no sugary carbs. This will keep your metabolism up 
but without the risk of spiking insulin levels and storing 
fat. 
Lunch:
 
Think about lean proteins and your carbs coming in the 
form of vegetables and fruit. You get an increase in anti-
oxidants and vitamins as opposed to breads and grains, 
so: 
•	 Lunch today should be warm leftovers from last 
night or prepared meals that are nutritionally bal-
anced and of the right portions 
•	 See sample ideas on “Sample Nutrition Days” sec-
tion next
•	 Use the “Best Foods by Category” to plan a meal
•	 Ask your researchers what to eat!
Tip: cook a large batch on Sundays and portion off 
into containers and freeze for weekly lunches .
PS - Salad dressings are usually terrible sources of fat 
and calories. A great salad dressing would be two table 
spoons of olive oil (excellent source of monounsaturat-
ed essential fats) mixed with some vinegar and a pinch 
of oregano. Spinach is an excellent choice over lettuce 
because it has a lot more antioxidants, vitamins and 
minerals. Also condiments of any kind should be used 
sparingly and always look for low fat low sugar options 
of ketchup and BBQ sauce. Mayonnaise is not a good 
choice, mustard is fine. 
All seasonings and spices are fine and can add lots of 
flavor to otherwise dull meals. 
MS. Dash has lots of great flavors · If you don’t have ol-
ive oil or a serving of essential fats from the list then 
take 2 omega 3 capsules. 
Mid Afternoon Snack:
 
Must have feeding mid afternoon. Fruit, veggies, al-
monds, yogurt or choose from the list of snacks from 
out endorsed food list. Mid afternoon snack can be ex-
actly the same size as mid morning snack This snack 
fires the metabolism up again gives the muscle the en-
ergy to repair itself which in-turn burns more fat. A mid 
afternoon feeding also reduces the tendency to overeat 
during supper which is when most people break down 
and lose their commitment to nutrition. 
Dinner:
 
Continue to eat lean protein (see meal planner list), 
vegetables and a small serving of fruit. Stay away from 
potatoes, white rice and bread, try yams, brown rice or 
whole wheat pasta but try and stay away from lots of 
carbs coming in these forms. In general only have half 
of a serving of the starchy sources listed in the serving 
size section as you do not need alot of energy in the 
form of carbohydrates at that point in the evening.
Remember your supper should essential be a 6-8 oz. 
of protein with a serving of vegetables the greener 
the better with only a little bit of high energy car-
bohydrates because we don’t need too much energy 
at that point in the day). 
 
Pre Bed Time Meal:
 
1 cup cottage cheese or Greek Yogurt 
This is the last meal of the day before a long fast (sleep). 
Cottage cheese or Greek yogurt are great choices here as 
it is very slow digested. 
Workout Nutrition:
You can complete cardio any time of the day you would 
like however it is important to understand you must 
have some food in your system either from a meal or 
snack before you train.
Complete prescribed cardio (if you are supposed to do 
it that day) after breakfast. If cardio is not prescribed for 
that day simply begin your day with breakfast. 
Cortisol (stress hormone which breaks down muscle) 
is increased by between 150-400% when cardio is per-
formed in a hypoglycemic state i.e. on an empty stom-
ach (27, 28). This in mind you should always do cardio 
after breakfast. The intensity dictated in your cardio 
prescription requires metabolism of both fat and car-
bohydrates. 
For the guidelines of this nutrition plan, this will serve 
as your pre training meal. For this meal, it is essential 
to consume high quality protein and carbohydrates that 
will be used for fuel during exercise. If proper pre work-
out nutrition is not consumed, your body will rely on 
other methods (breaking down muscle) in order to pro-
vide energy, which will be detrimental to your progress.
Examples of before workout foods could be a peice of 
fruit, half of a sandwich or can of tuna. 
Prior to each resistance training workout, you will be 
given Branch Chain Amino Acids to help improve gains 
from the workout. 
During Workout Nutrition: 
 
Water – Lots of it and it is advantageous to consume 
15 grams of BCAA’s during a workout. Doing this will 
allow these amino acids to be digested and placed in 
the blood stream where they will be used as a source 
of fuel during exercise. Using these BCAA’s during ex-
ercise is beneficial because it causes a glycogen sparing 
effect, meaning you will break down less muscle glyco-
gen (low levels of muscle glycogen is associated with 
impaired strength and performance). 
If you train at a different time of day please follow these 
recommendations for during training nutrition at those 
times. 
 
Post Workout Nutrition: 
 
Post workout shake:
•	 2 scoops whey protein (34-38 grams of protein) 
•	 1 scoop dextrose (20 grams of carbohydrates) 
So why do we need to take in protein following a work-
out? An equation that is necessary to understand is the 
Protein Balance equation: 
 
Protein Balance = amount of protein synthesized 
minus the amount of protein broken down. 
 
After a workout, your protein balance is in a nega-
tive state because protein synthesis has remained un-
changed, however, protein breakdown has gone up as 
a result of the damage of exercise on your muscles. Be-
cause you have used your body’s stored carbohydrates 
for energy the body begins to release the hormone cor-
tisol toward the end of a workout, which breaks down 
muscle for energy. This hormone must be stopped 
ASAP, or else protein breakdown will continue to rise. 
In order to stop this, your body must absorb carbohy-
drates as fast as possible. The best carbohydrates to do 
this is dextrose, which is one of the fastest absorbing, 
high Glycemic index carbohydrates. The workout it-
selfcauses the body to require an insulin spike which 
will shuttle nutrients to damaged muscles for repair, 
and these carbohydrates in the form of dextrose cause 
the spike to occur. These carbohydrates will help com-
bat the muscle breakdown caused by cortisol and are 
the fastest way to replenish muscle glycogen, so muscle 
breakdown is reduced and muscle growth is amplified. 
As it has been shown to be advantageous to consume a 
mixture of both of these nutrients in several scientific 
studies.  
The drink must also contain whey protein. Whey pro-
tein is the fasted absorbed source of protein, which 
immediately is used by your muscles for repair and 
growth. Also, it has been shown that whey protein and 
carbohydrates are more effective in replenishing muscle 
glycogen than carbohydrates alone. 
This drink must also contain adequate water. As ex-
plained, the goal here is to digest the nutrients as fast as 
possible. The rate of nutrients emptying the stomach is 
known as gastric emptying. Having high levels of water 
is essential after a workout because research has proven 
that a liquid meal with under 10% solution has been 
proven to digest as fast as pure water! 
Definitions will provide both the BCAA’s and the 
protein shake following the workout to ensure you 
are following the protocol without any undue ex-
pense.
What you should do with this is immediately after the 
workout, drink half of the mixture, then, for 1 hour, 
slowly sip on the rest of it. So you fill up the container, 
drink half the shake immediately, then, fill up the con-
tainer again with water and keep sipping for 1 hour (its 
essential for proper nutrient delivery to get a ton of wa-
ter after a workout.) 
 
We know this sounds confusing so let us summarize: 
 
1) Immediately after: chug half the shake 
2) For rest of hour, sip shake slowly



SAMPLE NUTRITION LOGS
You must fill out a nutrition log every weekin order to ensure youare on track with youreating plan. Kayla willrequest this from youeach week
You may al
so use sma
rt
phone calor
ie tracking 
on
online food
 tracking s
aftware
as long as 
logs are su
bmitted
weekly.
Also remem
ber serving
 sizes
must be wr
itten down
!!!
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Body Fat Assessment Techniques: 
The assessment of body fat can be accomplished in many ways including predictive 
equations, skinfold measurements and advanced imaging techniques. Each of these 
approaches has benefits and limitations related to cost, time, and accuracy. Due to 
adipose tissue’s metabolic role and its regional characteristics, the determination of total, 
depot and region specific body fat is relevant for overweight and obese populations. This 
is exemplified by the increased understanding of the visceral adipose deposit that has 
had a significant impact on obesity research. Therefore the assessment of regional body 
fat in comparison with circulating concentration of energy regulating hormones may 
provide insights into the role of these regional fat depots in the manifestation of obesity 
related metabolic disease. 
Body Mass Index: 
BMI is the most cost effective method to evaluate adiposity, it has been shown to have 
significant weaknesses in accurately determining adiposity. Body mass index, calculated 
as [(weight (kg) / Height (m)2] classifies degree of body fat as underweight, normal 
weight, overweight, obese class 1, obese class II and obese class III respectively (Table 
1).  One such weakness of the BMI is that there are no sex specific criteria even though 
gender differences for body fat percentage have been well documented (Kennedy et al., 
2009). BMI does not reflect either the clear accumulation of body fat with age nor the 
inter-individual difference of body fat percentage among people within the same BMI 
category. According to dual x-ray absorptiometry body fat percentage measurements, 
BMI scores can mis-classify by one or even two obesity categories (Geer & Shen, 2009; 
Machann et al., 2005). Lastly due to the fact that BMI was originally developed in 
Caucasian populations, the accuracy within various ethnic populations is problematic. 
These misclassifications of obesity status reduces the identification of those at higher 
risk of cardiometabolic diseases with lower body fat content (De Lorenzo et al., 2013).   
Skin Fold Thickness: 
Skin fold calipers have been used to determine body fat percentage, body density, 
osteoporosis, hypertension, and insulin sensitivity with accuracy. The modern skin fold 
caliper was designed in 1955 by the Harpenden Corporation in collaboration with 
Tanner and Whitehouse. The tool was developed to determine thickness of skin of 
specific regions and apply these values mathematically to determine body fat percentage 
or body density. Since its inception it has been utilized in numerous studies as a means 
of testing skin fold thickness and has been adopted by several governing bodies of 
physiology including the American College of Sports Medicine (ACSM), the National 
Strength and Conditioning Association (NSCA) and the Canadian Society of Exercise 
Physiology (CSEP) for the determination of body fat percentage. As a result, skin fold 
calipers have become an integral part of the field of kinesiology however due gold 
standard measures of the CT scan or the more convenient DXA scans research rarely 
employs the use of skin fold calipers in their assessment of body fat. One of the 
advantages of skin fold measurement is the ability to distinguish different patterns of 
adipose distribution from circumference indices or predictive equations (Jackson & 
Pollock, 2004). 
Skin fold calipers have shown a strong statistical correlation with measures of skinfold 
thickness determined by CT scan, a more accurate assessment than ultrasound, and are 
significantly less costly to administer then both CT and ultrasound. Although there are 
challenges with respect to skin compressibility and hydration status among those being 
tested, skin fold calipers have been shown to be an effective, low cost means of 
accurately assessing body fat and regional subcutaneous adipose deposits.  
Dual-Energy X-Ray Absorptiometry: 
Originally designed for determining bone mineral density and diagnosing osteoporosis 
and other bone diseases, DXA is also used to assess fat and fat-free soft tissue. By 
measuring the absorption (attenuation) of two X-ray photon energies, which allows for 
the differentiating of bone from soft tissue (Pietrobelli, Wang, Formica, & Heymsfield, 
1998). DXA further separates soft tissue into lean body mass and adipose tissue through 
providing a comprehensive view of body composition. The estimation of fat tissue may 
be influenced by conditions where the ratio of extracellular to intracellular water varies 
(e.g., due to edema, infancy, or aging), as it is assumed that the hydration of lean soft 
tissue remains constant.(Pietrobelli et al., 1998; St-Onge, Wang, Horlick, Wang, & 
Heymsfield, 2004) However, in normal, healthy conditions, a change in hydration of 5% 
influenced fat estimation by only 1–2.5%.(Lohman, 1984). An additional consideration 
in obese persons is that body thickness (>25 cm) can result in underestimation of fat 
mass (Genton, Hans, Kyle, & Pichard, 2002). 
DXA is considered to be a convenient, quick (5- to 13-min scan time), and safe modality 
for body composition assessment. It is used in people of all ages due to its low ionizing 
radiation, however it is not recommended during pregnancy (H. Wang, Chen, & 
Eitzman, 2014). When compared to the in vivo gold standard four-compartment model 
has demonstrated shows that DXA’s accuracy is within ±5% and is a useful tool for 
measuring changes in body fat over time (Toombs, Ducher, Shepherd, & De Souza, 
2012). More recent improvements, such as increased weight limit of the iDXA scanner 
bed to 400 lbs, allow heavier individuals to be assessed. In obese individuals whose 
bodies are wider than the scanner area, scans are typically performed by extrapolating 
data acquired from the right side of the body. While bilateral symmetry is assumed, half-
body scans accurately predict total fat mass, total lean mass, and percent body fat in 
adults (Tataranni & Ravussin, 1995). 
Anthropometric measurements such as body mass index, waist circumference and waist-
to-hip ratio are commonly used in large epidemiologic studies. However, these 
measurements actually assess total fat, and therefore cannot differentiate between 
viscerat and subcutaneous fat. (Kaul et al., 2012). Additional commercial software 
(CoreScan or Hologic’s InnerCore, GE Healthcare, Chicago, IL, USA) is now available 
to measure visceral fat and will add significantly to the data available to obesity 
research. Technical performance of DXA VF has been demonstrated in both American 
and Chinese populations. These studies showed a high correlation and small average 
difference between DXA and CT (Kaul et al., 2012; Lin et al., 2013). Recently, a Korean 
study showed that visceral fat measured by DXA is highly correlated with the visceral 
fat measured by CT scan and could be a reliable estimate of visceral fat in Korean 
population (Choi, Seo, Lee, & Chung, 2015).  
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Girth Measurements: 
Neck: 
The neck measurement is taken immediately above the thyroid cartilage (the 
Adam's Apple). When recording, you need to make sure the tape is not too tight or 
too loose, is lying flat on the skin. 
Arm Relaxed: 
This girth measurement is usually taken on the right side of the body. The arm is relaxed 
and hanging by the side, and the circumference is taken at the level of the mid-point 
between the acromion (boney point of shoulder) and the olecranon (boney point of 
elbow) processes.  
Arm Flexed: 
This girth measurement is usually taken on the right side of the body. The arm is raised 
to a horizontal position in the sagittal (forward) plane, with the elbow at about 45 
degrees. The subject maximally contracts the biceps muscle, and the largest 
circumference is measured.  
Chest: 
This measure is taken at the level of the middle of the sternum (breast-bone), with the 
tape passing under the arms. After the tape is in position, the arms should be relaxed by 
the side, and the measurement taken at the end of a normal expiration. When recording, 
you need to make sure the tape is not too tight or too loose, is lying flat on the skin, and 
is horizontal, particularly around the back. 
Waist: 
The waist measurement is taken at the mid point between the lowest rib and the top of 
the hip bone (illiac crest). Three measurements were taken and the lowest measure was 
recorded.   
 
Hip: 
The hip girth measurement is taken over minimal clothing, at the level of the greatest 
protrusion of the gluteal (buttock) muscles. The subject stands erect with their weight 
evenly distributed on both feet and legs slightly parted, making sure not tense the gluteal 
muscles.  
 
Thigh: 
The subject stands erect with their weight evenly distributed on both feet and legs 
slightly parted. The circumference measure is taken at the level of the mid-point on the 
lateral (outer side) surface of the thigh, midway between trochanterion (top of the thigh 
bone, femur) and tibiale laterale (top of the tibia bone). When recording, you need to 
make sure the tape is not too tight or too loose, is lying flat on the skin, and with the tape 
horizontal. 
Skin Fold Measurements: 
Skin fold measurements should be made on the right side of the body with the caliper 
placed 1-2 cm away from the thumb and finger and perpendicular to the skin fold. The 
measure should be taken halfway between the crest and the base of the fold. The tester 
should release the caliper lever so its spring tension is exerted on the skinfold while 
maintaining the pinch and the reading caliper between 1 to 2 seconds after lever has 
been released (to allow for adequate skin compression). Measures are taken to the 
nearest 0.5 mm and the average of three measures are recorded for each site.  
Triceps 
• Vertical fold
• Posterior midline of the upper arm
• Halfway between the acromion (shoulder) and olecranon processes (elbow)
• Arm held freely to the side of the body
Chest/Pectoral 
• Diagonal fold
• Men: one-half the distance between the anterior axillary line (crease of the underarm)
and the nipple
Midaxillary 
• Horizontal fold taken at the level of the xiphoid/sternal border in the midaxillary line.
Subscapular 
• Diagonal fold
• 1 to 2 cm below the inferior angle of the scapula
Suprailiac 
• Diagonal fold
• Anterior axillary line (modern technique)
• immediately superior to the iliac crest
• in line with the natural angle of the iliac crest taken
Umbilical 
• Vertical (modern technique)
• 2 cm or 1" to the right side of the umbilicus
Thigh 
• Vertical fold
• anterior midline of the thigh
• midway between the proximal border of the patella (upper knee) and the inguinal crease
(hip)
• 
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Push-Up Test: 
The push-up fitness test (also called the press up test) measures upper body strength and 
endurance. The standard push was used and began with the hands and toes of each 
subject touching the floor, with the body and legs in a straight line, feet slightly apart, 
the arms at shoulder width apart, extended and at a right angles to the body. Keeping the 
back and knees straight, the subject lowered their body to until their chest touched a 
tennis ball placed below them on the floor, then returned back to the starting position 
with the arms extended. This action was repeated, and test continued until subjects were 
not able to continue without pausing for longer than 2 seconds.  
Partial Curl-Up Test: 
The curl up test measures abdominal muscular strength and endurance of the abdominals 
and hip-flexors, important in back support and core stability. The subject laid on am 
exercise mat with knees flexed, at 90 degrees. Subjects hands were placed by their side 
and markers were placed on the ground 5 cms from the end of their finger tips which 
they were required to touch to successfully complete a repetition. The subject was 
required to raise their trunk in a smooth motion, keeping the arms in position, curling up 
the desired amount. The trunk was lowered back to the floor so that their shoulder blades 
touched the floor. The test was performed at a 2 second repetition tempo, and the 
maximum number of total sit ups were recorded  
 
Sit and Reach Test: 
The sit and reach test is a common measure of flexibility, and specifically measures the 
flexibility of the lower back and hamstring muscles. This test was first described by 
Wells and Dillon (1952) and is now widely used as a general test of flexibility. The test 
involved sitting on the floor with legs stretched out straight ahead. Shoes were removed 
with the soles of the feet placed flat against the sit and reach box. The subjects locked 
and pressed their knees flat to the floor with their palms facing downwards, and the 
hands on top of each other or side by side, the subject reached forward along the 
measuring line as far as possible. The primary investigator ensured that the hands 
remained at the same level, (not one reaching further forward than the other). After two 
practice reaches, the subject reached out and held the stretched position for two seconds 
while the distance is recorded. 
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Subject Consent Forms
Consent to Take Part in Research
TITLE: Hormone Level Changes with Weight Loss Programs and Physical Activity 
improvement in Men Ages 35-55.
" " "
INVESTIGATOR(S): Michael Wahl, Dr. Gerry Mugford, Dr. Majed Khraishi, Dr. Christopher 
Kovacs"
You have been invited to take part in a research study.  It is up to you to decide whether to 
be in the study or not.  Before you decide, you need to understand what the study is for, 
what risks you might take and what benefits you might receive.  This consent form 
explains the study.
The researchers will:
· discuss the study with you
· answer your questions
· keep confidential any information which could identify you personally
· be available during the study to deal with problems and answer questions
If you decide not to take part or to leave the study, you can do so at any time, however 
signing this consent form requires you return for follow up measures in order to complete 
the study.
You will also be required to submit a letter from your physician stating you are capable of 
taking part in this study.
1. Introduction/Background:
The goal of this study is to look at the effects of healthy lifestyle on hormones in men who 
are middle aged, slightly overweight and donʼt exercise. This study will use exercise and 
nutrition guidelines to look at their effect on some of the hormones which maintain healthy 
body weight. If you enroll in this study you will have a fitness test and may be randomized 
to exercise with a trainer at a gym and engage in healthy eating training for 3 months as 
well as have various tests during the study to see how you change during this period of 
time. This study may try to find clues to improve treatments of obesity and other diseases 
related with excess body fat.
 September 2011
 Version date: September 12/2011 -1- Initials: ________
2. Purpose of study:
To determine the effect of structured nutrition and exercise on hormones related to body 
fat.
3. Description of the study procedures and tests:
Subjects involved in the study will be tested in a series of baseline and follow up 
measurements at three locations:
Nexus Clinical Research: 120 Stavanger Drive 
• Study participants will complete a health habit questionnaire, including questions
about smoking, alcohol and food intake patterns.
• You will be asked to come to Nexus Clinical Research for blood sampling at the
beginning and the end of the study. About 1 tablespoon of blood will be drawn each
visit which will be used to determine if changes in your hormones are occurring
during the study.
• Feedback regarding abnormal blood values will be reported to the family physician.
Genetics Lab: H4353 
• Percent body fat, lean body mass and bone density will be measured using a bone
densitometer (lying on a bed, and a scanner will complete the measurement in
about 10 to 15 minutes.
• The scan will expose you to radiation levels similar to an x-ray.
Exercise Physiology Lab: PE2005A
• Cardiorespiratory Fitness, which is the ability of the body's circulatory and
respiratory systems to supply fuel and oxygen during sustained physical activity, will
assessed using a treadmill test. During this test you will be required to run on the
treadmill at an increasing pace of 4 intervals. Scores from each level will be
recorded to calculate your hearts use of oxygen.
• You will have your strength measured by using a hand grip test. This requires
squeezing a metal grip attached to a gauge. You will also have your leg strength
tested by attaching a cable to your foot and extending your leg as hard against the
cable.
• Your standing height, body weight will be taken using a medical scale. As well girth
measurements of your waist and hips will be taken with a standard measuring tape.
heart rate and blood pressure will be measured using an automated blood pressure
cuff and temperature will be measured using a standard thermometer.
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• Body fat will also be measured using skin fold calipers. We will test a series of sites
around the body including the arms, legs, and torso. We will also take girth
measurements of the arms, neck, chest, shoulders, legs, waist and hips using a
measuring tape.
All subjects will be required to undergo baseline and follow up testing.
Intervention Group: Definitions Training Facility, 120 Stavanger Drive
You will have a 50% chance of being allocated to the exercise group. Those involved in 
the study (both control and intervention group) must complete the following 
interventions as part of the study:
• Nutrition education seminar: This nutrition education will involve a one hour talk to
explain proper nutrition. This will be followed by 30 minutes of explaining food logs
and what will be required of you during the study. The remaining 30 minutes will be
used for handing out information, questions and booking you in for workouts.
• Completion of food logs - You will be asked to complete a daily food log to ensure
you are eating the right foods for 12 weeks. You will be asked to submit these food
logs to your research assistant once a week.
Those chosen for the intervention/exercise group will also have to complete:
• Supervised exercise training - (3) 1 hour sessions per week for 12 week. Subjects
chosen for the intervention will receive supervised exercise training with a certified
personal trainer for 12 weeks during the study. During this time you will be asked to
exercise with the trainer/research assistant 3 times each week. Flexibility in when
you want to exercise will be allowed and the trainer will be available between 6 am
and 8 pm daily.
4. Length of time:
The study will span 12 weeks from start to finish. All subjects, including those who 
were not selected for the exercise intervention and are part of the “control group” must 
attend all testing. Baseline and follow up testing after 12 weeks is required. People 
who are selected for the exercise intervention are required to attend a workout with a 
personal trainer 3 times a week for 1 hour and record food intake weekly. Control 
subjects will only be required to record weekly food intake and physical activity. 
Exercise sessions (for those in the intervention group) and food logging will last for 12 
weeks. 
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5. Possible risks and discomforts:
There is little risk when sampling blood. There is a possibility of bruising at the site and
a slight chance of infection. There will be a very low dose of X-ray exposure when you
receive measurement of percent body fat and bone density.
Some discomfort from healthy eating may occur. It will be recommended that subjects
take one day each week to eat foods which they crave.
Physical activity may also cause discomfort including muscle soreness, acute injury,
aggravation of previous injuries, fatigue, disrupted sleep patterns and hunger.
6. Benefits:
It is not known whether this study will benefit you personally.
However, potential benefits may include:
• Increased physical fitness
• Weight loss
• Nutrition education
• Education on how to exercise properly
• Access to professional lifestyle counseling
• Awareness of physical fitness and body fat percentage
7. Liability statement:
Signing this form gives us your consent to be in this study.  It tells us that you
understand the information about the research study.  When you sign this form, you do
not give up your legal rights.  Researchers or agencies involved in this research study
still have their legal and professional responsibilities.
8. What about my privacy and confidentiality?
Protecting your privacy is an important part of this study. Every effort to protect your
privacy will be made. However it cannot be guaranteed. For example we may be
required by law to allow access to research records.
A copy of this consent will be put in your health record.  If you agree, your family
doctor will be told that you are taking part in this study.
        When you sign this consent form you give us permission to
· Collect information from you
· Collect information from your health record
· Share information with the people conducting the study
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· Share information with the people responsible for protecting your safety       
Access to records
The members of the research team will see health and study records that identify you 
by study code. The names associated with the study codes will be separate from the 
study records and will be accessible by the research team only. 
Other people may however need to look at your health records and the study records 
that identify you by name. This might include the research ethics board. You may ask 
to see the list of these people. They can look at your records only when one of the 
research team is present.
Use of records
The research team will collect and use only the information they need for this research 
study.       
This information will be will kept for 5 years and will include your :
• date of birth
• sex
• address
• contact information
• emergency contact
• medical conditions
• medications
• the results of tests and procedures you had during the study
• information from questionnaires
Your name and contact information will be kept secure by the research team in 
Newfoundland and Labrador.  It will not be shared with others without your permission. 
Your name will not appear in any report or article published as a result of this study.
If you decide to withdraw from the study, the information collected up to that time will 
continue to be used by the research team.  It may not be removed. This information 
will only be used for the purposes of this study 
After your part in this study ends, we may continue to review your health records we 
collected during the study to check that the information we collected is correct. We will 
not be accessing your medical records at any time. 
Information collected and used by the research team will be stored by Michael Wahl 
the principle investigator of the study who is the person responsible for keeping it 
secure. 
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Study codes will be assigned to each individual record instead of names and kept 
secure by the research team to avoid identification of your information by those not 
involved with the study. 
Your access to records
You may ask the primary investigator to see the information that has been collected 
about you.  
9. Compensation:
In the event that you suffer injury as a direct result of taking part in this study,
necessary medical treatment will be available at no additional cost to you as covered
by MCP.
10. Questions:
If you have any questions about taking part in this study, you can meet with the
investigator who is in charge of the study at this institution.  That person is: Michael
Wahl
· Storage of Blood Samples:
The (blood) sample from this study will be securely stored at Nexus Clinical Research, 120 
Stavanger Drive, St. Johnʼs, Newfoundland for 5 years. These samples will not be used for 
further research outside of the scope of this project. The data guardian is Michael Wahl. 
Samples can be withdrawn by calling or emailing Michael Wahl using the contact 
information below.
Michael Wahl (709) 746-3355
 mikewahl@definitionsonline.com
Or you can talk to someone who is not involved with the study at all, but can 
advise you on your rights as a participant in a research study.  This person can 
be reached through:
Health Research Ethics Authority (HREA) at 709-777-6974 or  
Email: info@hrea.ca
After signing this consent you will be given a copy.
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Signature Page
Study title:
                                                                                                                                   
Name of principal investigator:                                                                                             
To be filled out and signed by the participant:
Please check as appropriate:
I have read the consent." " " " " " " " Yes { }  No { }
I have had the opportunity to ask questions/to discuss this study." " Yes { }  No { }
I have received satisfactory answers to all of my questions." " " Yes { }  No { }
I have received enough information about the study." " " " Yes { }  No { }
I have spoken to Mr. Wahl and he/she has answered my questions "" Yes { }  No { }
I understand that I am free to withdraw from the study"" " " Yes { }  No { }
• at any time
• without having to give a reason
I understand that it is my choice to be in the study and that I may not benefit. Yes { }  No { }
I agree to take part in this study.   " " " " " " Yes { }     No { }
___________________________________" " __________________________
Signature of participant " " " " " Date
____________________________________"           _________________________
Signature of witness (if applicable)" " " Date
To be signed by the investigator or person obtaining consent
I have explained this study to the best of my ability. I invited questions and gave answers. I 
believe that the participant fully understands what is involved in being in the study, any 
potential risks of the study and that he or she has freely chosen to be in the study.
" " " " " " " "         "" " "
Signature of investigator/person obtaining consent" " Date
Telephone number:    _________________________
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Appendix 11
Subject Recruitment Email
Good afternoon,
We would like to inform you about a study we will be conducting through Memorial 
University this fall. We are looking for candidates to participate in a study on the effects 
of weight loss on hormones who meet the following criteria:
- Male
- Age 35-55
- Have a BMI of 30-35
- No medically diagnosed illness including:
• high cholesterol
• high blood pressure
• diabetes
• kidney disease
• liver disease
To participate in this study you must be willing to engage in supervised exercise 
regularly and follow a structured eating plan. You will also be required to have weekly 
blood testing and complete series of physical fitness and body composition tests at the 
beginning and the end of the study. 
If you are interested in learning more please contact me at any time for specific 
information on what is involved in the study and it’s potential benefits and risks to 
subjects. You can reach me at: mikewahl@me.com or 746-3355.
Regards,
Mike Wahl
Primary Investigator
mikewahl@me.com
Appendix 12
Food Intake 
Questionnaire
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Appendix 13 
Dietary Assessment
Diet	Assessment	
Name:	___________________________________________________	
Email	Address:		____________________________________________	
Date:	_______________________		
Medical	Hx:		___________________________________________________________________________________	
_____________________________________________________________________________________________	
Medications:		__________________________________________________________________________________	
Ht:	______	 Wt:	_____	 BMI:	_____	 Age:		_______	 Wt	Hx:		_____________________________	
Activity	Level:	_____________________		(low/moderate/high)	
Occupation:	_____________________________________________________________	
Recreational	Activity:	_____________________________________________________	
Other:	_________________________________________________________________	
Possible	Barriers	to	PA:	____________________________________________________	
Energy	Level:			________(low/moderate/high)		Quality	of	Sleep:	____________	Hrs	Sleep	per	Night:	___________	
Stress	Level:	____________	(low/moderate/high)		____________________________________________________	
Bowel	Health:	_________________________________________________________________________________	
_____________________________________________________________________________________________	
Nutrition	Hx	
Allergies/Intolerances:	__________________________________________________________________________	
Meal	Frequency:	_______________________________________________________________________________	
Supplements:	__________________________________________________________________________________	
Fluid	Intake	(cups/day	and	types):	_________________________________________________________________	
Take-out/Fast	Food:	____________________________________________________________________________	
Alcohol:	______________________________________________________________________________________	
Perceptions	of	Barriers	to	Healthy	Eating:	
_____________________________________________________________________________________________ 
_____________________________________________________________________________________________	
Health	and	Wellness	Concerns:	
_____________________________________________________________________________________________	
_____________________________________________________________________________________________ 
_____________________________________________________________________________________________ 
_____________________________________________________________________________________________	
Diet	Hx:	
Breakfast	 Lunch	 Supper	
Time:	
Snack	 Snack	 Snack	
Energy:	
Goals	Set:	
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________	
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________	
_____________________________________________________________________________________________	
Notes:	
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________	
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________	
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________	
